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I 1015 131 Influenza Vaccination and Reduced Risk of 
Recurrent Association of Myocardial Infarction 
Zeba Barlas, Said Siadaty, Sameh Naguib, Morteza Naghavi, 
Ward Casscells. University of Texas Houston, School of Medicine, Houston, 
TX, USA 
Background: Numerous studies have suggested that microbial agents may 
promote atherosclerosis. A smaller body of research has suggested that 
acute respiratory infection may be a risk factor for myocardial infarction. 
We hypothesized that influenza vaccine might reduce the risk of recurrent 
myocardiai infarction (MI) in patients with documented coronary heart disease 
(CHD). 
Methods: A case-control study was performed on 233 CHD patients seen 
at Hermann Hospital during the influenza season of Ott 97-Mar 98. Patients 
who experienced new MI were included in the case group, and those who did 
not experience new Ml or unstable angina were placed in the control group. 
Data were collected by reviewing patients’ charts and through a subsequent 
telephone survey. 
Results: Adjusted for history of influenza vaccination in previous years, 
multivariate logistic regression revealed significant associations of current 
hypertension (odds ratio OR 4.96, p < O.OOl), hypercholesterolemia (OR 
4.08, p = 0.002) smoking (OR 3.75, p = 0.001) and influenza vaccine (OR 
0.33, p = 0.017) with risk of new Ml. Despite significant association in univari- 
ate analysis, multivitamin therapy and physical exercise were not associated 
with risk of reinfarction in multivariate analysis. 
Conclusions: In this study in patients with chronic coronary heart disease, 
vaccination against influenza was negatively associated with the develop- 
ment of new MI during the subsequent influenza season. However to address 
causal inference examination of prospective data sets will be needed. 
1015-I 32 Effects of Calorie Restriction on NF-r;B, 
Proinflammatory Cytokine, and Antioxidant 
Enzyme Gene Expression During Myocardial 
Reperfusion Injury 
Gregory L. Freeman, James F. Nelson, Bysani Chandrasekar. Medicine and 
Physiology, Univ. Texas HSC, San Antonio, Texas 78284, USA 
Background: The life prolonging effect of calorie restriction (CR) may be 
due to reduced damage from oxidative stress. 
Methods: To define if long-term CR alters the myocardial response to 
ischemia/repetfusion we studied male Fisher 344 rats (n = 32/group) fed ei- 
ther an ad libitum (AL) or restricted (40% less calories) diet. At 12 months of 
age the animals were anaesthetized, and subjected to thoracotomy followed 
by a 15 min LAD coronary artery occlusion. The hearts were reperfused (R) 
for 0, 0.25, 0.5, 1, 2, 3, and 6 hours (h) (n = Ugroup). DNA binding activity 
of NF-KB was measured by EMSA. mRNA (Northern) and protein (Western) 
levels of KB-responsive genes (interleukin [IL]-18, and tumor necrosis factor 
[TNF]-or, as well as antioxidant enzyme (catalase [CAT], Mn-superoxide dis- 
mutase [I&-SOD], and glutathione peroxidase [GSH-Px]) gene expression 
was defined in the ischemic zones. Sham-operated animals were used as 
controls. 
Results: A biphasic regulation in NF-KB (at 15 min and 3 h R) was 
observed in both groups, with I.&fold (p < 0.05) higher levels at 3 h R in the 
AL group. No detectable IL-lb or TNF-u mRNA was found in either group 
until 1 h R. While they rose and remained high until 3 h R in CR group, 
their levels were higher (at least 2.1-fold, p < 0.01) and remained elevated 
longer (until 6 h R) in the AL group. A similar trend was observed in their 
protein levels. CAT, Mn-SOD and GSH-Px mRNA were readily detected in 
both groups, but their expression was delayed and remained elevated longer 
in AL group. 
Conclusions: While the responses to ischemia/reperfusion were quick 
and short in CR animals, expression of proinflammatory cytokines and an- 
tioxidant enzyme gene expression was delayed and persisted for longer time 
in AL group. These results suggest that moderate dietary calorie restriction 
blunts postischemic inflammatory response. 
I 1015 133 C-260T Polymorphism in the Promoter of the 
CD14 Monocyte Receptor Gene is Associated 
With Myocardial Infarction in Japanese 
Population 
Kazunori Shimada, Yoshiro Watanabe, Hiroshi Mokuno, Yoshitaka Iwama, 
Hiroyuki Daida, Hiroshi Yamaguchi. Juntendo University Tokyo, Japan 
Background: The CD14 receptor plays an important role in the stimulation of 
monocyteimacrophages induced by the lipopolysaccharide. A recent study 
have suggested the association between C-260T polymorphism in the pro- 
moter of the CD14 monocyte receptor gene and myocardial infarction (MI). 
However, there is no report investigating the association this polymorphism 
with Ml in Japanese population. 
Methods: We assessed C-260T polymorphism of CD14 receptor gene 
by PCR RFLP method in 143 patients with angiographically defined coronary 
artery disease (CAD) and 56 age-sex matched healthy controls. CAD patients 
were divided into 83 Ml patients defined as clinical history of elevated enzyme 
and new appearance of abnormal Q wave and/or T wave inversion, and 60 
chronic CAD (CCAD) patients without prior MI. 
Results: Compared with control group, CCAD group showed no different 
frequency of TIT homozygotes. In contrast, Ml group had significantly higher 
frequency of TIT homozygotes than CCAD and control groups (Ml 33.7%, 
CCAD 18.3%, control 16.1%, Ml vs. CCAD P = 0.02, Ml vs. control P = 0.04, 
CCAD vs. control P = 0.74). 
Conclusion: These findings suggest that T/T homozygotes of CD14 
receptor gene may be one of the genetical risk factors for MI in Japanese 
population. It may be related to the plaque vulnerability induced by stimulation 
of monocyte/macrophages in acute coronary syndrome. 
/ 1015-l 34 1 Altered CD18 Leukocyte lntegrin Expression and 
Function in the Acute Coronary Syndromes 
Graham S. Hillis, William C. Dalsey, Carol A. Terregino, lerachmiel Daskal, 
Antoinette Mangione. Albert Einstein Medical Center, Philadelphia, 
Pennsylvania; Cooper Hospital/University Medical Center, Camden, New 
Jersey: USA 
Background: The adhesion of leukocytes to vascular endothelium is fun- 
damental in the pathophysiology of the acute coronary syndromes (ACS). 
One of the principal mediators of this process is the CD1 8/CD11 b leukocyte 
integrin. The aims of the current study were to assess the expression of this 
receptor in patients with an ACS and to assess whether these syndromes 
are associated with altered neutrophil CD18 function. 
Methods: Subjects included 22 patients with an ACS, 12 patients with 
angiographically proven coronary artery disease (CAD) but stable symptoms 
and 12 healthy controls. CD18 and CD11 b expression on neutrophils (PMN) 
and monocytes (Mra) was determined by flow cytometry and PMN CD18 
function by an in vitro adhesion assay. 
Results: Circulating MB from patients with an ACS express higher levels 
of CD11 b and CD1 8 than those from either healthy controls or patients with 
stable CAD (p < 0.05 for both chains and groups). PMN CD18 expression is 
highest among patients with an ACS, but in vitroadhesion is lower (9.5 f 2.1 
vs 15.3 f 2.1 in patients with stable CAD and 15.5 & 2.5 in healthy controls: 
p < 0.05). These changes are most pronounced in patients with concomitant 
myocardial necrosis (cardiac troponin I > 0.1 rig/ml) -who have the highest 
expression of CD18ICDII b but the lowest functional adhesion - but are not 
restricted to this subgroup. 
Conclusion: The ACS are associated with increased CD18EDll b ex- 
pression on MB. The expression of CD18 on peripheral PMN is also highest 
in the ACS, but in vitro adhesion is reduced. The explanation for these para- 
doxical changes remains unclear but they may indicate differences in the 
timing of functional changes and expression. Further work is required to as- 
sess whether changes in CD18 expression and/or function are of prognostic 
value in the ACS. 
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I 1016 101 Are Systemic Markers of Inflammation Associated With the Severity of Coronary Artery 
Disease in Patients With Angina Pectoris? 
Michael Cusack, Sola Odemuyiwa, Paul Collinson’, Michael Webb-Peploe, 
Cliff Bucknall, Michael Marber, Simon Redwood. Cardiothoracic Center, St. 
Thomas’ Hospita/; ‘Department of Clinical Chemistry, St. George’s Hospital, 
London, UK 
Background: Considerable interest surrounds the role of inflammation in the 
pathogenesis of atherosclerosis. Recent work has suggested that sensitive 
markers of inflammation may be used to predict the presence and estimate 
the severity of coronary artery disease among patients with angina pectoris. 
The aim of this study was to determine if plasma levels of Tumour Necro- 
sis Factor (TNF-ol), Interleukin-6 (IL-6) and C-reactive protein (CRP) were 
predictive in this respect among patients undergoing cardiac catheterization. 
Methods: We collected arterial blood samples from 38 patients (age 
60.1 f 1.8, 73% male) undergoing coronary angiography for investigation of 
angina, and 36 patients with Braunwald IIIB unstable angina (age 64.8 f 1.6, 
69% male). The levels of TNF-a, IL-6, and CRP were determined and related 
to the degree of angiographic coronary disease. Patients were stratified 
according to the number of coronary arteries diseased on angiography. 
Results: Inflammatory markers were elevated in patients with unstable 
angina as compared to stable angina and normal controls (see graph). In 
patients with stable angina, there was no relationship between the extent of 
coronary disease and the inflammatory markers. 
In contrast to previous reports, there was no difference seen in these 
markers in patients who were or were not on aspirin (IL-6: 2.7 f 0.9 vs. 4.6 
f 1 .O respectively, p = ns) or statin therapy (IL-6: 3.5 + 1 .I vs. 3.4 f 1 .O, p 
= ns). 
We conclude that: There does not appear to be any relationship between 
these inflammatory markers and the extent of coronary disease among pa- 
tients with stable angina. However, the levels of both IL-6 and CRP are 
significantly elevated in patients with unstable angina. Additionally, the lev- 
els of inflammatory markers among these patients were not modulated by 
treatment with either aspirin or lipid lowering therapy. 
I 1016 102 Stress SPECT Myocardial Pet-fusion Imaging for 
Predicting Future Cardiac Events in Diabetic 
Women: Confirmation of Gender and Myocardial 
lschemia Interaction 
Satyendra Giri, Leslee J. Shaw, D. Douglas Miller, Mark I. Travin, 
S. Barges-Neto, Rory Hachamovitch, Daniel S. Berman, David D. Waters, 
Gary V. Heller. Division of Cardiology Hartford Hospital Hartford, C7; USA 
Background: Coronary disease (CAD) mottality rates have not decreased in 
diabetic (DM) patients, and may even have increased in diabetic women. The 
aim of this study was to assess the value of risk stratification and the impact 
of gender on cardiac events in DM patients using stress SPECT myocardial 
perfusion imaging (MPI) in a large, prospective, multi-center, observational 
study. 
Methods: We followed 4,755 symptomatic patients from 5 centers under- 
going stress MPI for the 3-yr occurrence of cardiac events (death and Ml). 
Table 1 
Total 3yr MI free O-vessel, 1 -vessel, Z-vessel 3-vessel 
survival. % survival % % % % % 
Non-DM men 
DM men 
Non-DM women 
DM women 
97 
94.5 
99 
95.5 
94.2 
a9 
96 
90 
98 
98 
99 
97* 
96 
91 
97 
99* 
96 86 
91 70 
95 (>2 vessels) 
95* (>2 vessels~ 
Extent of ischemia in stress MPI results was classified as 0, 1, 2 or 3 vessel 
distribution. 
Results: Of 929 diabetic patients, DM women (n = 451; 49%) had sig- 
nificantly higher cardiac events than in 1635 non-DM women [36 (8.0%) vs 
53 (3.2%); p < O.Ol]. The Kaplan-Meier (KM) unadjusted 3-yr survival were 
lower for all diabetic patients, but once stratified by the number of ischemic 
vessel distribution, DM women had the worst survival (Table 1). 
In a risk-adjusted Cox model, DM women had worsened survival with 
increasing ischemia with a significant “gender x ischemia interaction” effect 
(p = 0.014). The multivariable cardiac death model (Table 2) rendered gender 
no longer independently predictive [Total model x2 = 65.61, p < O.OOi]. 
Table 2: Multivariable Predictors of DM Kaplan-Meier 3-yr Cardiac Survival 
E-Coefficient ic SE. 0 
Clinical risk 0.97 i 0.15 0.001 
Fixed defect 0.70 + 0.14 0.01 
lschemia extent 0.30 Y!7 0.14 0.04 
Female sender 0.32 5 0.32 0.32 
Conclusion: Risk stratification using stress MPI accurately predicts car- 
diac events in DM women. In conjunction with clinical risk assessment, stress 
MPI can improve risk stratification and neutralize the gender effect in diabetic 
patients. 
1016-l 03 A Simple, Easily Computed Clinical Score 
Provides Independent Prognostic Information to 
Rest Ejection Fraction in Patients With Coronary 
Artery Disease 
lndu G. Poornima, Todd D. Miller, David 0. Hodge, Timothy F. Christian, 
Raymond J. Gibbons. Mayo Foundation, Rochester, MN, USA 
Background: Left ventricular ejection fraction (EF) is a well-accepted sin- 
gle parameter to assess prognosis in patients with coronary artery disease 
(CAD). Although the prognostic value of clinical variables is recognized, they 
are generally more complex to consider. The purpose of this study was to 
determine if a previously published simple clinical score (CS) adds indepen- 
dent prognostic information to LVEF. The score is computed by assigning 1 
point for each variable- diabetes, insulin use, history of Ml, typical angina, 
male sex and each decade of age > 40. 
Methods: The study population consisted of 1244 patients who had 
undergone sestamibi perfusion imaging including first-pass LVEF. Follow-up 
was 94% complete at a mean of 1.9 f 0.4 years. The CS was significantly (p 
< 0.001) predictive of each of the endpoints of (1) cardiac death (2) cardiac 
death/nonfatal Ml (3) cardiac death/nonfatal Ml/late revascularization. Both 
LVEF and the CS were significant independent predictors of all 3 endpoints (p 
< 0.003). One year event-free survival for subgroups classified as high-risk 
or low-risk based on CS (>5 or ~5) and LVEF (~50% or ~50% were: 
LVEF Cardiac Death 
Nnnfatal MI 
250% 
<50% 
cs<5 
99% 
100% 
cs ? 5 
97% 
83% 
cs < 5 
97% 
98% 
cs>5 
95% 
80% 
Late Revascularization 
cs<5 csz5 
92% 88% 
91% 72% 
Conclusions: The CS, an easily derived index based on readily available 
clinical variables, adds independent prognostic information to LVEF. The 
outcome of patients with reduced LVEF and low CS is similar to those with 
normal LVEF. High-risk patients are those with both decreased LVEF and 
high CS. 
1 1016-l 04 1 Exercise-Induced Negative U Waves in 
Precordial Leads as a Marker of lschemic but 
Viable Myocardium in Patients With Recent 
Anterior Myocardial Infarction 
Kunihisa Miwa. Kansai Electric Power Hospital, Osaka, Japan 
Background: Exercise-induced electrocardiographic negative U waves in 
precordial leads (Negative U) is known to be an important sign of anterior 
myocardial ischemia. Detection of this finding may predict the presence of 
ischemic but viable myocardium in patients with recent anterior myocaidial 
infarction. 
Methods: Fifty-six patients with recent anterior myocardial infarction and 
total or subtotal occlusion of the left anterior descending coronary artery 
(LAD) were divided into 2 groups according to the presence (Group A, n = 
20) or absence (Group B, n = 36) of Negative U. The coronary arteriographic 
and exercise PO’ TI scintigraphic findings were compared between the groups. 
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Results: Good (index = 2 or 3) collateral circulation to the territory of LAD 
was observed more often (p < 0.05) in group A (100%) than in group B (61%). 
Patients wiih multivessel disease were more prevalent (p < 0.05) in group A 
(70%) than in group B (33%). The incidence of a significant partial redistribu- 
tion in the anteroseptal area in the sorTI images 4 hours after exercise was 
higher (p < 0.01) in group A (85%) than in group B (39%). In 29 patients with 
anterior Q-wave rnyocardial infarction and exercise-induced ST elevation in 
precordial leads, a significant s0’TI redistribution in the anteroseptal area was 
observed in 8 (80%) of IO patients of group A in contrast to only 4 (21%, p < 
0.05) of 19 in group B. In the diagnosis of the viability associated with 20’TI 
redistribution in the anteroseptal area by Negative U, the sensitivity was 67% 
and the specificity was 88% in these patients. 
Conclusion: Exercise-induced neg; 2 U waves in precordial leads are 
a convenient and specific marker for the presence of ischemic but viable 
myocardium in patients with recent anterior myocardial infarction and total or 
subtotal occlusion of LAD. 
1016-I 05 prevention of lschemic Preconditioning in 
Diabetic Patients With CAD Treated With 
Sulfonylureas 
Usman Khawaja, Richard Campeau, Alan Tenaglia, Frank Smart, 
Hector Ventura. Tulane University Medica/ Center, New Orleans, LA, USA 
Background: Diabetic patients have a high incidence of ischemic ST change 
and angina during coronary interventions. This study compares exercise in- 
duced ischemia between diabetic patients with known CA5 treated with 
sulfonyfureas and those patients treated with insulin and/or glucophage. The 
parameters measured were ECG changes, exercise capacity and scinti- 
graphic evidence of ischemia. 
Methods: Group I included 14 diabetic patients with CAD on insulin 
and/or glucophage and Group II included 14 diabetic patients with CA5 
on sulfonylureas. Easeline variables were equally matched in both groups 
including glycemic control. Exercise nuclear treadmill testing was performed 
using a Bruce protocol on all subjects with continuous blood pressure and 
ECG monitoring during the test. ECG and nuclear scans were interpreted 
following AHA/ACC guidelines by an independent observer. 
Results: N (%) ‘“p < 0.001 
ischemia by 
ECG 
(t) Nuclear 
SX" 
Chest pain Exercise 
cawcitv 
Group I 
Group II 
2114 (14%) 3114 (22%) 2114 (14%) 8.8 METS 
13/14 (92%)X 9/14 (64%)X 7/14 (50%)' 7.8 METS 
Conclusions: 1) Diabetic patients with CAD on sulfonylureas as com- 
pared to Insulin and/or Glucophage during treadmill stress test have signif- 
icant increase in angina, ECG changes ,for ischemia, positive nuclear scan 
for reversible ischemia and a decrease in exercise capacity. 
2) These findings may be due to the blockade of the K ATPase channel, 
which induces the prevention of ischemic preconditioning during exercise. 
/ 1016 106 Predicting Factors of Increased Cardiac Troponins in Chronic Hemodialysis Patients 
Marie C. Iliou, Christine Fumeron, Marie 0. Benoit, Philippe Tuppin, Victorio 
Menoyo Calonge, Nicole Moatti, Claude Buisson, Christian Jacquot. 
Broussais Hospital and AURA Hemodialysis Unit, Paris, France 
Background: Cardiac troponins (cTn) T and I, specific markers of myocardial 
injury, are frequently increased in hemodialysis (HD) patients (pts). Never- 
theiess, clinical relevance of these increased values remains unclear. The 
aim of this prospective study was to asses predicting factors of increased 
serum levels of cTn in HD pts. 
Methods: We include 258 chronic HD pts (I 08 males, mean age: 60 & 15 
years) without acute coronary symptoms. Patients were evaluated on clin- 
ical, echocardiographic and biochemical status and hemodialysis regimen. 
cTnT (Elecsys, Roche) and cTnl (Stratus, Dade-Berhing) were measured 
in pre-dialysis blood samples. Univariate and multivariate analyses were 
performed. 
Results: 18.6% of pts had cTnT > 0.1 ngiml and 12.4% had cTnl > 0.3 
rig/ml. Univariate analysis for each cTn were displayed on the table. 
In multivariate anafysis, age, diabetes and indexed left ventricular mass 
are significant independent factors related with cTnT > 0.1 rig/ml. Hyperlipi- 
demia and ischemic heart disease are independent factors for cTnl > 0.3 
ngiml. 
Conclusion: Increased serum levels of cardiac troponins were related 
to cardiovascular risk factors in chronic hemodialysis patients. Cardiac tro- 
ponins may be helpful markers for detection of myocardial injury in these 
patients, Prognostic value of cTnT and cTnl increases in HD patients needs 
to be evaluated. 
cTnT si- 0.1 rig/ml cTnl > 0.3 nglml 
n = 48 D " = 32 D 
Age (years) 
Diabetes (%) 
Hyperlipidemia (%) 
Anuria (%) 
Time on dialysis (years) 
lschemic heart disease (%) 
Indexed LV mass (g/m*) 
High flux membrane (%) 
CK-MB > 3 rig/ml (%) 
67h11 0.0001 56zti6 
37.5 0.001 25.0 
50.0 0.07 18.7 
93.8 0.07 96.9 
7.6 + 7.7 ns 7.3 * 7.9 
35.4 0.03 31.2 
125544 0.09 128144 
62.5 ns 81.3 
25.0 0.001 15.6 - 
0.09 
ns 
0.02 
0.06 
0.07 
0.05 
0.04 
0.09 
0.07 
1016-l 07 impact of Body Iron Status on Myocardiai 
Perfusion, Left Ventricular Function and 
Angiographic Morphology in Patients With 
Hypercholesterolemia 
Ayse Emre, M. Vefik Yazicioglu, Metin Giirsiirer, Mehmet Aksoy, 
Birsen Ersek, Siyami Ersek. Thoracic and Cardiovascular Surgery Center, 
isfanbul, Turkey 
Background: Previous studies have shown that the effects of iron stores 
on atherogenesis through promotion of free radical formation and low-den- 
sity lipoprotein (LDL) oxidation largely depend on the state of hypercholes- 
terolemia (HCL) in animal models. A synergistic association of serum ferritin 
and LDL-cholesterol with the risk of myocardial infarction and the presence 
of carotid artery disease has also been observed in humans. The aim of 
this study was to evaluate the relation of serum iron parameters to myocar- 
dial perfusion and functional abnormalities and to the extent and severity of 
angiographic coronary artery disease (CAD) in patients with HCL. 
Methods: 68 male patients (age 58 i 9 yrs) with hypercholesierolemia 
(total cholesterol > 200 mgidl) that had never been treated and 52 nor- 
mocholesterolemic male subjects of similar age scheduled for diagnostic 
coronary angiography were prospectively studied. All patients underwent 
coronary angiography because of suspected or known CAD. Blood samples 
for iron parameters (ferritin, total iron binding capacity (TIBC), iron) as well 
as basic hematologic parameters were taken on the day of angiography. All 
patients underwent exercise Tc-99m sestamibi gated SPECT imaging within 
10 days of the coronary angiography. Perfusion was graded on a 5-point 
scale (0 = normal, 4 = absent uptake) and wall motion on a 4-point scale (0 
= normal, 3 = absent) using the 20-segment model. 
Results: There was no statistical significance between pts with and with- 
out HCL in terms of clinical baseline characteristics. The differences in the 
iron parameters between the two groups were exclusively seen in ferritin 
values (158 & 82.8 vs 92.1 f 66.4 rig/ml, p = 0.02) which correlated with 
LDL-concentrations (r = 0.60, p x 0.01). Serum ferritin had significant cor- 
relation with perfusion index (r = 0.70, p < O.OOl), and to a lesser extent 
with wall motion index (r = 0.54; p < 0.05), whereas a relatively weak cor- 
relation was observed between TIBC and perfusion index (inversely) (r = 
-0.59, p < 0.01) in patients with HCL. Iron parameters were not associated 
with either perfusion or wall motion indices in the other group. Stepwise 
multiple regression analysis confirmed these results. Ferritin was a strong 
determinant of perfusion in patients with HCL only (p = 0.002). The severity 
of coronary stenosis was similar in the two groups, but the mean number of 
diseased vessels was significantly higher in patients with HCL (p = 0.04). Iron 
parameters were not related to the extent of CAD in either group, whereas 
serum ferritin levels z 200 ng/mL were associated with a higher incidence of 
complex lesions in patients with hypercholesterolemia (p < 0.05). 
Conclusion: Our data suggest that increased iron stores, as reflected 
by serum ferritin concentrations, are closely associated with a greater extent 
and severity of perfusion and functional abnormalities and angiographically 
complex lesions in patients with HCL. 
i-I 1016 108 Effects of Phosphodiesterase-5 Inhibition on Myocardial lschemia in Patients With Chronic 
Stable Angina in Therapy With Beta-Blockers 
Francesco Pelliccia, Filippo Leonardo, Paolo Pagnotta, Roberto Patrizi, 
Elena Cerquetani, Sergio L. Chierchia, Giuseppe M.C. Rosano. lsfiluto H 
San Raffaele, Roma-Mano, Italy 
Background: Phosphodiesterase-5 inhibition has been suggested to be po- 
tentially hazardous and to increase the risk of cardiac events in pts with 
coronary artery disease (CAD). To verify whether phosphodiesterase 5 inhi- 
bition with Sildenafil (S) affects exercise-induced myocardial ischemia in pts 
on beta-blockers we studied 14 pts with known CAD and positive exercise 
test (ET) in a randomized, double-blinded, placebo-controlled study. 
Methods: All pts underwent off-therapy a baseline ET and were then 
started on Atenolol (A, 100 mg o.d.). After a run-in phase of 2 weeks, pts 
underwent a second ET and were randomized to receive either S (50 mg) 
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or Placebo (P) given in a random order in 2 different days, 2 days apart. ET 
was repeated 2 hrs after the administration of S or P. 
Results: All pts had >l mm ST4 while off-drug. Eight pts had a negative 
exercise test response after A, which was unaltered by the adjunct of either 
S or P. In the remainders, A significantly prolonged time to 1 mm STJ 
and exercise time. S and P did not reverse the beneficial effect of A upon 
exercise-induced myocardial ischemia. 
Baseline A A+S A+P 
1 mm ST& 
HR @pm) 123521 115f12 116zt 10 114116 
SBP (mm Hg) 178124 182*22 178zt24 184zk28 
Time (set) 412145 584f42 592f35 579i52 
Not Attained 8/14 (57%) 8/14 (57%) 8/14(57%) 
Peak Exercise 
HR @pm) 131 524 13Ozkl8 132f16 128122 
SBP (mm Hg) 186*26 184zk32 182128 186126 
Time (set) 523*54 754zk42 762f53 74a*39 
Conclusion: Phosphodiesterase-5 inhibition with Scan be safely admin- 
istered in pts with chronic stable angina whose symptoms and exercise test 
response are well controlled by beta-blocker therapy. 
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( 1017-I 27 1 Coronary Bypass Surgery in Women: A Long 
Term Comparative Study of Quality of Life 
Following Bilateral Internal Mammary Artery 
Grafting in Men and Women 
Paul A. Kurlansky, Ernest A. Traad, David L. Galbut, Melinda Zucker, 
George Ebra. Miami Heart Research Institute, Miami Beach, Florida, USA 
Background: Coronary bypass surgery carries a higher operative mortality 
and less favorable long-term clinical benefit for women than it does for men. 
The impact of arterial revascularization on long-term results, including Quality 
of Life (QOL) in women, compared with men, has not been clearly defined. 
Methods: A retrospective analysis was performed comparing 261 con- 
secutive women patients from a single surgical practice receiving bilateral 
internal mammary artery (BIMA) and supplemental vein grafts between Jan- 
uary 1972 and October 1994 with a computer-matched cohort of 261 men 
undergoing BIMA surgery during the same time period. Univariate analysis 
confirmed the homogeneity of the two groups based on multiple preoperative 
variables. The SF-36 QOL assessment was completed for all patients at 
follow-up, which ranged from 1 month to 25 years, with a mean followlup of 
9.1 years for women, and 8.6 years for men. 
Results: There was no significant difference in operative mortality, nor 
in the incidence of any of 10 post-operative complications evaluated. The 
actuarial survival at 15 years was 53.7% f 4.8% for women and 50.9% 
i 5.6% for men (p = 0.21). At follow-up, 97% of women and 96% of men 
were free of angina and in CCS Class I. The need for reoperation (1.8% vs. 
1.9%) and PTCA (4.8% vs. 3.2%) was comparable in the two groups. Long 
term event-free survival was significantly better for men than for women (p = 
0.02), with a higher rate of Ml (1.8% vs. 0.6%) in women than in men. QOL as 
measured by the SF-36 was compared to the general population corrected 
for age and gender. Both men and women scored as well or better than 
the general population in those parameters defining the mental component 
of health status. However, with regard to physical health status, vitality and 
general health, men scored comparable to the general population, whereas 
women scored significantly lower (p < 0.05). 
Conclusions: Men and women undergoing coronary revascularization 
using arterial conduits experience comparable perioperative outcomes and 
excellent long term results. However, men appear to enjoy a better long-term 
event-free survival and quality of life as measured by the SF-36 than do 
women. 
1 1017-l 28 1 Influence of Preoperative Platelet Inhibitors and 
Low-Molecular-Weight Heparin on Hemostasis 
Following Coronary Bypass Surgery 
Marc R. Moon, Thoralf M. Sundt, Marci S. Bailey, Nikolaos J. Skubas, 
Hendrick B. Barner, Charles W. Hogue, Michael K. Pasque, William A. Gay, 
George J. Despotis. Washington UniversiM St. Louis, Missouri, USA 
Background: Recently introduced platelet inhibitors and low-molecular- 
weight heparin (LMWH) have a positive influence on post-stenting patency 
rates and in the treatment of acute MI. However, their effect on postopera- 
tive hemostasis following coronary artery bypass grafting (CABG) remains 
unclear. 
Methods: During the past 18 months, 56 patients received one of the 
following antithrombotic agents prior to CABG: clopidegrol (9), eptifibatide 
(3) abciximab (3) tirofiban (lo), LMWH (31). These patients were compared 
to a control group of 55 patients undergoing CABG during the same time 
period who did not receive one of these agents. 
Results: Age, preoperative platelet count, prothrombin time, cardiopul- 
monary bypass and cross-clamp times were similar between the groups 
(ANOVA, Bonferroni). While postoperative mediastinal drainage did not differ 
at 12 hours (629 + 626 vs. 608 + 597, p = 0.85) the antithrombotic group 
continued to drain for an extended postoperative period (total: 1596 + 2012, 
p < 0.01 vs. control). A greater number of red cell (5.4 + 6.0 vs. 2.0 + 2.2, p 
< 0.001) and platelet (1.1 + 1.6 vs. 0.4 + 0.7, p = 0.003) transfusions were 
required in the antithrombotic group. These outcome differences remained 
significant when factoring in other potentially confounding variables (preop 
heparin, warfarin, aspirin, reoperative surgery, etc.) as covariates in multivari- 
ate statistical methods. While none of.the control patients were reexplored 
for bleeding, five (9%) patients in the antithrombotic group required reexplo- 
ration (p = 0.06). Bleeding was attributed to coagulopathy in all patients, as 
none had a surgical source of bleeding identified at reoperation. 
Conclusion: Preoperative administration of antithrombotic agents was 
associated with increased transfusion requirements and reexploration for 
bleeding, suggesting impaired hemostasis following coronary bypass surgery. 
1017-129 Preliminary Results from the Patency Qutcomes 
and Economics of MIDCAB (POEMI Trial: 
Minimally InvasiveDirect Coronary 
Revascularization Versus Conventional Bypass 
Surgery 
Roxana Mehran, Valvanur Subramanian, Michael Mack, Paul J. Corso, 
Albert Pfister, Mercedes K.C. Dullum, lnterjiit S. Gill, E. Charles Douville, 
Trey Brunsting, Robert Matheny, James Magovern, Alexandra J. Lansky, 
Martin B. Leon. For fhe POEM Investigators; Cardiovascular Research 
Foundation, Washington Hospital Center, Washington, DC, USA 
Background: Minimally invasive direct coronary artery bypass (MIDCAB) 
is a new technique in which the LIMA is anastomosed under direct visu- 
alization to the LAD on a beating heart (without cardiopulmonary bypass). 
The prospective multicenter POEM trial was designed to assess the angio- 
graphic patency, clinical outcomes, and economics of MIDCAB compared to 
conventional CABG. 
Methods: In 9 experienced centers in the USA and Canada, parallel 
consecutive case registries including patients treated with either MIDCAB 
or conventional CABG were evaluated for in-hospital clinical events and 
6-month angiographic patency of the LIMA-LAD anastomosis (defined as 
<75% stenosis with TIMI- flow in the LIMA and the distal LAD). 
Results: Thus far, 162 MIDCAB and 149 conventional CABG patients 
have been enrolled. Baseline patient, characteristics were well matched. 
CABG MIDCAB D 
In-hospital outcomes 
Atrial fibrillation, % 
Death/Ml/revascularization, % 
Neurological events, % 
Bleeding requiring transfusion, % 
lime to extubation, h 
Post-operative length of stay, days 
B-month cumulative outcomes 
Death/MI/revascularization, % 
23.7 
0.8/0.8/O 
4.6 
20.6 
12fj3 
8.3i 11.8 
2.3/0.8/O 
15.1 0.04 
o/o/o NS 
1.3 0.1 
4.6 0.001 
1*3 0.001 
4.5 * 4.3 0.001 
2.6/0.7/2.6 NS 
Angiographic follow-up at 6-months has indicated the following initial 
results: MIDCAB 98.4% patency (60 of 61) CABG 96.3% patency (26 of 27), 
p=NS. 
Conclusion: Preliminary findings from the POEM trial suggest that post- 
operative complications and resource consumption are reduced with MID- 
CAB versus conventional CABG. Final clinical and angiographic results will 
be presented. 
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pitciq eating Heart Versus Conventional Coronary 
Artery Bypass Grafting in Octogenarians: Early 
Clinicai Outcomes 
Sotiris C. Stamou, Albert J. Pfister, Mercedes K.C. Dulium, Steven 
W. Boyce, Ammar S. Bafi, George Dangas, Peter C. Hill. Jorge M. Garcia, 
Paul J. Corso. Washington Hospital Center, Washington, DC, USA 
Background: Octogenarians have a higher morbidity and mortality (g-16%) 
after coronary artery bypass grafting (CABG) with cardiopulmonary bypass 
(On-pump), compared with younger age groups. It is unknown, however 
whether CABG wifhout cardiopulmonary bypass (Off-pump) may benefit 
octogenarians. 
Methods: We compared the peri-operative outcome and hospital stay in 
patients older than 80 years who underwent On-pump CABG (n = 83, 53% 
males) versus Off-pump CABG (n = 71, 51% males) from January 1987 
to July 1999. Only patients who received one or two grafts were included. 
The two groups were similar with respect to baseline characteristics and risk 
stratification; Parsonnet score was 27 & 9 for On-pump versus 25 i 8 for 
Off-pump patients (p = NS). 
Results: Comparative analysis is summarized in the table: 
On-bum0 Off-oumo !J 
PRBC during surgery, units 2*1 0.4 i 0.2 <O.OOl 
Prolonged ventilation 10 (12) l(1) 0.01 
Postoperative inotropes 39 (47) 15(21) <O.OOi 
Postoperative IABP 10 (12) 3 (4) NS 
In!ensive care unit staji 2*2 1*1 0.009 
Postoperative shy, (days) 9*3 6f2 0.01 
In-hospital mortality 7 (8) 3 (4) NS 
Values are expressed as as n (%) or mean i SD. PRBC = Packed red blood cell; IABP 
= Intra-aoliic ballan pump. 
Conclusion: Off-pump beating heart CABG can be safely performed 
in octogenarians that only need one or two gratis with a lower operative 
morbidity and an abbreviated hospital stay in comparison to conventional 
On-pump CABG. 
/ 1017-I 351 comparison of Saphenous Vein and lnternal 
summary Artery Graft Patency in Patients With 
Heparin-induced Thrombocytopenia 
Jayson C. Liu, Bruce E. Lewis, Lowell H. Steen, Eric D. Grassman, 
Ferdinand Leya, Laura Wrona, Eradford Blakeman, Mamdouh Bakhos. 
Loyola Universify Medica/ Center, Maywood, ///hois, USA 
Background: Patients with hcparin-induced thrombocytopenia (HIT) have 
demonstrated a 37% to 53% incidence of arterial and venous thrombosis. 
This study assesses graft patency of post-coronary artery bypass grafting 
(CABG) patients with HIT. 
Methods: Post-CABG patients who developed a clinical syndrome of HIT 
and myocardial ischemia (based on clinical signs, cardiac enzyme release 
and/or EKG changes) underwent coronary angiography. The diagnosis of 
HIT was based on thrombacytopenia with a positive heparin-induced platelet 
antibody test or serotonin release assay, or thrombocytopenia with evidence 
of vascular thrombosis. Patients without HIT who had coronary angiogra- 
phy performed for myocardial ischemia within six months post-CABG were 
chosen as controls. 
Results: ‘IS patients, 10 mafes and 8 females, with a mean age of 64 
years (range, 43-74) comprised the study group. 18 patients, 11 males and 
7 females, with a mean age of 60 years (range, 45-73) comprised the control 
group. A total of 47 SVGs and 14 left internal mammary artery (LIMA) grafts 
were present in the study group, while 35 SVGs and 17 internal mammary (15 
LlMAs and two right internal mammary arteries) bypass grafts were present 
in the control group. The occurrence of SVG occlusion and thrombosis was 
significan?ly higher in the study patients than in the control patients (68% vs. 
20%, p < 0.001). The incidence of IMA conduit occlusion/stenosis, however, 
was not significantly different (7% vs. 12%. p = 1.0). Within the study group, 
the incidence of SVG occlusion was significantly higher than that of the LIMAs 
(68% vs. 7%; p < 0,OOl). The average length of stay was also significantly 
higher in the HIT group (28.7 days vs. 13.6 days, p= 0.002). 
Conclusion: Patients with post-CABG HIT have vety high SVG occlusion 
rates. Internal mammary artery conduits offer higher patency rates than 
saphenous veins in patients with HIT. Therefore patients with active HIT 
who require urgent CABG should be considered for mammary artery conduit 
implantation whenever possible. 
I 1017 136 Pharmacologic Electrical Arrest With Intermittent Pacing Facilitates Off-Pump Bypass 
Surgery 
Marc P. Sakwa, Michael McCue, Jeff M. Altshuler, Steven 5. Timmis, 
Francis G. Duhaylongsod, Gregory M. Ayers, James A. Goldstein. William 
Beaumont Hospital, Royal Oak, Ml, USA 
Background: A motionless cardiac field facilitates off-pump coronary artery 
bypass (OPCABG). Mechanical stabilizers reduce but don’t eliminate motion. 
We hypothesized that pharmacologically-induced electrical arrest with pacing 
on-demand would provide a transient motionless surgical field to facilitate 
coronary anastomosis. 
Methods: A B-blocker-Cholinergic drug combination (CSS-9587, Transar- 
rest system, Corvascular, Inc, Palo Alto, CA, USA) was infused into the 
right coronary artey (RCA) in-patients undergoing routine on-pump bypass 
surgery Drugs were infused after completion of all anastomoses in 9 pts un- 
dergoing CABG with cardioplegic arrest. To perform surgical anastomoses 
using this technique, drugs were administered to 7 others in whom car- 
diopulmonary bypass was initiated without cross clamp or cardioplegia and 
in :O pts as the primary stabilization technique for OPCAB. A drug infusion 
catheter was introduced through an RCA guiding catheter and positioned 
just proximal to the AV nodal artery. Transarrest TM drugs were given until 
electrical arrest was achieved or a maximal dosage reached. 
Results: Complete electrical silence (asystole) was achieved in 23/26 
pts. Hearts were easily paced in the AV mode. Multiple 3-5 second pacing 
interruptions were performed, producing complete absence of cardiac motion 
on demand. In 2 pts in whom electrical arrest was not achieved, the AV 
nodal artery arose from the left coronary. In another, catheter induced RCA 
spasm limited drug delivery. In the 17 pts who underwent CABG using this 
technique, intraoperative angiography confirmed 100% graft patency. After 
drug termination and administration of atropine, sinus rhythm was restored 
within 60 sets. All pts tolerated the drugs without adverse effects and with 
preserved ventricular function. 
Conclusions: These findings demonstrate that pharmacologically in- 
duced electrical arrest with pacemaker controlled rhythm is feasible and 
safe. Brief interruptions of pacing produce a motionless surgical field to 
facilitate OPCAB. which allows for precise anastomotic suturing. 
1017-l 37 The Influence of Surgical Techniques on the 
Clinical Outcome in Coronarv Artery Bypass 
Grafting - A Prospective Randomized - 
Comparison Between the Conventionell and 
Three Different Less Invasive Techniques 
Vassilios Gulielmos’ , Markus Elier’ , Hans-Martin Dill’, Sebastian Thiele’ : 
Stefan Spitzera, Klaus Matschke’ , Stephan Schijller’ ‘Cardiovascular 
Institute, University of Dresden; ‘Institute for Cardiovascular Research, 
D-01307 Dresden, Germany 
Objective: Less invasive surgical techniques for the treatment of singie-ves- 
sel coronary artery disease (CAD) are becoming popular with good clinical 
results, however the benefit of the small surgical access and the absence of 
cardiopulmonary bypass (CPB) still remains unclear. 
Methods: In a prospective randomized clinical trial patients referred for 
surgery due to single vessel CAD were treated using four different techniques. 
Group 1: median sternotomy with CPB in IO patients; Group 2: median 
sternotomy and off-pump in IO patients: Group 3: minithoracotomy with 
CPB in IO patients; Group 4: minithoracotomy and off-pump in 10 patients. 
Demographical data and underlying diseases of the pts were comparable. 
Perioperative data, clinical outcome and 3 month coronary angiogram were 
monitored. 
Results: No death or major complications occurred. All patients received 
a LIMA-bypass to LAD. Three month coronary angiogram revealed patency 
of all gratis. Perioperative data are listed in the table. 
1 itl=lO~ Zitl=lO) 3(n=10) 4ln=101 
operative time (min) 97+14 983z 18 156&7 132+25 
Troponin T (pgiml) 24 h pa. 97+57 38+23 71 i51 12123 
bleeding volume (ml) 937 * 597 959f258 564zt173 7151472 
atrial fibrillation 0 1 2 1 
ICU-stay (h) 22 i 6.4 25 i 8.3 20 * 7.0 24f14 
hospitalisation (d) 6.4 zt 0.8 6.4 zk 0.9 6.3 i 0.8 6.Oh 1.0 
Conclution: Clinical outcome was excellent in all techniques. Small chest 
incision results in fess blood loss and superior cosmesis. Neigther the use of 
CPB nor the surgicai access could be identified as a risk faktor. 
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I101 7-138 1 Transmyocardial Laser Revascularization 
(TMLR): Preservation of Global and Diastolic 
Function in Chronic lschemia 
Olaf M. Muehling, Norben M. Wilke, Yimei Huang, Sam Wann, Ying Wang, 
Michael Jerosch-Herold, Mary M. Cayton, Mahmood M. Mirhoseini. Center 
of Magnetic Resonance Research, Deparfment of Radiology, University of 
Minnesota; Heart and Lung Institute Wisconsin and St. Luke’s Hospital, 
Milwaukee, WI, USA 
Background: TMLR improves symptoms in patients with refractory angina 
and endstage coronary artery disease. It is controversial if the relief in angina 
correlates with functional improvement. Cine MRI may be suggested as the 
most quantitative method to follow-up left ventricular function after TMLR. 
Methods: lschemia was induced in 12 pigs (20-25 kg) by catheter-guided 
hollow bead embolization of the LCx. The animals were randomized to treat- 
ment (T) or control group (C) one week after induction of ischemia. With a 
high-powered (850 W) Cop-laser 30 * 5 channels were made over the pos- 
tero-lateral aspect of the heart in 6 of the 12 animals. Follow-up tine magnetic 
resonance imaging (CMR) was performed before (n = 12) at 3 weeks (n = 
8), and 8 weeks (n = 12) after treatment. Left ventricular function was de- 
termined by stroke volume index (SV-Index, m//kg) and cardiac output index 
(CO-Index, m//min/kg)). Diastolic function was assessed by normalized early 
peak filling rate (NPFR, I/s). Microsphere studies were obtained to measure 
changes in regional myocardial blood flow (MBF, m//min/s)). TTC-staining 
was performed to determine infarct size. 
Results: 3 weeks after surgery CO- and SV-index decreased in T (119 f 
23 vs. 84 f 9, p < 0.05; 1.4 f 0.3 vs. 1.0 f 8.1, p < 0.02) then returned 
to near normal values after 8 weeks (117 f IO, 1.3 & 0.2). In C these 
parameters decreased throughout the experiment (172 f 34 vs. 79 * 18 (at 
8 weeks), p < 0.01; 1.4 f 0.3 vs. 1.0 f 0.2 (at 8 weeks), p < 0.02). There 
was a significant difference between C and T at 8 weeks (CO-Index: 79 f 
18 vs. 117 & IO, p < 0.01; SV-Index: 1.0 f 0.1 vs. 1.3 i 0.2, p < 0.02). 
NPFR decreased slightly in T and was not different from baseline at 8 weeks; 
whereas it decreased significant in C (9.3 f 2.3 vs. 6.2 * 0.8, p < 0.01). MBF 
was increased in the ischemic zone of T vs. C (0.6 & 0.2 vs. 0.2 f 0.1, p < 
0.04). TTC-stains revealed a significant decrease in infarct size in C (6.6% 
f 1.6 vs. 3.6% zk 1.5, p < 0.01). 
Conclusion: TMLR prevents a decline in diastolic and overall left ventric- 
ular function secondary to a decreased infarct size and improved perfusion. 
Quantitative non-invasive CMR shows for the first time a global functional 
benefit after TMLR. 
1017-l 39 A Minimally Invasive Coronary Artery Bypass 
Approach Improves Hospital Mortality and 
Length of Stay in Re-Do Coronary Artery Bypass 
Patients 
Mark W. Connolly, V.A. Subramanian, Nilesh Patel, Rita Considine, 
Karen Castello, John C. McCabe, Mark H. Genovesi, Laurence N. Spier 
Lenox Hi// Hospita/, New York, New York, USA 
Background: Since full sternotomy, standard redo CABG (SCAB) carries an 
increased operative risk and long-term results with catheter intervention of 
stenotic vein grafts are unsatisfactory, a sternotomy-sparing, multi-incision 
minimally invasive coronary artery bypass (MIDCAB) approach to redo CABG 
patients began in 1996 with the advent of mechanical stabilization. 
Methods/Results: In a redo CABG retrospective analysis, 125 MIDCAB 
patients (1996-l 999) were compared to 348 SCAB patients (1992-l 999). 
The MIDCAB group had a higher incidence of all risk factors below. 
MIDCAB 11251 SCAB (3481 P Values 
Female 
HTN 
CHF 
COPD 
Calcified Aorta 
PTCA 
Recent MI 
>l Reap 
EF < 40% 
I  I  I  
33 (27%) 52 (15%) 0.006 
85 (68%) 186 (53%) 0.006 
54 (43%) 81 (23%) 0.0001 
21 (17%) 21 (6%) 0.0006 
17 (13%) 15 (4%) 0.0008 
45 (58%) 116 (33%) 0.012 
37 (29%) 52 (15%) 0.001 
25 (32%) 21 (6%) 0.0001 
60 (50%) 121 (34%) 0.003 
Incisional exposures in the MIDCAB group were: left anterior thoracotomy 
(41), left anterolateral thoracotomy (5), lateral thoracotomy (39) transabdom- 
inal (23), subxyphoid (ii), combination (6). Inflow conduits were LIMA, RIMA, 
GEA, SVG and/or radial artery as a composite, or proximal to left subclavian 
artery, thoracodorsal artery or descending aorta. The number of grafts per- 
formed per patient was higher in the SCAB group than the MIDCAB group 
(2.9 f 1.1 vs 1.29 f 0.7, p < 0.0001). 
The MIDCAB group demonstrated a significantly decreased hospital mor- 
tality than the SCAB group [I .2% (2/125 vs. 9.2% (32/348), p = 0.0638]. The 
incidence of periop renal failure [61 (17%) vs 8 (6%) p = 0.0041 and sepsis 
[20 (6%) vs 1 (I%), p = 0.0207] was significantly higher for SCABS. Length 
of stay was also significantly less in the MIDCABs (6.3 days & 7.3 vs 13.4 
days f 21 .I, p < 0.0001). By multiple regression analysis, diabetes mellitus, 
CHF, and SCAB were significant contributors to hospital mortality. 
Conclusion: Even with a higher preop risk profile, MIDCAB technique 
in redo CABG patients achieved a similar hospital mortality rate as primary 
CABG. Larger clinical studies are warranted to determine potential long-term 
benefits, and whether MIDCAB may be an alternative for graft restenosis in 
symptomatic 
1 1017-140 1 Predictors of Outcome After Transmyocardial 
Revascularization 
Mukesh Garg, Mike Coen, John Spettus. For the CO, TMR Investigators; 
Mid America Heart Institute/UMKC, Kansas City: Missouri, USA 
Background: Transmyocardial ravascularization (TMR) is superior to Medi- 
cal Management in improving health status among patients with symptomatic, 
nonrevascularizable coronary artery disease (CAD). Among patients receiv- 
ing TMR, it is not yet known which patients benefit the most from the proce- 
dure. 
Methods: 93 patients were randomized to TMR in a multicenter ran- 
domized trial of TMR vs maximum medical therapy. They were followed 
every three months for a year with well validated health status measures 
(the Seattle Angina Questionnaire and the Short Form 36). We integrated 
the area under the health status curves over time and divided these by the 
best (or worst) possible health status that could have been achieved. This 
generates the ‘benefit statistic’ (the % of perfect benefit attained, range = 
-100% to +I 00%). Multivariate analyses of baseline characteristics were 
performed to define which clinical characteristics were associated with the 
greatest treatment benefits. Potential variables included congestive heart 
failure (CHF), ejection fraction (EF), baseline health status scores, previous 
MI, previous PTCA, previous CABG, and smoking history. Dependent vari- 
ables were the benefits attained in control of angina frequency and quality of 
life (QOL). 
Results: In multivariate modeling, patients with a prior CABG attained 
29% less benefit in terms of controlling their angina than patients without a 
prior CABG (P = 0.048). Patients with a prior Ml received 20% less benefit (p 
= 0.02) and 7% more benefit (p = 0.003) for each IO points on the baseline 
mental component scale in terms of benefit in their quality of life from TMR. 
Conclusion: Patients with prior CABG attained less symptom benefit 
from TMR than those without prior CABG. Patients without a prior Ml and 
those with better mental status at baseline attained more quality of life benefit 
from TMR. These parameters may improve patient selection for TMR. 
I 1017 141 Determinants of Cognitive Functioning Before and After Coronary Artery Bypass Graft 
Gilles H. Dupuis, Elaine Kennedy, Ruth Lindquist, Franca B. Barton, 
Michael L. Terrin, Byron J. Hoogwerf, Susan M. Czajkowski, Alan Herd. 
Montreal Heart Institute, Montreal, Quebec, Canada; Minneapolis Heart 
Institute, Minneapolis, Minnesota; Maryland Medical Research Institute, 
Baltimore, Mary/and; National Heart, Lung and Blood Institute, Bethesda, 
Maryland; Baylor College of Medicine, Houston, Texas, USA 
Background: The prospective multicenter Post CABG Biobehavioral Study 
examined the effect of CABG on cognitive functioning before and 6 months 
after surgery, considering gender, age (< or 265) and education (< or 2 high 
school). 
Methods: Three hundred and sixty-five patients (pts) (M: 242, W: 123) 
were evaluated before CABG, 549 (M: 333, W:216) at 6 months, and 296 
(M: 197, W: 99) at both times. Assessment included: verbal naming ability, 
(Boston Naming Test), verbal fluency (Controlled Word Association), atten- 
tion/concentration (WAIS-R digit), logical verbal memory (Weschler Memory 
Scale, A&B stories), visual memory (Wechsler Visual Reproduction Test) and 
memory of faces (facial recognition: Benton). 
Results: Men’s baseline scores were better than women’s for logical 
verbal memory story B (p < 0.001) and visual memory (p = 0.007). Younger 
pts performed better (p < 0.001) than older pts on: attention/concentration, 
logical verbal memory (A&B), and visual memory. More educated (2 high 
school) pts’ scores were better than less educated pts’ ones on each test (p 
< 0.001). Adjusting for medical and demographic variables showed that high 
school education may account for many of the age and gender differences 
found. Results for the 6-month evaluation do not differ markedly from baseline 
findings. There were no differences in change scores (6 month-baseline) for 
each test, between men and women, age groups and education groups. No 
decline was observed for verbal naming ability, visual memory and memory of 
faces. Performance improved (p < 0.001) for attention/concentration. verbal 
fluency and logical verbal memory (A&B). 
JACC Febmary 2000 
Conclusion: Gender and age did not seem to be major determinants 
of cognitive functioning before surgery and 6 months after. No decline was 
observed in cognitive function test scores from baseline to follow-up and 
improvement was consistent across gender, age and education groups. 
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/ 1037 101 Tolerance and Safety of Cangrelor, a Novel Purin Receptor Antagonist, Used as a Platelet 
Aggregation Inhibitor in the Acute Coronary 
Syndrome 
Filip Jacobsson’, Mikael Dellborg’, Eva Swahn’, Lars Wallentin3. 
’ Sahlgrenska University Hospita//&tra, Giiteborg; ‘University Hospital, 
Linkoping; 3Akademiska Hospital, Uppsala, Sweden 
Cangrelor is a new agent which inhibits the ADP induced platelet aggregation 
by antagonism of the P 2T-receptor. The KISS study is the first double-blind, 
randomised, placebo-controlled study in which this agent was given to pa- 
tients with unstable angina/non Q wave MI. 
Method: Patients with angina pectoris or nonQwave myocardial infarction 
from 8 centres in Sweden were randomised to 72 hours infusion of cangrelor 
or placebo as an adjunctive therapy to aspirin and low molecular weight hep- 
arin. Other treatment was at the discretion of the local investigator. The aim of 
the study was to assess the safety, tolerability and the plasma concentrations 
at steady state. The follow-up time was 30 days. 
Results: 94 patients were randomised and 91 received treatment. 45 
were randomised to cangrelor, 46 to placebo. The plasma concentration 
of cangreior was as predicted, there were no signs of accumulation and 
the inter-individual variability in clearance was low. 4 patients receiving can- 
grelor discontinued treatment due to minor bleedings and 5 patients receiving 
placebo discontinued treatment due to minor bleeding or deterioration of dis- 
ease. No serious bleeding events were seen during treatment. The incidence 
of minor bleeding events was slightly higher in patients receiving cangrelor. 
38% vs. 26%. The drug was well tolerated hemodynamically and there were 
no significant changes in other laboratory findings between the to groups. 
Conclusion: Cangrelor is a novel Purin 2T-receptor blocker which inhibits 
the ADP induced platelet aggregation. As an adjunctive therapy to aspirin 
and low molecular heparin in the acute coronary syndrome it seems safe and 
well tolerated. Larger trials of this compound are motivated. 
/ 1037 102 Role of Oral Blockade of Platelet Glycoprotein 
llblllla on Neutrophil-Platelet Interactions in 
Patients With Acute Coronary Syndromes 
Carlos V. Serrano Jr.‘, Margareth Venturinelli’ , Jose A.F. Ramires’ , Chris 
P. Cannon*, Jose Carios Nicolau’ ‘Heari lnstifufe (/n&x), Univ. of.520 
Pauio Medical School, S&o Paula, Brazii; 2Brigham and Women’s Hospital 
and Harvard Medical School, Boston, MA, USA 
Background: Oral orbofiban prevents platelet (PL) aggregation related to 
plaque rupture as it blocks PL glycoprotein (GP) Ilb/llla. However, it is un- 
known if orbofiban affects neutrophil (PMN)-PL interactions in patients (pts) 
with acute coronary syndrome (ACS). 
Methods: We characterized the effects of orbofiban on PMN superoxide 
production and adhesion molecule expression of PMNs (CD18, CDllb and 
L-selectin) and PL (P-selectin and GP Ilb/llla) in ACS pts. Venous blood 
samples were collected at baseline and on hospital days 5-7. We compared 
orbofiban (100 mg/day)-treated with placebo-treated pts; all pts (myocardial 
infarction, n = 20; unstable angina, n = 18) were managed noninvasively. 
Results: See Figure. Days 5-7 vs Basal: p < *0.005; t0.03; Orbofiban 
vs Placebo: $p < 0.005. 
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Conclusion: These data show that by preventing PL aggregation, or- 
bofiban results in a more prolonged and sustained elevation in PMN adhe- 
sion molecule levels. Thus, anti-PMN adhesion therapy could provide further 
benefit over anti-PL therapy in ACS pts. 
1 1037-l 03 1 Mwked Variability in Inhibition of Fibrinogen 
Bmdrng to Platelets by Tirofiban and Abciximab 
in Patients With Acute Coronary Syndromes 
Michael B. Holmes, Samer S. Kabbani: Matthew W. Watkins, Burton 
E. Sobel, David J. Schneider. University of Vermont, Burlington, VT; USA 
Background: Tirofiban and abciximab reduce the incidence of subsequent 
cardiac events in patients with acute coronaty syndromes. This study was 
performed to determine inter-individual variability in platelet inhibitory effects 
in patients treated with these agents. 
Methods: Blood was taken from 4.5 patients with both stable and unsta- 
ble coronary disease and anticoagulated with corn trypsin inhibitor. Platelet 
reactivity was determined before treatment and during steady state infusion 
of abciximab (0.125 bgikglmin) or tirofiban, either with the PRISM-PLUS 
dosage (0.1 Fgikglmin.) or the RESTORE dosage (0.15 pgikgimin). Fibrino- 
gen binding to platelets was determined by flow cytometry after stimulation 
with ADP (0.2 or 1 w.M) or TRAP (25 PM). Values are mean reduction 
(percentage of pretreatment) f SD. 
Results: Both tirofiban and abc,ximab reduced the binding of fibrinogen 
to platelets in response to 0.2 @I ADP (PRISM-PLUS tirofiban by 33 & 
54%; RESTORE tirofiban, 46 f 24%; abciximab, 54 * 35%). Fibrinogen 
binding in response to 1 WM ADP was reduced (PRISM-PLUS tirofiban, 30 + 
32%; RESTORE tirofiban, 48 f 22%; abciximab, 65 f 24%). In each case, 
inhibition of ADP-induced fibrinogen binding ranged from ~5% to >95%. 
TRAP-induced fibrinogen binding was reduced by abciximab (40 f 16%) 
and by the RESTORE dosage of tirofiban (41 f 24%). Mean reductions were 
significant (p < 0.05) in each case. 
Conclusions: Substantial inter-individual variation in the inhibition of 
agonist-induced fibrinogen binding was seen despite evidence of efficacy 
on average. Although clinical correlation is required, the variation in patient 
response to each agent indicates that monitoring of platelet function may 
facilitate optimizing dosage in individual patients. 
1037-I 04 Eptifibatide Reduces the Incidence of Coronary 
Etients in Patients With Non-ST-Elevation Acute 
Coronary Syndromes Undergoing Early Cardiac 
Catheterization and Revascularization 
Regardless of Patient Gender 
Lisa G. Berdan, Todd J. Lorenz, Judith S. Hochman. Duke University 
Medical Center, Durham, North Carolina; COR Therapeutics, Inc., South 
San Francisco, California; St. Luke’sRoosevelt Hospital Center, New York, 
New York, USA 
Background: PURSUIT randomized 6,103 men and 3,357 women with 
non-ST-segment elevation acute coronary syndromes to treatment with ep- 
tifibatide or placebo. In the overall population, there was a trend toward 
greater efficacy with eptifibatide in men than in women. We previously re- 
ported gender-related geographic differences in treatment strategies; fewer 
women than men underwent angiography and/or percutaneous coronary in- 
tervention (PCI) while on drug therapy outside of North America. The current 
analysis undertook to determine whether gender-related differences in out- 
comes were present among the overall population of patients who had early 
coronary angiography. 
Methods: The incidence of death or Ml at 30 days among patients who 
underwent cardiac catheterization and PCI within 72 hours of randomization 
was analyzed according to patient gender. 
Results: The reduction of death or Ml at 30 days was similar in men and 
women who underwent cardiac catheterization and PCI (Table). 
% Death/Ml Placebo Epiifibatide OR (95% Cl) 
Cardiac cath within 72 hr. 
Mt?n 16.8(194/1154) 13.9 (159/1144) 0.80(0.64-1.00) 
Women 14.9(84/564) 10.6 (591558) 0.68 (0.47-0.96) 
PCI within 72 hr. 
M.W 17.4 (78/449) 12.3 (51/416) 0.67 (0.45-0.97) 
Women 15.4 (28/182) 10.8 (22/203) 0.67 (0.37-1.22) 
Conclusion: Women with non-ST segment elevation acute coronary 
syndromes who underwent early angiography and/or PCI experienced a 
similar reduction in death/Ml with eptifibatide compared to men. 
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I 1037 105 Enhanced Levels of Membrane-Bound CD40 Ligand on Platelets in Patients With Unstable 
Angina 
Christoph D. Garlichs, Alexander SchmeiRer, Saeed Eskafi, Dorette Raaz, 
Carsten Pohle, Joseph Ludwig, Werner G. Daniel. Medical Clinic /I, 
Friedrich-Alexander-University Erlangen-NWnberg, Germany 
Background: inflammatory and immunologic mediators may play a role 
in the pathogenesis of atherosclerosis and coronary artery disease. CD40 
ligand (CD40L) was recently found on activated platelets and thus may 
be activating matrix metalloproteinases, inducing procoagulant activity, and 
be involved in the pathogenesis of acute coronary syndromes (ACS) by 
promoting plaque rupture in atheroma. To study the role of CD40L in ACS, 
we analyzed membran-bound CD40L on platelets in the peripheral blood 
from patients with unstable and stable angina. 
Methods: From IO patients fulfilling the criteria for unstable angina (is- 
chemic chest pain at rest within the preceding 24 hours, no evidence of 
myocardial necrosis by enzymatic criteria, transient ST-T segment depres- 
sion and/or T-wave inversion) and IO patients with stable angina (sex- and 
age-matched) peripheral blood was drawn and platelet-rich plasma (PRP) 
prepared. After incubating the probes directly with anti-CD40L (phycoey- 
thrin) and anti-CD62P (P-selectin, fluorescein isothiocyanate, all Pharmin- 
gen, USA) antibodies, flow cytometry was performed (FACS Calibur, Becton 
Dickinson). In addition, a second fraction of PRP from all patients was stim- 
ulated with 5 GM ADP for IO min followed by analysis with flow cytometry. 
Results: Patients with unstable angina showed significantly raised levels 
of CD40L on platelets (unstimulated) compared to patients with stable angina 
(7.14 vs. 1.71, p < 0.05 net geometrical mean of fluorescence). P-selectin 
was elevated in patients with unstable angina as well (21.68 vs. 8.61, p 
< 0.05). Stimulation of platelets of patients with ACS with ADP showed 
significantly raised levels of CD40L and P-selectin compared to controls 
(CD40L: 32.19 vs. 12.46, p < 0.05; CD62P: 169.45 vs 104.01, p < 0.05). 
Conclusion: In patients with ACS membran-bound CD40L and P-selectin 
on unactivated platelets are significantly enhanced. In addition, platelets of 
patients with ACS express significantly higher levels of membran-bound 
CD4OL and P-selectin after stimulation with ADP than platelets from pa- 
tients with stable angina. This suggests that CD40LCD40 interaction may 
play a pathogenic role in the triggering and propagation of acute coronary 
syndromes. 
1 1037 106 Low-Molecular-Weight Heparin in Acute Coronary Syndrome: Evidence for Superior or 
Equivalent Efficacy Compared to Unfractionated 
Heparin? 
Sanjay Kaul, Bojan Cercek, Prediman K. Shah. Cedars-Sinai Medical 
Cenfer, Los Angeles, California, USA 
Background: Low-molecular-weight heparins (LMWHs) have a number of 
advantages over unfractionated heparin (UFH) leading to their increasing 
use for thrombotic vascular disorders. 
Methods: Data from 3 recent clinical trials evaluating LMWHs in the 
management of patients with unstable angina and non-ST segment elevation 
Ml were studied. Endpoints analyzed were death (D), myocardial infarction 
(Ml), recurrent angina (RA) and revascularization (CABG/PTCA) at 6 days 
in FRIC (dalteparin, n = 1482) and at 14 days in ESSENCE (enoxaparin, n = 
3171) and TIMI-1IB (enoxaparin, n = 3910). RR = relative risk vs. UFH. 
Results: 
DIMIIRA 
FRIC ESSENCE TIMI-116 
RR P value RR P value RR P value 
1.18 0.33 0.84 0.02 0.85 <0.03 
D 3.37 0.55 0.98 0.92 0.79 ns 
MI 0.81 0.50 0.71 0.06 0.79 W 
RA 0.92 0.69 0.83 0.03 0.67 ns 
CABG/PTCA 0.88 0.55 0.84 0.001 0.85 ns 
57% (66/116) of total Ml in ESSENCE and 74% (174/236) in TIMI- B 
were diagnosed by CWMB criterion alone. 45% (521116) of total Ml in 
ESSENCE were post-procedural, mostly post-CABG (Ml defined by CK > 
5 xULN). Mortality was higher in ESSENCE (3.3%) and TIMI-IIB (3.9%) 
as compared to FRIC (2.4%). Revascularization rates were 2-fold higher in 
ESSENCE compared to FRIC (30% vs 15%). 
Conclusion: LMWH is as effective as UFH in reducing the hard end- 
points of death and recurrent myocardial infarction. Convincing evidence for 
a superior efficacy is limited to: 1) recurrent angina, the least robust endpoint 
which accounts for >70% of the composite endpoint of D/MI or RA; 2) high- 
risk patients; 3) aggressive revascularization strategy: and 4) Ml defined by 
periprocedural CPK elevations. The logistic ease of administration without 
the need for monitoring anticoagulation appears to be the major advantage 
over UFH. LMWHs have the potential of being cost-neutral or even cost-sav- 
ing by reducing resource utilization. Lastly, whether one LMWH preparation 
is more effective than others can be answered only by direct head-to-head 
comparison of different LMWH preparations in randomized trials. 
1 1037 107 Heparin-Induced Thrombocytopenia in Patients With Unstable Angina: Clinical Implications 
Anna Vittoria Mattioli, Emma Tarabini Castellani, Stefania Sansoni, 
Sabina Sternieri, Lorenzo Bonetti, Giorgio Mattioli. Dpf of Cardiology, 
University of Modena, Italy 
Background: Unfractionated heparin (UH) and very low molecular weight 
heparin (VLMWH) are commonly used in the therapy of unstable angina. The 
aim of the present study was to evaluate heparin-induced thrombocytopenia 
associated with heparin dependent Ig G antibodies in patients (pts) treated 
with UH or VLMWH. 
Methods: 124 consecutive pts with unstable angina were randomized to 
treatement with UH for at least 7 days (62 pts, group A) or VLMWH (62 pts, 
group B). They were all taking aspirin (100 mg). An immunoassay ELISA 
was used to detect anti-heparin/PF4 antibodies. Blood samples were taken 
at baseline and on the 71h and the 40th day. Cardiac events were evaluated 
during a one year follow-up. A Cox regression analysis was used to calculate 
RR and 95%CI. 
Results: The frequency of a positive ELISA did not vary with patient’s age 
or gender. In group A 14 pts (11%) tested positive for heparin/PF4 antibodies 
by ELISA at 7h day and 16 pts (13%) became positive on day 40. The test 
was frankly positive in 16 pts and intermediate in 18 pts. In group B none 
pts tested positive for heparitYPF4 antibodies. In group A the platelets count 
decrease from baseline to 7th day (185 f 56 vs 168 f 23 mm3; p < 0.01). It 
was further reduced after 40 days (166 rt 45 mm3). In group B the platelets 
count did not change from baseline to Fh day (216 f 56 vs 229 & 66 mm3; 
p = ns.), after 40 days was 210 i 78 mm3. The log-rank test showed that 
after 1 year there was significant reduction of cardiac events in group B (X2 
= 19.03; p < 0.001). The RR for cardiac death was 2.14 (C.I. -95 to +lO), for 
myocardial infarction was 2.63 (C.I. -7.6 to +8), for urgent revascularization 
was 1.93 (C.I. -11 to +12), for stroke was 1.52 (C.I. -6.8 to +6.9). 
Conclusion: In the present study heparin induced IgG antibodies are 
more common in pts treated with UH than in those treated with VLMWH. 
Cardiac events were significantly lower in pts who used aspirin plus VLMWH 
after one year. The prevalence of antibodies to heparin/PF4 complexes in pts 
treated with UH was considerably high, even if we did not find a correlation 
between thromboembolic events and antibodies. We can suppose that other 
mechanisms may be responsible for the beneficial effect of VLMWH. 
1 1037 108 Standard Tests to Assess Heparin Efficacy May Not Accurately Reflect Anticoagulation 
Gregory J. Dehmer, Laura G. Melton, Cheryl M. Thompson, David A. Tate, 
Sidney C. Smith, Don A. Gabriel. University of North Carolina at Chapel Hi//, 
NC, USA 
Background: Heparin is commonly used to treat unstable coronary syn- 
dromes, but its effect is variable since it is inhibited by platelet degranulation 
products, is absorbed by vascular proteins and requires antithrombin Ill. Al- 
though aPTT and ACT tests are used to monitor anticoagulation induced by 
heparin, these tests do not reflect total hemostatic function. Therefore, we 
assessed the effect of heparin on both platelet activity and soluble phase 
coagulation using the Clot Signature Analyzer@ (CSA) flow device. 
Methods: Blood samples were collected before and 5 min. after a 2000 
U bolus injection of unfractionated heparin from 30 patients (60 & 10 yr, 11 F, 
19 M) undergoing cardiac catheterization. All samples were collected before 
contrast was given. ACT, aPTT, whole blood aggregation (WBA) and CSA 
flow device (PHT, Platelet Hemostasis Time) testing were performed on all 
samples. 
Results: Three different responses to heparin were characterized by 
the flow device. In Group 1 (n = 13, 43%), no pt. had an increased PHT 
(defined as 22 standard deviations above the mean value at baseline). In 
Group 2, PHT was elevated in all pts (n = 9, 30%) while in Group 3 (n = 
8, 27%) markedly elevated PHTs (>30 min) were measured. However, the 
Mean i Standard Deviation 
After Heparin 
Test Parameter Baseline Group 1 Group 2 Group 3 
PHT (sac) 
ACT (secj 
243 f 88 314+ 152 962 i 330 18OOiO 
123& 14 1s9*21 207 * 37 ZOO i 18 
AP- (set) 24 zk 2 105zt38 91 zt 38 1081!c28 
WBA:Collagen (ohms) 9*5 lOzt7 12+7 7-F-6 
WBA:ADP (ohms) 8zb5 9f4 lo+6 954 
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ACT, aPTT find WBA values after heparin were not significantly different in 
these 3 groups. 
Conclusion: Althorugh all patients appeared to have “therapeutic” anti- 
coagulation based on the ACT and aPTT, the flow device identified a lack 
of effect in 43%. These findings likely reflect a variable effect of unfraction- 
ated heparin on platelet function and may explain the poor heparin effect or, 
aiternatively, the excessive bleeding after heparin occurring in some patients. 
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1 ~~~~s~~~~~ ~vai~~%io~ of Reperfusion Therapy 
for Acufe ~~ocar~~aj l~fa~ct~on~ To Sent or Not 
to Sent 
Yasunori Ueda, Osamu Yamaguchi, Yuji Okuyama, Hiroyoshi Yamamoto, 
Masahiko Shimizu, Atsushi Hirayama, Kazuhisa Kodama. Cardiovascuiar 
Division, Osaka Police Hospital, Osaka, Japan 
Background: Repen’usion therapy of acute myocardial infarction includes 
thrombolysis, balloon angioplasty (PQBA), and stenting. However, the effects 
of those interventions on the culprit lesion morphology have been poorly 
understood. Therefore, we angioscopically evaluated the effects of those 
reperfusion therapies. 
Methods: The patients (pts) with acute myocardial infarction received 
reperfusion therapy after demonstrating the culprit lesion by angiography. 
The method of reperfusion therapy was thrombolysis with rescue POBA from 
1994 to 1996, direct POBA from 1996 to 1998, and direct POBA with stenting 
from 1998 to the present The culprit iesions were angioscopically observed 
before and after each reperfusion therapy. 
Results: Angioscopic observation was performed before reperfusion in 
32 pts, after thrombolysis in 17 pts, after POBA in 30 pts, and after stenting 
in IO pts. Coronary lumen at the culprit lesions was filled with massive white 
thrombus before and even after reperfusion by thrombolysis in 24 (75%) pts 
and 14 (82%) pts, respectively. Although PQBA compressed thrombus and 
only littie thrombus was observed by angioscopy in 7 (23%) pts, massive 
thrambus was left in 23 (76%) pts even after POBA that was not detected by 
angiography. After stenting, no angiographically significant stenosis and no 
angioscopically massive thrombus was detected in any pt. 
Conclusion: MassNe thrombus was left at the culprit lesion in most pts 
after thrombolysis, and only little thrombus was left after stenting. However, 
angiog:aphy could not detect the massive residual thrombus after POBA, 
which was angioscopicaily revealed in most pts after POBA. Therefore, 
angioscopically determined stenting in those pts might be useful to reduce 
the incidence of thrombus-related adverse cardiac events. 
1038-l 28 intravenous Atria1 ~atriuretic Peptide Prevents 
Left Ventricular Ftemadeling in Patients With 
Anterior Acute Myocardial Infarction 
Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda, 
Naoko Mabuchi, Takashi Tsutsui, Masato Ohnishi, Masahide Sawaki, 
Masanori Fujii, Takehiro Matsumoto, Hajime Horie, Masahiko Kinoshita. 
§higa Unillersity of Medical Scjence, O&u, Japan 
Background: Nitroglycerin (GTN) may stimulate renin angiotensin aldos- 
terone (RAA) system in spite of the beneficial hemodynamic effect in patients 
(pts) with acute myocardial infarction (AMI). Atriai natriuretic peptide (ANP) 
was demonstrated to suppress RAA system and endothelin-I. 
Methods: To evaluate the effects of ANP on left ventricular remodeling 
after AMI, 40 consecutive anterior AMI pts with successful direct PTCA were 
randomly divided into two groups, treatment with ANP (n = 20) or GTN (n = 
20) for more than 24 h (mean = 55 h). After the treatment with ANP or GTN, 
all pts were received angiotensin-converting enzyme inhibitors, 
Results: Baseline characteristics including peak creatin phosphate ki- 
nase and hemodynamic changes during the infusion periods were not differ- 
ent between the two groups. There was no difference in the left ventricular 
ejection fraction (EF) and left ventricular end-diastolic volume index (EDVI) 
on day 1 between the two groups. A significant improvement in the EF was 
observed in the both group (ANP p < 0.0001, GTN p < 0.05; day 1 vs. 1 
month), however the ANP group was much improved than in the GTN group 
at 1 month (p x 0.005, ANP vs. GTN). A significant reduction in EDVI and the 
LV end-systolic volume index (ESVI) was observed in the ANP, but not in the 
GTN group. In the ANP group, plasma levels of angiotensin II, aldosterone 
and endothelin-1 were significantly suppressed during the infusion periods 
compared with the GTN group. 
EF (%) EDVI (ml/ms) ESVI (ml/mz) 
ANP day 1 48.6 zt 1.7 87.3 i 4.6 44.8 + 2.7 
1 month 58.9 h 1.1-S 79.5 i 4.11 33.3 zk 2.1* 
GTN day 1 48.1 + 1.9 85.7 i 7.0 44.6 z!z 4.9 
1 month 52.2 zt 1.8’ 94.1 * 5.9 45.2 + 3.5 
=: p < 0.005 “s GIN, b: p < 0.01 vs. GTN, #: p < 0.05 vs. day 1,s: p < 0.01 vs. day 1 
Canclusion: These findings indicate that ANP is more useful than GTN 
to prevent lefl ventricular remodeling in pts with anterior AMI. 
I. 1038 129 Coronary Artery By-Pass Versus Coronary 
Angroplasty: Prognostic Impact in Patients With 
Three Vessel Disease, Left Venticular 
Dysfunction and Maintained Myocardial Viability 
Alessia Gimelli, Paolo Marzullo. institute of Clinical Physiology, CNR, Piss, 
My 
Background: In patients (pts) with ischemic left ventricular dysfunction, three 
vessel disease and maintained viability, little is known on the prognostic 
efficacy of coronary artery by-pass grafting (CABG) versus percutaneous 
transluminal angioplasty (PTCA). 
Methods: One hundred and forty-six pts, with three vessel disease docu- 
mented at coronary angiography, previous myocardial infarction (~6 months), 
an angiographic ejection fraction below 0.45 underwent PTCA (51 pts, mean 
ejection fraction 30 f 15) or CABG (95 pts, mean ejection fraction 29 i 16) 
and were followed-up for 31 & 14 months. Dominance of tissue viability in 
dyssynergic areas was demonstrated by maintained Thallium-201 uptake in 
more than 50% of dyssynergic segments at rest in an II-segment model. In 
this model, left anterior descending coronary artery territory was correlated 
with 6111 (or 7/11, including the apex) segments. Therefore, it was the most 
dyssynergic when compared to the other territories and the mostly viable. All 
pts were reviewed and operative management were examined. 
Results: The 2 groups did not differ with respect to known determinants 
of post-infarction prognosis (age, sex, diabetes, hypertension, cholesterol 
levels) and symptoms (angina and heart failure). The extent of coronary 
revascularization was greater in CABG pts (2.9 f 1.2 grafts when compared 
to the 1.3 i 1.2 procedures of PTCA group, p < 0.05). However, revascular- 
ization rate of the left anterior descending coronary artery was similar in the 
two groups (94% versus 93%, respectively in PTCA and CABG patients, p = 
ns). Cumulative survival at 3 years was 89% in CABG and 92% in PTCA pts 
(log rank at Kaplan Meier survival analysis = 0.1256, not significant). 
Conclusions: In pts with depressed left ventricular function and main- 
tained viable myocardium, coronary revascularization is associated with a 
favourable long-term outcome, independently from the number of revascular- 
ized vessels and from the revascularization technique. Revascularization of 
the proximal left descending coronary artery is probably the main determinant 
of improved outcome. 
1038-l 30 The Combined Use of Pravastatin With 
Thrombolytic Agents in Acute Myocardial 
Infarction: Results of Clinical and 
Angiographical Follow-Up 
Meral Kayikcioglu, Ciineyt Turkoglu, Levent Can, Serdar Payzin, 
Hakan Ktiltiirsay. Ege University Medical School, Cardio/ogy Dept, lzmir, 
Turkey 
Background: Recent infarct related lesions treated with thrombolytjc agents 
show a high propensity for reocclusion. In this study, pravastatin was admin- 
istrated to patients (Pts) with AMI, in combination with thrombolytic therapy 
(TT) in order to achieve an earlier plaque stabilization. Effects on the mortality, 
cardiovascular events (CVE), infarct related arteries (IRA) stenosis and reste- 
nosis after PTCA were evaluated angiographically and clinically for 6 months. 
Methods: Pts of AMI (n = 164) within the first 6 hours of their chest pain 
were prospectively randomized into 2 groups. Group I (n = 79) received 
pravastatin (40 mg/day) within the first hour of TT irrespective of serum lipid 
levels. Group-II (n = 85) was given only TT without any ctiolesterol lower- 
ing agent. In both groups t-PA and streptokinase administration rates and 
basal characteristics were similar. Lipid levels were determined immediately 
on admission, and end of the 1 and 6rh months. IRA stenosis rates were 
compared between the 2 groups QCA one month after the infaction. 40 pts in 
pravastatin-group and 37 pts in control group underwent invasive interven- 
tion (PTCA). After the 6-month follow-up, pts were reevaluated with clinically 
and angiographically for CVE and restenosis. 
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Results: 
Clinical &perfusion 
LDL (mg/dl) admlssion 
(mg/dl) 61h month 
Angina (at follow-up) 
IRA lesion % ls’ month 
#’ month 
De nova lesion 
Restenosls rates 
Pravastatin-group 
81% 
140130 
98f23 
30% 
86f10 
35 * 31 
16% 
33% 
Contr&group 
76% 
128127 
139*35 
59% 
90 * 6 
46 k 33 
%I9 
41% 
P 
NS 
NS 
0.000 
0.02 
NS 
NS 
NS 
NS 
Conclusion: The early and combined use of pravastatin with TT in AMI 
did not affect short-term arterial patency on the first month angiography; 
however, at 6 month control, arterial patency and restenosis rates were 
better for pravastatin group. Incidence of CVE were also lower in pravastatin 
group. These benefits of the combination of a statin with TT, may be due to 
early plaque stabilization or regulation of endothelial and platelet functions 
apart from lipid lowering effects of statins. 
/ 1038 135 lntracoronary Enalaprilat in Patients With Acute Myocardial Infarction 
Ulrich Schafer, Gert Richardt, Andreas Dendorfer’ , Ralf Ttilg, 
Franz Hartmann, Walter Raasch’, Hugo Katus, Peter Dominiak’ , 
Thomas Kurz. Medizinische Klinik /I; ‘Insfitut fijr Experimentelle und 
Klinische Pharmakologie und Toxikologie, UniversiM zu Lfibeck, Germany 
Background: Although ACE-inhibition is protective in ischemia/reperfusion 
injury, there is concern about an early treatment of patients with acute my- 
ocardial infarction (AMI), due to adverse systemic hemodynamic effects. This 
limitation can be probably avoided by low-dose intracoronary (i.c.) application 
of ACE-inhibitors. 
Methods: Twenty two patients with large AMI (Killip class 11-111) were 
randomized to receive either enalaprilat (50 pg i.c.) (E) or placebo (C) imme- 
diately after reopening of the infarct vessel by primary PTCA. Patients were 
monitored continuously by ECG, SG-catheter and samples for determina- 
tion of ACE activity (ACE), angiotensin II (ANG), and bradykinin (BK) were 
collected from pulmonary arterial (PA) and central venous (CV) blood. 
Results: At baseline there were no diffelences between both groups, 
but during reperfusion (REP) there was a significant drop of blood pressure 
and heart rate (2 min REP: -15.8 f 22.9 mmHg*; -4.0 f 4.0 bpm*) in the 
placebo group, and only minor hemodynamic changes in the treatmentarm 
(2 min REP: -2.3 & 14.4 mmHg; +0.9 f 0.9 bpm) were documented. 
Cardiac ACE-inhibition was indicated by a 67 f 20% reduction of ACE-activity 
in PA. E induced a distinct increase in BK in PA (see Fig.) but not CV, 
whereas ANG was not significantly affected by E. Analysis of ECG showed 
a significant suppression of ventricular arrhythmias during REP with E. Left 
ventricular ejection fraction measured during primary angiography and after 
IO d suggested an improved left ventricular recovery in the treatment arm 
(AEF E VS. C: +5.1% VS. -0.8%; p = 0.07). 
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Conclusion: Cardiac ACE-inhibition can be achieved by low-dose i.c. 
application of E, without adverse effects on systemic hemodynamics. In fact 
there was an improvement in hemodynamics and electrical stability after E 
i.c.. The results suggest, that a cardioprotective action of intracoronary E is 
primarily mediated by potentiation of BK. 
(24 dogs) received laser irradiation (infrared laser, 803 nm wavelength) 
epicardially at an energy of 1.08 joules/cm’. Control group dogs were sham 
operated and laser was not applied. All dogs were sacrificed at 5-6 weeks 
post MI. Infarct size was determined by TTC staining and histology. The 
acute and chronic Ml models in rats were used for electron microscopic 
examination of the infarcted zone. 
Results: The laser treatment significantly (p < 0.05) lowered mortality 
from 30% to 6.5% following induction of Ml in dogs. The infarct size in 
the laser irradiated dogs was significantly (p < 0.0001) reduced (52%) as 
compared to non-irradiated dogs. Troponin-T release to blood 48 hrs post Ml 
in the laser irradiated dogs was also significantly reduced (47%). Catalase 
enzymatic activity (antioxidant marker) in dogs’ blood serum was 2.9 fold 
significantly (p < 0.05) elevated 24-hrs post Ml in the laser irradiated dogs as 
compared to 1.6 fold elevation in the control dogs. Histological observation 
of the infarct revealed a typical sear tissue in control dogs and cellularity in 
most of the laser irradiated dogs. Desmin immunostaining was higher in the 
infarcted and peri-infarcted zone in the laser irradiated dogs as compared 
to control non irradiated dogs. The number of damaged mitochondria in the 
cardiomyocytes in the infarcted zone in non irradiated rats was 2.6 fold higher 
than in the irradiated ones. 
Conclusion: The laser irradiation appears to inhibit cell degeneration 
trader acute ischemia and has a cardioprotective effect. Our observatiolis 
indicated that delivery of laser energy to the heart, using novel navigation 
systems and common interventional cardiology procedures, may have an 
important beneficial effect on patients following acute MI and ischemic heart 
diseases. 
1038-I 37 Early ACE Inhibitor Treatment is Associated 
With lmoroved Short-Term Survival in Diabetics 
After Adute Myocardial Infarction 
Gregory W. Barsness, R. Scott Wright, Bernard J. Gersh, Charanjit S. Rihal, 
Kirk N. Garratt, Guy S. Reeder, Brent A. Williams, David L. Dvorak, Stephen 
L. Kopecky. Mayo Clinic, Rochester, MN, USA 
Background: Patients with diabetes mellitus (DM) have worse shoti- and 
long-term prognosis after acute MI than non-diabetics (NDM). ACE inhibitors 
(ACEI) have been shown to improve intermediate-term outcome among 
DM after acute MI, although the effect on short- and long-term outcome in 
non-selected Ml survivors has not been clearly established. 
Methods: We studied 1206 consecutive patients (193 DM and 1013 
NDM) with acute Ml in the Mayo Clinic CCU database, comparing outcome 
based on treatment with ACEI within 24 hours of hospitalization. Patients 
who died within 24 hours of hospitalization were excluded. 
Results: DM tended to have more HTN and lower EF at presentation, 
with more history of CHF, prior revascularization and pridr Ml than NDM. In 
both DM and NDM, risk factor profiles were markedly worse in those treated 
with ACEI than without ACEI. Unadjusted in-hospital survival was better in 
DM treated with ACEI (below). Five-year survival was worse in DM than 
NDM, both with ACEI (33% vs 57%) and without ACEI (59% vs 76%). After 
adjustment, early ACEI treatment was not associated with a difference in 
long-term survival in either DM (p = 0.1) or NDM (p = 0.9). 
InHospital Event (%) DM NDM 
ACEI No ACEI ACEI No ACEI 
(n=51) (n=142) p (n=131) (tl=882) p 
Death 5.9 16.2 0.06 6.2 9 0.3 
Death/Ml 17.6 24.6 0.3 9.2 14.2 0.1 
Conclusions: Despite a worse risk-factor profile among DM, early ACEI 
treatment after acute Ml is associated with improvement in in-hospital survival 
to a rate similar to that observed in NDM. DM is associated with poor 5-year 
survival after Ml, however, and efforts to reduce non-fatal reinfarction and 
improve long-term outcome in this group are required. 
1 1038-I 36 1 Low Energy Laser Irradiation Reduces 
Formation of Scar Tissue Following Myocardial 
Infraction 
Uri Oron, Tali Yaakobi, Lidya Maltz, Amir Oron, Gal Hayam, 
Dan Mordechowitz, Rona Shofti, Lior Gepstein, Uzi Dror, Tamir Wolf, 
Christian Haudenschield, Shlomo Ben Haim. Tel Aviv Universifx Tel-Aviv; 
Technion, Haifa, lsrael 
Background: Low energy laser (LEL) irradiation has been found to atten- 
uate various biological processes in tissue culture and experimental animal 
models. The aim of the present study was to investigate the effect of LEL 
on the formation of scar tissue in experimentally induced acute and chronic 
infarct in rats and dogs. 
Methods: Myocardial infarction (Ml) was induced in 46 dogs by ligation 
of the left coronary artery. Following induction of Ml the experimental group 
I 1038 138 Contemporary Use of Evidence-Based Therapies in High Risk Groups After Myocardial Infarction 
Blair J. O’Neill, lqbal R. Bata, David E. Johnstone, Gordon Flowerdew, 
Jafna L. Cox. For the /CONS Investigafors: Dalhousie University: Halifax 
Nova Scotia, Canada 
Background: Numerous clinical trials have demonstrated improved out- 
comes using several therapies for patients after myocardial infarction (MI). 
Furthermore, evidence would suggest these benefits are increased in those 
at highest risk after an Ml, particularly diabetics and the elderly. 
Methods: We decided to examine the use of proven cardiovascular 
therapies in a large non-clinical trial cohort of patients with a diagnosis of 
acute MI. From October 15, 1997 until October 14, 1999, a total of 1829 
patients had a separation diagnosis of acute Ml. Patients were stratified by 
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diabetes (DM), non-diabetic (non-DM), or undocumented in chart (DM not 
dot). Detailed chart audits were carried out on all residents of Nova Scotia 
admitted with MI as part of the Improving Cardiovascular Outcomes in Nova 
Scotia (ICONS) project, a registry-based disease management study. The 
rates of various proven post MI therapies at discharge were recorded and 
use between groups was compared. 
Results: 
ACEI BB ASA LL 
N 574% 75+ 574” 75+* (74* 75+= 574 75t 
DM 529 40.2 36.3 63.7 47.5 63.4 48.9 34.6 10.3 
WWDM 931 27.6 37.5 79 62.5 76.3 65.7 40.3 15.5 
DM not dot 369 25.5 32.4 64.8 48.0 66.3 51.4 30.1 14.5 
Total 1829 30.6 35.8 72.5 53.9 71.5 56.6 37.0 13.5 
* = p < 0.05, DM vs non-DM, (Fisher’s Exact Test, 2 tailed), ACEI = angiotensin converting 
enzyme inhibitor, ES = beta blocker, ASA = Acetylsal~cyl~c acid, LL = lipid lowering therapy 
Conclusion: Up to 20% of patients do not have their diabetic status 
recorded on their chart. Other than ACEI use in younger diabetics, in this 
large contemporary cohort of Ml patients, evidence based therapy tends to 
be used less in higher risk patients such as the elderly and diabetics. Fur- 
ther study is required to determine how to optimize use of evidence based 
therapies across !arge populations. 
1038-I 39 Gender Based Differences in Treatment and 
Mortality of Acute Myocardial infarction 
Tobias Heer, Anselm K. Gitt, Rudolf Schiele, Steffen Schneider, 
Frank Fischer, Harm Wienbergen, Christoph Dommke, Hans G. Glunz, 
Gerd Berg, Peter Limbourg, Jochen Senges. For the MlTRA Study Group; 
Herzzenirum Ludwigshafen, Germany 
Background: There is conflicting information about gender specific differ- 
ences in therapy and mortality of acute myocardiai infarction (AMI). 
Results: (OR in table adjusied for age, follow-up 18 months): 
Methods: Within the MITRA study 6067 consecutive patients with AMI 
were prospectively registered in 54 hospitals in south-west Germany from 
6194 until 2197. The pecentage of women was 34% (2033). Women (mean 
age 71 i 12 y) were 9 years older than men (mean age 62 f 12 y). 
Thrombolysis/PTCA 
Hospital Mortality 
Longterm Mortality 
Women Men OR P 
48.6% 62.5% 0.83 0.002 
20.9% 12.3% 1.13 0.14 
15.5% 10.0% 0.91 0.36 
Women received acute recanalisation therapy less frequently than men. 
Even after multivariate analysis adjusting for 13 variables (including age and 
concomitant diseases) women still received thrombolysis or primary PTCA 
less frequently than men (OR 0.82; p = 0.01). No differences were found in 
therapy with aspirin, beta-blockers and ACE-inhibitors. Mortality was more 
than 50% higher in women as compared to men, which was no longer 
significant after adjusting for age. A comparison of age groups showed that 
older but not younger women had a higher mortality. 
Conclusion: Women with AMI received recanalisation therapy (throm- 
bolysis or primary PTCA) less often as compared to men. However, the 
difference in mortality between men and women was not due to age and not 
to gender. Younger women did not represent a high-rise group. 
1038-140 A Novel Non-fnvasive Short Hospital Stay 
Strategy for Low Risk Myocardial Infarction: 
Six Month Follow-Up 
Peter Bogaty, Gilies E. Q’Hara, Lute Boyer, Lucie Auclair, Marie Arsenault, 
Marie-Helene Leblanc, Jean-Roth Boudreault. Quebec Heart Institute/Lava/ 
Hospifal, Quebec City Canada 
Background: The usual hospital stay for uncomplicated myocardial infarction 
(Ml) is 6-8 days. Previous studies evaluating a shorter hospital stay have 
relied heavily on invasive stratification and treatment. 
Methods: This study evaluated a short (3 day) hospital stay for patients 
with low risk MI using easily applicable non-invasive clinical criteria. Consec- 
utive eligible patients were randomized at 48 hours in 2:l ratio to short or 
usual stay. Short stay patients then underwent 24 hour ambulatory ST seg- 
ment monitoring. In the absence of ischemia on ST monitoring and post-Ml 
angina, patients were discharged at 72 hours, returning for exercise testing 
4-7 days later. 
Results: The 120 consecutive eligible patients were comparable in age 
(56 i 9 years), sex (85% male), risk factors, and MI characteristics. Sev- 
enteen short stay patients (21%) were not discharged at 3 days because of 
anginaiischemia at 48-72 hours. At 6 months, findings were: 
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Short Stav Usual stav P 
n=SO’ n=40* 
Death/new Ml/unstable angina o/311 2 1 /o/5 0.8 
Re-hospltallzatlon 12 (15%) 5 (12.5%) 0.8 
Davs hosoitalized (mean * SD: mediani 
Initial 4.9 i 3.8; 3.3 8.3 i 5.0: 6.8 <0.000! 
Total 5.9 zt 4.9; 3.6 9.2 i 5.0; 7.2 0.0006 
Total no. invasive cardiac procedures 46/80 pts 35/40 pts 0.0009 
Exercise test (METS/% + for ischemia) 9.7 i 2 7135% 9.9 i 2.5134% 1.010.7 
Conclusion: This short hospital stay strategy for low risk Ml patients 
appears feasible and safe and results in fewer invasive cardiac procedures 
and a substantial and sustained reduction in days hospitalized. 
L--d 1038 141 Mortality With Coronary Artery Bypass Grafting for Non Q Ml; Results From the 1996 New York 
State Cardiac Surgery Database 
Venu Menon, Peter Homel, Sherief M. Kamel, Rupert Fincke, Daniel 
G. Swistel, Judith S. Hochman. St. Luke’+Roosevelt Hospital Center, New 
York, N’r: USA 
Background: Although CABG mortality following acute MI has been exten- 
sively studied, outcomes with early surgery for the subset with Non Q Ml 
(NQMI) remain controversial. The VANQWISH trial recently reported a high 
mortality rate in this group. 
Results: 
Methods: To assess CABG mortality in relation to time aider NQMI we an- 
alyzed all isolated CABG cases in the 1996 NY State database (n = 20,078). 
We excluded all emergency, and hemodynamically unstable cases, all cases 
operated within 24 hours post Ml and cases with missing risk information (n 
= 1073). The study group consisted of 5452 patients with NQMI who were 
divided into 4 groups (IA, IB, IC, ID) based on time from NQMI-CABG 
(i-2, 3-7, 8-14, 15-21 days). Comparative groups included those operated 
following Q Ml (2A, 28, 2C, 2D), plus CCS III/IV angina and CCS l/II angina. 
Baseline variables and mortality rates were compared. Unadjusted OR and 
adjusted OR aider adjustment for differences in prognostic variables are 
presented using the group operated for CCS VII (mortality rate 1.3%) as 
baseline. 
Group 
1A 
18 
IC 
1D 
2A 
26 
2c 
2D 
N Unadjusted OR (95% Cl) 
145 5.40 (2.38. 12.24) 
1204 1.70‘(0.90, 3.22) 
935 1.46 (0.73, 2.91) 
3168 2.09 (1.20,3.62) 
83 4.75 (1 X8, 13.40) 
743 2.48 (1.29,4.76) 
662 1.26 (0.57, 2.75) 
3901 1.85 (1.07.3.20) 
Adjusted OR (95% Cl) 
2.79 (1.15, 6.79) 
1 .Ol (0.51, 1.98) 
0.75 (0.36, 1.55) 
1.35 (0.75,2.42) 
2.47 (0.81,7.58) 
1.47 (0.73,2.95) 
0.73 (0.32, 1.68) 
1.22 (0.69,2.18) 
ccs Ill/IV 7044 1.08 (0.63, 1.87j 0.85 (0.48, 1.51) 
Conclusion: CABG is not associated with increased risk when performed 
>2 days following NQMI. The increased OR with CABG on days 1-2 after 
NQMI though significant (p = 0.023) may reflect unrecorded severity of illness 
i.e. post Ml angina, spontaneous ischemia and hemodynamic variables that 
were not collected in the database. Adopting an early invasive strategy does 
not appear to confer increased early risk for patients referred for CABG 2 
days after NQMI. 
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1039-l 31 Clinical and Therapeutic Profile of Patients 
Presenting with Acute Coronary Syndromes 
Who do not Have Significant Coronary Artery 
Disease 
Matthew T. Roe, Robert A. Harrington, E. Magnus Ohman, Robert M. Califf, 
A. Michael Lincoff, Deepak L. Bhatt, Danielle M. Prosper, Eric J. Topol. 
Duke Clinical Research lnsfitufe, Durham, NC; C/eve/and Clinic Foundation, 
C/eve/and, OH, USA 
Backaround: A orooortion of oatients with acute coronarv svndromes (ACS) 
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are found to have insignificant coronary artery disease (CAD) during coronary 
angiography, but these patients have not been well characterized. 
Methods: Patients with non-ST-segment elevation ACS enrolled in the 
PURSUIT trial who underwent in-hospital coronary angiography (n = 5,779) 
were evaluated. Outcomes were evaluated based on the severity of CAD 
identified during angiography. 
Results: Significant CAD (at least 1 coronary stenosis ~50%) was found 
in 88% of patients while insignificant CAD (0% < stenosis ? 50%) was found 
in 6%, and no CAD (no stenosis -0%) was found in 6%. The frequency 
of death or nonfatal MI at 30 days was reduced with eptifibatide treatment 
in the group with significant CAD (18.3% vs. 15.6%, p = 0.006), the group 
with insignificant CAD (6.6% vs. 5.4%, p = 0.62), and the group with no 
CAD (3.0% vs. 1.2%, p = 0.28). The incidence of major or minor bleeding 
in eptifibatide-treated patients was higher in the group with significant CAD 
(34.5% vs. 9.7% vs. 8.1%, respectively, p < 0.001). Multivariable predictors 
of insignificant and no CAD included younger age, female sex, and the 
absence of enrolling Ml, previous angina, diabetes, or STdepression. These 
factors were used to develop a scoring nomogram to predict the likelihood of 
insignificant CAD on presentation. 
Conclusions: A sizable proportion of patients with suspected ACS do 
not have significant CAD. Patients without significant CAD have a low risk 
of adverse outcomes and can be reliably predicted using baseline charac- 
teristics. Treatment with eptifibatide appears to provide overall benefit to all 
patients regardless of the severity of CAD and is associated with a low risk 
among patients who do not have significant CAD. 
1039-l 32 Preexisting Atherosclerotic Disease as a 
Predominant Determining Factor for Ultra 
Long-Term Prognosis of Vasospastic Angina 
Treated With Calcium Channel Antagonists: 
Evidence From Twenty Year Follow-Up Study 
Kenichi Ito, Hiroshi Tsutsui, Kazuo Haze, Tetsuya Sumiyoshi, 
Kenichi Fukami, Kunio Miyatake, Masakazu Yamagishi. Cardiology Division 
of Medicine, National Cardiovascular Center, Osaka, Japan 
Background: Although the patients with vasospastic angina treated with 
calcium channel antagonists have relatively good outcome, few data exist 
regarding the effect of underlying coronary atherosclerosis at the site of 
vasospasm on long term prognosis. Therefore, we studied the relationship 
between the ultra long term outcome of vasospastic angina prospectively 
followed up to 20 years and the factors influencing the prognosis inclusive of 
the preexisting atherosclerotic disease. 
Methods: Total 256 pts (219 men and 37 women with mean age of 
54 f 9.4) who had angiographic evidence of intense coronary vasospasm 
without or with preexisting disease (~50% diameter stenosis) at the sites 
of vasospasm were enrolled and prospectively followed to 20 (mean 13 5 
3.7) years. Cardiac events consisted of the cardiac death and the ischemic 
events which included acute myocardial infarction and unstable angina. Cox 
analysis, that was used to identify potentially important prognostic variables, 
selected the presence of the preexisting coronary lesions and coronary risk 
factors such as hypertension, diabetic mellitus, hyperlipidemia and history of 
smoking. 
Results: Among the enrolled pts, 63 pts had preexisting coronary lesions 
where vasospasm was superimposed to occur. Cardiac death occurred in 
25 pts (9.8%) and the ischemic events in 31 pts (16%) during the follow up 
period. Under these conditions, the presence of the preexisting lesions (OR = 
2.29, 95%CI = 1.40-3.76, P = 0.0011) and hyperlipidemia (OR = 0.44,95%CI 
= 0.2-0.97, P = 0.042) were independent predictors of event-free survival by 
multivariate analysis. Kaplan-Meier survival analysis revealed a significantly 
lower event-free survival in pts with preexisting lesions in comparison with 
those without lesions (P = 0.0008 by Log-rank test). 
Conclusion: These results demonstrate that the most important factor 
affecting ultra long term prognosis of vasospastic angina is the preexisting 
coronary lesions at the Sites of vasospasm. We suggest that this patient 
group requires the further intensive management with the calcium channel 
antagonists or, if necessary, the interventional procedures. 
1039-l 33 Vasospastic Angina: Long-Term Follow-Up 
Manuel Abeytua, Raul Moreno, Javier Soriano, Jaime Elizaga, Javier Betas, 
Javier Bermejo, Nicasio PBrez-Castellano, Jose A. Serrano, Francisco 
J. Portales, Eulogio Garcia, Juan L. DelcBn. Cardiology Department, 
Gregorio Marafidn Hospital, Madrid, Spain 
Background: The long-term outcome of patients (P) with symptomatic va- 
sospastic angina without significant coronary lesions has not been well stud- 
ied. 
Methods: All 86 consecutive P with vasospastic angina without significa- 
tive coronary lesions were prospectively followed-up for a mean of 8.8 years 
JACC February 2000 
(range 0.5-22 years). Coronariography was performed in all paiients and 
provocative ergobasine test in 74. All of them were discharged on calcium 
channel blockers. An angiographic reevaluation was performed in presence 
of effort angina or myocardial infarction at a long-term. Follow-up was ob- 
tained in all P (100%). 
Results: Mean age was 51.2 years, and 76 (88.4%) were male. In the 
beginning the clinical presentation was: rest angina 83 P (96.5%), exercise 
angina only 1 P, and sudden death the first symptom 2 P. The outcome was: 
15 P (17.4%) died all causes; 5 (6%) suffered a myocardial infarction; 25 
(29%) had a recurrent rest angina; 13 (15.1%) developed effort angina; 49 
(59%) were alive and free of events at the end of the follow-up. Development 
of significative coronary artery disease (CAD) at angiography was demon- 
strated in 13 P (15%). Cardiac death happened in IO P, (5 of them was 
sudden death and the others 5 after develop CAD in the follow-up). 
Conclusion: Long-term follow-up of vasoespastic angina without sig- 
nificative coronary lesions is associated with frequent recurrent ischemia 
despite treatment with calcium channel blockers. Sudden death and the 
development of significative CAD were the main cause of cardiac mortality. 
1039-I 34 Myocardial Infarction With Normal Coronary 
Arteries: A Ten Year Follow-Up 
Pier-Giorgio Golzio, Fulvio Orzan, Carla Rassat, Marco Bobbio, 
Serena Bergerone, Gianpaolo Trevi. University of Turin, Turin, Italy 
Background: Myocardial infarction (Ml) with Normal Coronary Arteries (NCA) 
has generally a good prognosis, although discrepancies are reported. More- 
over, NCA have included a broad spectrum of angiographic definitions, from 
truly NCA to non-critical lesions. Since acute coronary events are known to 
occur in Patients (Pts) with non-critical and even trivial coronary lesions, our 
aim is therefore to re-assess clinical features and late course of MIS with 
NCA. 
Methods: We studied 53 consecutive Pts admitted to the Coronary Care 
Unit of an academic tertiare care centre between 1985 and 1990, with Ml 
and a culprit lesion at coronary angiography of ~50%. They were divided 
into 3 subgroups: Group A, truly NCA; Group B, minor irregularities of the 
wall contour: and Group C, discrete non significant lesions ~50%. 
Results: Follow-up (FU) was 125 f 32 months. Group A Pts had no is- 
chaemic events and a 100% ten year survival, compared with 46% and 50% 
cardiac events and 77% and 58% survival of Group Band C Pts, respectively. 
Univariate analysis showed that ischaemic events were significantly associ- 
ated with even trivial coronary lesions (RR 1.9; IC 95% 1.4-2.6), while cardiac 
death correlated with coronary lesions (RR 1.4; 1.1-l .7), no thrombolysis in 
the acute setting (RR 1.4; 1.1-I .8), post Ml angina (RR 1.6; 0.9-2.7), post 
Ml diabetes (RR 1.1; 0.9-1.3) and EF < 50% (RR 3.2; 1.1-9.2). Mu/fivariate 
analysis showed that only the angiographic morphology of coronary vessel 
was significantly predictive of ischaemic events at FU (p = 0.006), while co- 
variates extracted as significant predictors of cardiac death were EF < 50% 
(p = 0.004), post Ml angina (p = O.OOl), post Ml diabetes (p = 0.006) and post 
Ml smoking (p = 0.04). Cumulative survival without ischaemic events was 
significantly better in Pts with truly NCA by Kaplan-Meier survival analysis, 
while cumulative survival without cardiac death was influenced by EF. 
Conclusion: Pts with Ml and truly NCA have very few ischaemic events 
at FU, and can be separated even from Pts with minor irregularities of 
the wall contour. Cardiac mortality on the contrary correlates strictly and 
independently with a depressed ventricular function. 
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1059-I 01 Left Ventricular Remodeling After Myocardial 
Infarction in Angiotensin II Type 1A Receptor 
Knockout Mice 
Yasuhiro Nakamura, Minoru Yoshiyama, Takashi Omura, Ken Yoshida, 
Masakazu Teragaki, Kazuhide Takeuchi, Junichi Yoshikawa. First 
Department of Infernal Medicine, Osaka City University Medical School, 
Osaka, Japan 
Background: Many studies have suggested that the renin-angiotensin sys- 
tem plays an important role in the development of left ventricular remodeling 
after myocardial infarction. Moreover, it has been reported that left ventricular 
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remodeling is prevented by ACE inhibitors or angiotensin II type IA receptor 
antagonists in vivo. These results suggest that the ATI -mediated signaling 
is critical for the development of left ventricular remodeling after myocardiai 
infarction. However, the previous studies are still phenomelogical and we do 
not still have a direct evidence of it. 
Method and Result: To determine whether ATl-mediated signaling is 
indispensable for the development of left ventricular remodeling after my- 
ocardial infarction, myocardial infarction was produced by ligation the left 
anterior descending coronary artery of ATIA knockout (KO) and wild type 
(WT) mice (each group, n = 7). Cardiac geometry and function were examined 
by Doppler echocardiography. Doppler echocardiograms were measured 4 
week after myocardial infarction (MI). LV internal diastolic dimension was 
greater MI-WT than in MI-K0 (P cc 0.01) (MI-WT 7.2 i 0.3 mm, MI-K0 5.2 & 
0.3 mm, control 4.6 f 0.3 mm). The functional shortening more decreased 
in MI-K0 than in MI-WT (P < 0.01) (MI-WT 32 i 4%, MI-K0 45 k 4%, 
control 61 i 3%). Peak early filling velocity in MI-WT increased more than 
in MI-K0 (P < 0.05) (MI-WT 91 & 5 cmisec, MI-K0 81 + 5 cmisec, control 
72 i 4 cmisec). Late filling velocity in MI-WT decreased more than in MI-K0 
(P x 0.05) (MI-WI 16 i 3 cm/set, MI-K0 20 * 3 cm/set, control 35 -+ 6 
cmisec,), resulting in a marked increase in the ratio of early filling to late filling 
between three groups (MI-WT 7.1 + 1.2, MI-K0 4.1 i 1.9, control 2.5 f 0.4). 
Left and right ventricular weights m MI-K0 was significantly smaller than in 
MI-WT. There were significant differences between MI-WT and MI-K0 in the 
left ventricular cavity, systolic function and diastolic function as revealed by 
the transthoracic echocardiogram. 
Conclusion: AT1 -mediated Ang II signaling is essential for the develop- 
ment of left ventricular remodeling after myocardial infarction. 
1059-f 02 / Ang~ote~sin II Receptor Antagonism Alone Does 
’ Not Limit Post-Infarction Left Ventricular 
Remodeling 
Sunil Mankad, Jeffrey 6. Lin, Amy Shaffer, Therese M. Theobald, Waiter 
J. Rogers, Nathaniel Reichek, Christopher M. Kramer. Allegheny General 
h’ospiial, MCP/Hahnemann School of Medicine. Pittsburgh, Pennsylvania, 
USA 
Backgrounds We have previously shown that, when added to angiotensin- 
converting enzyme inhibition, angiotensin II type IA receptor (AT,) antago- 
nism further limits post-infarction LV remodeling in a well-characterized ovine 
model. However, the effect of ATI blockade alone in this setting is unclear. 
Methods: Twenty-two sheep were randomized to losartan (50 mgiday, n 
= 11) or no therapy (n = 11) 48 hours after transmural anteroapical Ml by 
coronary ligation. Cine and tagged magnetic resonance imaging before and 
8-weeks after Ml was used to quantify changes in LV end-diastolic volume 
index (EDVi), end-systolic volume index (ES&), mass index (LVMi), ejection 
fraction (EF), and regional intramyocardial circumferential percent shortening 
(%S) in noninfarcted segments adjacent to (within 2 cm) and remote from 
the infarct. 
Results: Baseline LV volumes, mass. and systolic function were similar 
between groups. Infarct size as a percentage of LV mass at 8-weeks post-MI 
was similar: 24 + 4 vs 23 i 6% (p = ns). Baseline, 4-, and &-week post-MI 
blood pressures were similar, but heart rate was lower at 8-weeks post-MI in 
the group treated with AT, blockade compared to infarcted controls (110 * 
13 vs 127 * 16 bpm, p =Z 0.02). Left atrial pressure at 8-weeks post-MI was 
similar (IO f 2 vs 11 & 2 mmHg, p = ns). ATI antagonism did not attenuate 
post-infarction LV remodeling or limit global systolic dysfunction (AEDVi: +0.9 
& 0.5 vs +0.8 -ir 0.4 ml/kg, AESVi: +0.9 5 0.5 vs +0.9 & 0.4 ml/kg, ALVMi: 
+O.i i 0.4~~10.1 k 0.4 mg/kg, and AEF: -19 + 10~s -23 f 7%; p= nsfor 
ATI blockade vs control for ail). There was a strong trend towards less decline 
in adjacent %S with AT, blockade compared to no therapy (a%S: -4 i 2 vs 
-8 * 5%, p = 0.056). No change in remote %S was seen in either group. 
Conclusion: In this model, AT, antagonism alone does not attenuate 
post-infarction LV remodeling or limit global systolic dysfunction, although 
beneficial effects on adjacent noninfarcted regional function were seen, 
1059-l 03 Prolonged Cardiomyocyte Apoptosis in the 
Remote Myocardium is Associated With Left 
Ventricular Remodelling After Experimental 
Myocardial Infarction 
Eeva Palojoki, Antti Saraste, Anders Eriksson, Kari Pulkki, Markku Kailajoki, 
llkka Tikkanen, Liisa-Maria Voipio-Pulkki. University of Turku and Minerva 
Research Institute, liirku and Helsinki. Finland 
Background: Remodeliing of the left ventricle (LV) after acute myocardial in- 
farction (AMI) is associated with progressive cardiac dysfunction and adverse 
outcome both in man and in experimental models, 
Methods: To clarify the role of cardiomyocyte loss by apoptosis (CA) 
in this process, we produced AMI by coronary artery ligation in rats and 
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sacrificed them and sham-operated control animals at 24 hrs and I, 4 and 
12 weeks post-AMI. Infarct size planimetry, quantification of CA (TUNEL 
method) in the infarct, border and remote zones and echocardiography (LV 
end-diastolic dimension EDD, ejection fraction EF) were performed. 
Results: Sham-operated animals showed low CA rate (mean 0.03%) 
and no statistically significant change in EDD or EF during the study. In 
AMI rats on day I, TUNEL positivity was high (4.9%, SD 2.5, p = 0.01 vs. 
sham) in the border zone, declining to 0.26% (p = 0.04) at 4 and 0.10% at 
12 weeks. In the remote non-infarcted myocardium, CA was increased to 
0.07% (SD 0.03, p < 0.05) on day 1 and remained on the same level up to 4 
weeks when 63% of all apoptotic cardiomyocytes were found in the remote 
areas. By echocardiography, mean EF decreased (19%) and EDD increased 
(14%) after AMI. EF did not correlate with CA. However, the increase in 
EDD from baseline to 4 weeks correlated (r = 0.51, p = 0.05) with CA in the 
non-infarcted myocardium. Notably, there was no correlation between infarct 
size and remote area CA. 
Conclusion: In a rat AMI model, CA remains high in the viable border 
zones for 4-12 weeks. However, ventricular enlargement correlates with 
apoptosis in the remote noninfarcted areas which quantitatively contributes 
most to the apoptotic cell loss in the LV. 
Erl 1059 IO4 Differential Regulation of Bcl-2, P53, AP-1 and 
NFKB on Cardiomyocyte Apoptosis During 
lschemic Preconditioning 
Nilanjana Maulik, Sankar Addya, Nathaniel Galang, Richard M. Engelman, 
Dipak K. Das. University of Connecticut School of Medicine, Farmington, 
CT; University of Pennsylvania, Philadelphia, PA, USA 
Background: Acute ischemia followed by prolonged reperfusion has been 
shown to induce cardiomyocyte apoptosis which can be reduced by ischemic 
preconditioning. This study sought to determine the regulation of apoptosis 
by the transcription factors. 
Methods: Isolated rat hearts were subjected to 30 min ischemia followed 
by 2 hours of reperfusion. Another group of hearts were preconditioned by 
subjecting them to four cyclic episodes of 5 min of ischemia, each followed 
by another 10 min of reperfusion. The preconditioned hearts were then made 
ischemic for 30 min and reperfusecl for a further period of 2 hours. 
Results: In this report, we demonstrate that myocardial adaptation to 
ischemia induced by repeated cyclic episodes of short-term ischemia each 
followed by another short duration of reperfusion reduced cardiomyocyte 
apoptosis and DNA fragmentation. This was associated with the induction of 
the expression of B&2 mRNA, downregulation of p53 and translocation and 
activation of NFKB. Another transcription factor, AP-I, remained unaffected 
by repeated ischemia and repetfusion, but exhibited significant upregulation 
by a single episode of 30 min ischemia followed by 2 hr of reperfusion. Both 
AP-I and NFKB are induced through the oxidative stress developed in the is- 
chemic repetfused myocardium. Cardiomyocyte apoptosis occurs when AP-I 
remains high and NFKB remains low as in the case of ischemia/reperfusion. 
The NFKB binding activity is almost 5 times more compared to its binding 
activity during ischemia and reperfusion. 
Conclusion: The results of this study indicate that ischemia/reperfusion 
upregulates AP-I and the pro-apoptotic gene P53 whereas ischemic precon- 
ditioning upregulates anti-death gene BCL-2 and the nuclear transcription 
factor NFKB and downregulates P53 and AP-I and thereby inhibits apo- 
ptosis. 
I . 1059 105 Effects of Carvedilol Versus Probucol on Survwal, Left Ventricular Function and 
Morphology in lschemic Heart Failure in Rats 
Ying Tung Sia, Michel White, Jean-Lucien Rouleau. Montreal Heart 
Institute, Montreal, Quebec, Canada 
Background: Carvedilol reduces infarct size in animals pretreated prior to 
myocardial infarction (Ml) and provides clinical benefits when used in patients 
post-MI. In this study, we evaluated the effects of carvedilol post large MI 
in rats and we compared these effects with the powerful antioxidant pro- 
bucol. 
Methods: Rats with large Ml created by LAD ligation were assigned to 
vehicle (soya bean oil), to carvedilol (20 mg/kg, bid) or to probucol (61 mgikg, 
die) for 4 weeks. In vivo hemodynamy was assessed under light anesthesia, 
and LV and scar morphologies were assessed on the explanted hearts. 
Results: Probucol improved survival of rats with large Ml (87.9%) com- 
pared with carvedilol (38.8%) and vehicle (50.6%) (both p x 0.05). Both 
treatment partially preserved left ventricular (LV) systolic function, increased 
LV hypertrophy and scar thickness, and decreased cardiac fibrosis (see 
table). 
Conclusions: Carvedilol treatment does not improve post-MI mortality 
at 4 weeks despite some preservation of LV systolic function and some 
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Groups LVSP 
CmmHg) 
LV + dP/dt 
(mmHg/s) 
Cardiac 
Fibrosis’ 
LVWBW 
(g/kg) 
Sham 101 l z 5015 * 170 - 2.99 i 0.18 2.10 f 0.03 
(n = 46) 
Ml-vehicle 89i2" 3308zk144" 0.33 * 0.04 6.64i 053* 1.97 zt 0.03’ 
(n =46) 
MI-CR!! 105 + Zt 4166 zt 17’2t 0.55 + 0.05t 5.03i 0.25t 2.11 zk 0.03.t 
(n=28) 
MI-PRO 104 + 2t 4051 i 156t 0.64 & 0.07t 2.68 zt 0.06t 2 03 * 0.06 
fn = 291 
Data & SEM; *p c 0.05 vs sham; tp < 0.05 vs Ml-vehicle; LVSP = LV systolic pressure; 
’ = % collagen volume density x LV weight/body weight. 
beneficial affects on LV remodeling Probucol markedly improves post-MI 
survival and provides similar effects on LV function and morphology than 
carvedilol. This suggests that antioxidant agents may play important role on 
cardioprotection and survival in ischemic heart failure. 
1059-l 06 Carvedilol Limits Infarct Size Via 
Adenosine-dependent Mechanisms in Dogs 
Hiroshi Asanuma, Masafumi Kitakaze, Shoji Sanada, Seiji Takashima, 
Yasuhiko Sakata, Masanori Asakura, Tsunehiko Kuzuya, Masatsugu Hori. 
Osaka Univ. Graduate School of Med., Osaka, Japan 
Background: Calvedilol is known to decrease the incidence of cardiovas- 
cular death in patients with chronic heart failure compared with the other 
B-blockers, and the priority of calvedilol may be attributable to its anti-oxidant 
effect. Since we have previously repotted that superoxide attenuates the 
increases in adenosine (ADO) levels in ischeniic myocardium, and that ADO 
plays a major role for attenuation of the severity of chronic heart failure and 
the ischemia/reperfusion injury, we tested whether calvedilol limits infarct 
size via ADO-dependent mechanisms in the canine hearts. 
Methods: In the open chest dogs, the LAD was perfused with blood 
through a bypass tube. We occluded the bypass tube for 90 min followed by 
6 hours of reperfusion. Infarct size was assessed by TTC staining. 
Results: Calvedilol (0.3 mg/kg) limited infarct size compared with the 
untreated condition (19.6 & 3.0 and 41.2 f 3.4%, p < O.Ol), which was com- 
pletely blunted by an ADO receptor antagonist, 8-SPT, (48.5 f 4.0 and 49.4 
f 5.8% in the calvedilol and the calvedilol with 8-SPT groups). Furthermore, 
exogenous ADO limited infarct size to 17.2 i 1.2%, the comparable level of 
calvedilol group. 
Conclusion: We conclude that calvedilol potently limits infarct size via 
ADO-dependent mechanisms. We suggest that the cardioprotective effects 
of calvedilol may be partially attributed to ADO. 
1 1059-l 07 ( Effect of Caspased Inhibitor on Myocyte 
Apoptosis and Left Ventricular Remodeling in 
the Ischemia-Reperfused Rat Heart 
Masayasu Kimura, Toshiro Miura, Takayuki Okamura, Hiroshi Iwamoto, 
Mitsuo Iwatate, Yuka Dairaku, Masunori Matsuzaki. Yamaguchi University 
School of Medicine, Ube, Japan 
Background: A role of myocyte apoptosis on the left ventricular pathophys- 
iology in the ischemia-reperfused heart is unclear. To clarify the roles, the 
effect of caspase-3 (CPP32) inhibitor on myocyte apoptosis and remote left 
ventricular remodeling were examined. 
Methods: Sprague-Dawley rats were subjected to 30-min ischemia and 
reperfusion. Caspase-3 inhibitor, DEVD-aldehyde, at 3.5 mg/kg (DEVD group; 
n = 7) or dimethyl sulfoxide (vehicle group; n = 7) were administered intra- 
venously 5 minutes before the ischemia. lmmunohistochemical staining of 
the in situ end labeling (TUNEL) was performed at 6 hours after reperfusion 
and the percentage of TUNEL positive myocyte (%TN) in the risk area was 
quantified. The infarct size was defined by TTC stain at 6 hours after reper- 
fusion and expressed as the percentage of the risk area. At 3 weeks after 
reperfusion, left ventricular (LV) pressure-volume relation of excised heart at 
O-30 mmHg was evaluated (n = 7, each). 
Results: %TN was significantly reduced from 20 f 1% to IO & 3% in the 
risk area with DEVD-aldehyde (p < O.Ol), however, the percentage of infarct 
size was not significantly changed by DEVD-aldehyde (61 i 5% in vehicle 
group vs 61 f 9% in DEVD group, NS). There were no significant shift of LV 
pressure-volume curve between vehicle and DEVD (243 f 77 vs 270 & 62 
WL at 0 mmHg, 721 f 65 vs 703 f 61 WL at 15 mmHg, 900 f 34 vs 798 f 
45 FL at 30 mmHg, all N.S.). 
Conclusion: Although myocyte DNAfragmentation was inhibited by DEVD- 
aldehyde, neither infarct size nor remote LV remodeling was not affected. 
Thus, apoptosis plays a minor role on the ischemia-repetfusion injury. 
1 1059-I 08 1 Estrogen Replacement Inhibits Angiotensin 
Converting Enzyme Activity After Large 
Myocardial Infarction in the Rat 
Laura J. Collins, Dorothy Martinez-Bonugli, May A. Garcia, Robert 
E. Shade. University of Texas Healfh Science Center at San Antonio & 
Southwest Foundation for Biomedical Research, San Antonio, JX, USA 
Background: Elevated levels of angiotensin converting enzyme (ACE) are 
present after large myocardial infarction (MI). We have previously shown that 
estrogen decreases collagen content (a marker of ventricular remodeling) 
of the noninfarcted myocardium after Ml, but the effect of estrogen on ACE 
levels is unknown. This study sought to determine whether estrogen replace- 
ment would suppress plasma ACE levels and prevent ventricular remodeling 
after large MI in the rat. 
Methods: Ovariectomized Wistar female rats (n = 21) underwent large 
MIS by ligation of the left coronary artery. Animals were replaced with sub- 
cutaneous 17/+estradiol (to achieve plasma estradiol levels of 20-40 pg/ml) 
or sesame oil (control). Transthoracic echocardiograms were performed at 
baseline (B) and 13 wks after MI. Infarct size was estimated from the histo- 
logic sections. Plasma and tissue myocardial ACE activity were determined 
using a spectrophotometric substrate assay. 
Results: Animals treated with 17/J-estradiol (E) after large MI showed a 
29% reduction (p < 0.005) in plasma ACE levels compared to control (C) an- 
imals (189 f 21 IU/L vs 268 + 15 IU/L). The ACE levels in the 17@-estradiol 
treated animals after Ml were similar to age-matched noninfarcted ovariec- 
tomized controls (189 IU/L vs. 190 IUIL). Mean infarct size was 43 f 7% for 
E treated and 43 f 5% for C animals. There was no significant difference in 
the echocardiographic parameters between the groups at 13 weeks. 
LVDD FS PWd E/A 
s ‘E 6.3 42 1.3 1.6 
c 6.2 47 1.3 1.5 
13 wks *E 9.1 20 1.7 1.7 
C 8.6 21 1.5 2.8 
LVDD = Left Ventricular Diastolic Dimension (mm), PWd = Posterior WallThickness (mm), 
FS = Fractional Shortening (%), E/A = Early/Late Diastolic Filling Velocities *p = NS 
(bO.05 for all echo parameters at S & 13 wks between E & C 
Conclusions: Estrogen replacement downregulates plasma ACE levels 
after MI, however no significant effects were noted on left ventricular ge- 
ometry, hypertrophy of the noninfarcted myocardium or diastolic parameters 
between groups. These findings suggest that estrogen may play an important 
role in the prevention of left ventricular remodeling through the modulation of 
the renin angiotensin system. 
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1060-l 35 Emergency Catheterisation Immediately After 
Coronary Artery Bypass Grafting for Extensive 
lschemia 
Hans de Swat?, Jindra Vainer, Vincent van Ommen, Frits BBr, Gijs Geskes’ , 
Jos Maessen’, Kees Prenger’ , Hein J.J. Wellens. Deparfment of 
Cardiology; ’ Cardiothoracic Surgery, University Hospital Maastricht, 
Maastricht, The Nefherlands 
Background: Myocardial infarction (AMI) after coronary artery bypass graft- 
ing (CABG) is allegedly observed in 15% of the cases. Extensive AMI in the 
early post-operative phase, however, is reported less frequently but is caus- 
ing a major dilemma in choosing the optimal treatment modality. Thrombolytic 
agents are contra-indicated and percutaneoub interventions may cause se- 
vere damage to newly sutured grafts. In order to clarify the best strategy 
of treating extensive ischemia after CABG we retrospectively studied our 
patients. 
Methods: From September 1997 to August 1999 in total 1576 patients 
(pts) undetwent CABG with or without valve replacement. Seventeen pts 
with extensive ischemia within the first hours after the operation refractory to 
increasing dosages of nitroglycerine and heparin were referred for cardiac 
catheterisation. All pts were on mechanical ventilation. Coronary angiography 
was performed by femoral approach after administration of 5000 U of heparin. 
Results: Mean age of the pts was 66 & 8 years, 13 were male and 
4 were female. CABG only was performed in 15 pts, 2 pts had additional 
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valve replacement, In all pts the catheterisation was uneventful. Grafl oc- 
clusions (thrombotic or surgical) were observed in 11/17 pts, kinking of the 
graft in 4117 pts and spasm of the graft or native coronary arteries in 2117 
pts. An intra-aortic balloon pump was inserted in 12 pts. In 12117 pts the 
imperfect surgical result found necessitated an urgent invasive intervention. 
Subsequently, a PTCA was performed in 5 pts and 7 pts required immediate 
re-operation. The 5 remaining pts were treated conservatively (2 pts with 
spasm, 3 pts not amenable to invasive treatment). In-hospital mortality was 
18% (3/l 7 pts) caused by late complications of the surgery. 
Conclusions: 1) Cardiac catheterisation and PTCA immediately after 
CABG is feasible and safe. 2) In all cases the cause of ischemia could be 
detected. 3) In the majority of cases findings necessitated further invasive 
treatment. 4) Urgent intervention for extensive ischemia after CABG may 
improve prognosis 
/ 1060-l 36 1 Home is Where, the Heart is - Hospital in the 
Home Management of Myocardial Infarction 
Lisa Jenkins, Lisa J. Keighran, Sandra L. LeVasseur, Heather A. Jarman, 
John Boxall. A&X&J Medical Centre, Mona& Universifl: Melbourne, 
Australia 
Background: The management of uncomplicated acute myocardial infarc- 
tions (Ml) in the home was a 12 monih pilot study, funded by the Department 
of Human Services, Victoria, Australia and was carried out in collaboration 
with the Heart & Chest & the Hospital in the Home (HITH) programs. The 
program assessed whether selected uncomplicated Ml patients could be 
safely iransferred home on Day 3 and managed at home on Day 4 and 5 by 
nurse practitioners. 
Methods: The pilot project commenced in February 1998 and completed 
recruitment in January 1999. During this time a total of 308 patients were 
admitted to Cardiac Care Unit with Ml’s All Ml’s were then assessed for 
entrance to the H!TH program by 3 forms of criteria. General Criteria: ~75 
years of age, live within It .6 mile radius, a caret to stay with, not diabetic, 
telephone available and be able to speak and read English (important due 
to the research component). Medical Criteria: no post Ml angina, LVF or 
uncontrolled arrhythmia’s Home Transfer Criteria: ie: approval by treating 
cardiologist; able to ambulate 200 metres, and consented to both HITH and 
Research component. 
Results: Of the 308 patients, 57% (176) were excluded by General 
Criteria, a further 29% (90) were excluded by the Medical Criteria and a 
further 4% (13) went onto be excluded by tha Home Transfer Criteria or other 
factors such as co-morbidites. Leaving 10% (29) that fulfilled the criteria 
and were successfully transferred to the MI HITH program. There were no 
readmissions, relnfarctions or deaths in HITH. However, 4 patients (14%) 
experienced angina, their cardiologist was notified and investigations were 
brought forward. A total of 5 telephone calls were made by the 29 patients 
and related to medication or anxiety related symptoms. 
Conclusion: The results of this pilot study show that approximately 10% 
of Ml patients may be safely managed and suitable for early transfer to HITH 
thus increasing the availability of critical care beds and therefore permitting 
a reduction in costs to the Heart & Chest Program. 
1 1060-l 37 / Clinical Si~n~fi~anca of Antegrade Flow to the 
Infarct Zone Before Primary Percutaneous 
Transluminal Coronary Angioplasty in Q-Wave 
Acute Myocardial Infarction 
Kengo Hatada’, Tetsuto Sugiura”, Nobuyuki Takahashi’, 
Seishi Nakamura’ 1 Fumio Yuasa’, Toshiji Iwasaka’ ‘Kansai Medical 
University, Osaka; “Kochi tvledical School, Kochi, Japan 
Background: Successful reperfusion of the culprit coronary artery in acute 
phase of myocardial infarction (Ml) is reported to limit infarct size and reduce 
mortality. However, less is known about the effect of antegrade flow to the 
infarct zone before primary percutaneous transluminai coronary angioplasty 
(PTCA) on in-hospital clinical course. 
Methods: To assess the influence of antegrade flow before repetfusion 
therapy, we studied 264 consecutive patients (pts) with Q-wave acute Ml 
admitted ~12 hours from onset and had successful primary PTCA. Pts 
were classified into 2 groups: G-l = 190 pts with total occlusion and G-2 = 
74 pts with antegrade flow to the infarct zone. Left ventricular wall motion 
abnormality and pericardial effusion (PE) were studied by two-dimensional 
echocardiography. Incidence of pericardial friction rub (PR) and in-hospital 
complications were also evaluated. 
Results: Collateral flow io the infarct zone was more frequently obsetved 
in G-l than in G-2 (49% vs 27%; p < 0.01). When pts in G-l were divided 
into two groups (G-l a: presence of collateral flow, G-1 b: no collateral flow), 
pts in G-lb had higher incidence of left ventricular aneurysmal motion (11% 
vs 1%; p = 0.03) PR (15% vs 3%; p = 0.03) and bundle branch block (21% 
vs 5%: p = 0.02) than those in G-2. Moreover, the incidence of PE (34% vs 
17%, 9%; p = 0.02, p x 0.01) and in-hospital mortality (8% vs I%, 1%; p = 
0.04, 0.06) were significantly higher in G-lb than those in G-la and G-2. 
Conclusion: Despite successful primary PTCA, absence of antegrade 
flow and collateral flow to the infarct zone results in higher incidence of 
in-hospital complications. 
/ 1060-l 38 1 In-Hcspita! Mortality for Patients With 
Cardrogemc Shock Undergoing PTCA and 
CABG in 1998: Results From the National 
Cardiovascular Network (NCN) 
Elizabeth M. Mahoney, Trevor D. Thompson, Emir Veledar, Haitao Chu, 
Robert W. Emery, Charles W. Abbottsmith, William S. Weintraub. Nafionai 
Cardiovascular Network and Emory University, Atlanta, GA, USA 
Background: In-hospital outcomes of patients with cardiogenic shock (CS) 
undergoing PTCA or CABG from l/1/98 to 6/30/98 at 19 NCN centers were 
examined. 
Methods: PTCA patients (n = 130) were 39% female, age 66 rt 12, 56% 
HTN, 28% DM, 15% prior PTCA, 13% prior CABG, EF 35 * 16%, multisite 
30%, and stent(s) 72%. CABG patients (n = 93) were 42% female, age 65 
* 11, 70% HTN, 33% DM, 12% prior CABG, 17% prior PTCA, EF 36 f 15, 
IMA 48%. PTCA mortality was 34%. 
Results: Multivariate analysis revealed female gender, lower EF, and no 
stent placement to be significantly associated with a higher risk of death. 
Overall, CABG mortality was 33%; significant predictors were # distal anas- 
tomoses (non-linear), age and diabetes, and there was an age*diabetes 
interaction whereby the risk of death increased with increasing age for dia- 
betics but not for non-diabetics. C-indices from bootstrap validation of PTCA 
and CABG models were 0.76 and 0.75, respectively. See table for odds ratios 
(* from bootstrap validation): 
PTCA CABG 
OR 95% Cl OR 95% Cl 
Diabetes 
Female 2.45 1.03-5.79 60 yrs 0.42 0.05-3.38 
70 yrs 4.39 1.29-l 4.97 
LVEF (&IO%) 1.79 1.21-2.62 # distal anastomoses - 
Aw(11’J!A 
No Sent 4.0 1.68-9.49 non-diab 0.96 0.53-1.71 
diabetic 9.87 1.62-60.15 
C-index 0.77 C-index 0.62 
Corrected C-index* 0.76 Corrected C-index” 0.75 
Conclusion: The mortality is high in cardiogenic shock, whether patients 
are revascularized by angioplasty or coronary surgery; models to predict 
outcome may help guide therapy. 
I 1060 139 Mechanism of No Reflow Phenomenon in Patients With Acute Myocardial Infarction: Its 
Impact on Coronary Zero Flow Pressure and 
Flow Pressure Slope Index 
Kazuo Terai, Hiroshi Ito, Katsuomi Iwakura, Ken Sugimoto, 
Shintani Yamamoto, Yorihiko Higashino, Kenshi Fujii. Sakorabashi 
Watanabe Hasp, Osaka, Japan 
Acute myocardial infarction (AMI) is often associated with substantial no 
reflow phenomenon (NR), that is an indicator of poor clinical and functional 
outcomes. But its impact on coronary hemodynamics has not been elucidated 
in patients. In this study, we investigated the impact of NR on coronary zero 
flow pressure (Pzf) and flow pressure slope index (FPSI) in patients with AMI. 
Methods: Study population was consisted of consecutive 22 patients with 
AMI. Six patients with angina pectoris were served as control subjects. All 
patients underwent successful PTCA with minimal residual stenosis within 
24 hours of the symptom onset. We inserted Doppler guidewire and pressure 
wire over the culprit lesion in each patient. After the intracoronary injection 
of ATP (12 fig to RCA, 24 pg to LCA), we recorded coronary flow velocity 
and pressure and calculated Pzf and FPSI with analyzing the pressure-flow 
relation during diastole. We performed myocardial contrast echocardiography 
with intracoronary injection of microbubbles shortly after reperfusion and 
divided the patients into two groups based on the presence or absence of 
substantial NR; good reflow (GR, n = 16) and NR (n = 6). 
Results: Peak CK was higher in NR than in GR (4471 vs. 1555 IUil, P 
= 0.005). Pzf was higher in AMI patients than in control subjects (48 i 17 
mmHg vs. 27 i- 3 mmHg). Among AMI patients, Pzf was significantly higher 
in NR than in GR (70 f 17 vs. 40 & 8 mmHg, P = 0.003). FPSI in NR was 
significantly higher than that in GR and control subjects (NR; 3.96 f 2.96 
cm/sec/mmHg (p < 0.05 vs. others), GR; 0.81 & 0.58, control; 0.93 f 0.24), 
indicating higher coronary conductance. 
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Conclusion: NR in AMI is attributable not to a decrease in coronary vas- 
cular conductance but to an extreme increase in Pzf. Thus, the augmentation 
of coronary perfusion pressure over Pzf with the intra-aottic balloon pumping 
might be a useful therapeutic option. 
/ The ENACT Study 
Keith A.A. Fox. On behalf of the ENACTInvestigators; Royal Infirmary, 
Edinburgh, UK 
Background: Unstable angina (UA) is recognised as a major cause of emer- 
gency hospital admission with chest pain, but little information is available in 
Europe on its prevalence relative to that of myocardial infarction (Ml) or on 
current treatment practices. The ENACT study was designed to collect this 
information prospectively on a pan-European basis, Data were collected on 
a total of 3082 patients from 389 sites in 29 European countries. 
Methods: Cardiologists were recruited for ENACT by a series of mailings; 
those agreeing to take part were asked to collect information prospectively 
on a patient log on consecutive patients admitted with a working diagnosis 
on admission of unstable anginainon-ST-elevation MI, Ml or suspected acute 
coronary syndrome (ACS), over a period of one week between April and July 
1999. 
Results: The initial diagnosis was UAInon ST Ml in 46%, Ml in 39% and 
suspected ACS in 14%. There was little difference between countries in the 
ratio of UA/MI. The mean age for UA patients was 65.1 years (median 66) 
compared with 63.9 years (median 64) for Ml. 31% of those with UA and 
27% of Ml patients were female. Patients with UA were more likely to have 
experienced angina in the previous 6 months (60% vs 35% for Ml) and were 
more likely to have undergone prior revascularisation (20% vs 7%). Most 
patients presented within 12 hours of the onset of symptoms, but the figure 
was higher for Ml (72%) than for UA (59%). An initial diagnosis of Ml was 
subsequently confirmed in 88%: an initial diagnosis of UA was confirmed 
in 67%. Angiography was done during the index admission in 41% of UA 
patients (range: 19% in UK to 69% in France) and scheduled in a further 
20%. 23% of all UA patients underwent PTCA (range: 9% in UK to 51% 
in France). Use of aspirin, nitrates and any form of heparin was uniformly 
high; some national differences were observed in use of calcium antagonists, 
B-blockers and ACE inhibitors. Overall 50% of UA patients and 34% of Ml 
patients received LMW heparin; 6% and 9% respectively received a GP 
llbillla inhibitor. The in-hospital mortality rate was 1% for patients with a final 
diagnosis of UA, 5% for patients with a diagnosis of Ml evolved from UA and 
6% for Ml. 
Conclusion: UA is more common than Ml as a cause of hospital admis- 
sion in Europe and the relative prevalence is consistent between countries. 
There is wide variation in the use of angiography/PTCA and some variation 
in pharmacological treatment across Europe. 
I 1060 141 Coronary Stenting in Stable and Unstable 
Angina Patients: Results, Complications and 
6-Month Clinical-Angiographic’Outcome 
Daniela Trabattoni, Franc0 Fabbiocchi, Alessandro Loaldi, Piero Montorsi, 
Stefano Galli, Paolo Ravagnani, Antonio L. Bartorelli. institute of Cardiology: 
University of Milan, “Monzino” Foundation, W/an, lfaly 
Higher rates of major adverse events and restenosis after PTCA have been 
reported m unstable angina compared to stable angina patients. Aim of 
our study was to compare clinical and angiographic outcomes following 
coronary stent implantation in 736 stable (S) and 360 unstable (U) angina 
pts between May ‘92 and February ‘98. The analysis of major coronary risk 
factors showed a relative increase in male gender (86.5% vs 79.7%, p = 
0.004), higher cholesterol levels (52.9% vs 45.5%, p = 0.02) and a previous 
history of Q-wave Ml (41.4% vs 31.9%, p = 0.002) in stable compared to 
unstable pts. No differences were observed in coronary disease extension 
(I-VD: 53.8% Svs51.9% U, ns; 2-VD: 31.8%vs35.5% U, ns; 3-VD: 14.4% S 
vs 12.5% U, ns), stented vessel (LAD: 49% S vs 53.4% U, ns; RCA: 30% S vs 
28.7%U,ns; LCx: 17.8%Svs12.8%U,p=0.02;Graft:2.9%Svs5%U,ns) 
and lesion type (A: 5.7% S vs 7.8% U, ns; Bi: 41.7% S vs 32% U, p = 0.05; 
82: 40.6% S vs 49% U, ns; C: 12.4% S vs 11.4% U, ns). Coronary lesions 
were longer in stable pts: 16.7 & 8.6 mm vs 13.8 f 7.8 mm in U (p = 0.01). 
Bailout stenting in U pts was twice that observed in S (20.2% vs 11.8%, 
p = 0.001) due to a more frequent occurrence of flow limiting dissections 
and abrupt closure. Similar were the number of stenffpt, maximal inflation 
pressure and final balloon diameter used for stent postdilation in both groups. 
High procedural and clinical success were achieved in unstable pts (95.8% 
and 96.4%), similar to that obtained in stable angina (96.6% and 97.9%, ns). 
Amongst in-hospital complications, no differences were observed in stent 
thrombosis (0.5% S vs. 0.9% U, ns) and need for urgent CABG (0.5% S 
vs 1.4% U, ns) while a greater incidence of death (0.1% S vs 1.6% U, p = 
0.006) Q and non-Q wave Ml (1.7% S vs 4.7% U, p = 0.009) and major 
bleeding (0.9% S vs 4.1% U, p = 0.0007) occurred in U pts. Cumulative data 
of 6-mos F/U, so far available in 70% of S and 72.9% of U pts, showed a 
three-fold higher incidence of recurrent angina in U pts (4.4% S vs. 10.6% 
U, p = 0.001) but no difference in the rate of Q-wave Ml (0.5% S vs. 0.8% U, 
ns), death (0% S vs 0.8% U, ns), Re-PTCA (14.5% S vs. 16.2% U, ns) and 
CABG (2.5% S vs 2.9% U, ns). Angiographic restenosis was 25.8% in S and 
35.8% in U patients (p = 0.002). 
Conclusions: 1, Stenting was associated with high and comparable acute 
success in S and U pts; 2. Although MACE were observed more frequently in 
unstable angina, their incidence was significantly lower than that previously 
reported for PTCA; 3. Six-month F/U showed higher recurrence of angina 
and angiographic restenosis in unstable pts. 
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1 1061-I 27 ] Can Effort Angina Pectoris be Diagnosed at 
Rest? 
Akihiko Sasaki, Tomio Arai, Hiroshi Shigeta, Akira Yamashina. Tokyo 
Medical lJnivers& Tokyo, Japan 
Background: The normal ECG-T wave is asymmetrical because its de- 
scending limb is steeper than its ascending limb. Thus, we evaluated the 
symmetry of resting ECG-T wave without ST-T abnormality in effort angina 
pectoris patients using the 1st derivative electrocardiogram (FDECG). 
Methods: We studied 104 effort angina pectoris patients on the basis of 
(1) normal resting ECG, (2) angiographically proven one-vessel stenosis, and 
60 age- and sex-matched normal subjects (N group). The 104 effort angina 
pectoris patients consisted of 52 patients with LAD disease (LAD group), 30 
patients with LCX disease (LCX group) and 22 patients with RCA disease 
(RCA group). We recorded X, Y and 2 lead scalar ECG with the Frank lead 
system, and obtained a 1st derivative wave at each lead. The 1st derivative 
waves were indicated IdX/dtj, jdY/dt/ and jdZ/dtj. All FDECG-T waves had 
two peaks, The first peak of the FDECG-T wave was designated as the 
Ti wave and the second peak as the T2 wave. The ratio of the T2 wave 
magnitude to the Tl wave magnitude (T2/Tl ratio) was used as an index of 
the degree of symmetry of the ECG-T wave. We compared the T2fTI ratio 
in four groups, 
Results: (1) The TZITI ratio in the X lead was significantly decreased in 
the LAD, LCX and RCA groups compared to the N group (p < O.OOl), but 
there were no significant differences among the LAD, LCX and RCA groups 
(LAD group: 1.60 i 0.37 vs LCX group: 1.64 + 0.34 vs RCA group: 1.61 f 
0.25 vs N group: 2.04 * 0.29). (2) The T2/Ti ratios at the Y and Z leads had 
no significant differences among four groups. (3) Using a X lead T2/Ti ratio 
cutoff of 1.8, the diagnostic ability to detect effort angina pectoris patients 
was 77% in sensitivity, 77% in specificity and 77% in accuracy. 
Discussion: The magnitude of Ti and T2 waves correspond to the 
maximum slope of the ascending and descending limbs of the T wave on 
ECG, and it is possible to quantify the symmetry of the ECG-T wave by the 
T2TTi ratio. The symmetrization of the T wave was found only at the X lead 
regardless of coronary stenosis location. Since the X lead corresponds to 
V5 and 6 leads, the repolarization abnormalities that we don’t notice by the 
conventional ECG appear in the left ventricle apex as the symmetrization of 
the T wave. 
Conclusion: The T2/Ti ratio in the X lead is a useful index to diagnose 
effort angina pectoris at rest even when the resting ECG is normal. 
/ 1061 128 Ambulatory Electrocardiographic Monitoring 
Predicts Coronary Angiographic Findings in 
Women With Suspected lschemic Chest Pain: 
Results From the NHLBI Sponsored Women’s 
lschemia Syndrome Evaluation (WISE) Study 
Angiographic Core Laboratory 
Barry L. Sharaf, Carl J. Pepine, Richard A. Kerensky, Marian 8. Olson, 
Sheryl F. Kelsey, Nicholas J. Miele, Steven E. Reis, William J. Rogers, C. 
Noel Bairey Merz. For the W/SE Investigators; Rhode /s/and Hospital, 
Brown University Providence, Rhode /s/and, USA 
Background: The association of ambulatory electrocardiographic (AECG) 
ST segment depression with adverse outcome and severe coronary artery 
disease (CAD) is derived from studies enrolling mostly men. 
JACC February 2000 ABSTRACTS - Myocardial Ischemia and Infarction 353A 
Methods: Accordingly, we performed a quantitative analysis of coronary 
angiograms of 126 women who underwent AECG monitoring (with indepen- 
dent core lab computerized analysis) as pat? of the larger Women’s lschemia 
Syndrome Evaluation (WISE) Study referred with suspected ischemic chest 
pain. 
Results: Their mean age was 56 & IO yrs (range 27-85). Most (78%) 
had no (~20% stenosis) or minimal (min) (>20% but &iO% stenosis) CAD. 
Of the 28 (22%) women with significant (sig) (?50% stenosis) CAD, 14 (50%) 
had single, 7 (25%) had double and 7 (25%) had triple vessel disease. Of 
those with min or sig CAD, the worst stenosis averaged 53 & 25% and 
occlusion was uncommon (13%). The AECG was abnormal with >I mm ST 
segment depression in 20 (16%) and no:mal in 106 (84%) women. Extent 
of disease (no, min, 1, 2, 3), severity score, worst stenosis, and presence of 
a proximal LAD stenosis ? 50%, TIMI flow grade < 3 or occlusion did not 
differ (p = NS) between those with and without an abnormal AECG. Women 
with an abnormal AECG however, had smaller left coronary arteries than 
those with a normal AECG (4.1 i 0.6 vs 4.6 & 0.7 mm, p = 0.01, 3.3 i 
0.4 vs 3.7 i 0.7, p = 0.03, 3.1 f 0.5 vs 3.4 + 0.6, p = 0.03 and 3.4 f 0.6 
vs 3.8 i- 0.7, p = 0.07 for the LM, LAD, LCX and RCA proximal reference 
diameters respectively). Complex plaque (clot or ulcer) was uncommon (6%). 
However, 90% of women with an abnormal AECG had a small left coronary 
(<median) or a complex plaque vs. 66% of those with a normal AECG 
(p = 0.03). 
Conclusion: An abnormal AECG is not always associated with severe 
stenosis in women, bur is associated with smaller arterial caliber and steno- 
sis complexity. Therefore, the pathophysiologic mechanism of an abnormal 
AECG in women may not always be related to fixed coronary obstruc- 
tion. 
1061-f 29 Is There a Release of Endothelin-1 During 
Exercise Testing in Patients With Syndrome X? 
Biro1 Say, Bengi Yaymaci, M. Muhsin TOrkmen, Fikret Turan. Kosuyo/u 
Newt and Research Center, istanbul, Turkey 
Background: Previous studies have shown an increase in plasma endothe- 
lin-l levels in early hours of acute myocardial infarction, in unstable angina 
and in patients with abnormal thallium scans. its significance in patients with 
syndrome X has not yet been defined. 
Methods: We evaluated the effect of exercise testing on plasma endothe- 
lin-l levels in 16 patients with proven syndrome X (group 1). A group of 9 
healthy subjects served as controls (group 2) and 12 patients with angio- 
graphically confirmed coronary artery disease and positive exercise testing 
constituted group 3. 
Results: In group 1 patients, plasma endothelin-I concentrations signif- 
icantly increased at peak exercise compared to baseline values (4.0 f 0.6 
to 5.2 f 1.1, p < 0.05), whereas it decreased in healthy control subjects 
(4.4 f 1.2 to 3.5 * 0.9, p i 0.05). In group 3 patients, endothelin levels also 
increased from baseline values (4.4 ?: 0.8 to 6.2 -+ 1.4, p < 0.01). The degree 
of increase in endothelin-l concentrations compared to the baseline levels 
was higher in group 3 patients compared to group 1 patients. There was no 
statistically significant relation between endothelin, blood pressure and heart 
rate at peak exercise among the three groups. Additionally, no differences 
were obsetved in systolic and diastolic blood pressures and in heart rate at 
peak exercise among the groups. 
Conclusion: These data suggest that exercise testing results in eleva- 
tions of plasma endothelin-1 concentrations in patients with syndrome X. 
1061-l 30 Prognostic Value of the Exercise Testing 
Parameters in Active Elderly Patients With 
Stable Coronary Artery Disease 
Marcel0 Ochiai, Otavio Gebara, Paulo Moffa, Ligia B. Pinto, 
Amit Nussbacher, Humbetio Pierri, Jade Serro-Azul, Antonio C.P. Barretto, 
Mauricio Wajngarten, Jose A.F. Ramires. Geriatric Cardiology-Heart 
institute (InCor) University of 90 Paula fviedical School, Brazil 
Background: The hen-invasive evaluation of the active elderly population 
with stable coronary artery disease (CAD) is a clinical challenge. Despite 
a wide utilization, the predictive value of exercise test (ET) parameters in 
elderly patients, particularly in the CAD population, is not fully investigated. 
Methods: We selected 64 consecutive patients, 61 males, with mean 
age 73 i 5 years (ranging from 64 to 88 years) with stable CAD (~70% 
narrowing of the luminal diameter in at least one major coronary artery), 
ejection fraction 1 40% and ischemia detected on the exercise stress test. 
Patients were followed up by ambulatory visits every 6 months. 
Results: After 48 months of follow-up, 23 patients (36%) experienced 
a cardiac event. There were no differences in clinical or angiographyc pa- 
rameters between those with or without events. The figure shows a worse 
prognosis on those with lower double product (DP) and chest pain on ET. 
HR at ST depression onset 
DP at ST depression omet 
Patients with chest pain, n (%) 
With Events 
113111 
18593*33112 
15 (65) 
No events P 
124zkZO 0.005 
22411 i 5107 0.002 
13 (32) 0.070 
Conclusion: In the elderly population with stable CAD, double product at 
onset of ischemia was the strongest prognostic factor and the presence of 
chest pain has an additive effect to predict adverse outcome. The ET should 
be used to predict prognosis of elderly patients with stable CAD. 
/ 1061 131 Surface Gradient Method Detects Exercise 
Induced lschemia on Multichannel 
Magnetocardiographic Mapping 
Helena Hlnninen, Panu Takala, Markku MBkijBrvi, Juha Montonen, 
Jukka Nenonen, Toivo Katila, Lauri Toivonen. Division of Cardiology and 
BioMag Laboratory, Helsinki University Central Hospital, Helsinki; 
Laboratory of Biomedical Engineering, Helsinki University of Technology; 
Espoo, Finland 
Background: Myocardial ischemia causes repolarization changes detected 
by magnetocardiography (MCG). Rotation of the magnetic field has been 
suggested as a parameter separating coronary artery disease (CAD) patients 
from healthy volunteers. We introduce a novel, computer-based surface 
gradient method to evaluate ischemia-induced changes of the magnetic 
field. 
Methods: The method was tested in 40 subjects (11 patients with left 
anterior descending (LAD) stenosis, 8 patients with fight coronary, artery 
(RCA) stenosis, 4 patients with left circumflex (LCX) stenosis and 17 healthy 
volunteers). MCG was recorded over anterior chest during supine bicycle 
ergometry. Signal-averaging of the ST-segment at cessation of exercise (ST-O 
min), and of the ST-segment and T-wave apex 2 and 4 minutes postexercise 
(ST-2 min, ST-4 min and T-2 min, T-4 min) was performed. Location of the 
steepest spatial magnetic field gradient and its two-dimensional direction was 
determined using the computer based surface gradient method. 
Results: The orientation of the ST-segment gradient at cessation of 
exercise separated CAD, LAD and RCA patients from controls (ST-O min 
mean i SD: 183” & 58, 195” * 56, 175” & 57 and 106” i 49; p < 0.001, 
p < 0.001 and p < 0.05 respectively). Both ST-segment, and T-wave apex 
gradient orientation 2 and 4 minutes postexercise separated CAD patients 
from controls (T-4 min mean f SD: 93” 5 63 and 58” i 18, respectively, p < 
0.05). Orientation of the ST-segment gradient 2 and 4 minutes postexercise 
separated LAD patients from controls (ST-2 min p < 0.05 and ST-4 min, p < 
O.Ol), and T-wave apex gradient 2 and 4 minutes postexercise RCA patients 
from controls (T-2 min p < 0.01 and T-4 min, p < 0.05). 
Conclusion: Transient acute myocardial ischemia causes significant 
changes in the magnetic field during ST-segment and T-wave apex. The 
orientation of the maximum gradient of the magnetic field can be used as an 
objective parameter to localize myocardial ischemia. 
L-.--d 1061 132 Coronary Artery Constriction: A Mechanism for Abnormal Nuclear Perfusion Scans 
Jan L. Houghton, Brian K. McCandless, Warren M. Breisblatt, Vivienne 
E. Smith. Albany Medical College, AlbanK New York, USA 
Background: During exercise normal coronary arteries dilate but abnormal 
vessels demonstrate paradoxical constriction. The results of intracoronary 
(IC) acetylcholine (ACh) predict coronary vasomotor responses to exercise. 
The purpose of our study was to investigate the association of coronary 
artery constriction during IC ACh with ischemia occurring during nuclear 
stress testing in pts with normal coronary arteries. 
Methods: Using IC ACh infusions, the Doppler wire, and QCA, significant 
coronary constriction was defined as diffuse or asymmetric but nonfocal 
conduit (CON) artery diameter constriction z 20% and by any resistance 
(RES) artery constriction during max (1O-5 M) or submaximal (IO-” or 10m7 
M) ACh as evidenced by depression in provoked coronary blood flow below 
baseline. 
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Results: GPI consisted of 9 pts with ~20% but ~50% diffuse CON con- 
striction: GP2 consisted of 5 pts with severe (>50%) asymmetric but nonfocal 
CON constriction; GP3 consisted of 19 pts with RES artery constriction: GP4 
consisted of 11 pts with marked (>20%) epicardial dilation. Stress ECG and 
thallium scans were abnormal in 0 of 9 and 3 of 8 (38%) tested GPI pts; in 
2 of 4 (50%) and 3 of 4 (75%) tested GP2 pts; in 3 of 14 (21%) and 9 of 15 
(60%) tested GP3 pts; and in 2 of 9 (22%) and 2 of 7 (29%) tested GP4 pts. 
Angina1 chest pain was present in 1 of 9 (11%) in GPI; in 4 of 5 (80%) in 
GP2; in 13 of 19 (68%) in GP3; and in 8 of 11 (73%) in GP4. 
Conclusion: We identified a group of pts with normal coronaries and 
chest pain who demonstrated significant CON and/or RES coronary con- 
striction during IC ACh testing. The majority of pts with severe asymmetric 
CON or RES coronary artery constriction had angina1 pain and abnormal 
thallium scans. lschemia may present due tot diffuse or asymmetric coronary 
endothelial dysfunction which will not be identified by conventional coronary 
angiography. 
1 1061-l 33 1 Serum Levels of Circulating Adhesion Molecules 
Reflect the Severity of Coronary Atherosclerosis 
Yoshifumi Oishi, Tetsuzo Wakatsuki, Norikazu Hiura, Toshihiro Toyoshima, 
Takashi Oki. The University of Tokushima, Tokushima, Japan 
Background: Recruitment of circulating leukocytes at the atherosclerotic 
sites is mediated through a family of adhesion molecules. The purpose of 
the present study was to evaluate the relationships between the serum 
levels of the circulating adhesion molecules, and the severity of coronary 
atherosclerosis. 
Methods:,Subjects consisted of 81 consecutive patients who underwent 
diagnostic coronary angiography. Twelve patients (control group) demon- 
strated normal coronary angiograms. The remaining 69 patients demon- 
strated coronary atheroscleroses, and were divided into 2 groups based on 
Gensini’s scores; mild coronary atherosclerosis group (n = 36, Gensini’s 
score 1 to 20), and severe coronary atherosclerosis group (n = 33, Gensini’s 
score > 20). Serum levels of circulating ICAM-I, VCAM-I and E-selectin 
were measured just before angiography, and were compared among the 3 
groups. 
Results: 1) There were no significant differences in age and sex between 
the 3 groups. 
2) Table shows the serum levels of circulating adhesion molecules in the 
3 groups. 
ICAM- (na/ml) 
Control Mild atherosclerosis Severe atherosclerosis 
195+44 245 zt 62* 267 zt 98”* 
VCAM-l‘(t$kl) 675f 172 669 * 189 723 zk 225 
E-selectin [na/mll 26zk6 52 zlz 23**zt 41 * 20* 
*p < 0.05, **p < 0.01 vs Control group. tp < 0.05 vs Severe &herosclerosis group. 
Conclusions: These findings suggest that E-selectin is related to the 
early stage, and ICAM- is related to the advanced stage of coronary athero- 
sclerosis. With progression of atherosclerosis, one step adhesion by ICAM- 
may be more important than multi-step adhesion by E-selectin, ICAM-I and 
VCAM-I. 
1061-I 34 The Relation Between Endothelial Dysfunction 
of Coronary Artery and Major Adverse Coronary 
Events 9:45 a.m. 
Tatsuaki Murakami, Kazuo Ohsato. Fukui Cardiovascular Cenfer, Fukui, 
Japan 
Background: Although endothelial dysfunction is supposed to contribute 
to atherogenic or thrombogenic processes and have prognostic impacts, 
there have been little clinical evidence for the relation between evolution of 
atherosclerosis and endothelial dysfunction. This study aimed to determine 
whether endothelial dysfunction of cordnary artery has clinical prognostic 
impacts. 
801-3 Acute and Long-Term Outcomes of Minimally 
Invasive Direct Coronary Artery Bypass (MIDCAB) 
Surgery. A Comparison to Single-Vessel Stenting of 
the Left Anterior Descending Artery 
Methods: Endothelial dysfunction of coronary artery was graded by the 
reactive changes to infusion of acetylcholine (50 Kg) into the normal or mini- 
mally diseased (%-diameter stenosis ~30%) left coronary artery using quan- 
titative coronary atteriography and intracoronaty doppler-tipped guidewire in 
150 patients. The enrolled patients were categorized into three groups ac- 
cording to the values of the reactive increase of coronary blood flow and their 
major adverse coronary events (MACE: cardiac death, crossover to CABG, 
non-fatal acute coronary syndrome) were prospectively followed-up. 
Roxana Mehran, Albert Pfister, George Dangas, Mercedes KC. Dullum, 
Michael A. Peterson, Nasra Hashmi, Sotiris C. Stamou, Regina Deible, 
Ajith Purush, Gregg W. Stone, Martin B. Leon, Paul J. Corso. Washington 
Hospifal Center, Washington, DC, USA 
Background: In MIDCABsurgery, the left internal mammary artery is anasto- 
mosed to the LAD wifhoutcardiopulmonaty bypass. The long-term outcome 
of this procedure has not been compared to LAD stenting. 
Methods: We studied a consecutive series of 254 patients who under- 
went MIDCAB, and compared them with 1073 consecutive patients who had 
stenting of the proximal or mid-LAD during the same time period. All clinical 
events were source documented and independently adjudicated. 
Results: Baseline clinical variables and medications were similar among Results: Baseline clinical characteristic,s were not significantly different 
the three groups. For a mean follow-up period of 46 months (range: 37 to between the groups. Long-term follow-up was obtained in 90% of eligible 
60), ten patients (20%) in the lower third (Group-L), two patients (4%) in patients. Acute and long-term results are shown (see table). 
the middle third (Group-M), and no patient in the upper third (Group-H) later Three patients (1.2%) required acute revascularization for graft occlusion 
developed MACE (Group-L vs Group-M and H, p < 0.001, by Kaplan-Meyer and two (0.8%) returned to the OR for bleeding. 
analysis). And the difference reached statistical significance (p < 0.05) in the 
early fourteen months. 
Conclusion: These ‘results suggest endothelial dysfunction of coronary 
artery is associated with worse clinical outcomes in the near Future and 
clinical assessment of coronary endothelial function may provide prognostic 
information. 
ORAL 
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I 801-2 5 Year Experience With Complete Arterial Revascularization Using an Internal Thoracic 
Artery/Radial Artery T-&aft 
Thoralf M. Sundt, Hendrick B. Barner, Marci S. Bailey, Cynthia J. Camille. 
Washington University: St. Louis, Missouri, USA 
Background: Complete arterial revascularization may improve the late re- 
sults of coronary artery bypass (CAB) via superior long term graft patency to 
all target vessels. While several longitudinal studies of bilateral ITA grafting 
have been reported, there are few data regarding CAB using arterial grafts 
exclusively. 
Methods: Over the last 5 years we have achieved complete arterial 
revascularization with an internal thoracic artery/radial artery (ITAfRA) T-graft 
in 608 patients undergoing isolated primary CAB. Demographics of the study 
population were: mean age 60 years (range 30-81); male sex 72%: triple 
vessel disease 85%; severe left ventricular (LV) dysfunction (ejection fraction 
< 35%) 10%; previous myocardial infarction (Ml) 49%; diabetes mellitus 25%; 
hypertension 48%; chronic obstructive pulmonary disease 5.7%; peripheral 
vascular disease (PVD) 10%; cerebrovascular disease (CVD) 7.0%; renal 
dysfunction 2.3%; previous percutaneous transluminal coronary angioplasty 
(PTCA) 15%. The mean number of distal anastomoses was 3.7 (range 2-6). 
Mean follow up was 26 months (range 3.8-64). 
Results: There were 2 perioperative (30 day) deaths (0.3%). lntraaortic 
balloon or inotropic support for >24 hours was required in 14 patients (2.0%). 
The incidence of perioperative q wave Ml was 4.9%, perioperative stroke 
1.9%, and deep sternal wound infection 1.0%. There were 24 late deaths 
(4.3%). Predictors of late death by multivariate analysis were PVD (odds ratio 
4.4), CVD (odds ratio 3.0), LV dysfunction (odds ratio 1.6) and preoperative 
renal dysfunction (odds ratio 9.7). Angina class improved from a mean 
2.8 preoperatively to 1 .I postoperatively (p < 0.005). At 3 years, actuarial 
survival was 94%, freedom from reintervention (CAB or PTCA) was 94%, 
and freedom from known Ml was 94%. 
Conclusions: Complete arterial revascularization can be achieved with 
an ITAJRA T-graft with low perioperative risk. Survival and freedom from 
reintervention up to 5 years postoperatively are encouraging. These data 
support further investigation of this grafting strategy in the interest of achiev- 
ing improved long-term results from CAB. 
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MIDCAB (n = 254) sent (n = 1,073) 
Outcome (%) In-HDSnItal 1 -Year In-Hcsoital 1 “Year 
Deaih 0.8 6.3 1.0 6.0 
Q-wave Ml 0.0 0.6 0.6 0.9 
TLR, any method 1.6 63 1.9 17.4 
TLR intervention 0.8 5.1 1.0 11.8 
TLR surgery 0.8 1.7 1.9 6.6 
MACE 2.4 12.5 31 23.4 
TLR = target lesion revascularization; MACE = major acute cardiac events. 
Conclusion: The MIDCAB operation results in excellent acute results 
and acceptable clinical event rates at one year. A randomized trial should 
compare these strategies for the treatment of single vessel LAD disease. 
IO:00 a.m. 
i . . 801 4 Myocardial Functional Recovery Early After 
Mmrmally Invasive Coronary Surgery: 
A Transesophageal Echocarciiographic Study 
Marco Zimarino, Sabina Gallina, Anna Lorena lace’, Teresa iovino, 
Marco Contini, Antonio Barsotti, Antonio Maria Calafiore. Department of 
Cardiology and Cardiac Surgery University of Chiefi, ltaly 
Background: Extension and reversibility of myocardial contractile function 
depression during Left Internal Mammary Artery (LIMA) grafting to Left An- 
terior Descending (LAD) artery via Left Anterior Small Thoracotomy (LAST) 
is a major concern. 
Methods: We prospectively performed TransEsophageal Echocardio- 
graphy (TEE) in 91 patients (pts) (age 61 i IO years, 87% M) during LAST 
operation. Waif Motion Score Index (WMSI) (each segment scored from 1 = 
normal to 4 = dyskinetic in a 16 segment model of left ventricle) was calcu- 
lated before (pre), during (occl) and after (post) distal LAD artery occlusion. 
Cononary angiograms were analyzed with respect to the number of vessels 
(V) with Coronary Artery Disease (CAD), Mitral Regurgitation (MR) LAD TIMI 
flow grade and Collateral Circulation (CC). 
Results: LAD occlusion lasted 22 f 8 min; contractile impairment was 
observed 3.6 f 2.6 min after LAD occlusion, recovery 4.2 & 2.1 min after 
LAD opening. Peak CPK and CPK-MB were 400 * 178 IU/ml and 18 f 10 
IUiml, respectively. WMSI was as follows: 
OV~Fili 
IIIR (o-4 scale) 
CAD-l Vf 
-2vt 
-3v 
TIM13 
TlMls2-CC 
-NoCC 
Pts 
91 
53 
18 
20 
50 
32 
9 
PE 
1.36 * 0.34 
0.6 -c 0.5 
1.25i 0.27 
1.36 zt0.29 
1.70 * 0.40 
1.34 f 0.28 
1.35 i0.36 
1.541.0.47 
OCCI Post 
1.51 + 0.38* 1.32 I 0.34 
0.7 io.5 0.6 5 0.6 
1.38 * 0.33* 1.21 i0.27 
1.58*0.31* 1.3610.31 
1.87zt 0.35* 1.64% 0.39 
1.5oi 0.371 1.31 i 0.34 
1.48+ 0.35- 1.2910.30 
1.73f 0.54' 1.54 + 0.48 
*p < 0.05 "s Pre, Post;i p < 0.05"s. 3 V CAD for Pre,Occland Post 
At 20 min post occl evaluation, contractility was identified as ameliorated 
in 10 pts (II%), unchanged in 53 pts (58%) and worsened in 28 pts (31%) 
when compared with pre findings. In all 28 pts with worsened post ventricular 
function, a 48 h transthoracic study documented functional recovery. 
Conciusions: LAD occlusion during LAST operation causes significant 
depression of myocardial function in all subgroups of pts analyzed. However, 
contractile depression is usually reversible ~20 min after the anastomosis is 
accomplished, even if myocardial stunning has been documented in some 
pts. 
lo:15 a.m. 
801-S / A Prospective Randomized Analysis of the 
Inflammatory Response in Coronary Artery Bypass 
Grafting Combining Different Surgical Access 
and/or the Use of Cardiopulmonary Bypass 
Vassilios Gulielmos’, M. Menschikowski”, Sebastian Thiele’, Markus Eller’ 
Hans-Martin Dill’, Utz Kappert’ , W. JaroR’, Stephan Schuller’ 
’ Cardiovascular Institute, University of Dresden; ‘Institute for Laboratory 
Medicine, Dresden, Germany 
Objective: The traumatic effects of Cardiopulmonary bypass (CPB) and 
the surgical approach (median sternotomy (MS) or lateral minithoracotomy 
(LMT)) can be evaluated using serum markers, 
Methods: In a prospective randomized trial four different surgical tech- 
niques for the treatment of single-vessel coronary artery disease were com- 
pared. 
Group 1: CPB and median sternotomy in i 0 patients; Group 2: off-pump 
and median sternotomy in IO patients: Group 3: CPB and minithoracotomy in 
IO patients: Group 4: off-pump and minithoracotomy in IO patients. Clinical 
data andserum markers were monitored. Demographical data and underfying 
diseases were comparable. 
Results: All patients were treated with single LIMA-bypass to LAD. No 
mortalities or major surgical complications or minor morbidities (pneumonia) 
occurred. Three month follow up revealed good patency of all grafts. 
group 1 9roup 2 group3 group4 
Homovanrllic acid urine 35.1 Zt 12.2 21.7 i 6.2 36.2i 14.3 23.4 i 7.0 
(fimolid) 
IL-10 (pgiml) 24 h po. 
IL-6 (pgiml) 24 h po. 
CRP imclill48 h DO. 
13.5 It 5.2 11.4*5.2 18.3 z!z 11.2 25.5 zt 24.1 
110*79 9Ozk63 164h90 182*105 
176183 169zt76 203i67 240f74 
~ “ I  
Lymhocytes 12 h po. 28.1 ill.0 29.7 i 11 .o 29.9 i 6.0 25.9 i4.7 
CD3/CD45-RO(%) 
Leukocvtes(GPVll2h 130. 12.3 z!z 2.7 10.8 i 3.2 13.6 5 3.3 10.7 + 3.2 
Conclutions: Inflammatory response detected after single LIMA-bypass 
to LAD is not only influenced by the use of CPB but also by the surgical 
access. Patients receiving LMT showed higher levels of interleukins and CRP 
indicating a higher activation of the immune system. There was no correlation 
between these findings and the clinical outcome which was excellent and 
uneventful in all groups. 
ORAL 
/ 836 Myocardial Infarction: Genetics and the Role 
of Growth Factors 
Monday, March 13, 2000, 1l:OO a.m.-l 2:i 5 p.m. 
Anaheim Convention Center, Room 213A 
1l:OO a.m. 
L--L 836 1 Marked Reduction of Insulin-Like Growth Factor-l in Acute Myocardial Infarction 
Elena Conti, Felicita Andreotti, Patrizia Riccardi, Alessandro Sciahbasi, 
Maria Molfese, Cinzia Varlotta, Giampiero Marra, Edoardo Menini, 
Giovanni Ghirlanda, Attilio Maseri. institute of Cardiology, Catholic 
University Medical School, Rome, Italy 
Background: Insulin-like growth factor-l (IGF-I) promotes insulin sensitivity 
(IS) and arteriolar dilation, and protects against cell death. Yet, to date, IGF-1 
serum levels in the acute phase of myocardial infarction (MI) have not been 
studied. 
Methods: We assessed IGF-I levels and IS in 12 patients (pts) with MI 
and in 11 healthy controls (CTR). Pts were’enrolled within 12 h of symptoms. 
Age > 80 yrs, obesity, hypertension, diabetes and LV ejection fraction < 45% 
were excluded. Peripheral venous blood was taken for IGF-1 (IRMA, Diag- 
nostics System Laboratory) at 8, 12, 17 and 23 h on the day after admission. 
The next morning, IS was assessed as blood glucose disappearance (T/2) 
after an i.v. insulin bolus (0.1 IU/kg) using Bonora’s insulin tolerance test, 
previously validated with the euglycaemic clamp technique. Controis were 
age-, sex- and BMI-matched. In pts with an uneventful course, IGF-1 levels 
were measured again after 1 yr. 
Results: On admission, pts vs CTR had -5fold lower IGF-1 values (mean 
f SEM: 92 f 20 vs 554 f 68 rig/ml, p c 0.0001) and significantly lower T/2 
(1.05 i 0.4 vs -2.3 & 0.4 mgimin, p = 0.04). Lowest IGF-1 concentrations 
were recorded in the pt who died in-hospital (4.4 f 0.4 rig/ml) and in the 
single other pt who had recurrent angina out-of-hospital (20 f 14 ngiml). In 
CTR but not in pts, a significant inverse relation was found between T/2 and 
BMI (r = -0.5, p = 0.05 on multivarjate analysis). Pts reexamined at follow-up 
had normalized their IGF-I values (524 i 113 ngiml, p = 0.001 vs admission, 
p = NS vs CTR). 
Conclusion: During the acute phase of Ml, pts exhibit reduced insulin 
sensitivity, unrelated to BMI, and dramatically reduced IGF-I levels compared 
with CTR. In pts with an uneventful course, IGF-I concentrations returned to 
normal values at one year. Low IGF-I values in the acute phase of Ml may 
contribute to impaired IS and an adverse prognosis. 
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1836-2/ Decreased &Adreneraic Sensitivitv of Ventricular 
/ L-Type Calcium Curreit in Infarct-Induced 
Hypertrophy in Rats Is Related to Reduced 
,&Adrenergkz Receptor Density 
Roberto M. Saraiva, Ciria Carolina Quintero, Ntibia Gabriela B Chedid, Luiz 
Eduardo G. Diaz, Masako 0. Masuda. Universidade Federal do Rio de 
Janeiro, Rio de Janeiro, Brazil 
Background: Previous studies of the ventricular L-type calcium current 
(&)) density and its /?-adrenergic sensitivity in infarct-induced cardiac hy- 
pertrophy in rats have reported conflicting results. We reexamined these 
questions in this model and studied possible mechanisms responsible for 
alterations in fl-adrenergic sensitivity of left ventricular Ica(t.). 
Methods: Myocardial infarction was induced in adult Wistar rats by lig- 
ation of the left coronary artery. After 2 months, myocytes were obtained 
by enzymatic digestion with collagenase. Electrophysiological recordings 
were made through the patch-clamp technique in the whole-cell configura- 
tion. Badrenergic receptor density was determined by 13H] dihidroalprenolol 
([3H]-DHA) binding in left ventricle homogenates. Intracellular calcium tran- 
sients (Tea) were investigated via FURA- fluorescence in electrically stimu- 
lated myocytes (0.5 Hz). 
Results: Left ventricular myocytes from infarcted rats (INF) were larger 
than those from control rats (CON), as indicated by their larger capacitance 
(pF): 233 f 67, n = 43 versus 155 Jr 53, n = 58, p < 0.001. Ica(~) density 
(pA/pF) was smaller in INF: 6.0 f 2.3, n = 43 versus 7.7 f 2.7, n = 57, p = 
0.002. The maximal Tea was smaller in INF: 0.12 f 0.01, n = 4 versus 0.17 
i 0.02, n = 6, p < 0.01. lsoproterenol (1 PM), ,&adrenergic agonist, induced 
smaller increase in peak Ica(L) in INF than inCON (64f 15%, n=3versus 122 
rt: 33%, n = 3, p = 0.01). The dose-response lines for isoproterenol and lc=(~) 
percent increase have respective values for INF and CON of Emax: 63.6% 
and 123.3% and EDsc(nM): 38 and 44. Forskolin (IO PM), an adenyl-cyclase 
activator, induced similar increases in Ica(L) density in both groups: 86 & 23% 
in INF, n = 4 and 60 & 15% in CON, n = 5, p = 0.07. 13H]-DHA binding was 
reduced in INF: Bmax (fmol/mg) 118.6 against 295.0 in CON; Kd (nM) 14.0 
in INF and 27.3 in CON. 
Conclusion: We demonstrated the presence of reduced I&(L) density and 
sensitivity to /+adrenergic stimulation in INF. The decrease in Ica(~) sensitivity 
is not due to changes in adenyl-cyclase activity, as indicated by the results 
obtained with forskolin, but is related to changes in /r-adrenergic receptors, 
as indicated by reduced [3H]-DHA binding. 
11:30 a.m. 
El 836 3 Cardioprotective Effects of Preconditioning is 
Mediated Through Both Protein Kinase C-Dependent 
and Independent Pathways 
Nilanjana Maulik, Richard M. Engelman, Motoaki Sato, Dipak K. Das. 
Department of Surgery: University of Connecticut Medical Centel; 
Farmington, CT; and Baystate Medical Center, Springfield, MA, USA 
Background: Preconditioning (PC) has been shown to trigger a signaling 
pathway by activating multiple kinases and NFwB. Since NFKB is a target of 
oxygen free radicals, we hypothesized that reactive oxygen species (ROS) 
might play a role in the signaling process. 
Methods: To test this hypothesis, isolated rat hearts were perfused in 
the absence or presence of either dimethyl thiourea (DMTU), a OH. radical 
scavenger, or SN 50 peptide, a NFKB blocker. Hearts were then subjected 
to PC by four repeated episodes of 5 min ischemia each followed by 10 min 
reperfusion. All hearts were then made ischemic for 30 min followed by 2 hr 
of reperfusion. 
desults: The results demonstrated enhanced tyrosine kinase phospho- 
rvlation during PC which was blocked by DMTU. DMTU also inhibited PC 
mediated increased phosphorylation of ~38 MAP kinase and MAPKAP kinase 
2 activity. However, DMTU had no effect on the translocation and activation 
of protein kinase C (PKC). The cardioprotective effect of PC was abolished 
by both DMTU and SN 50. PC resulted in the nuclear translocation and 
activation of NFKB. Increased NFKB binding was blocked by both DMTU and 
SN 50. 
Conclusion: The results suggest that ROS play a crucial role in signal 
transduction process which seems to be independent of PKC although PKC 
is activated during PC, implicating the existence of two separate signaling 
pathways in PC. 
11:45 a.m. 
836-4 Basic Fibroblast Growth Factor Inhibits 
Lipopolysaccharide-Induced Apoptosis in Cardiac 
Myocytes 
Makoto Araki, Koji Hasegawa, Eri Iwai-Kanai, Masatoshi Fujita, 
Tsuyoshi Kakita, Tatsuya Morimoto, Shigetake Sasayama. Kyoto University: 
Kyoto, Japan 
Background: Basic fibroblast growth factor (bFGF) is an important angio- 
genie factor produced by the heart subjected to ischkmia. Protection by bFGF 
from myocardial ischemic injury is mediated, in part, through the increase of 
blood flow by angiogenesis. However, direct effect of bFGF on myocardial 
cell apoptosis and its precise signaling mechanisms are unknown. 
Methods: Primary cultured cardiac myocytes from neonatal rats were 
stimulated with lipopolysaccharide (LPS), a potent inducer of inducible nitric 
oxide synthase (iNOS) for 48 hours in the presence or the absence of bFGF 
(100 ns/ml). 
Results: LPS induced the expression of iNOS in cardiac myocytes, 
demonstrated by Northern blot and immunohistochemistry. LPS markedly 
increased the number of TUNEL-positive cells (% TUNEL-positive nuclei > 
40%) compared with saline stimulation (<IO%). Apoptosis was also con- 
firmed by DNA fragmentation in agarose gels and morphologic features. 
LPS-induced myocardial cell apoptosis was completely blocked by the ad- 
ministration of L-NAME, an inhibitor of NOS. This indicates that LPS induces 
myocardial cell apoptosis via an iNOS-dependent pathway. Administration 
of bFGF inhibited LPS-induced aooptosis. To dissect sianalina pathwavs for 
this inhibitory effect, we utilized PDO98059, a MEK-l-specific inhibitor. 20 PM 
of PD098059 blocked bFGF-induced activation of ERKIB and neutralized 
the apoptotic inhibitory effect by bFGF. 
Conclusion: bFGF inhibits iNOS-dependent apoptosis and this inhibition 
requires MEK-I-ERK pathway. 
Noon 
L-L 836 5 Reduced Insulin-like Growth Factor-l in Patients With Syndrome X 
Elena Conti, Felicita Andreotti, Gaetano A. Lanza, Patrizia Riccardi, 
Alfonso Sestito, Alessandro Sciahbasi, Dionigi Fischetti, Edoardo Menini. 
Attilio Maseri Institute of Cardiology; Catholic University Medical School, 
Rome, ltaly 
Background: Insulin-like growth factor-i (IGF-I) has been found to induce 
relaxation of coronary arteriolar vessels. Serum levels of IGF-1 have been 
reported to be low in patients (pts) with major coronary artey disease (CAD), 
but have not been investigated in pts with syndrome X, in whom a coronary 
microvascular dysfunction has been hypothesized. 
Methods: We measured serum IGF-1 in 9 pts with svndrome X (i.e., tvpi- 
cal angina, positive exercise test, normal coronary angiography and‘negattve 
ergonovine test) (56 + 9 yrs, 4 men), in 15 pts with CAD (~50% diameter 
stenosis in ‘1 .major coronary vessels) (64 5 8 yrs, 13 men), and in 13 
healthy controls (54 & 12 yrs, 8 men). Obesity (BMI =- 30 kg/m”) and other 
conditions possibly interfering with IGF-1 secretion were excluded. IGF-I 
concentrations were measured by immunoradiometric assay (Diagnostics 
System Labs) in fasting blood samples taken between 8 and 9 a.m. Values 
are medians with interquartiles. 
Results: IGF-1 concentrations did not differ significantly between syn- 
drome X pts [337 (321-452) rig/ml] and CAD pts [332 (241-431) ngiml], 
but both groups had significantly lower values compared with controls [630 
(417-771) rig/ml, p < 0.04 vs both syndrome X and CAD]. IGF-1 concen- 
trations were not significantly correlated with age and did not differ between 
men and women, 
Conclusion: We confirm the reduction of IGF-1 levels in pts with signif- 
icant CAD, and show a reduction of similar entity in pts with syndrome X. 
Reduced IGF-1 values, therefore, are not associated exclusively with epicar- 
dial CAD. Our data suggest that impaired IGF-l-mediated arteriolar dilatation 
may be involved in the pathogenesis of syndrome X. 
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m 837-l Substantial enefit of Hirudin Compared to Heparin Among Unstable Angina Patients Undergoing Early 
Percutaneous Coronary Intervention 
Shamir Mehta, Salim Yusuf, Hans JOrgen Rupprecht, Thomas Wittlinger, 
Marcus Flather, Janice Pogue, Lisa Cronin, David Hunt, John Varigos, 
Mgty& Keltai, Leopoldo Piegas, Basil Lewis, Cam Joyner, Sonia Anand, 
Matthias Luz. On b&a/f of the OASIS-Z Investigators; !&Master University, 
Hamilton, Canada 
lo evaluate the effects of prior or concomitant IV hirudin (HIR) compared to IV 
heparin (HEP) in patients with acute coronary syndromes (ACS) undergoing 
percutaneous coronary intervention (PCI), we studied major ischemic events 
in the OASIS-2 tria! (n = 10,141). 
Results: 
572 hrs 
HIR HEP Rel. Risk 
(95% Cl) 
Cardiovascular death/Ml (%) 
No PCI 2.0 2.4 0.85 
(0.65-l .lO) 
PCI 6.3 21.4 0.18 
(0.04-0.79) 
Cardiovascular death/Ml/Refractory lschemia 
No PCI 3.1 3.6 0.85 
(0.69-1.08) 
PCI 14.9 32.9 0.41 
(0.17-0.95) 
Cl = confidence mterval 
HIR 
6.8 
6.4 
12.6 
17.0 
<35 days 
HEP Rd. Risk 
(95% Cl) 
7.3 0.93 
(0.80-1.07) 
22.9 0.25 
(0.07-0.86) 
13.1 0.95 
(0.85-l .06) 
37.1 0.40 
(0.18-0.89) 
Conclusions: Hirudin offers a large protective effect compared to heparin 
when used in the setting of PCI in patients with ACS to prevent major ischemic 
events. 
11:15 a.m. 
/ 837-2 / Effects of Sodium/Hydrogsn Exchange Inhibition 
With Cariporide on Wall Motion Abnormalities and 
Stunning in the GUARDIAN Trial 
Jean-Claude Tardif, Lise-AndrBe Mercier, Pierre ThBroux. For the 
GUARQlAN TriaE Investigators; Montreal Heart Insiifufe, Montreal, Canada 
Background: Experimental data suggest that NaiH exchange (NHE) inhi- 
bition may circumvent intracellular Ca overload and may thus provide pro- 
tection to cardiac cells by decreasing necrosis during myocardial ischemia 
and repetfusion injury. The primary objective of the GUARDIAN (GUARD 
during lschemia Against Necrosis) trial was to determine the effect of NHE 
inhibition with cariporide on the prevention of death and myocardial infarc- 
tion at day 36 in patients at high risk. In the echocardiographic sub-study, 
patients enrolled because of unstable angina or non-q wave MI and with 
LV wall motion abnormalities on a baseline transthoracic echocardiogram 
(n = 238) underwent repeated examinations at 48 hours to evaluate the 
extent of recovery (stunning) and at 36 days to determine final myocardial 
damage. 
Methods: Pts were randomized to 1 of 3 doses of cariporide (20, 80 or 
120 mg IV TID) or placebo for 2-7 days. The standard semi-quantitative wall 
motion score index (WMSI) based on the 16-segment model was used to 
assess regional LV dysfunction. In this scoring scale, a normally contracting 
segment is assigned a score of 1, hypokinesis 2, akinesis 3, and dyskinesis 
4. WMSI is the sum of all scores divided by 16. Quantitative assessment of 
regional wall motion was also performed using the centerline method (area 
under the curve, number of abnormal chords). 
Results: Baseline WMSI was 1.52 f 0.41, 1.60 i 0.38 and 1.60 i 0.47 
in the 20, 80 and 120 mg cariporide groups, respectively, and 1.64 f 0.44 
in the placebo group (p = 0.68). WMSI decreased (improved) from baseline 
to Day 36 by 0.11 f 0.17, 0.16 + 0.34 and 0.14 i 0.29 for the 3 cariporide 
groups, and by 0.10 & 0.17 in the placebo group (p = 0.57). The decrease 
in WMSI from baseline to 48 hrs was 0.02 f 0.13, 0.09 f 0.21 and 0.04 i 
0.23 for the cariporide groups and 0.02 f 0.12 for placebo (p = 0.46). Similar 
results were obtained with the centerline method (p = NS). 
Conclusion: The NHE inhibitor cariporide does not appear to limit either 
myocardial stunning or final infarct size in patients with high-risk unstable 
angina or non-q wave Ml. 
II:30 a.m. 
L-l. 837 3 Multivessel Percutaneous Coronary Interventions Durmg Acute Coronary Syndromes Appear to be 
Safe in the Glycoprotein llblllla Antagonist Era 
John P. Gassler, Mitchell J. Silver, David J. Moliterno, A. Michael Lincoff, 
Stephen G. Ellis. Cleveland Clinic Foundation, Cleveland, Ohio, USA 
Background: Multivessel coronary interventions (PCI) during acute coronary 
syndromes (ACS) are considered to be at heightened risk for ischemic 
complications. 
Methods: To assess whether multivessel interventions are as safe as 
single vessel PCI for ACS in the glycoprotein Ilb/llla antagonist era, we 
pooled data from the EPIC, EPILOG, EPISTENT, RAPPORT, and CAPTURE 
databases. 
Results: Patients in the multivessel group (n = 183) had a significantly 
higher incidence of diabetes, hypertension, and unfavorable target lesion 
anatomy as compared with the single vessel PCI group (n = 3111). As 
might be expected, with the standard therapy (aspirin and heparin), the 
incidence of death was substantially higher among multivessel PCI patients. 
With abciximab this rate was reduced to equal the single vessel PCI rate 
at both 30 day and 6 month follow-up (Table), depite the worse baseline 
characteristics in the multivessel PCI group. The rates of Ml and target 
vessel revascularization were similarly reduced. 
30 day 
Composite (%) 
Death/Ml (%) 
Death (%) 
MI (%) 
urgent TVR (%) 
6 month 
Death/Ml (%) 
Death (%) 
Ml (%) 
Single Vessel Multivessel 
Placebo Abciximab Placebo Abciximab 
12.6 5.8 12.6 6.7 
9.7 4.0 9.7 4.5 
1.2 0.9 2.8 0.9 
8.9 3.5 7.7 3.6 
5.5 2.4 4.3 3.1 
12.6 6.8 12.6 6.3 
2.4 2.1 4.2 1.8 
10.7 5.3 8.6 5.5 
Conclusion: When using abciximab, multivessel interventions for acute 
coronary syndromes appear to be as safe as single vessel PCI. 
II:45 a.m. 
1837-4 ( Quality of Life in Unstable Coronary Artery Disease 
- A Comparison of Early Invasive Versus 
Non-Invasive Treatment. Six Months Follow-Up From 
the FRISC II Invasive Trial 
Magnus Janzon’ , Lars-Ake Levin’, Eva Swahn’ ‘Institution of Medicine 
and Care: ‘Dept of Tema Research/Center for Medical Technology 
Assessment, Linktiping University, Sweden 
Background: Both early invasive and non-invasive treatment strategies in 
patients presenting with unstable coronary artery disease have been used 
during the acute phase of the disease. Until today there is no published study 
analysing the quality of life in this important and large patient group. The 
aim of this study was to identify differences in quality of life between the two 
treatment groups. 
Methods: A total of 2 457 patients, median age 66 years and 70% men, 
with unstable angina or non-Q-wave myocardial infarction were randomised 
to early invasive or non-invasive treatment. The quality of life was measured 
with the generic quality of life instrument SF 36 (Short Form 36 Health 
Survey) at time for randomisation, outpatient visits at 3 and 6 months. SF-36 
is presented in eight scales (range O-100, where 100 corresponds to full 
health) 
Results: See figure. In the FRISC II trial the invasive treatment showed 
a reduction in the incidence of death or Ml (9.4% vs. 12.1%, p = 0.031). 
6 months follow-up 
I  
It 80 
PF= Physical function / 
$ 60 
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BP= Bodily Pain 
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SF= Social Functioning 
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I 
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At time for randomisation there was no significant differences in quality of 
life between the groups in six of the scales. At 3 months follow-up it was a 
highly significant difference (p < 0.001 in all eight scales) in quality of life 
favouring the invasive group. At 6 months follow-up the significant differences 
still remained. 
Conclusions: Patients with unstable coronary artery disease treated with 
early invasive strategy have better quality of life measured with SF-36 at three 
and six months follow-up compared to patients treated with non-invasive 
strategy. 
Noon 
1837-5 1 Cost-Comparison of Early Invasive Versus 
Non-Invasive Treatment in Unstable Coronary Artery 
Disease - A Six Months Follow-Up From the FRISC II 
Invasive Trial 
Magnus Janzon’, Lars-Ake Levin’, Eva Swahn’ ‘Institution of Medicine 
and Care; ‘Dept. of Tema Research/Center for Medical Technology 
Assessment, Link6ping UniversiQ Sweden 
Background: Both early invasive and non-invasive treatment strategies in 
patients presenting with unstable coronary artery disease have been used 
during the acute phase of the disease. It has not until recently been conclu- 
sively demonstrated which of these strategies has a better clinical outcome. 
Until today there is no prospective study analysing the economic implica- 
tion in this important and large patient group. The aim of this study was to 
compare the direct medical costs of these strategies. 
Methods: We determined in-hospital and 6 months follow-up costs for 
2 457 patients in the FRISC II trial with unstable angina or non-Q-wave 
myocardial infarction who were randomised to early invasive or non-inva- 
sive treatment. Investigations, interventions and hospitalisations were docu- 
mented prospectively. The costs were based on Swedish hospital charges at 
1997 price level. 
Results: In the FRISC II trial the invasive treatment showed a reduction 
in the incidence of death or Ml (9.4% vs. 12.1%, p = 0.031). In the cost 
comparison there was no significant difference in hospitalisation at cardiac 
care unit, cardiology ward nor total number of days in hospital (14.1 vs. 
13.2). The total cost (investigations, interventions and hospitalisations) was 
significantly higher in the invasive treatment group 102,900 SEK (12,350 
USD) vs. 75,800 SEK (9,100 USD) p < 0.001. 
Conclusions: Already at six months there was no difference between the 
invasive and non-invasive group regarding days in hospital. Anyhow due to 
the costly initial interventions there was still a higher total cost in the invasive 
treatment group at six months follow-up. 
MODERATED POSTER SESSION 
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1005-I 67 Acute Phase Inflammatory Reaction Depends on 
the Troponin Status in Unstable Angina Pectoris 
Hans Martin Hoffmeister, Raila Ehler, Eva Biittcher, Silke Kazmaier, 
Uwe Helber, Sebastian Szabo, Martin E. Beyer, Ludger Seipel. Med. Depf. 
III, University Tiibingen, Germany 
Background: An inflammatory acute phase reaction is known in patients with 
unstable angina pectoris (UAP). Additionally, in a subgroup of patients with 
UAP a troponin T (TnT)-release is detectable indicating impaired prognosis. 
Methods: Prospectively 85 patients with UAP were compared with 30 
control persons. 63.5% of the UAP patients were TnT-positive. C-reactive 
protein (CRP; mg/dl), serum amyloid A (SAA; mgil), and fibrinogen (mg/dl) 
were serially determined as acute phase reactants. The soluble adhesion 
molecule ICAM- (rig/ml) was measured as inflammatory marker without 
acute phase reaction and as indicator of endothelial activation. 
Results: 
UAP (0 d) 
TnT+ TnT- 
UAP (2 d) 
TnT+ TnT- 
controls 
CRP 1.9io.5 0.6 -ir 0.2 4.3* 1.2 0.5 * 0.1 0.2 * 0.02 
SAA 86zt40" 5.0 i 0.8 248%90* 7.8 i 2.1 2.2 io.4 
fibrinogen 485*28* 393f20 649zk45" 382i29 314113 
slCAM-1 ?lSlt9 248+18 240f13 243f23 183h8 
Means i SEM; ** = p .Z 0.01; * = p < 0.05 between TnT+ and TnT- 
Inflammatory markers are slightly elevated at baseline in patients with 
UAP. A further increase (acute phase reaction) with additional unfavorable 
effects is detectable only in patients with myocardial damage and release of 
troponin T. 
Conclusion: Elevation of inflammatory markers is initially present in all 
patients with UAP. Development of a marked acute phase reaction is strongly 
associated with the prognostically unfavourable subgroup of patients in whom 
troponin release indicates myocardial damage. 
12:12 p.m. 
r-q :.. 1005 168 Oxrdrzed Low Density Lipoprotein (Ox-LDL) is 
Assocrated With Plaque Inflammation and 
Destabilization in Human Coronary 
Atherosclerotic Lesions 
Hajime Yamashita, Takahiko Naruko, Makiko Ueda, Shouichi Ehara, 
Ryushi Komatsu, Akira Itoh, Kazuo Haze. Osaka City Genera/ Hospital, 
Osaka City University Medical School, Osaka, Japan 
Background: Previous studies have shown that recent activation of the im- 
flammatory response in coronary atherosclerotic lesions relates to rapidly 
progressive plaque destabilization. In vitro studies have suggested that ox- 
idized low density lipoprotein (ox-LDL) is a key factor in the pathogenesis 
of the imflammatory processes. To elucidate the role of ox-LDL in plaque 
destabilization in human coronary arteries, we immunohistochemically stud- 
ied the presence of ox-LDL in coronary atherectomy specimens obtained 
from patients with stable angina (SAP) and unstable angina pectoris (UAP). 
Methods: All these patients underwent atherectomy at primary athero- 
sclerotic lesions responsible for SAP (n = 12) and UAP (n = 24). Paraffin 
and frozen samples were studied with antibodies against smooth muscel 
cell, macrophages (MQ), endothelial cells, and ox-LDL (DLHS). The pres- 
ence of ox-LDL and M@ immunoreactivity was quantified, respectively, using 
computer-aided planimetry. For the identification of the cell types which stain 
positive for ox-LDL, immunodouble staining was also performed. 
Results: In 20 of 24 lesions with UAP, abundant ox-LDL positive M@ 
and ox-LDL positive foam cells were found in atherosclerotic lesions. How- 
ever in twelve lesions from patients with SAP, only five lesions showed 
ox-LDL positivity. In these lesions ox-LDL positivity was found in occasional 
macrophage-derived foam cells. The percentage of ox-LDL positive area was 
significantly higher (P < 0.05) in patients with UAP than in patients with SAP. 
Conclusions: These results suggest that ox-LDL plays an important role 
in the development of inflammatory processes and foam cell formation, which 
could induce plaque inflammation, and may give rise to rapidly progressive 
plaque destabilization. 
12:24 p.m. 
1005-l 69 Heat Production of Atherosclerotic Plaques and 
Inflammation Assessed by the Acute Phase 
Proteins in Acute Coronary Syndromes 
Christodoulos Stefanadis, Leonidas Diamandopoulos, John Dernellis, 
Emanuel Economou, Eleftherios Tsiamis, Konstantinos Toutouzas, 
Charalambos Vlachopoulos, Pavlos Toutouzas. Department of Cardiology 
University of Athens, Athens, Greece 
Background: Several studies have shown that inflammation plays an im- 
portant role in the pathogenesis of coronary heart disease (CHD). Serum 
amyloid A (SAA) and C-reactive protein (CRP) reactants of the acute phase 
of inflammation, have been shown to be increased in patients with CHD. 
Recently ex viva studies demonstrated that some types of atherosclerotic 
plaques show substantially warmer regions. We have developed a catheter 
based technique to measure the temperature of human arteries in viva. 
Therefore, the aim of the present study was to measure the luminal surface 
temperature in patients with CHD and to correlate it with the acute phase 
proteins in order to discriminate the role of inflammation in heat production 
in acute coronary syndromes. 
Methods: We have studied 60 patients with CHD (20 with stable angina, 
20 with unstable angina and 20 with acute myocardial infarction) and 20 
sex- and age- matched controls without coronary artery disease, by mea- 
suring plasma levels of SAA, CRP, plasma lipids and intracoronary arterial 
luminal wall temperature. lntracornary temperature was measured with a 
thermography catheter developed in our Institution: a thermistor probe with 
a temperature accuracy of 0.05 “C, was attached at the distal end of a long 
3 F polyurethane shaft. 
Results: We found that the median temperature differences at the site 
of the lesion from the background temperature was increased in patients 
with unstable angina (0.850 “C) and acute myocardial infarction (1.925 sC) 
compared with stable angina (0.100 “C), p < 0.001 for each comparison. 
Furthermore, stable angina has increased temperature differences compared 
with controls (0.000 “C, p c 0.001). There were very good correlations 
MCC February 2000 
between CRP and SAA with the temperature (r = 0.853, p = 0.01 and r = 
0.902, p = 0.01, respectively). 
Conclusion: Local heat production at the site of lesion is increased in 
patients with acute coronary syndromes and may arise from an aggressive 
inflammatory response occurring in these situations. The sensitive measure- 
ment of plaque temperature as a prognostic marker maybe useful in the 
management of coronary heart disease. 
1236 p.m. 
i__r 1005 170 An Enhanced Response of Circulating Monocytes to Low-Grade Inflammatory Stimuli 
in Unstable Angina is Associated With 
Recurrence of Coronary Events 
Giovanna Liuzzo, Vittoria Rizzello, Dominick J. Angiolillo, Christian Colizzi, 
Micaela Capponi, Francesca Ginnetti, Attilio Maseri, Luigi M. Biasucci. 
Cardiology Catholic Universifl: Rome, My 
Background: In unstable angina (UA), plasma levels of proinflammatory cy- 
tokines and C-Reactive protein (CRP) have been associaied with short- and 
long-term occurrence of coronary events. We hypothesized that an enhanced 
response of inflammatory cells to a variety of infectious and non-infectious 
stimuli could contribute to the development of coronary instability. To test this 
hypothesis we studied 25 patients with history of UA followed for 24 months 
and asymptomatic for at least 6 months (Gi), 12 patients with chronic stable 
angina (62) and 12 healthy controls (G3). 
Methods: Gl patients were sub-grouped according to the presence of new 
coronary events during the follow-up: Glaconsisted of IO patients with events 
(3 had an acute myocardial infarction and 7 new CCU admission for recurrent 
instability) and Gl b of 15 patients event-free. In all groups we assessed the in- 
terleukin-6 (IL-6) production by circulating monocytes after in vitro stimulation 
with increasing doses of lipopolysaccharide (LPS) for 4 hours. 
Results: No difference was found in monocyte count among the 4 groups. 
A dose-dependent increase in iL-6 production after LPS-challenge was ob- 
served in all groups. For high doses of LPS (IO and 100 ng/mL), monocytes 
of patients with history of UA (Gla and Gl b) exhibit a greatly enhanced IL-6 
production as compared to stable angina patients (G2) and controls (G3). 
More interestingly, for low doses of LPS (1 ng/mL, which can be compared 
with low-grade systemic inflammatory stimuli) Gi a patients had a significantly 
higher response than the other groups, including Gl b. The table shows IL-6 
production (ng/mL) as median and range: 
LPS Gla Glb G2 G3 
1 ng/mL 4.3 (3-10.6) 1.9 (0.1-8.4) 0.7 (0.1-3.3) 0.4 (0.1-3.5) 
10 ng/mL 25.8 (7s44)f 20.9 (6-68)t 9.2 (4.4-24.2) 8.3 (3.3-18.9) 
100 ng/mL 48 (22.4-150)t 53 (37-l 50)t 29.6 (15.9-68) 23 (10.4-65.2) 
- P < 0.01 Gla “S Gi b, G2 and G3; t P < 0.01 Gla and Gl b “S G2 and G3 
Conclusions: Monocytes of patients with recurrent phases of instability 
exhibit a greatly enhanced production of IL-6 in response to low-grade in- 
flammatory stimuli (such as that determined by chronic infections), 6 months 
after the last acute event. Thus, novel pharmacological approaches designed 
to modulate the monocyte response may offer additional lines of treatment 
and prevention of acute coronary syndromes. 
12:48 13.m. 
1005-I 71 is the Response to Chlamydia Pneumoniae 
Infection in Unstable Anaina Geneticallv 
Mediated? The Role of thk Lewis Antigenic 
System 
Dominick J. Angiolillo, Giovanna Liuzzo, Erica De Candia’, 
Simona Pelliccioni, Vittoria Rizzeilo, Christian Colizzi, Raffaele Landolfi’ , 
Attilio Maseri, Luigi M. Biasucci. ‘Cardiology and Semeiofica Medica, 
Cafhoiic Universifl: Rome, /fa/y 
Background: Chiamydia pneumoniae (CP) has been associated to acute 
coronary syndromes (ACS). However, although CP seropositivity (CP+) is 
relatively high, only some CPc pts are affected by ACS. It is also unclear 
whether CP is causative or an innocent bystander. Also C-Reactive Protein 
(CRP), an acute phase reactant, and the Lewis antigenic system (LAS), 
composed of genetically determined cell membrane surface antigens with 
receptorial functions towards several infectious agents, are associated to 
ACS. The aim of the study was evaluate if there is any association between 
CP infection and the LAS in pts with unstable angina (UA) and if there is any 
relation between LAS, CRP levels and prognosis. 
Methods: We studied 51 pts with Braunwald’s class Ill6 UA. CRP levels 
and CP seropositivity (>1/16) were evaluated on CCU admission. The Lewis 
antigens (Le a+; Le b+; Le a-b-) were also determined by direct hemoag- 
glutination. Since the Le b+ antigen is associated with respiratory infections, 
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pts were divided according to positivity or negativity towards this antigen, into 
4 groups: A) CP+ Le b+ (21 pts); B) CP+ Le b- (13 pts); C) CP- Le b+ (13 
pts); D) CP- Le b- (4 pts). Pts were followed for 1 year and new episodes 
of instability were evaluated. 
Results: No significant association between a specific Lewis antigen and 
seropositivity to CP was observed. CPc pts belonging to group A (Le b+) 
had CRP significantly higher than group B pts (Le b-) (p = 0.04; median and 
range group A: 6.2, 0.7-188 mg/L; group B: 2.5, 0.5-15 mg/L). CRP levels 
> 3 mg/L were present in 14/21 (66%) group A pts and only in 303 (23%) 
group B pts (p = 0.034). Recurrence of instability was present in 12/21 (57%) 
group A pts and only in 3/13 (23%) group B pts (p = 0.04); recurrence of 
instability occurred also in 4/l 3 (30%) and in l/4 (25%) group C and D pts, 
respectively. 
Conclusions: A greater inflammatory response and a worse prognosis 
are present in UA pts who are CP+ and have the Le b+ antigen. Therefore, this 
specific genetically determined membrane antigen, having receptorial func- 
tions for different infectious agents, may modulate the inflammatory response 
to CP in UA. The identification of subjects genetically more susceptible to 
environmental factors, such as infectious agents, may open novel strategies 
in the management of UA. 
I:00 p.m. 
1005-l 72 Ch/amydia Pneumoniae and Inflammatory 
Markers in Acute Coronary Syndrome 
Harish R. Chandra, Nivedita Choudhat-y, Carol O’Neill, Marcus J. Zervos, 
Ann Kroetsch, Marykutty Philip, Linda Luzon, James M. Colar, Judith Boura, 
Gerald C. Timmis, William W. O’Neill. William Beaumont Hospital, Royal 
Oak, Ml, USA 
Background: The role of infection with Chlamydia pneumoniae (CP) and 
inflammation in coronary artery disease is controversial. Several studies have 
demonstrated higher levels of CP titres (CPIgG): C-Reactive protein (CRP) 
and fibrinogen levels in patients with CAD compared to healthy controls. 
Methods: We conducted a prospective study on patients (n = 814) who 
were admitted to the chest pain center of our institution between March 15, 
and June 11, 1999. Clinical information and blood tests were obtained at the 
time of admission, and data on in-hospital management and outcome were 
collected. We looked at the differences in the CP titres, CRP, and fibrinogen 
levels in patients who were diagnosed with acute coronary syndrome (ACS) 
vs. those who were not (non-ACS). 
Results: Patients diagnosed with ACS were older (65 f 13 vs. 51 l 16, 
p = 0.02), more often male (63% vs. 51%, p = O.OOi), more often non-whites 
(52% vs. 48%, p = 0.001) and had a higher prevalence of hypertension (70% 
vs. 56%, p = O.OOi), hyperlipidemia (46% vs. 36%, p = 0.003), diabetes (31% 
vs. 15%, p = O.OOl), prior myocardial infarction (39% vs. 26%, p = O.OOl), 
prior percutaneous intervention (26% vs. 18%, p = 0.005), bypass surgery 
(25% vs. 14%), and smoking (46% vs. 30%, p = 0.001). The CPlgG E I:512 
was 53% vs. 46% (p = 0.05) and ~1 :I 024 was 35% vs. 26% (p = 0.004). The 
mean, fibrinogen level was higher in ACS group (338 rt 123 vs. 315 I! 99, p 
= 0.004). The CRP levels divided into tertiles were not significantly different 
between ACS and non-ACS groups (p = 0.12). On multivariate analysis, 
CPlgG 2 I:1024 (RR = 1.47, p = 0.02) diabetes (RR = 1.54, p = O.Ol), 
hypertension (RR = 1.55, p = O.Ol), prior myocardial infarction (RR = 1.68, p 
= 0.002), smoking (RR = 1.50, p = O.Oi), nonwhite race (RR = 2.0, p = 0.002) 
and male sex (RR = 1.54, p = 0.001) were the only factors independently 
associated with ACS. 
Conclusion: We found a very strong association between high level 
seropositivity to Chlamydia pneumoniae with acute coronary syndrome in 
patients admitted with chest pain after controlling for known coronary risk 
factors. This may indicate recent re-infection with CP or an exaggerated 
immune response to it as an etiological factor for ACS. 
1:12 p.m. 
1005-l 73 Can Systemic Markers of Inflammation 
Accurately Predict Short-Term Outcome in 
Patients With Unstable Coronary Syndromes? 
Michael Cusack, Sola Odemuyiwa, Kavan Kamalvand, Annie Redwood, 
Paul Collinson’ i Michael Webb-Peploe, Cliff Bucknall, Michael Marber, 
Simon Redwood. Carcfiofhoracic Center, St Thomas Hospital; 
‘Department of Clinical Chemistry, St George’s Hospital, London, UK 
Background: Inflammation is recognised as a key factor in the pathogen- 
esis of the acute coronary syndromes, Tumour Necrosis Factor (TNF-ol), 
Interleukin-6 (IL-6) and C-reactive protein (CRP) are produced in response 
to inflammatory stimuli. The aim of this study was to determine if plasma 
levels of TNF-a, IL-6 and CRP were predictive of an unfavourable outcome 
in patients with unstable angina (UA). In addition their predictive value was 
compared to that of cardiac Troponin-T (cTnT). 
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Methods: We prospectively studied 38 patients (age 64.8 i 1.8, 66% 
male), with Braunwald IllB UA. All patients were treated with standard medical 
therapy. TNF-n, IL-6, CRP and cTnT were determined at 0, 6, 24 and 48 hrs 
following hospital admission. 
Results: IL-6, CRP and cTnT were consistently elevated following ad- 
mission in those having an in-hospital major adverse cardiac event (MACE)- 
Group 1, as compared to those who stablized with medical therapy-Group 2. 
No significant difference was seen in TNF-a between these two groups. 
Oh 6h 24!w 1*r 
The predictive value of IL-6 and cTnT was determined at a number of 
dichotomy limits. IL-6 had the greatest predictive value at a dichotomy limit 
of 8 pg/ml, and cTnT at a dichotomy limit of 0.1 ug/dl. 
IL-6 (8 pg/ml) cTnT (0.1 ugldl) 
Sensitivity 
Specificity 
Predictive Value 
86% 80% 
100% 80% 
100% 80% 
Conclusions: Adverse events in unstable angina are associated with 
elevated IL-6 on admission, with a later rise of both CRP and cTnT. Inter- 
estingly, admission IL-6 is a more powerful predictor of MACE than cTnT in 
patients with unstable angina and may allow improved risk stratification in 
these patients. 
1:24 p.m. 
/ 1005-l 74 1 Interleukin-1 Receptor Antagonist: 
An Inflammatory Marker of Instability at Baseline 
and During Follow Up in Patients With lschemic 
Heart Disease Undergoing Coronary. 
Angioplasty 
German0 Di Sciascio, Andrea D’Ambrosio, Antonio Abbate, Giuseppe Patti, 
Alessandro @lanzoli, Giordano Dicuonzo, Gianfranco Guarnieri, 
Aldo Dobrina. Campus Bio-Medico Universifx Rome, Italy 
Background: High levels of inflammatoty substances have been associated 
with unstable phases in patients (pts) with ischemic heart disease (IHD). 
We studied interleukin-I receptor antagonist (IL-l Ra), which modulates the 
activity of IL-l, and C reactive protein (CRP) to determine their ability to 
identify clinical instability and/or predict MACE in the follow up period after 
PTCA. 
Methods: Serum levels of IL-IRa and CRP were determined in 106 
consecutive IHD pts studied with coronary angiography: 57 with unstable 
angina (Group A, mean age 61 i 10 yrs, 47 males), 49 with chronic stable 
angina (Group B, mean age 61 * 9 yrs, 45 males). Thirty-one pts (17 of Group 
A and 14 of Group B) joined a prospective follow up study (mean duration 
12 months, range 10-22) after complete revascularization with PTCA and 
coronary stenting. Follow up assessment included office visit and serum level 
determinations of IL-l Ra and CRP at 3 months after the procedure. 
Results: At baseline, IL-IRa serum levels were significantly higher in 
unstable pts (Group A: median value 158 pgiml, interquartile range 110-224) 
compared to stable pts (Group B: 108 pg/ml, 95154; P = 0.001); no significant 
difference was notable regarding CRP serum levels. At follow up, 23 pts had 
no signs or symptoms of ischemia and showed IL-1 Ra levels at 3 months 
significantly lower compared to 8 pts with MACE (Ml, death, TLR) 3 to 6 
months after the procedure (134 pg/ml, 92-195 vs 221 pg/ml, 162-330; P = 
0.028). Variations of IL-I Ra levels during follow up were significantly different 
between the symptomatic and asymptomatic pts (mean variation +64% vs 
-33% respectively, P = 0.002). The positive predictive value of an increase 
of IL-I Ra levels at 3 months was 53% in predicting cardiac events during 
clinical follow up, while the negative predictive value of a decrease of IL-I Ra 
levels was 100%. Considering only the unstable pts the positive predictive 
value was 94%. Regarding CRP levels we did not notice any significant data. 
Conclusion: Thus, unlike CRP, IL-l Ra clearly identifies pts with clinical 
instability at baseline and predicts the incidence of a new acute cardiac event 
during the follow up period after coronary angioplasty. 
I:36 p.m. 
I 1005 175 Lymphocyte Count in Peripheral Blood Improves 
Risk Stratification in Unstable Angina Patients 
Emmanouil G. Zouridakis, Xavier Garcia-Mall, Juan Carlos Kaski. 
Cardiological Sciences, St George’s Hospital Medical School, London, UK 
Background: Cardiac troponin I (cTnl) has been shown to have prognostic 
value in unstable angina (UA). Studies have also shown that low relative 
lymphocyte count has prognostic significance in patients with known or sus- 
pected coronary heart disease. The aim of our study was to examine whether 
lymphocyte count (LyC) may add prognostic information to that already pro- 
vided by cTnl in patients with UA. 
Methods and Results: We studied 71 patients (42 men, mean age: 61.5 
& 9.2 ys) who were admitted with UA (Braunwald Ill-B). LyC and cTnl were 
measured in blood samples drawn within 24 h from admission. Patients 
were followed-up for a mean period of 12 f 2 months. During follow-up 20 
patients developed an adverse cardiac event (readmission for UA requiring 
revascularization: 16, myocardial infarction: 1 and cardiac death: 3). Quartile 
lymphocyte distribution analysis showed that patients in the lower 3 quartiles 
had a 5.3-fold (95% Cl: 1 .ll-25.49) risk of developing events than those 
in the highest quartile (p = 0.024). We therefore used the inferior limit of 
the highest quartile (2.40 x IO9 lymphocytes/L) as a cut-off point to assess 
patients outcome during follow-up. Patients with abnormal cTnl (>0.4 mg/L) 
had a relative risk 3.9 (95% Cl: 1.2-12.2) times higher of having an event 
than patients with normal cTnl (p = 0.019). The combination of both variables 
yielded a 65fold (95% Cl: 1.90-22.19) increase of risk of events during 
follow-up (p = 0.003). 
Conclusion: Our results indicate that low lymphocyte count provides 
additional prognostic information over and above that of an abnormal cTnl 
in patients with unstable angina. The addition of this simple test to the 
prognostic evaluation of UA patients may improve risk stratification. 
1:48 p.m. 
CITI 1005 176 C-Reactive Protein Levels Do Not Correlate With the Severity of Coronary Atherosclerosis 
Gaby B. Aoun, Francis J. Kiernan, Daniel B. Fram, Alan H.B. Wu, David 
D. Waters, Rabih R. Azar. Hartford Hospital, CR The University of California 
San Francisco, CA, USA 
Background: A high level of C-Reactive Protein (CRP) is associated with 
adverse cardiac events in healthy patients and in those with coronary artery 
disease (CAD), but whether CRP level correlates with the extent and severity 
of CAD is still unknown. 
Methods: We prospectively measured CRP level in 101 patients under- 
going coronary angiography. Patients with recent acute coronary syndromes 
(<I4 days) and those with conditions that may increase CRP or who were on 
anti-inflammatory medications were excluded. Angiograms were reviewed 
by two experienced cardiologists who where blinded to the CRP results. For 
each patient, the coronary tree was divided into 9 segments and each seg 
ment was scored from 0 to 3 (0 = normal, 1 = stenosis c 50%, 2 = stenosis 
between 50-99% and 3 = complete occlusion). A Coronary Atherosclerosis 
Score (CAS) was calculated as the sum of the scores in all segments. 
Results: Mean CRP level was 2.07 & 1.8 mg/l and mediah CAS was 9. 
There was no correlation between CRP levels and CAS (R = 0.04; p = ns). 
CRP mg,, 
l * . 
Conclusion: CRP level does not correlate with the severity of coronary 
atherosclerosis. Other mechanisms, such as instability of individual coronary 
lesions, may explain the adverse outcome of patients with high CRP. 
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se of Early Troponin I and Continuous 12-Lead 
ST Segment Monitoring to Predict Need for 
Subsequent Urgent Revascularization for 
Refractory Unstable Angina 
Don D. Wurzburg, G!oria Darovic, Frank Sun, Lloyd W. Klein, Joseph 
E. Parrillo, James E. Calvin. Cardiology: Rush Medical College, Chicago, 
Illinois, USA 
To determine independent of clinical criteria, the value of Troponin I and 
continuous 12-lead ST segment monitoring to predict risk of urgent revas- 
cularization in patients (pts.) with suspected acute coronary syndromes, 221 
pts. admitted to Rush Medical Center between January 1998 and July 1999 
were studied. Continuous 12-lead ST segment monitoring was performed for 
a minimum of 12 hours and Troponin I measurements at 8 hrs after presen- 
tation were obtained. ST depression (STD) ? 1 mm at baseline or a change 
~1 mm from baseline and a Troponin I assay 10.2 ngimi were considered 
significant. Group I consisted of the 21 pts. who required urgent revascu- 
larizalion for refractory angina (PTCA 19 pts.; CABG = 2 pts.) and Group 2 
consisted of 200 pts who did not. Group 1 pts. had a higher frequency of 
several recognized clinical predictors of cardiac risk including diabetes (33% 
vs 13%, p = 0.013), Ml 5 14 days old (14% vs I%, p = O.OOl), need for IV 
nitroglycerin (38% vs O%, p = O.OOl), use of B-blocker prior to hospitalization 
(32% vs 16%, p = 0.099) and STD at baseline (33% vs II%, p = 0.004;. 
The groups had similar age (55 years). The frequency of Troponin I 2 0.2 
rig/ml was also greater in Group 1 (85% vs 35%, p = 0.001) giving a sensi- 
tivity of 85%, a specificity of 65%, +predictive value (PV) of 25% and -PV 
of 97%. Spontaneous changes in STD 2 1 mm from baseline were more 
common in lateral leads oi group 1 patients, leads I and V5 (14% vs 3%, p 
= 0.02) and Vs (14% vs 2%, p = 0.002). STD was less sensitive (15%) but 
had excellent specificity (97%) and -PV (92%). Multiple logistic regression 
confirmed Troponin I ? 0.2 ngiml (odds ratio (OR) = 11.39, p = 0.0005) as 
an independent marker of recurrent angina requiring revascularization after 
adjusting for diabetes (OR = 5.94; p = 0.0006), and MI 5 14 days old (OR = 
29.69; p = 0.0196). 
Conclusions: While both peak Troponin I and STD (baseline and sponla- 
neous) predict recurrent angina requiring revascularization in pts. with acute 
coronary syndromes, Troponin I had greater sensitivity. In addition, both Tro- 
ponin I and ST had very high -PV making them useful predictors of low risk 
pts. 
‘ i 082-l 02 Utility of Troponin-I in Predicting Short-term 
Cardiovascular Events in Patients With Unstable 
Angina and Normal CK-MB Levels 
Evan Appelbaum, Michael E. Farkouh, M. Urooj Zafar, Sebastian Stec, 
Daniel Spevak, James H. Chesebro. Mount Sinai Schooi of Medicine, New 
York, NI: USA 
Background: Numerous studies have determined that troponin is a valuable 
marker in determining long-term prognosis of patients presenting with acute 
coronary syndromes. What remains controversial is the role ihat varying 
degrees of troponin elevation have in determining patient triage and man- 
agement in the emergency department (ED) when the serial CK-MB values 
are normal and when the patient has been appropriately risk stratified. 
Methods: We retrospectively identified ail 719 consecutive paiients pre- 
senting to the ED with symptoms consistent with unstable angina (UA) in 
the first 4 months after our hospital adopted routine cardiac troponin-I (cTnl) 
testing in all patients with unstable angina (08198 to 12198). 261 patients were 
found to have normal serial CK-MB levels but elevated cTnl levels of ~0.4 
at either time 0 or 6-9 hours after presentation. Patients were excluded from 
our analysis if they had acute myocardial infarction or percutaneous coro- 
nary intervention within 4 weeks or ST segment elevation on the qualifying 
EKG. This lefi 212 paiients meeting eligibility criteria. The prirnaty outcome 
measure included at least one of the following: death, non-fatal myocardial 
infarction, acute congestive heart failure: refractory angina or cardiac arrest 
during the total ED and in-hospital stay, 
Results: Table 1 demonstrates the in-hospital event rates for 212 study 
patients who were risk stratified according to the AHCPR criteria. 
Only intermediate risk patients wilh a cTni > 2 were at significantly 
Table 1: Short-term prognosis for patients with elevated Troponin I and normal CK-MB 
Total = 212 Low Risk Intermediate Risk High Risk Total 
No. of case?. 32 (15.1%) 156 (73.6%) 24 (11.3%) 212 
Cardiac Event 0 (0) 18 (11.5%) 7 (23.2%) 25 (11.8%) 
CTnl > 2 015 (0) 12/33 (36.4%) 418 (50%) 16/46 (34.8%) 
0.4 < cTnl c 2 O/27 (0) 61123 (4.3%) 306 (18.8%) 9/l 66 (5.4%) 
increased risk for cardiac events compared with patients with only mild 
elevations (p i 0.001). 
Conclusion: cTnl determinations in patients with normal CK-MB mea- 
surements appear to be of greatest value in AHCPR intermediate risk UA 
patients and should be incorporated into ED UA management guidelines. 
1082-l 03 The Significance of Elevated Troponin I Level 
Prior to Primary Angioplastv for Acute 
Myocardial lnfa?ctioi - 
Shlomi Matetzky, Tali Sharir, Marko Not, Michelle Domingo, Neil Eigler, 
Bojan Cercek. Cedars-Sinai Medical Center, Los-Angeles, California, USA 
Background: Troponin (CTn) provides important information in risk stratifi- 
cation of patients with unstable angina and non Q wave acute myocardial 
infarct (AMI). Its prognostic value in patients undergoing primary angioplasty 
(PTCA) for ST-elevation (ST?) AMI is unknown. 
Methods: Included were 110 consecutive patients with ST? AMI referred 
for primary PTCA. Prior to the PTCA, 54 patients (49% group A) had ele- 
vated (~0.4 rig/ml) CTnl and 56 patients (54% group B) had normal CTnl. 
Patients were followed for 18 months for occurrence of death, reinfarction, 
and revascularization. 
Results: Primary PTCA was successful (TIMI Ill flow, residual stenosis 
~30%) in 77% of group A as compared to 96% of group B patients (p = 
0.03). In-hospital incidence of mortality or heart failure was higher in group A 
(30%) compared with group B patients (9% p < 0.006). During the 18-month 
follow-up, group A patients had higher incidence of cardiac mortality 11% vs. 
0% (p = 0.013), occurrence of cardiac event (death or nonfatal Ml) 18% vs. 
5% (p = 0.04) or cardiac event and/or target vessel revascularization 30% vs. 
14% (p < 0.04). interestingly there was no correlation between admission 
CTnl levels and time from onset of symptoms to presentation (r = -0.007, p 
= 1 .O). Duration of symptoms had no incremental value over admission CTnl 
in predicting angiographic or clinical outcome. 
Conclusion: In AMI patients with ST?, elevated admission CTnl predicts 
lower success rate of primary PTCA and worse short- and long-term clinical 
outcome. 
1082-I 04 What is the Optimal Cut-Off Value for Troponin? 
A Comparison Using Two Different Troponin I 
Assays 
Michael C. Kontos, F. Philip Anderson, Lucie Fritz, James L. Tatum, Joseph 
P. Ornate, Robert L. Jesse. IMCWVCU, Richmond, VA, USA 
Background: Troponin could replace CK-MB as the gold standard for Ml, 
though the specific cut-off values chosen may have substantial impact on the 
number of patients (pts) diagnosed with Ml. Two values often considered are 
the lower limit of detectability (LLD) and the manufacturers’ suggested upper 
limit of normal (MUL). 
Methods: To detect the impact on the diagnosis of Ml, we compared two 
Tnl assays, Assay 1 (LLD 0.5 ngirnl, MUL 2.0 ng/mL) and Assay 2 (LLD 
0.1 ng/mL. MUL 0.9 ng/mL) in two pt groups admitted for possible Ml. Tnl 
was assayed at the iime of admission and 8 hours later. The optimal cut-off 
value was determined using ROC curve analysis to optimize sensitivity (SN) 
and specificity (SP). Criteria for Ml was a CK-MB ? 8.0 ng/mL with a relative 
index of ~4.0. 
Results: Assay 1 was tested in 1929 pts (9% with Ml; optimal cut-off 1 
ng/mL) and Assay 2 in 1205 pts (13% with MI; optimal cut-off 0.3 ng/mL). SN 
and SP for the cut-off values are shown below. Area under the ROC curve 
as well as SN and SP for the various cut-off values were similar between the 
assays. The LLD significantly over- and MUL under-diagnosed Ml compared 
to the optimal cut-off. 
Assav 1 
Assay 2 
LLD 
optimal 
MUL 
LLD 
SN 
37% 
SP 
86% 
% (+) Tnl 
21% 
96%* 93%** 15% 
90% 97% 11% 
98% 80% 30% 
optimal 
MUL 
96%” 92%-t 20% 
88% 97% 14% 
* = 13 < 0.02 compared to MUL: t = p < 0.01 compared to LLD 
Conclusions: Optimal cut-off values for different Tnl assays are higher 
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than the LLD and lower than the MUL. ROC curve analysis should be used 
to optimize SN and SP for Tnl assays. 
I 1082 105 Relationship of Troponin T and C-Reactive Protein With Transient Myocardial lschemia in 
Unstable Angina 
Gaetano A. Lanza, Antonio G. Rebuzzi, Domenico Cianflone, Luigi 
M. Biasucci, Giovanna Liuzzo, Filippo Crea. Universita’ Cattolica de/ Sacro 
Cuore, Roma, lfaly 
Background: Transient myocardial ischemia (TMI) on 24-hour Holter ECG 
monitoring (HM) and high plasma levels of troponin T (TnT) and C-reactive 
protein (CRP) have been reported to predict clinical events in unstable 
angina (UA). However, it is still largely unknown whether TnT (a marker 
of myocardial damage) and CRP (a marker of inflammation) plasma levels 
reflect the severity of ongoing myocardial ischemia in these patients (pts). 
Methods: To address this issue, TnT and CRP plasma levels were mea- 
sured at hospital admission and HM was performed within 24 hours from 
admission in 129 UA pts (93 men, 63 f IO yrs). The ischemic burden was 
assessed by the detection of episodes of transient myocardial ischemia on 
HM, which was diagnosed in case of ST segment depression (horizontal or 
downsloping) or elevation pi mm, lasting for ~1 min. 
Results: One or more episodes of TMI were found in 11 of 16 pts (68.8%) 
with high (20.2 pg/L) and in 38 of 113 pts (33.6%) with low TnT plasma 
levels (p < 0.01). On the other hand, episodes of TMI were detected in 30 
of 66 pts (45.4%) with high (>3 mg/L) and in 19 of 63 pts (30.2%) with low 
CRP plasma levels (p = 0.07). Furthermore, TMI was detected in 9 of 13 pts 
(69.2%) with increased levels of both TnT and CRP, in 23 of 56 pts (34.8%) 
with high levels of either TnT or CRP, and in 17 of 60 pts (28.3%) with low 
levels of both TnT and CRP (p = 0.02). 
Conclusion: Thus, our data show that, in UA pts, TMI on HM was 
strongly associated with increased levels of TnT, but not of CRP. The lowest 
prevalence of TMI was found in pts with normal values of TnT and CRP, but 
the detection of TMI in a significant number of these latter pts suggest that 
these biochemical markers of prognosis may have some limitations for the 
assessment of the severity of the ischemic activity in unstable angina. 
1082-l 06 Association of Presence of lntracoronary 
Thrombus and Troponin I Levels in Patients With 
Unstable Angina or Non-Q-Wave Myocardial 
Infarction in PRISM-PLUS 
Xue-Qiao Zhao, Steve Snapinn, Ik-Kyung Jang, Rick Sax, Pierre Theroux. 
University of Washington, Seattle, WA; Harvard Medical School, Boston, 
MA; Merck Research Lab, West Point, PA, USA; Montreal Heart Institute, 
PQ, Canada 
Background: The presence of intracoronary thrombus and elevation of tro- 
ponin levels are independently associated with poor prognoses in patients 
(pts) with acute coronary syndromes. 
Methods: To explore the relationship between thrombus and troponin I 
levels, we studied 80 pts with unstable angina or non-Q-wave myocardial 
infarction in the PRISM-PLUS trial who had angiographic analysis on throm- 
bus and troponin I measurements. In PRISM-PLUS, coronary angiography 
was performed a mean 65 f 17 hours after randomization to combination of 
tirofiban plus heparin or to heparin alone. All angiograms were analyzed by 
a Core Lab to detect intracoronary thrombus. Serial troponin I levels were 
measured over the initial 24 hours after enrollment of this study. Presence of 
thrombus was correlated to baseline, peak and mean troponin I levels. 
Results: Among 80 pts in this substudy, 42 pts with thrombus, compared 
to 38 pts without, had significantly higher troponin I levels (3.8 f 6.4 vs. 1 .O 
f 2.4 ng/mL, p < 0.001) at baseline. The peak troponin I level also was 
significantly higher in pts with thrombus (15.8 & 24.6 vs. 2.1 f 3.9 ng/mL, 
p < 0.001) The mean troponin I levels over initial 24 hours were 9.1 f 13.4 
ng/mL in pts with thrombus and 1.3 rt 2.4 ng/mL in whom without thrombus (p 
< 0.001). The correlation coefficients between intracoronaty thrombus and 
troponin I levels were 0.38 (p < 0.001) at baseline, 0.42 (p < 0.001) at peak, 
and 0.44 (p < 0.001) for the mean. 
Conclusions: In PRISM-PLUS, presence of intracoronay thrombus is 
significantly correlated with higher levels of troponin I indicating myocardial 
injury. These data may explain the fact that presence of intracoronary throm- 
bus strongly predicts poor clinical outcomes and the benefits observed with 
tirofiban and other antithrombotic therapies in patients with unstable angina 
or non-Q-wave myocardial infarction. 
JACC February 2000 
Is Quantitative Bedside Determination of 
Troponin T Equal to Laboratory Testing? Results 
of a German Multicenter Study in Emergency 
Rooms 
Britta U. Goldmann, Lukas Langenbrink, Christian W. Hamm. For the 
CARE-T Study Group; University Hospital Eppendorf, Hamburg; Kerckhoff 
Heart Center, Bad Nauheim, Germany 
Bedside determination of troponin T (TnT) for emergency room triage and 
decision making in the heterogenous group of chest pain patients (pts) 
will become exceptionally valuable. As the TnT stares is known to be closely 
related to the outcome of pts with acute coronary syndromes a cardiac reader 
was developed, which allows quantification of TnT in whole blood samples 
within 12 minutes. The increasing intensity of a signal line on a strip assay 
detected by a camera sensor is proportional to the TnT concentration in the 
sample. To clinically evaluate this reading system a prospective, multicenter 
study (CARE-T) was performed and heparin treated venous blood samples 
from n = 640 pts with suspected coronary syndrome were analyzed with 
the reading system and the TnT ECLIA (Elecsys, cut-off 0.1 rig/ml) and 
the relationship of both results were decribed using nonlinear regression 
analysis. 
Results: Regression analysis of paired TnT measurements between 
ECLIA and the cardiac reader in n = 300 specimens over the concentration 
range of the rapid assay (0.1 rig/ml to 3.0 ngiml) showed a high correlation 
of r = 0.823 (y = 0.77x + 0.182, r* = 0.677). The 95% confidence intervats 
were 0.710-0.832 for the slope and 0.128-0.236 for the intercept. 
Conclusion: Quantification of TnT test strips enabled reliable determi- 
nation of TnT concentration in whole blood samples. The new rapid device 
performed at the patients bedside facilitates decision making and risk strat- 
ification in a heterogeneous chest pain population and may constitute an 
attractive alternative to centralized laboratory testing. 
1082-l 08 Detection of Anti-Actin and Anti-Myosin 
Antibodies in Acute Coronary Syndromes: 
Clinical Associations and Prognostic 
Implications of Humoral Immune Response 
George Dangas, Manos M. Konstadoulakis, Christodoulos I. Stefanadis, 
John H. Shao, Marina G. Toutouza, David J. D’Agate, George D. Kymionis, 
Adam M. Cohen, Christina Liakou, Mitrey Valabajosyula, 
Helen Kroubouzou, John N. Nanas, Ara Sadaniantz, James H. Chesebro, 
Pavlos K. Toutouzas. Cardiovascular Research Foundation, Washington, 
DC; Mount Sinai School of Medicine, N’r: NY; Brown University: Providence, 
RI, USA; National University of Athens, Greece 
Background: During myocardial injury, intracellular proteins are released 
into the circulation and may trigger the development of auto-antibodies (AAb) 
as has been described after surgery. The clinical significance of these AAb 
is unknown. We hypothesized that ischemic injuy may be in part related to 
AAb, which may have prognositc implications. 
Methods: We investigated the presence of IgG AAb against actin, and 
myosin, after an acute ischemic clinical event, and their correlation with 
CPK and Troponin-I (Tnl) in 33 consecutive patients hospitalized for acute 
coronary syndromes (ACS) without a history of myocardiai infarction, and 2.5 
in controls who had no evidence of coronary disease. Measurements were 
done in-hospital, at 1 and 3 months, and patients were followed clinically for 
2 years. The nonparametric Wilcoxon z-test was used for comparisons. 
Results: In-hospital the group with ACS was 39% antiactin positive and 
44% antimyosin positive. In contrast, the respective AAb positivity of the 
controls were 13% and 18% (p 4 0.04, ACS versus control for both). At 
1 month, 50% were antiactin positive and 44% antimyosin positive, and 
no further change was observed at 3-month follow-up. At 1 and 3 month 
follow-up, persistence of either antiactin or antimyosin AAb correlated with 
elevated in-hospital serum Tnl (z < 0.03) and CPK (z < 0.01). Conversely, 
elevated serum Tnl at 1 or 3 months correlated with positive AAb in-hospital: 
antiactin (z = 0.08), and antimyosin (z = 0.03). AAb positivity at 1 or 3 months 
correlated with reinfarction at 2 year follow-up: 100% versus 25% for AAb 
negative, p = 0.01. 
Conclusions: lschemic myocardial injury is associated with presence of 
antiactin and antimyosin AAb. Patients with elevated Tnl and CPK during 
an ACS, develop AAb l-3 months after the ACS. Persistence of these AAb 
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correlates both with elevated Tnl at 3 month follow-up (this may indicate 
sub-clinical cardiac injury). and with reinfarction at two-year follow-up. 
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1 f 083-l 35 1 Primary PTCA With and Without Stent 
Implantation in 671 Patients With Acute 
Myocardial Infarction Complicated by 
Cardiogenic Shock. Results of the ALKK 
Primary-PTCA Registry 
U. Zeymer, A. Vogt, W. Niederer, U. Tebbe, H.-J. Engel, K.-W. Heinrich, 
W. Merx, C. Pfafferott, M. Gottwik, K.-L. Neuhaus. For the ALKK-Study 
Group; Medizinische K/irtik /I, Kiinikum Kassel, Germany 
Background: In-hospital mortality in patients with acute myocardial infarction 
(AMI) complicated by cardiogenic shock (CS) is extremely high, even with the 
use of thrombolysis. Observational reports from small patient groups suggest 
a benefit from early interventional therapy. 
Methods: Between 7194 and 12/98 a total of consecutive 4552 primary 
PTCAs in patients with AMI were performed in 72 centers within 24 hours 
after symptom onset and entered into the Primary-PTCA registry of the ALKK. 
AMI was complicated by cardiogenic shock (CS) in 671 patients (15%). Mean 
age of patients with CS was 64 i 12 yrs, 67.5% were men. The time intervai 
between symptom onset and start of PTCA was 244 5 243 min. One-, two- 
and three vessel disease was present in 35%, 27% and 38% of the patients, 
respectively. 
Results: The intervention was successful in 85% of the patients with a 
final TIMI 3 flow in 76% and TIMI 2 flow in 9%. The total in-hospital mortality 
was 47.4% and was highest in patients with TIMI O/l flow (82%), somewhat 
lower in patients with TIMI 2 flow (64%) and lowest in patients with TIMI 
3 flow (38%). Mortality in patients with additional stent implantation was 
41% (l’l51281) compared to 52% with PTCA alone (2021390) (p = 0.006). 
in-hospital mortality in the two groups according to TIMI flow grade is shown 
in the table. 
PakllCV PTCA Death MWt. stent Death MOti 
TIMI 3 
TIMI 2 
TIMI 011 
270 (69%) 
34 (9%) 
86 (22%) 
107 39.6% 
24 70.5% 
71 82.5% 
241 (86%) 90 37.3% 
25 (9%) 14 56% 
15 (5%) 11 73.3% 
Conclusion: In-hospital mortality in patients with AMI complicated by CS 
remains high despite early interventional therapy. TIMI flow grade after the 
intervention is a major determinant of outcome. The incidence of TIMI 3 flow 
is higher in patients with stent implantation, explaining the significantly lower 
mortality compared to PTCA alone. However, a negative selection bias is 
most likely in the PTCA alone group, which includes all patients in whom 
crossing of the occlusion with the guidewire was unsuccessful. 
I 1083 136 Stent PAMI: Are Excellent Outcomes Achieved 
Only by Experienced Sites? 
David A. Cox, Gregg W. Stone, Bruce Brodie, Yele Aluko, Eulogia Garcia, 
John Griffin, Luis Mattos, William W. O’Neill, Marie-Claude Morice, 
Judith Boura, Cindy L. Grines. Mid Carolina Cardio/ogy/Amicus Research 
Foundation, Charlotte, NC, USA 
Background: It has been suggested that the results of primary PTCA 
achieved by expert investigators may not be reproducible at non-study sites. 
Methods: The PAMI Stent Randomized Trial, in which 900 patients with 
AMI were randomized to PTCA vs. stenting. was designed as a “real world” 
study; only 17 international sites (enrolling 417 pts) had been involved in 
any of the prior PAMI trials, while 42 clinical sites (enrolling 481 pts) had not 
participated in prior studies. The acute procedural outcomes, core laboratory 
angiographic analysis, and long-term results appear in the Table. 
Results are presented in the table. 
Conclusion: Excellent results, including final TIMI-III flow, in the Stent 
PAMI trial were equally achieved by sites with and without prior experience in 
PAMI protocols. These favorable outcomes should be readily achieved by all 
interventionalists committed to primary PCI and not limited to a select core 
of expeii investigators. 
EF 
IABP 
Abciximab 
Final TIMI-III 
6.mo. Events 
Death 
Reinfarction 
Restenosis 
lschemlc TVR 
Composite 
Prior PAMI Sites 
54% i 12 
1.5% 
3% 
91% 
4% 
2% 
25% 
12% 
16% 
New Sites P 
55% * 12 0.314 
1.4% 0.867 
7% 0.004 
91% 0.756 
3% 0.556 
2% 0.912 
29% 0.273 
12% 0.926 
16% 0.962 
1 1083-l 371 Is the Diagnostic Catheterization in Acute 
Myocardial Infarction Therapeutic? Rate of 
Opening of Closed Arteries With Diagnostic 
Injections Following Thrombolytic 
Administration in TIMI IOB and 14 
C. Michael Gibson, Michael Anshelevich, Sabina Murphy, Colin Hynes, 
Timothy Saunders, Rebecca Mesley, Robert Zemble, Susan J. Marble, 
Carolyn H. McCabe, Christopher P. Cannon, Eugene Braunwald. For fhe 
T/M/ Study Group; University of California San Francisco, Brigham & 
Women’s Hospital, Boston, USA 
Background: The TIMI angiographic core laboratory uses the I*’ injection 
(inj.) at each timepoint following thrombolytic administration to assess the 
TIMI flow grade & the corrected TIMI frame count (CTFC). The frequency 
with which this first inj. mechanically opens an occluded coronary artery is 
not well defined. 
Methods: We hypothesized that mechanical opening is infrequent, and 
we studied 4,021 consecutive first inj. in the TIMI IOB & 14 studies to define 
its frequency. 
Results: If only closed arteries are examined, 52 of 815 closed arteries 
were opened by inj. (6.4%). In the TIMI 14 trial, data was prospectively 
collected regarding the timing after thrombolytic administration of vessel 
opening. At 90 minutes, 16 of 194 closed arteries (8.2%) were opened 
during the injection (i.e. dye temporarily stopped at the lesion giving the initial 
appearance of TIMI grade 0 flow, &subsequently continued down the artery) 
& 10 of 194 closed arteries (5.2%) were open at the start of the 2”d injection 
for a total of 26/194 (13.4%). This exceeded the number of closed arteries 
opened by injection at 60 & 75 minutes combined (7/243, 2.9%, p < 0.001). 
If both open and closed arteries are included in the analysis, then 52/4,021 
(1.3%) arteries were opened by the first injection. In the TIMI 14 trial where 
the timing of opening was studied, 16/l ,067 (1.5%) arteries opened during 
the injection and IO/l,067 (0.9%) opened after the injection for a total of 
2611,067 (2.4%). This exceeded the rate of opening at 60 or 75 minutes 
(711,084, 0.6%, p = 0.001). Use of an 8F catheter was associated with a 
higher rate of opening (O.R. 3.4, p = 0.002). 
Conclusions: The mechanical force of injection at 90 minutes opens 
the culprit artery during the first injection in 13.4% of closed arteries. How- 
ever, because the proportion of closed arteries is relatively small (81514,021, 
20.3%), injection of the culprit artery has minimal impact upon the overall 
patency rates in thrombolytic trials (alters patency by 2.4% for open & closed 
arteries combined). 
I 1083 138 Relative Prognostic Importance of Preserved 
Antegrade Coronary Blood Flow Before 
Compared to After Angioplasty in Patients 
Undergoing Primary PTCA 
Gregg W. Stone, David Cox, Eulogia Garcia, Bruce Brodie, 
Marie-Claude Morice, John Griffin, Luis Mattos, Alexandra J. Lansky, 
William W. O’Neill, Cindy L. Grines. Washington Hospital Center, 
Washingfon, DC, USA 
Restoration of TIMI 3 flow after primary PTCA has been shown to result in 
enhanced survival. The relative importance of preserved antegrade coronary 
blood flow prior to angioplasty is less clear. We therefore examined the 
outcomes from 2753 pts undergoing primary PTCA in the first 4 PAMI trials 
(PAMI-1, n = 175; PAMI-2, n = 982; PAMI Stent Pilot, n = 312; PAMI Stent 
Trial, n = 1284). By core laboratory analysis, improved TIMI flow both pre 
and post PTCA was strongly related to early and late mortality (Table). 
Pte-PTCA TIMI rates 
in-hospital mortality 
6 month mortality 
Post-PTCA TIMI rates 
In-hospital mortality 
6 month mortality 
TIMI O/l 
71% 
2.6% 
4.3% 
1% 
15.2% 
18.2% 
TIMI 2 
13% 
1 .4% 
4.2% 
6% 
3.7% 
6.6% 
TIMI 3 
16% 
0.6% 
1.4% 
93% 
1.6% 
3.4% 
P value 
0.03 
0.03 
<0.0001 
<0.0001 
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By multivariate analysis, TIM1 3 flow both before as we//as ar?erPTCA was 
an independent determinant of survival; for any given level of TIMI flow post 
PTCA, survival was greater if TIMI flow pre-PTCA was preserved (Figure). 
Conclusions: Preserved antegrade coronary blood flow prior to PTCA is 
art important determinant of early and late mortality, even in pts achieving 
TIMI- flow post procedure. These data justify efforts to investigate the role 
of early pharmacological restoration of TIMI- flow in as many pts as possible 
(e.g. with lytic + GP Ilb/llla) prior to definitive PTCA. 
1 1083-I 39 ] Primary Angioplasty Without Surgical Back-up 
at All. Results of a Five Years Experience in a 
Community Hospital in Europe 
Flavio Ribichini, Giuseppe Steffenino, Antonio Dellavalle, Paolo Russo, 
Valeria Ferrero, Antonello Vado, Eugenio Uslenghi. Ospedale S. Croce di 
Cuneo, ha/y 
Background: Primary angioplasty (PA) has shown similar results in Centres 
with and without on-site surgical back-up in the US. Similar comparisons 
have not been performed in Europe, where very few Centers perform PA 
without surgical backup at all. Angioplasty in acute myocardial infarction 
(AMI) opening an occluded artery carries fewer risks than elective procedures 
performed in open vessels. The feasibility, safety and efficacy of PA should 
not necessarily depend on the presence of a surgical team in the hospital, or 
nearby. 
Methods: A program of elective and PA was started in 1993 with an 
emergency team available 24 hour/day. Since then, 310 patients (pts) with 
suspected acute myocardial infarction underwent emergency coronary an- 
giography. Angioplasty was performed in 284 cases (91.6%) 55 (19.4%) after 
failed systemic thrombolysis. In 13 cases (4.2%) PA was obviated because 
of complete spontaneous reperfusion; 9 pts with unfavorable anatomy were 
treated with intracoronary lysis, (5 had subsequent by-pass and 4 followed 
medical care): and in 6 pts the diagnosis of AMI was not consistent with the 
angiographic findings. 
Results: Infarct site was anterior in 156 pts (55%); 51 (18%) were fe- 
males, 37 (13%) diabetics; 148 (52%) had multivessel disease, 60 (21%) 
had a previous infarction; and 37 (13%) had left-sided cardiogenic shock 
at admission. Mean time from hospital arrival to the first dilatation was 56 
* 17 minutes. TIMI 3 coronary flow was obtained in 90.3% of cases, and 
95.8% had TIMI 3 or 2. Stents were placed in 179 (63%) pts, and balloon 
counterpulsation was used in 52 (18.3%). In-hospital mortality was 8.5% (24 
pts) in the entire cohort, 32.4% (12/37) in pts with cardiogenic shock, 16.4% 
(g/55) in rescue procedures and 1.6% (3/192) in the remaining. No patient 
needed surgery because of procedure-related complications, and 8 (28%) 
with an open infarct-related artery were operated in another hospital within 
one week. In-hospital non fatal reinfarction, non fatal stroke, and bleeding 
needing transfusion occurred in 14 (4.9%) 2 (0.70%), and 9 (3.2%) pts re- 
spectively. The global mortality after discharge at 1 year follow-up was 2.9% 
(with 78% follow-up). 
Conclusion: results of PA in a community centre in Europe without 
surgical backup are as good as those reported from US surgical centres. 
The absence of surgery, per se, should not limit the benefits of this valuable 
treatment in a broad spectrum of patients with AMI that includes pts ineligible 
for lysis and in shock. 
1 1083-l 40 1 Postinfarctional Remodelling: Effects of Muscle 
Perfusion in the Infarcted Area After Angioplasty 
of the Culprit Vessel 
Gianni Destro, Paolo Marino, Enrico Barbieri, Andrea Zorzi, 
Giovanna Brighetti, Massimiliano Meines, Piero Zardini. Division of 
Cardiology: University of Verona, Italy 
As a residual critical coronary stenosis (CS) of the infarct-related vessel 
unfavourably affects ventricular volume changes and extent of dysfunction 
(RWM) in the infarcted area, angioplasty (PTCA) has been proposed to 
reverse remodelling. Any benefit, however, might be blunted by persistently 
impaired muscle perfusion (MP) of this area. 56 patients (pts) (4 females, 56 
& 6 years old) with single critical left anterior descending (LAD) CS and first 
anterior infarction, were selected. We performed coronary angiography (CA) 
and primary PTCA in 22 pts, “late” (after 7 + 2 days) PTCA in 44 pts. CS was 
assessed using biplane quantitative CA. Normalized maximal intensity (Ml) 
of dye contrast in LAD muscular territory after CA, was also quantified before 
and after PTCA using a l-5 unit (poor-optimal) perfusion scale and used as 
an index of MP. Pts were subdivided in group A, with increased MI (>2 unit, 
n = 29) and group B, no change (~2 unit, n = 27). From echocardiography, 
performed after PTCA and at 6 months, end-diastolic (EDVI) and end-systolic 
volumes (ESVI) were than computed as well as extent of RWM, expressed 
as number of chords with shortening (centerline) below 2SD of a group of 
normals. In IO pts, doppler coronary flow reserve (CFR) was computed and 
related to Ml before and after PTCA. Repeated ANOVA was used to look 
for any interaction between changes in the two groups over time using the 
effect of PTCA on MP as between-patient factor. There was a significant 
time*group interaction for Delta (6 months-prePTCA) volumes (EDVI -2.6 
f 15% for group A vs +13.4 f 17% for group B, p x 0001; ESVI +0.5 & 
13% for group A vs +6.8 f 10% for group 8, p = 0.02). No interaction was 
evident for Delta CS (-46 f 10% for group A vs -32.3 i 21% for group 
B, p = 0.08) and Delta RWM (~3.3 f 12 chords in group A vs -+I * 10 in 
group B, p = 0.32). Linear regression of CFR vs MI pre and postPTCA was 
significant (r = 0.75, p < 0.001) In conclusion, myocardial dye intensity is 
related to CFR. After PTCA of the culprit vessel, postinfarctional remodelling 
is reversed only when the procedure guarantees improved perfusion at the 
muscular level, independently by different degrees of vessel restenosis or 
extent of dysfunction in the infarcted area. 
1 1083-141 1 Angiographic No-Reflow During Primary 
Angioplasty Portends Impaired Six-Week 
Perfusion and Functional Recovery: 
A Dipyridamole Tcggm Sestamibi Gated SPECT 
Imaging Study 
Satyendra Giri, Joseph F. Mitchel, Ross Prpic, Abdul Alkelyani, 
Deborah Katon, Daniel B. Fram, Jeffrey A. Hirst, Michael P. White, Jeffrey 
J. Popma, Francis J. Kiernan, Gary V. Heller. Hartford Hospita/, Hartford, 
CT; USA 
Background: During primary angioplasty (PA), some pts develop angio- 
graphic no reflow (NR) which may represent impaired microcirculation. The 
impact of NR on early and late recovery of myocardial perfusion and systolic 
function, in pts with successful PA (% diameter stenosis ~20%) has not been 
described. 
Methods: Of 39 pts being treated with PA < 12 hr of their first acute 
MI (73% male, symptom-to-balloon time: 271 + 70 min), ten developed NR. 
Dipyridamole Tcggm gated SPECT myocardial perfusion imaging (MPI) was 
performed 48 hrs and at 6 weeks post-procedure using a 17-segment model 
(0 = normal, 4 = no photon activity) and compared by 3 nuclear cardiologists 
unaware of clinical information using summed rest (SRS) and stress score 
(SSS) and ejection fraction (EF). Two angiographers performed quantitative 
coronary analysis and determined NR, TIMI flow, and lumen dimensions. 
Results: NR pts were similar in age (54 f 15 vs 54 & 12 yr), ischemia 
time (4.7 + 1.4 vs 4.4 * 1.2 hr), diseased vessels (1.8 f 0.6 vs 1.8 f 
0.6), reference vessel diameter (2.99 + 0.48 vs 2.98 f 0.45 mm.), minimal 
luminal diameter (2.54 f 0.47 vs 2.57 f 0.46 mm.), residual %diameter 
stenosis (15.2 f 6.1 vs 14.0 & 6.9), abciximab (60% vs 72%) and stent (80% 
vs 69%) use to normal reflow pts. perfusion defect scores (SSS and SRS) 
and EF did not improve in NR pts. 
Normal reflow pts improved LVEF (+I 8.0%*), reduced perfusion detect at 
stress (SSS = -28.9%*) and rest (SRS = -4O.O%*). 
Conclusion: Despite PA establishing infarct-artery patency, no reflow 
results in impaired systolic function and perfusion. 
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\ 1084-I 27 A Common Variant of the AMPDl Gene Predicts 
improved Survival in Patients with CAD 
Jeffrey L. Anderson, Jessica Habashi, John F. Carlyuist, Joseph 
B. Muhlestein, Benjamin D. Horne, Tami L. Bair, Robert R. Pearson, 
Noal Hart. University of Utah, LDS ffospif.4, Salt Lake City Utah, USA 
Background: Reduced activity of adenosine monophosphate deaminase 
(AMPD) may increase production of adenosine, a cardioprotective agent. 
A common, non-sense polymorphism of the AMPDi gene (C34T) results in 
enzymatic inactivity and has been associated with prolonged survival in heart 
failure. We tested whether it also is associated with improved cardiovascular 
(CV) survival in coronary artery disease (CAD). 
Methods: Blood samples were collected from 376 patients undergoing 
coronary angiography. Genotyping was done by PCR amplification and re- 
striction enzyme digestion, resulting in allele-specific fragments. CAD was 
defined (blinded to genotype) as ~70% stenosis of ‘1 coronary artery. Pa- 
tients were followed prospectively to death or end-of-study (maximum, 4.8 y). 
Hetero-(+/-) or homozygote (-/-) carriers were compared with non-carriers 
using survival statistics. 
Results: Patients were 66 i lb y old; 79% were male; 22.6% were het- 
erozygous and 1.9% homozygous for AMPDI(-). During a mean of 3.2 j: 
0.9 y, 48 pts (12.8%) died, 37 (9.8%) of CV causes. CV mortality was 4.4% 
for AMPDI (-) allele carriers compared with 11.9% for non-carhers (log rank 
statistic, 4.0, p = 0.046). In multivariate Cox regression analysis, including 
6 clinical characteristics (age, sex, smoking, diabetes, hypertension, hyper- 
lipidemia), only age (hazard ratio [HI?], 1.11/y, p x 0.001) and AMPDI(-) 
carriage (HR, 0.36, p = 0.058) were selected as independent predictors of 
CV mortality. 
Conclusion: Carriage of a common genetic variant of the AMPDI gene 
was associated with improved CV survival in patients with angiographically 
documented CAD. We speculate that the dysfunctional AMPDI(-) allele 
may lead to increased production of adenosine in skeletal muscle, increased 
circulating levels of adenosine in the coronary circulation, and increased 
levels of cardioprotection during ischemic events. AMPDI genotyping may 
provide useful prognostic, mechanistic: and therapeutic insights in CAD. 
/ 1084 128 Long-Term Prognostic Value of a Rapid Troponin T Bedside Test in Patients With Acute Coronary 
Syndromes 
Ron T. van Domburg, Christa Cobbaert, Gerrit-Jan P. Kimman, 
Rainer Zerback, Maarten L. Simoons. University Hospital Dijkzgt 
Rofterdam, fhe Netherlands; Roche Diagnostics GmbH, Mannheim, 
Germany 
Background: The early presence of troponin T has been found to have 
important prognostic significance in patients with acute coronary syndromes. 
We investigated the prognostic significance of the troponin T rapid assay 
(TROPT) bedside lest and compared this with the quantitative troponin T 
assay (cTnT ELISA), myoglobin and CK-MB mass on the long-term outcome 
of mortality. 
Methods: One hundred en sixty three patients with chest pain and sus- 
pected acute myocardial infarction (AMI) were studied and followed prospec- 
lively for a median of 3 years. Serial blood specimens were taken at admission 
and at 3, 6, 12, 24, 48, 72 and 96 hours after admission. 
Results: According to WHO criteria the patients were classified as hav- 
ing AMI in 99 patients (61%), unstable angina in 34 patients (21%) and no 
evidence for acute cardiac ischemia in 30 patients (18%). At 3 years 27 
patients (15%) died of which 24 were cardiac. Fifteen patients (9%) suffered 
a nonfatal (recurrent) myocardial infarction. At admission 30% of the pa- 
tients was TROPT positive (~0.2 pg/L), another 32% became positive later 
(up to 12 hours), and 38% remained negative. When adjusted for baseline 
characteristics, a positive TROPT (any sample between 0 and 12 hours) was 
independently associated with a higher riskof mortality (RR 2.80, 1.03-7.50). 
The cTnT ELISA (any sample O-12 hours) was similar predictive when a cut- 
off of 20.2 fig/L was used, but not predictive with a cutoff of ~0.1 Kg/L. 
Myoglobin seemed only a predictor if the baseline results and at 3 hours 
were combined (RR: 2.83, 0.93-8.65). CK-MB mass was no predictor of 
mortality. The admission measures of all cardiac markers had no predictive 
value of mortality on the long-term outcome. 
Conclusion: A positive rapid assay for troponin T in the first 12 hours 
in patients with acute coronary syndromes identifies a subgroup at risk for 
higher mortality. CTnT ELISA appears to be similar predictive and myoglobin 
and CK-MB mass appears to be a less sensitive indicator for the long-term 
outcome of mortality. 
I 1084 129 Can Long-Term Outcome in Acute lschemic Syndromes be Reliably Predicted by Abnormal 
Acute ECG and Enzyme Abnormalities? 
David Kovar, William J. Rogers, Christopher P. Cannon, 
Andrew Charlesworth, Allan Skeene, A. Caspi, Anatoly Langer. University of 
Alabama at Birmingham, Birmingham, AL, USA 
Background: Patients with acute coronary syndromes (ACS) having is- 
chemic ECG changes or elevated cardiac enzymes are considered at high 
risk for adverse clinical outcomes. 
Methods: To determine whether increased risk extends beyond 30 d 
follow-up, we studied 10,291 ACS patients enrolled in the OPUS-TIMI- 
trial. Outcome at 30 d and 300 d post-entry was compared between 9,137 
patients having ECG changes or elevated enzymes at entry (Hi-Risk) with that 
of 1,178 patients lacking these findings but having prior history of coronary 
artery or peripheral vascular disease, diabetes, stroke or age 265 yrs with 
positive stress test (Lo-Risk). 
Results: At entry, mean age was similar between groups, but Lo-Risk 
patients had significantly higher prevalence of prior Ml, angina, PTCR, CABG, 
CHF and risk factors for CAD. During the first 30 days, death or Ml occurred 
more frequently in the Hi-risk group. However, after 30 days, there were, 
surprisingly, higher event rates in the predefined “Lo-Risk” group (Table). 
Death/ 
30 Days 
Recurrent *camp. 
31-300 Days 
Death/ Recurrent *Camp. 
Hi-Risk 
(%) 
Lo-Risk 
Ml lschemia Endpoint MI lschemia Endpoint 
5.1 4.1 10.5 4.1 6.1 9.0 
2.6 5.6 9.3 4.7 ii.2 14.7 
w 
P <O.OOi 0.016 0.18 0.44 <0.001 <O.OOi 
*Camp. endpoint defined as death, MI, recurrent ischemia, revascularization or stroke 
Conclusion: In patients with acute coronary syndromes, abnormal ECG 
and enzymes predict a higher 30-day mortality. However, long-term events 
may be more reliably predicted by risk factors for CAD or by history of prior 
cardiac disease. 
1 1084-I 301 Prognostic Influence of Different Cardiac 
Troponin I Curves at One-Year Follow-Up in 
Unstable Angina 
R. Teles, J. Ferreira, C. Aguiar, A. Timbteo, M. Almeida, J. Figueira, 
E. Melo-Gomes, R. Seabra-Gomes. Cardiology Deparfment, Santa Cruz 
Hospital, Lisbon, Porfugal 
Background: Cardiac troponins (Tn) are valuable tools in unstable angina 
(UA). However, isolated Tn determinations might be confusing, as clinicians 
are often confronted with different elevation patterns that seem to represent 
distinct prognostic profiles. 
Aim: To examine the prognostic influence of different Tn I (Tnl) curves in 
patients with UA, defined as chest pain at rest within 24 h before hospitali- 
sation with ischemic ECG changes and normal CK (<I30 U/L) and CK-MB 
(<I6 U/L) over the first 24 hours. 
Methods: Blood samples for cardiac enzymes and Tnl were collected 
at least on admission, every 6 h during 24 h and 48 h after admission. 
EVENT FREE SWtVlVAl AT WEAR F-UP 
ACCORMRG TO TROPOWIS I CURVE 
(cLMyb?* PmpMon “mmng ~Ke@!Me~O 
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Serum Tnl was determined by chemiluminescent immunoassay method 
(Acces@/Sanofi Pasteur). Patients were divided into two groups accord- 
ing to their serial measurements until 12 hours after admission: Group A (n 
= 37)pts who had a Tnl increase of at least 0.03 yglL within the first 12 h; 
and Group 6 (n = 92)-pts with no such increase. Peak Tnl was considered 
positive (above 0.1 WgIL) in 30 pts (21/37-group A, 9/92-group 6). The pri- 
mary endpoint was the one-year composite occurrence of death, myocardial 
infarction and recurrent angina. 
Results: Event free survival rate at one-year follow-up (Graph) was sig- 
nificantly lower in patients from group A compared with group B, respectively 
38.4% versus 62.1% (p = 0.004, Log-Rank test). Although less striking, this 
difference was also observed when positive and negative peak Tn I pts out- 
comes were compared (respectively 39.5% versus 61.9%, p = 0.01, Log-rank 
test). 
Conclusions: These data confirmed that Tnl is an important prognostic 
marker in patients with UA at one-year follow-up. Tnl curves were a useful 
tool for increased risk and, therefore, their evaluation should be considered 
in UA patients. 
u 1084 131 Failure of Cardiac Markers to Predict Survival in 
Patients With Suspected Myocardial Infarction 
and Heart Failure 
Pekka Porela, Hans Helenius, Kari Pulkki, Kim Pettersson, 
Liisa-Maria Voipio-Pulkki. Departments of Medicine and Clinical Chemistry, 
University of Turku, Turku, Finland 
Background: The combination of severe myocardial ischemia and heart 
failure (HF) is considered to carry a high risk of future cardiac events and 
death. In patients with suspected acute myocardial infarction (AMI), troponin 
(Tn) and creatinine kinase MB (CK-MB) positivity are associated with adverse 
outcome. Previous studies have not clarified how HF may interact with such 
prognostication, particularly in unselected patient cohorts. 
Subjects and Methods: We followed total and cardiac mortality for 5 
years in 263 consecutive patients who were discharged from a regional 
referral hospital after definite or suspected AMI. The following univariate 
and multivariate predictors were studied: computerised ECG score, peak 
CK-MB and Tn I, radiographic signs of decompensated HF during index 
hospitalisation, hyperlipidemia, diabetes, hypertension, smoking, previous 
AMI, age and gender. 
Results: Total mortality was 32% and cardiac mortality 25% at 5 years. 
Although both ECG, CK-MB and Tnl were significant univariate predictors of 
outcome, the only independent variables for total mortality were in-hospital 
HF (risk ratio RR 3.3., 95% Cl 2.0-5.2, p < 0.001) and age (RR 1.06 per 
year). For cardiac mortality, previous AMI (RR 1.9) and hyperlipidemia (RR 
2.0) remained in the model, followed by elevated CK-MB in patients without 
HF. In the 82/263 patients (31%) with HF, 5-year mortality (total 62%, cardiac 
52%) was independently predicted by age, hypertension and hyperlipidemia. 
Kaplan-Meier survival curves were identical for CK-MB and Tnl positive and 
negative patients with HF. 
Conclusion: In unselected patients who survive hospitalization for sus- 
pected AMI, in-hospital HF indicates a 3-fold increased risk of death within 5 
years. This mortality associates with higher age, hypertension and hyperlipi- 
demia, whereas the predictive power of cardiac injury markers is limited to 
patients without HF. 
I 1084 132 Immediate and Long Term Endothelial Activation in Diabetics Patients With Acute Coronary 
Syndromes 
Niall Mulvihill, J. Brendan Foley, Ross Murphy, Gordon Pate, Peter Crean, 
Michael Walsh. Department of Cardiology, St. James’s Hospital, Dublin, UK 
Background: Diabetics presenting with acute coronary syndromes have a 
worse prognosis than non-diabetics. An inflammatory reaction at the site of 
coronary plaque rupture with increased expression of surface and soluble 
cell adhesion molecules (CAMS) is a pathological feature of acute coronary 
syndromes. We set out to characterise the expression of soluble CAMS in 
diabetics and non diabetics presenting with unstable angina (UA) and non 
Q-wave infarction (NQMI). 
Methods: Patients presenting with UA and NQMI had serum samples 
taken on presentation and then 3 and 6 months after discharge. Levels of 
soluble ICAM-1, VCAM-1, P-selectin and E-selectin were measured using 
an ELISA technique. 
Results: 91 patients entered the study, 15 diabetics (M/F = 13/2, mean 
age 66 f 10 yrs) and 76 non diabetics (M/F = 60116, mean age 61 f IO 
yrs). Levels of soluble E-selectin were elevated in the diabetic patients in 
comparison to the non diabetics at all measured time points (74 f 10 rig/ml 
vs 53 i 2 rig/ml, p < 0.01 at T = 0 hrs, 67 f 11 rig/ml vs 57 f 2 rig/ml, p 5 
0.1atT=3/12and68f12ng/mlvs55~2ng/ml,p~0.04atT=6/12). 
There was no significant difference in levels of soluble ICAM-1, VCAM-I and 
P-selectin between diabetic and non diabetic patients. 
Conclusion: Diabetic patients presenting with UA and NQMI have signif- 
icantly elevated levels of soluble E-selectin for up to 6 months in comparison 
to non-diabetics. This finding may reflect enhanced endothelial activation in 
diabetics which could contribute to their adverse prognosis. 
I. 1084 133 Benefit of Treatment With Tirofiban for Patients Wrth Unstable Angina According to Treatment 
Regime and Troponin Status 
Christopher Heeschen, Christian W. Hamm, Ariane Due, 
Lukas Langenbrink, Harvey White. Stanford University School of Medicine, 
Stanford, CA, USA; Kerckhoff-Clinic, Bad Nauheim, Germany; Green Lane 
Hospital, Auckland, New Zealand 
The PRISM trial demonstrated that the platelet glycoprotein Ilb/llla receptor 
antagonist tirofiban reduces cardiac events (death, AMI) in patients with 
unstable angina. This therapeutic benefit was mainly achieved in patients with 
elevated levels of either troponin I (Tnl) or troponin T (TnT). We investigated, 
whether this benefit at 30-day follow-up was related to the treatment regime 
chosen after the 48-hour infusion period. 
Methods and Results: Baseline plasma samples for measurements of 
troponin I (Tnl, Abbott) and troponin T (TnT) were available in 2240 patients of 
the PRISM trial (69%). Tnl was 21 .O fig/L in 28.1% and TnT was ~0.1 @g/L in 
28.9% of the patients. Coronary revascularization following 48-hour infusion 
therapy was necessary in 21.3% of the patients; without a difference between 
heparin and tirofiban group (21.6% vs. 21 .O%; heparin vs. tirofiban; P = 0.76). 
For Tnl-positive patients receiving heparin, however, the recurrence of chest 
pain during initial 48 hours (9.3 versus 3.0%; P = 0.003) the necessity for 
coronary revascularization following the 48-hour infusion period (34.0 vs. 
17.3%; P < O.OOl), and the duration of hospitalization (15 vs. 8 d; P < 0.001) 
was higher as compared to Tnl negative patients. When such Tnl-positive 
patients were treated with tirofiban, this difference was no longer observed 
for any of these variables. Regarding the 30-day follow-up, the benefit of 
treatment with tirofiban in troponin-positive patients was independent of the 
treatment regime following the 48-hour infusion therapy (OR 0.37 vs. 0.33; 
patients with vs. patients without coronary intervention). Similar results were 
obtained for TnT measurements. 
Conclusions: Tirofiban was highly effective in reducing both major car- 
diac events and necessity for coronary intervention. This outstanding benefit 
of tirofiban in troponin-positive patients was independent of an interventional 
procedure. 
I 1084 134 Not So Benign Short and Long-Term Prognosis of a Non-Q Wave Myocardial Infarction Following 
Thrombolytic Therapy 
Jayan Nagendran, Selma M. Shaben, Manohara P.J. Senaratne. Division of 
Cardiac Sciences, Grey Nuns Hospital, Edmonton, Alberta, Canada 
Background: Non-Q wave myocardial infarctions (NQMI) can result from: 1) 
ST-segment depression (STD) in the presenting ECG with no thrombolytics 
(NTNQ) given; 2) ST-segment elevation in the presenting ECG with throm- 
bolysis (TNQ). Clinical characteristics and outcomes of these two groups are 
believed to be different, yet no comparative studies are available. 
Methods: Data collected prospectively from 310 (TNQ = 65, NTNQ = 
245) conse+rtive patients who developed NQMI were analysed to determine 
in-hospital course and post-discharge outcome. 
Results: The two groups were similar in incidence of smoking, dyslipi- 
demia, history of angina, history of myocardial infarction, family history, and 
gender distribution. NTNQ were older and more likely to have a history of 
diabetes, hypertension, and congestive cardiac failure (CCF) (p < 0.05). 
TNQ showed a higher maximum creatine kinase level (p < 0.05). Rates 
of in-hospital mortality for NTNQ and TNQ were similar at 4.9% and 3.1% 
respectively. In-hospital complications (arrythmias, re-infarction, post-infarct 
angina, CCF, artificial ventilation and cardiac arrest) were not significantly 
different (p > 0.05). At six weeks post-discharge there was no significant 
differences in unscheduled visits to a doctor’s office, ER, or readmission 
to hospital (p P 0.05). Rates of coronary events within one year (unstable 
angina, re-infarction, angioplasty, CCF, and bypass surgery) were similar (p 
> 0.05). NTNQ had much higher one year mortality rates (NTNQ = 18.9%, 
TNQ = 5.7%). 
Conclusion: NTNQ and TNQ patients have similar in-hospital courses 
and six week post-discharge results. One year mortality rates are significantly 
higher in the NTNQ population (p < 0.05). However, the rate of serious 
coronary events was high in both groups (TNQ = 30.8%, NTNQ = 42.0%). 
Thus TNQ requires the same vigilance in follow-up as NTNQ patients. 
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! 846 1 Prespecth~e Study of Pathogen Burden and Risk af 
yocardial infarction and Cardiovascular Death 
Jianhui Zhu, F. Javier Nieto, Benjamin D. Horne, Jeffrey L. Anderson, 
Joseph B. Muhlestein, Stephen E. Epstein. The Cardiovascular Research 
Institute, WHC, Washington, DC; The Cardioiogy Division, LDSH and UU, 
Saalf Lake City; U7: USA 
Background: We have demonstrated that coronary artery disease (CAD) 
risk increased in relation to the number of pathogens to which an individual 
is seropositive (;‘pathogen burden”). However, the previous study was cross- 
sectional in design and could only be regarded as hypothesis-generating. We 
therefore evaluated, in a prospective study, the effect of pathogen burden 
on the risk of myocardial infarction (Ml) and cardiovascular death among 
individuals with CAD. 
Methods: IgG antibodies to cytomegalovirus (CMV), hepatitis A virus 
(HAV), herpes simplex virus type 1 (HSVI), HSV type 2 (HSV2), Chlamydia 
pneumoniae and H. pylori, and C-reactive protein (CRP) levels were tested in 
baseline blood samples from 890 patients who were found to have significant 
(~70% stenosis) CAD by angiography. The mean follow-up was 3 years. 
Results: The baseline prevalence of antibodies directed against CMV, 
HAV, HSVI or HSV2, but not Chlamydia pneumoniae and H. py/ori, was 
higher among 167 patients who subsequently developed a Ml or cardio- 
vascular death than control subjects (all P < 0.05). The relative hazards 
for Ml or death were 2 (95% Cf, 1.36-3.2) for CMV, 1.6 (1 .I-2.3) for HAV, 
1.6 (0.9-2.8) for HSVf and 1.5 (1 .O-2.2) for HSV2 after adjustment for tra- 
ditional risk factors, number of diseased vessels and clinical presentation. 
Importantly, pathogen burden was significantly associated with increasing 
risk of MI or death. After adjustment, the relative hazards for MI or death 
in individuals with antibodies to 2, 3, 4, 5 and 6 vs. O-l pathogens was 
2.4 (95% Cl, O&20.8), 3 (0.4-22.8), 4.8 (0.7-35.6), 6.4 (0.9-47.2) and 6.3 
(0.8-46.1), respectively (P trend = 0.0005). In stratified analyses, adjusted 
relative hazards of MI or death associated with pathogen burden were signifi- 
cant both among individuals with low and with high CRP levels, thus suggest- 
ing that pathogen burden is a significant predictor of MI or death independent 
of CRP. 
Conclusion: Our prospective data demonstrate that infection with CMV, 
HAV or HSV is significantly associated with MI and cardiovascular death. 
Moreover, the risk posed by infection is strongly and independently related 
to the aggregate pathogen burden. These results add further evidence that 
infection plays an important role in cardiovascular disease. 
2:15 p.m. 
ecretory phospholipase AZ Acting as a Precursor 
of Complement Activation in Human Myocardial 
infarction 
Remco Nijmeijer, Wim K. Lagrand, Hans W.M. Niessen, Yvonne 
PT. Lubbers, Wim Th. Hermens, Chris J.L.M. Meijer, Cees A. Visser, C. 
Erik Hack. University Hospital KU. Amsterdam, Sanquin Blood Supply 
Foundation Amsferdam, Netherlands 
~ack~r~u~d: in recenr studies we have found that C-Reactive Protein (CRP) 
contributes to inflammation in ischemic myocardium by activating comple- 
ment. We hypothesize that lysophospholipids constitute the ligand for CRP 
in ischemic myocardium. These lysophospholipids can be generated by se- 
cretory Phospholipase Aa (sPLAs). To test this hypothesis we studied sPLA2 
in serum and myocardial tissue of patients with Acute Myocardial Infarction 
(AMI). 
Methods: Sera of 107 patients with AMI or Unstable Angina Pectoris 
(UAP) where taken at admittance and at 2, 6, 12, 24, 48 and 72 hours 
after admission at the hospital, sPLA2 was measured by means of ELISA. 
Cumulative release values of sPLAs were assessed from the course of its 
plasma levels in time, as calculated in a 2-compartment model. By this we 
were able to compare the course of sPLAs rearranged in time according to 
the first symptoms of AMI. lmmunohistochemical staining for sPLAs, CRP 
and complement was performed on myocardial tissue of 34 patients that died 
subsequent to AMI. 
Results: A rise in cumulative sPLAa in serum couid be found from 12 
hours following the onset of AMI (P < 0.03), compared with the sera of 
patients of the UAP group. In the tissue study we found sPLAa in the ischemic 
pans of the myocardium and its borderzone, 12-24 hours after onset of the 
AMI. This staining of sPLAs was earlier and beyond the area of positivity of 
complement and CRP. 
Conclusions: To the best of our knowledge this is the first report showing 
depositions of sPLAs in human ischemic myocardium. The staining pattern 
of sPLAp in ischemic myocardium, in combination with the time interval of 
its rise in serum studies, are in line with the supposed role of sPLAs as 
a precursor of CRP binding and subsequent complement activation, in the 
local inflammatory reactions of infarcted human myocardium. 
2:30 p.m. 
/ 846-3 / Lymphocyte Activation After Acute Myocardial 
Infarction is Associated With Increased Chlamydia 
Pneumoniae Antibody Titers 
llka Ott, Franz-Josef Neumann, Dominik Zieglgansberger, Stefanie Geith, 
Valerie Malcouvier, Thomas Miethke. Deufscbes Herzentrum and lnstifuf 
fiir Medizinische Mikrobiologie und Hygiene der Technischen Universifat, 
Munich, Germany 
Background: Recently, the hypothesis has gained attraction that inflamma- 
tion responses in atherosclerois may be modified by angiotropic infectious 
agents, such as chlamydia pneumoniae. This study investigates the poten- 
tial role of previous chlamydia pneumoniae infection in lymphocyte activation 
after acute myocardial infarction. 
Methods: In 34 patients with acute myocardial infarction blood sam- 
ples were taken before, immediately, 48 and 96 hours after direct stenting. 
Lymphocyte activation was assessed by whole blood flow cytometry. To in- 
vestigate T-cell activation monoclonal antibodies to CD3, CD4, CD8, CD69, 
CD29 and HLA-DR were used. Chlamydia pneumoniae antibody titers were 
analyzed in serum samples obtained on admission. 
Results: In the entire study population, HLA-DR surface expression on 
CD3+ cells was maximal on admission and it declined by 15 f 5% (mean 
f SEM, p < 0.05) until 96 hours after stenting. The lymphocyte activation 
markers CD69 and CD29 on CD3c cells showed similar changes. No changes 
in the ratio of T-helper and suppressor cells were observed. Twenty-eight 
patients had detectable antibody titers for chlamydia pneumoniae. This titer 
was significantly correlated with HLA-DR surface expression on circulating 
lymphocytes at 48 hours after acute myocardial infarction (r = 0.351, P = 
0.042. 
Conclusions: After direct stenting in acute myocardial infarction early 
T-cell activation with increased surface expression of CD69, HLA-DR and 
CD29 is found. A significant correlation of chlamydia pneumoniae titers with 
HLA-DR surface expression on lymphocytes was found at 48 after stenting 
suggesting a role for chlamydial antigen exposure in the plaque as a cause 
for subsequent lymphocyte activation. 
2:45 p.m. 
846-4 Is Unstable Angina Associated With an intracardiac 
Inflammatory Response? 
Michael Cusack, Sola Odemuyiwa, Kavan Kamalvand, Paul Collinson’, 
Michael Webb-Peploe, Cliff Bucknall, Michael Marber, Simon Redwood. 
Cardiothoracic Center, St Thomas’ Hospita/; ‘Department of Clinical 
Chemistry, St George’s Hospital, London, UK 
Background: Accumulating evidence supports the concept that an inflam- 
matory process plays a role in the initiation and progression of atherosclerosis 
and its complications. Although both Interleukin-6 (IL-E) and Tumour Necro- 
sis Factor-a (TNF-ol) are elevated among patients with unstable angina, their 
soume is unclear. The aim of this study was to determine whether these 
substances are released by the heart in patients with unstable angina. 
Methods: In 18 patients (mean age 65.4 * 1.8,55% male) with Braunwald 
IIIB unstable angina undergoing cardiac catheterization, we simultaneously 
sampled coronary sinus (CS) and Aortic root blood prior to angiography. IL-6 
and TNF-o( levels were determined by two-site chemiluminescent enzyme 
immunometric assay. All samptes were tested for cardiac Troponin T (cTnT) 
to determine the extent of myocardial cellular necrosis. 
Results: Systemic TNF-ol and IL-6 levels were elevated in all patients. 
Compared with Aortic levels, CS levels were greater for both TNF-a (18.9 & 
4.8~. 21.0 h5.0 pgiml respectively, p < 0.02) and IL-6 (8.4f 1.4~. 11.4k2.1 
pgiml, p < 0.01) suggesting cardiac production, Systemic cTnT levels were 
elevated in 11 of the 18 patients (mean 0.11 & 0.03 ug/l, normal < 0.1 ug/dl). 
All patients had disease of at least one major epicardial coronary artery at 
angiography; 14 of the 18 patients underwent urgent revascularization. 
We conclude that: Inflammatory markers are elevated in patients with 
refractory unstable angina. Greater coronary sinus levels imply synthesis 
within the heart, although it remains unclear whether this is in response to 
plaque rupture or as a result of myocardial injury, and a co-existent systemic 
inflammatory response cannot be excluded. 
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El 846 5 Adventitial Fibrosis and Inflammation Surrounding Atheroma: Implications for Different Arterial 
Remodeling in Stable and Unstable Plaques 
Maria L. Higuchi, Hiram G. Bezerra, Suely Palomino, Vera D. Aiello, Jose 
A. Fiamires, Peter Libby. Hear-f lnsfifufe (InCor) University of 520 Paula, S&J 
Paula, 90 Paula, Brazil; Brigham & Women’s Hospital, Boston, 
Massachusetts, USA 
Background: Recently we demonstrated that coronary atheroma that cause 
fatal thrombosis are larger (predominant positive remodeling) than equi 
stenotic stable lesions (predominant negative remodeling or no remodel- 
ing) in the same patient. Now we studied the adventitial layer searching for 
histological features which may explain such differences. 
Methods: The culprit vessel segment (CVS) and a stable equi stenotic 
segment (SVS) from the same patient were compared histologically and 
immunohistochemically to evaluate the amount of fibrosis, vasa vasorum 
and inflammatory infiltrate in the adventitia (paired Student t test) in 18 
patients who died due to acute myocardial infarction. The % of adventitial 
fibrosis/total area of the vessel was correlated with the area of the vessel. 
Results: The % adventitial fibrosis/total area of the vessel was lower in 
CVS than SVS (14.5 vs 23.6 p < 0.001); the mean number of microvessels 
was higher in CVS than SVS (52.2 vs 33.6 p < O.Ol), the mean numbers of B, 
CD8 and CD4 T cells/mm2 were higher il l CVS than SVS (respectively 22.8, 
27.3, 14.2 vs 1.7, 5.0, 4.1). The % of adventitial fibrosis correlated negatively 
with the vessel area in the CVS (r = -0.64, p < 0.01); absence of correlation 
in the SVS group. 
Conclusions: The adventitia of unstable plaques exhibits more intense 
inflammation, microvascularization and less collagen than equi stenotic non- 
culprit plaques. Adventitial inflammation may contribute to positive remodel- 
ing (compensatory enlargement) in unstable plaques. In contrast, the higher 
adventitial fibrosis may play a fundamental role in the negative remodeling 
or no remodeling of stable stenotic plaques. 
3:15 p.m. 
846-6 Estrogen and Progesterone but not Tamoxifen 
Inhibit Oxidized Low Densitv Lipoprotein Induced 
Matrix Metalloproteinase-9 in C&bred Human 
Macrophages 
Xiao-Ping Xu, Xiaoou Helen Xu, Kuang-Yuh Chyu, Jennifer M. Collins, 
Tripathi Rajavashisth, Sanjay Kaul, Bojan Cercek, P.K. Shah. 
Atherosclerosis Research Center, Division of Cardiology Cedars-Sinai 
Medical Center and UCLA School of Medicine, Los Angeles, California, USA 
Background: Female hormone replacement therapy has long been viewed 
beneficial in reducing coronary heart disease (CHD) in post-menopausal 
women. However, the HERS trial recently showed an unexpected early in- 
crease in CHD event rate with estrogen (EST) plus progesterone (PROG) 
combination compared to placebo in women. Since matrix metalloproteitase-9 
(MMP-9) produced by macrophages (M$) in atherosclerotic plaques has 
been implicated in plaque disruption, the pathological basis for acute CHD 
events, we tested the hypothesis that EST and/or PROG upregulate basal 
and oxidized low density lipoprotein (ox-LDL)-induced MMP-9 in monocyte- 
derived macrophages. 
Methods: Mononuclear cells were isolated from normal human subjects 
and adherent cells were allowed to differentiate into M@ during 7 days of 
culture. M@ was then treated with EST or PROG in the presence or absence 
of ox-LDL. Culture medium was assayed for MMP-9 by ELISA. Western blot, 
enzyme activity assay and Zymogram. 
Results: Ox-LDL markedly increased MMP-9 expression. Ox-LDL in- 
duced MMP-9,protein expression and activation could be significantly abro- 
gated by EST and/or PROG but not tamoxifen (Fig 1 and 2, n = 12, *# P < 
0.05). 
Conclusions: Estrogen and/or progesterone but not tamoxifen reduce 
ox-LDL induced MMP-9 expression and activity in human M+. The observa- 
tions suggest that the increased CHD event rate observed in HERS trial with 
EST plus PROG may involve mechanisms other than MMP-9 upregulation. 
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L.---- II 05 132 Persistent Translocation of Protein Kinase C and 
Activation of Adenylyl Cyclase are Not Essential 
for lschemic Preconditioning 
Gregor Simonis, Christof Weinbrenner, Ulrike Oehl, Ruth H. Strasser. 
Department of Cardiology University of Heidelberg, Heidelberg, Germany 
Background: Brief periods of ischemia precondition the heart and reduce 
the size of infarction in subsequent sustained ischemia. The molecular mech- 
anisms leading to preconditioning, however, are not fully elucidated. The role 
of various components of the adrenergic systems, i.e. adenylyl cyclase (AC) 
and B-adrenergic receptors (BAR), is not known. Furthermore, it is open if 
a persistent activation of protein kinase C (PKC) is essential for ischemic 
preconditioning. 
Methods: To define the effects of various cycles of ischemia (5 min, Pi, 
P2, P3) and reperfusion (10 min, RI, R2), rat hearts were perfused according 
to the method of Langendotff. In the particulate fraction of these hearts, the 
density of BAR, the activity of AC and the activity and the isozyme distribution 
of PKC-ol, PKC-S, and PKC-E were determined. 
Results: The ischemia-induced upregulation of ,BAR is not influenced by 
repetitive periods of ischemia. In contrast, sensitization of AC observed after 5 
min of ischemia is lost after repetitive periods of ischemia and reperfusion. In 
a comparable way, translocation of PKC activity (see figure) to the particulate 
fraction, involving its major isozymes could be shown after I and two periods 
of ischemia (Pl, PZ), with a rapid relocation of the activity after reperfusion 
(RI, R2). A third period of ischemia (P3) was unable to promote an additional 
translocation of PKC. 
Conclusion: These data suggest that, independent of PAR regulation, 
the initial burst of activation of PKC suffices to trigger ischemic precondition- 
ing. Reperfusion rapidly relocates PKC. Persistent activation of PKC is not 
essential to maintain myocardial protection. 
1 1105-l 33 1 Temporal Evolution of the Contractile State of 
Neighboring Myocardium in the Early Phase of 
Acute Myocardial Infarction 
Gustav0 Camarano, Michael Jones, Raisa Freidlin, lnez Ernst, Arthur 
D. Zetts, Julio A. Panza. National lnsfitutes of Health, Bethesda, Mary/and, 
USA 
Background: Spontaneous improvement in left ventricular function may 
occur after myocardial infarction (Ml) due to recovery of stunned myocardium. 
However, whether changes in the contractile state of neighboring myocardial 
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regions may contribute to this process is unknown. Therefore, the present 
study was designed to investigate changes in the relation between the extent 
of myocardial injury and wall motion abnormalities in the early phase of MI. 
Nlethods: MI was created in 21 adult sheep by permanently ligating 
arterial branches on the anterior or posterior coronary circulation. Real-time 
3-dimensional echocardiographic (RTBD echo) images were obtained either 
immediately (group I; n = IO) or 24 hours (group II; n = 11) after coronary 
occlusion. In group I animals, Evans blue dye was injected into the occluded 
coronary artery after image acquisition for subsequent anatomic identification 
and planimetry of abnormally petfused myocardium. In group II animals, 
direct planimetry measurements of the anatomic infarct were obtained from 
the pathologic specimens. Extent of wall motion abnormalities was measured 
off-line from RT3D echo images using an interactive tracing technique based 
on a Silicon Graphics workstation and expressed as endocardial surface with 
abnormal wail motion. The difference between endocardial surface with wall 
motion abnormalities and the anatomic extent of perfusion deficit (group I) or 
myocardial necrosis (group II) was considered neighboring myocardium. 
Results: The anatomic extent of myocardial necrosis at 24 hours (group 
II) was significantly greater than the anatomic extent of perfusion deficit 
(group I) (15.8 ZIZ 2.8 vs. 11.6 i 2.7 cm 2; P = 0.002). In contrast, there 
was a trend toward decreased extent of wall motion abnormality at 24 hours 
compared to immediately following ligation (21.9 & 4.4 vs. 25.9 + 5.9 cm*; 
P = 0.09). Of note, the extent of neighboring myocardium with wall motion 
abnormalities was significantly reduced at 24 hours compared to immediately 
after coronary occlusion (6.1 * 2.1 vs. 14.2 +Z 2.7 cm”; P < 0.0001). 
Conclusion: In an animal model of permanent coronary occlusion, there 
is an early reduction in the extent of dysfunctional myocardium surrounding 
the infarcted area. This phenomenon may partly explain the spontaneous 
recovery in left ventricular function which may be observed following an 
acute Mi. 
/ 1105 134 Myocardial Conditioning Via Mechanical Channelinq Plus Healing Limits lschemic 
Consequences of AcuteCoronary Occlusion 
Marvin J. Slepian, Pascal LePrince, Bruce Toporoff, Karl B. Kern, Ronald 
W. Hilwig, Vahid Saadat, William R. Roeske, Jack G. Copeland. 
Interventional Cardiology: Sarver Heart Center, University of Arizona, 
Tucson, AZ, USA 
Background: Transmyocardial revascuiarization (TMR) holds promise as a 
therapeutic modality for the treatment of refractory myocardial ischemia. To 
overcome limitations associated with laser TMR we developed a simplified 
alternative method for myocardial channel formation via combined rotary 
coring and vacuum tissue extraction. In the present sttidy we tested the 
hypothesis that conditioning the myocardium via a process of mechanical 
myocardiai channeling (MMC) plus 60 day healing will result in enhanced 
myocardial viability in the setting of acute ischemic challenge. 
Methods: In 15 pigs (female, 30 kg.) left thoracotomy was performed and 
the heart was exposed. in 8/15 pigs channels (1 mm., 5 mm inter-channel 
spacing, 3Oipig) were created mechanically in the mid left ventricular an- 
terior wall (AW), from the level of the second diagonal to the apex (MMC 
group). 7/15 pigs, w/o MMC, served as controls (non-MMC group). All pigs 
were recovered and allowed to heal for 60 days. All pigs were then sub- 
jected to acute ischemic challenge via LAD ligation at the level of the sec- 
ond diagonal. ST elevation Vd-V6, PVC frequency (scoring: 1 (cairnin), 2 
(2-IOimin), 3 (>I O/min)), # Vfib episodes and regional wall motion (2D Echo, 
AW segments, scoring (blinded observer): 1 NML, 2 hypokinetic, 3 akinetic, 
4 dyskinetic, 5 aneurysmal) at 60 min post LAD occlusion were monitored 
in surviving MMC-conditioned pigs (5/8 pigs) and compared to surviving 
non-MMC controls (4/7 pigs). 
Results: ST elevation Vd-Ve was reduced with MMC conditioning versus 
control (1.79 f 2.6 vs 5.86 + 2.0, p = 0.017). PVC frequency (1 .I3 i 1.05 vs 
3.0 f 0, p f 0.001) and # of VFib episodes (0.63 i 0.70 vs i 36 i 1.12, p = 
0.03) were less for MMC-conditioned pigs than non-MMC controls. Regional 
AW motion was more presetved in the MMC conditioned group than control 
(1.36 i 0.65 vs 2.25 * 0.5 p = 0.02). 
Conclusion: Myocardium conditioned via MMC plus sixty day healing 
manifests reduced ischemia and arrhythmia and enhanced function preser- 
vation despite severe ischemic challenge from total coronary occlusion. MMC 
may be a useful adjunct method for protecting ischemic myocardium, provid- 
ing a simple therapeutic alternative to laser TMR. 
1 1105-I 35 1 Transient Exposure of Nicotine Attenuates the 
Severity of Canine Myocardial Stunning Via 
a,-Adrenergic Receptor Activation and 
Augmentation of Ecto 5’-Nucleotidase Activity 
Shoji Sanada, Masafumi Kitakaze, Hiroshi Asanuma, Hisakazu Ogita, 
Kengo Harada, Seiji Takashima, Yasuhiko Sakata, Masanori Asakura, 
Tsunehiko Kuzuya, Masatsugu Hori. Osaka University Graduate School of 
Medicine, Suita, Japan 
Background: It is accepted that adenosine attenuates the severity of both 
reversible and irreversible ischemic myocardial cellular injury. We have 
previously reported that 011 -adrenergic receptor activation mediates the in- 
farct size-limiting effect of ischemic preconditioning through augmentation of 
ecto-Y-nucleotidase activity. Since nicotine may increase the plasma nore- 
pinephrine level and stimulate 011 -adrenergic receptors in the heart, we exam- 
ined whether nicotine attenuates the severity of myocardial stunning through 
augmentation of ectod’-nucleotidase activity in the canine model. 
Methods: Prior to a 15 min occlusion of the LAD branch of the coronary 
artery followed by 3 hours of reperfusion, nicotine (2 p gikgimin) was infused 
for 30 min into the systemic vein with or without an intracoronary infusion 
of either prazosin (2 @ g/kg/min), a blocker of orI-adrenergic receptors, or 
AMP-CP (80 p g/kg/min), an inhibitor of ecto-B-nucleotidase (n = 5 each), 
measuring myocardial fractional shortening by ultrasonic crystal dimension 
gauges. 
Results: The control group (n = 5) received no drugs. Although fractional 
shortening decreased 3 hours afterthe repeffusion in the control group (Mean 
f SEM, 23.0 f 2.4% vs. 11.0 & 1.8%, p < O.Ol), nicotine pretreatment 
markedly (p < 0.05) attenuated the reduction of fractional shortening (24.4 f 
1.2% vs. 22.8 i 2.2%, N.S.) compared with the control group. Furthermore, 
this effect induced by nicotine was completely blunted by co-treatment with 
either prazosin (22.44 f 1 .I% vs. 12.6 & 0.8%, p < O.Ol), or AMP-CP (23.0 
i 0.9% vs. 12.04 i 2.3%, p < 0.01). 
Conclusion: We conclude that pretreatment with nicotine attenuates 
the severity of myocardial stunning via or,-adrenergic receptor activation 
and augmentation of ecto-5’-nucleotidase activity. This observation may be 
related to the smoker’s paradox. 
L---L- 1105 136 Attenuation of Tumor Necrosis Factor-Alpha by 
Ultrasound-Targeted Antisense Oligonucleotide 
John M, Erikson, Danny Escobedo, Tracy L. Garcia, Bysani Chandrasekar. 
Department of Medicine/Cardiolog~ The University of Texas Health Science 
Center at San Antonio, San Antonio, Texas, USA 
Background: Tumor necrosis factor (TNFn) is a key mediator of inflamma- 
toy processes in the heart. Specific antisense oligonucleotides provide a 
unique approach for attenuating protein expression and modifying the car- 
diac inflammatory response during myocardial ischemia-reperfusion injury. 
Recently, interest has focused on using therapeutic ultrasound to deliver 
microsphere-bound oligonucleotides to target tissues. The current study was 
undertaken to evaluate the feasibility of using an ultrasound-targeted anti- 
sense oligonucleotide to attenuate TNFol expression following a myocardial 
ischemia-reperfusion injury. 
Methods: Pet-fluorocarbon-containing albumin microspheres were incu- 
bated with 100 ug of an antisense oligonucleotide directed against TNFol. 
WKY rats (n = 8) were anesthetized and a central venous catheter placed. 
Animals received an infusion of microspheres either with (n = 4) or without 
(n = 4) bound oligonucleotide. All animals underwent external application 
of therapeutic ultrasound (0.6 W/cm* x 15 min). Twenty-four hours after 
treatment all animals were subjected to 15 min of LAD ischemia followed 
by 2 hours of reperfusion. Eight additional animals served as controls; 4 
underwent sham-operation only and 4 underwent ischemiaireperfusion only. 
Heads were removed and Northern and Western blotting performed. 
Results: All 12 animals in the ischemia-reperfusion group demonstrated 
TNFa mRNA production. All control animals showed robust protein expres- 
sion, as did 3 animals receiving microspheres only. In the group receiving the 
oligo-nucleotide, 2 animals showed a marked decrease, and 1 animal exhib- 
ited a modest decrease in TNFa protein expression. The 4 sham-operated 
control animals did not express either TNFol mRNA or protein. 
Conclusion: Ultrasound-targeted antisense oligonucleotides can effec- 
tively attenuate cardiac TNFa protein expression following 15 min of ischemia 
and 2 hours of reperfusion. 
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I_) . . 1105 137 Lecrthmized Copper, Zinc-Superoxide Dismutase 
Reduced the Infarct Size in Rats With Myocardial 
Ischemia-Reperfusion Injuries 
Misako Hangaishi, Hiroyoshi Nakajima, Junichi Taguchi, 
Nobukazu Ishizaka, Tom Aizawa, Yukihiro Kuwada, Satoshi Kimura, 
Minoru Ohno, Rie Igarashi, Yutaka Mizushima. University of Tokyo, Tokyo; 
St Marianna Universifl: Kawasaki, Japan 
Background: Increased oxygen free radicals are responsible, in part, for my- 
ocardial ischemia-reperfusion injury. Thus many basic and clinical studies to 
protect ischemia-reperfusion injury have been conducted using various kinds 
of modified or unmodified SOD. However the effect remains controversial. 
Lecithinized SOD, a human recombinant copper, zinc-superoxide dismutase 
(SOD) that covalently binds with lecithin derivatives (phosphatidylcholine 
palmitoyl), has a much longer half-life and much higher affinity to the cell 
membrane than unmodified (UM)-SOD (Igarashi R, JPET 1992, 1994). We 
tested the effect of lecithinized SOD in rats in reducing the infarct size of 
myocardial ischemia- reperfusion. 
Methods and Results: Rats were subjected to left descending coronary 
artery ligation for 45 min followed by 120 min reperfusion. Lecithinized SOD 
(20000 U/kg, n = 7) polyethylene glycol (PEG)-SOD (20,000 U/kg, n = 5) 
UM-SOD (60,000 U/kg. n = 8), free phosphatidylcholine (0.32 mg/kg, n = 8) 
or PBS as the control (n = 9) was administered intravenously 5 min before 
repet-fusion. Infarct area ratio (IAR) was defined as [Infarct area]/[Total LV 
area] assessed by TTC staining. IAR of the lecithinized SOD group was 
smaller (1.4 f 0.8%, P * 0.05) than that of PEG-SOD (12.8 f 5.4%), 
UM-SOD (6.9 f 2.0%), free phosphatidylcholine palmitoyl (8.4 f 1.6%) or 
the control group (9.8 ZIZ 3.3%). The hemodynamic values including blood 
pressure and heart rate during the procedure was similar among each group 
except for the PEG-SOD group. Using ELISA assay, SOD concentration in 
the ischemic risk areas of the heart was higher in the lecithinized SOD-treated 
group (15 i 1.3 bg/wetg, P < 0.05) than in the PEG-SOD (7.1 f 2.3 bglwetg) 
or UM-SOD-treated groups (4.9 i 1.4 kglwetg, n = 5). The serum SOD levels 
were higher both in the PEG-SOD and lecithinized SOD-treated groups than 
in the UM-SOD-treated group. 
Conclusions: Bolus intravenous administration of lecithinized SOD had 
a striking protective effect in the rat model of myocardial reperfusion injury 
due to its higher bioavailability and tissue concentration. 
1105-I 38 Myocardial Protection in Man During Sequential 
Coronary Angioplasty is not Due to Collateral 
Recruitment 
Richard J. Edwards, Simon R. Redwood, Pier D. Lambiase, Roby R. Rahkit, 
Emma Tomset, Michael M. Webb-Peploe, Michael S. Marber. St Thomas’ 
Hospital, London, UK 
Aims: PTCA as a surrogate model of ischemic preconditioning has been 
criticized. Firstly, balloon inflation times of 90s are too short to consistently 
initiate protection and secondly ischemic tolerance may be due to collateral 
recruitment. 
Methods: 18 Patients (59 & 7 years) with isolated LAD disease and nor- 
mal LV function under went 2 balloon inflations of >I80 s each, separated 
by >5 min reperfusion. Balloon occlusion pressure (Pocc) was measured 
with a 0.014’ pressure wire positioned distal to the balloon. Collateral flow 
index (CFI) was calculated on the basis of simultaneous measurements of 
mean aortic (Pa) and coronary sinus pressure (CSP): (Pocc-CSP)/(Pa-CSP). 
Myocardial ischemia was assessed by degree of ST shift from the intracoro- 
nary and surface ECG chest lead with greatest deviation. The patient graded 
chest pain severity on a scale of 1-I 0. 
Results: The line graph represents the change in CFI over time whilst 
the bar graphs show ST deviation and chest pain score at peak inflation. 
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Conclusion: 1. We have demonstrated that ischemic parameters improve 
significantly during the second occlusion. 2. In contrast to previous studies 
this is achieved without an increase in CFI suggesting preconditioning is the 
dominant mechanism of protection in our study. 
I 1105 139 MX68, a New Derivative of Methotrexate, Limits Infarct Size Via Adenosine-Dependent 
Mechanisms in Dogs 
Hiroshi Asanuma, Masafumi Kitakaze, Shoji Sanada, Seiji Takashima, 
Yasuhiko Sakata, Masanori Asakura, Tsunehiko Kuzuya, Masatsugu Hori. 
Osaka Univ. Graduate School of Med., Japan 
Background: Either methotrexate or sulfasalazine, an anti-rheumatic agent, 
has been recently reported to mediate its anti-inflammatory action via ecto-5’- 
nucleotidase activation (Morabito, Cronstein et al., J Clin Invest 1998; 101: 
295). Since ecto-5’nucleotidase contributes to the production of adenosine, 
and adenosine mediates potent cardioprotection against ischemia and reper- 
fusion injury, we tested whether MX68, limits infarct size via ectod’nucleo- 
tidase-dependent mechanisms. 
Methods: In the open chest dogs, the LAD was perfused with blood 
through a bypass tube. We occluded the bypass tube for 90 min followed by 
6 hours of reperfusion. Infarct size was assessed by TTC staining. 
Results: MX68 (1.5 fi g/kg/min) limited infarct size compared with the 
untreated condition (16.3 i 2.9 and 41.2 f 3.4%, p < O.Oi), which was com- 
pletely blunted by either an adenosine receptor antagonist, b-sulfophenyltheo- 
phylline (8-SPT, 48.5 & 4.0 and 46.8 i 5.2% in the MX68 and the MX68 with 
8-SPT groups), or an inhibitor of ecto+nucleotidase, oi,p-methylenadeno- 
sine 5’-diphosphate (AMP-CP, 48.5 f 4.0 and 46.7 Z!Z 5.8% in the MX68 and 
the MX68 with AMP-CP groups). Furthermore, exogenous adenosine limited 
infarct size (11.2 f 1.2%), the comparable level of MX68 group. 
Conclusion: We conclude that MX68 potently limits infarct size via 
adenosine-dependent mechanisms mainlythrough activation of ecto&nucle- 
otidase. We propose that MX68, a new derivative of methotrexate, may be a 
useful drag for the treatment of acute myocardial infarction. 
1 1105-l 40 1 Lecithinized Cu, Zn-Superoxide Dismutase 
Ameliorates Hypoxic Injury in Cultured 
Cardiomyocytes 
Hiroyoshi Nakajima, Nobukazu Ishizaka, Misako Hangaishi, 
Jun-ichi Taguchi, Rie Igarashi, Ryozo Nagai, Minoru Ohno. Department of 
Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, 
Tokyo; Institute of Medical Science, St. Marianna Universifl: Kawasaki, 
Japan 
Recent studies have suggested that prolonged hypoxia results in increased 
production of reactive oxygen species in cardiomyocytes, which leads to 
apoptosis of these cells, We have previously shown that lecithinized recom- 
binant human copper, zinc-superoxide dismutase (rhSOD) showed increased 
bioavailability by more facilitated intracellular delivery and by longer half-life 
than unmodified SOD. The purpose of this study was to investigate whether 
or not lecithinized SOD played a protective role against the hypoxic injury 
in cardiomyocytes. Cultured rat cardiomyocytes incubated with lecithinized 
SOD (100 U/mL), unmodified SOD (100 U/mL), or vehicle alone were sub- 
jected to hypoxia for up to 72 h. Lecithinized SOD, but not unmodified SOD, 
was successfully delivered intracellularly, which was verified by the Western 
blot and immunocytochemistry. Treatment of cells with lecithinized SOD sig- 
nificantly suppressed the hypoxia-induced cell death. Since lecithinized SOD 
also suppressed hypoxia-induced DNA fragmentation, improved cell survival 
provided by lecithinized SOD is thought to be mediated by its anti-apoptotic 
effect. In summary, lecithinization resulted in a facilitated rhSOD delivery 
into cultured cardiomyocytes, which reduced mortality of cardiomyocytes 
exposed to the prolonged hypoxia. 
CIII 1105 141 Losartan and Captopril Reduce Myocardial 
Infarct Size, Arrhythmias, and Mortality in a Rat 
Model of Ischemia-Reperfusion 
Bo-qing Zhu, Yi-ping Sun, Richard E. Sievers, Amanda E.M. Browne, 
Satyavardhan Pulukurthy, Krishnankutty Sudhir, Randall J. Lee, Tony 
M. Chou, Kanu Chatterjee, William W. Parmley. University of California San 
Francisco, San Francisco, California, USA 
Background: ACE inhibitors and angiotensin II receptor blockers inhibit 
the renin-angiotensin system in different ways. The comparative effects of 
pretreatment on acute myocardial infarct size and arrhythmias are unknown. 
Methods: 117 Sprague-Dawley rats were randomized into 3 groups: a 
control (Con) and two pretreatment groups in which Captopril (Cap) and 
Losartan (Los) were given 40 mg/kg/day in drinking water respectively. After 
IO wks, 25 rats in each group were subjected to 17 min of left coronary artery 
occlusion and 2 hr of reperfusion with hemodynamic and ECG monitoring. 
Ventricular fibrillation (VF) thresholds were measured. 
Results: Mortality during ischemia and reperfusion was lower in Los 
compared to Con (0% vs 19.2%, p = 0.05). Rats treated with losartan had 
markedly higher levels of angiotensin II (Los vs Cap and Con: 131 & 47 vs 42 
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i 6, 22 i 3 pg/ml, p = 0.036, 0.006, respectively). Hemodynamics were not 
significantly different among the 3 groups at any time point. VF thresholds 
before occlusion (VFTbo) and after reperfusion (VFTar) were significantly 
higher in Los and Cap. Average episodes of VF per rat were lower in Los 
and Cap. Infarct size was significantly smaller in Los and Cap. 
Groups Inf size (%) VFTbo (mA) VFTar (mA) VFepisode Mortality 
Control (Con) 44 l 0.3 1.2*0.2 1.0 f 0.1 2.8 i 0.4 19.2% 
Captopril (Cap) 35 -t 3* 1.9 + 0.3" 1.8 i 02 1.2 * 0.3* 7.4% 
Losartan (LOS) 34 + 3* 2.0 ?c 0.2‘ 2.1 *0.3-t 1 .o * o.z** 0%" 
* p 5 0.05, ** p < 0.001, when compared to controls 
Conclusion: Losartan and captopril both have cardiovascular protec- 
tive effects independent of hemodynamic changes in a rat model of is- 
chemia-reperfusion. Pretreatment with either losartan or captopril for IO wks 
increased the VF thresholds, decreased episodes of VF, and reduced my- 
ocardial infarct size. Losartan decreased mortality. 
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l---L-i 1106 101 Platelet Glycoprotein Ilb/llla Receptor Blockade After Failed Thrombolysis is Associated With 
Risk of Bleeding 
Eelko Ronner, Ron T. van Domburg, Marcel J.B.M. van den Brand, Pim 
J. de Feyter, David P. Foley, Wim J. van der Giessen, Patrick W. Serruys, 
Maanen L. Simoons. Thoraxcenter Rotterdam, Netherlands 
Background: Failed thrombolysis in patients with myocardial infarction is 
associated with increased mortality. Possible strategies are rescue percu- 
taneous coronary intervention (PCI) and re-administration of thrombolysis 
(Re-Adm). The role of platelet glycoprotein Ilb/llla receptor blockers after 
thrombolysis is unknown. 
Methods: We reviewed 135 patients who received additional reperfusion 
therapy after thrombolysis. In hospital bleeding and mortality are reported 
of patients receiving Ilb/llla blockers alone or in adjunct to Re-Adm or PCI. 
Bleeding was defined by intracranial bleeding, transfusions, need for surgery 
or Hb decrease over 2 mmol/L (3.2 g/dL). 
Results: 
Treatment after thrombolvsis within 24 hours of onset of infarction: 
Re-administration + + + + - - - All All All 
PCI + + - - + + - All All All 
Ilb/llla blockers + - + - + - - All 
Number 17 8 1 28 46 29 i 7'0 65 135 
Death % 6 0 0 7 2 10 17 4 8 6 
Major bleeding#% 41 25 0 7 22 7 50 29# 9 19 
* and * = p < 0.05 for comparison with total (*) and rest of groups (#) (x2). 
Ilb/llla blockers were significantly associated with bleeding (29 vs. 9%, p 
= 0.004) but not with reduced mortality (4.3 vs. 7.7%, p = 0.4). Combination 
of Ilb/llla blocker and Re-Adm also demonstrated bleeding (39 vs. 16%, p = 
0.02; death 5.6 vs. 6.0%, p = 0.9). Re-Adm was not associated with bleeding 
(20 vs. 19%) nor with mortality (5.2 vs 6.2%, p = 0.9). The same was true 
for PCI (bleeding 21.0 vs. 14.3%, p = 0.4; death 5.0 vs. 8.6%, p = 0.4). Total 
hospital death is reasonable (5.9%) considering the patient characteristics 
and not statistically different between groups. 
Conclusion: Administration of Ilb/llla blockers after failed thrombolysis is 
associated with increased bleeding (p < 0.05). Other trials indicate that the 
combination of half dose thrombolytic with full dose of Ilb/llla blockers is safe 
and improves coronary patency. Ilb/llla blockers in adjunct to repetfusion 
therapies for failed thrombolysis should be used with caution. 
L-.-L-- 1106 102 Interim Results of the Tirofiban Given in the 
Emergency Room Before Primary Angiopiasty 
(TIGER-PA) Pilot Study 
David P. Lee, Michelle Huston, Niail A. Herity, Michael R. Ward, Steven 
D. Filardo, Sidney Lo, Donald Schreiber, Andrew J. Carter, Alan C. Yeung. 
Stanford University: Stanford, CA, USA 
Background: Recent studies in the treatment of acute myocardial infarction 
(Ml) have focused upon the adjunctive use of glycoprotein Ilb/llla inhibitors. 
Methods: TIGER-PA is a single center, randomized open-label pilot study 
with patients receiving a 24-hour infusion of tirofiban started either in the 
Emergency Room (ER) or in the catheterization laboratory (cath lab) be- 
fore primary angioplasty. The dose is 10 @g/kg over 3 minutes, then 0.15 
bg/kg/min for 24 hours. The primary endpoint is the corrected TIMI-frame 
count (CTFC) and TIMI grade flow (TGF) at pre-interventional angiogra- 
phy. The secondary endpoint is a composite of death, recurrent MI, urgent 
revascularization, and re-hospitalization for acute coronary syndrome at thirty 
days. The tertiary endpoint is bleeding as defined by TIMI criteria and throm- 
bocytopenia. 
Results: 33 patients (26 men and 7 women; average age 65 f 12) have 
thus far been enrolled with 21 receiving tirofiban in the ER. 19 patients had an 
inferior MI, IO anterior and 4 lateral. Average peak creatine phosphokinase 
was 1774 f 1226. The pre-intewentional CTFC was 46 f 25 and TGF 1.3 * 
1.5 in the ER group. After intervention the CTFC was 22 + 17 and TGF 2.7 * 
0.8. For the cath lab group, pre-interventional CTFC was 50 f 19 and TGF 
0.3 f 0.7; post-interventional CTFC was 15 f 5 and TGF 2.7 i 0.9. Eight 
patients in the ER group had initial TGF 2 or 3 (7 with TIMI-3) while 1 patient 
in the cath lab group had TIMI- flow (P = 0.03). 1 patient in each group 
was re-hospitalized for chest pain. Major bleeding was seen in 2 ER group 
patients with no major bleeding in the cath lab group. No thrombocytopenia 
was seen in either group. 
ER 
Cath Lab 
* P = 0.03 
Pm-intervention 
CTFC TGF 
46 i 25 1.3*1.5* 
50119 0.3 zk 0.7 
Post-intervention 
CTFC TGF 
22zt17 2.7 f 0.6 
1515 2.7 i 0.9 
Conclusion: Early adjunctive administration of tirofiban before primary 
angioplasty appears to be feasible, safe and well-tolerated and may improve 
early blood flow. 
1106-l 03 Platelet Activation as a Potential Mechanism of 
GP llb/llla Inhibitor-Induced Thrombocytopenia 
Karlheinz Peter, Andreas Straub, Benedikt Kohler, Thomas Nordt, 
Johannes Ruef, Martin Moser, Meike Schwarz, Wolfgang Kiibler, 
Christoph Bode. University of Freiburg and University of Heidelberg, 
Germany 
Background: Thrombocytopenia is described as an adverse effect in pa- 
tients (pts) treated with GP Ilb/llla inhibitors but its mechanism has not been 
elucidated yet. 
Methods: Using flow cytometry, the activation status of platelets was 
monitored in 26 pts presenting with acute myocardial infarction who were 
treated with the GP Ilb/llla inhibitor abciximab alone or in combination with 
the fibrinolytic agent reteplase. 
Results: Binding of fibrinogen and the GP Ilb/llla activation-specific mon- 
oclonal antibody PAC-I, as well as P-selectin expression on unstimulated 
platelets were constant in 25 pts throughout a follow up of 7 days. In one 
pt (D.F.) the percentage of nonstimulated platelets that bound fibrinogen in- 
creased from 2.2 to 17.8%, for PAC-I from 2.8 to 13.2%, and for P-selectin 
expression from 10.2 to 58.3% at 10 minutes after start of treatment. Fur- 
thermore, D.F. had a drop in single platelet count in blood anticoagulated 
with EDTA (nadir: 8/nl), citrate (67/nl), and heparin (65/nI) as well as in native 
blood (136/nl). Thus, depending on the type of anticoagulant used, vari- 
ous degrees of pseudothrombocytopenia were present. Furthermore, blood 
films of D.F. revealed small platelet aggregates after abciximab was given. 
In vitro exposition of D.F. blood to abciximab 2 and 4 weeks after initial 
admission demonstrated re-induction of fibrinogen and PAC-I binding to 
non-stimulated platelets, and the formation of platelet aggregates. P-selectin 
expression increased directly dependent on the in vitro abciximab concen- 
tration (no addition: 3.2%; 0.1 Kg/ml: 5.8%; 1 &ml: 6.2%; 3 pg/ml: 12.6%; 5 
&ml: 15% (each fig/ml of abciximab: % of platelets expressing P-selectin). 
In vitro activation of platelets by reteplase could not be seen. 
Conclusion: This report describes the induction of platelet activation by 
a GP Ilb/llla inhibitor as a potential mechanism of GP Ilb/llla inhibitor-asso- 
ciated thrombocytopenia and furthermore suggests a cautious interpretation 
of platelet counts in patients treated with GP Ilb/llla inhibitors. 
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EII 1106 104 Incremental Effects of Anti-Platelet, Anti-Thrombin and Fibrinolytic Therapy on the 
Speed and Stability of ST-Segment Recovery 
After Acute Ml 
Arthur C. Maas, Cynthia L. Green, Sidharth A. Shah, Kathleen M. Troliinger, 
John K. French, E. Magnus Ohman, R. Harrington, Harvey D. White, Eric 
J. Topol, Robert M. Califf, Mitchell W. Krucoff. Duke University Medical 
Center, Durham, NC, USA 
Selection of fibrinolytic and/or adjunctive therapy may influence the speed 
and stability of reperfusion in acute MI. Continuous 12-lead ST-segment 
recovery analysis from clinical trials examining each of these therapeu- 
tic regimens provides a quantitative measure of such incremental benefit. 
From TAMI-9, DUCCS II, GUSTO-l, IMPACT-AMI, PARADIGM, PRIME and 
HERO-l, 1298 pts with 12 lead ST analysis, all treated with ASA & fibrinolytics 
(t-PA, streptokinase, or APSAC) were variously treated with anticoagulants 
(heparin, efegatran, hirulog) and/or anti-platelets (lamifiban, eptifibatide). Pt. 
treatment groups were categorized as “any anti-platelet” (AP), “any anti- 
thrombin” (AT), “CPA only” or “Streptokinase/APSAC (SK/A) only.” Using 
published ST recovery analysis methods, ST outcome variables analyzed 
were PEAK ST level, CYCLIC flow, time to stable ST recovery (TSST), 
recurrent ST elevation (RE-ST) and AREA under the ST trend curve. 
Results were (median values or %): 
Variable AP 
N 254 
PEAK (JLV) 395 
RE-ST, % 29.4 
CYCLIC, % 17.1 
TSST (min) 67 
AREA 4920 
AT t-PA SKJA p-VdUC2 
266 547 231 
436 500 500 <O.OOl 
40.4 49.9 50.6 <O.OOl 
29.7 33.0 34.1 <O.OOl 
107 116 120 <O.OOl 
5134 6094 7168 0.007 
By univarlable analysis, these data suggest that use of parenteral AP and 
AT agents provides significantly greater incremental benefit than does the 
choice of fibrinolytic agent. 
1106-I 05 Higher aPlTs Associated With Worse Outcomes 
After Thrombolytic Therapy With Reduced-Dose 
Heparin: Results From ASSENT-2 
John H. Alexander, Christopher B. Granger, Robert M. Califf, Harvey 
D. White, Judith Hochman, Eric J. Topol, Frans Van de Wed. For the 
ASSENT-2 Investigators, Duke Clinical Research Institute, Durham NC, USA 
Background: Following thrombolytic therapy and standard intravenous hep- 
arin dosing, higher aPTTs are known to be associated with higher risk of 
bleeding, reinfarction and death. In order to further evaluate this relationship, 
we analyzed the relationship between aPTT and outcomes in the ASSENT-2 
trial, which compared single-bolus weight-adjusted tenecteplase with accel- 
erated t-PA. 
Methods: In ASSENT-2, heparin was administered as a bolus of 5,000 u 
and infusion rate of 1,000 u/hr for patients over 67 kg, and a bolus of 4,000 
u and infusion of 800 u/h for patients under 67 kg (to avoid higher aPTTs), 
with adjustment to a target aPTT of 50-75 seconds. During the first 12 hours, 
heparin was only decreased for bleeding or aPTT P 100 seconds. 
Results: A total of 13,240 patients had aPTTs reported at 12 f 1 hr. 
API-r at 12 hours: 
Age (median) 
Weight (median) 
Female 
30 d mortality 
Major bleeding 
Reinfarction 
<50 sac 
(n = 4968) 
57 yr 
62 kg 
16% 
3.0% 
2.8% 
3.6% 
50-75 se0 
(n = 5312) 
63 yr 
76 kg 
22% 
3.4% 
4.0% 
3.7% 
>75 se0 
(n = 2960) 
66 yr 
73 kg 
32% 
5.6% 
6.5% 
4.4% 
Worse outcomes were observed with higher aPTTs for both thrombolytics. 
Conclusions: Even with reduced-dose heparin for lower weight patients, 
22% of patients following thrombolysis have above-target aPTTs and much 
worse clinical outcomes. The degree to which this is explained by higher 
risk baseline characteristics will be addressed with multivariable analysis. 
More efforts are needed to avoid over-anticoagulation with heparin following 
thrombolysis. 
0 1106 106 Tirofiban and Heparin are Synergistic With Low Frequency High-Intensity Ultrasound for In-Vitro 
Blood Clot Dissolution 
Shaul Atar, Huai Luo, Yochai Birnbaum, Tomoo Nagai, Thomas Peterson, 
Robert J. Siegel. Cedars-Sinai Medical Center, Los Angeles, CA, USA; 
Rabin Medical Centel; Petah-Tiqva, Israel 
Background: Glycoprotein Ilb/llla antagonists andfor heparin are commonly 
used in acute coronary syndromes and coronary interventions. However, 
there is currently no data on the possible synergistic effect of these drugs 
with low frequency high-intensity ultrasound (USD) energy for in-vitro clot 
dissolution. 
Methods: Human blood clots from 3 healthy donors (n = 360) weigh- 
ing 288 f 40 grams were incubated for 5’, IO’, 15’ and 30’ minutes in 
normal saline containing clinically used concentrations of heparin, tirofiban 
(Merck &Co.), t-PA and Optison (echocardiographic contrast agent, Mallinck- 
rodt) alone and in combinations. Clots were then randomly exposed to low 
frequency high-intensity ultrasound (26 kHz, Cybersonics, Erie, PA) for 5 
minutes. The percent difference in clot weight reduction and the incremental 
effect of ultrasound energy were calculated. 
Results: The greatest and most rapid synergistic effect of ultrasound ap- 
plication was detected with the combination of tirofiban and heparin (39 f 2% 
augmentation after 10’ of incubation, p 4 0.0001). The greatest magnitude 
of percent clot weight reduction was observed with ultrasound energy com- 
bined with either t-PAalone (72 f 1% after 30’ incubation, p = 0.0016) or with 
the combination of t-PA + tirofiban + heparin + Optison (68 f 4% after 30’ 
incubation, p = 0.015). However, we also found a rapid and high magnitude 
of % clot weight reduction with USD and the combination of tirofiban and 
heparin (without t-PA) - 44 f 7% and 48 f 5% after 5’ and IO’ respectively 
(p < 0.0001). 
Conclusions: Low frequency high-intensity ultrasound is highly synergis- 
tic with antiplatelet and antithrombotic drugs, specifically with the combination 
of tirofiban and heparin; this effect is observed after a very short incubation 
period 
Anaheim 
March 12-15 
/- \ 
i‘-- + Comprehensive 
Cardiology 
\ .‘. 
L with Special 
Spotlight Sessions 
JACC February 2000 ABSTRACTS - Myocardial Ischemia and Infarction 373A 
1 1106-I 08 / The Veterans Administration Cooperative Study 
Program Trial: “Combination, Hemotherapy and 
Mortality Prevention” (CHAMP): Rates of Major 
Hemorrhage 
Louis Fiore, Michael 0. Ezekowitz, Mary T. Brophy, Valia Boosalis, 
John Taper, Peter Peduzzi. For the CHAMP Study Group, Boston VAMC, 
Boston, MA, USA 
The CHAMP Study was a multi center, open labeled trial comparing all 
cause mortality in survivors of acute myocardial infarction randomized within 
14 days to either combined warfarin (target INR 1.5-2.5) and aspirin (81 
mgid) therapy (WA) or aspirin (162 mg/d) monotherapy (A). Bleeds were 
independently adjudicated to assure that they met criteria for major bleeding 
(MB): fatal, intracranial or retroperitoneal bleeds or hemorrhage that led 
to hospitalization or transfusion provided the hemoglobin fell by at least 2 
grams/dl. 5,059 patients, mean age 6.5 years, were randomized from 20,036 
patients screened. Bleeding risk was the primary exclusion criteria in 11.9% of 
non-randomized patients. Median follow-up was 2.75 years (range 1 .O-6.0). 
Mean INR in WA was 1.9. By intention to treat analysis the rate of MB per 
100 pt-yrs (%) of follow-up was significantly higher in WA vs. A (1.25 vs. 0.69, 
p < 0.001). Similarly calculated rates using an “on treatment” analysis were 
I .30 and 0.56 for WA and A respectively. Intracranial hemorrhage (ICH) was 
identical in the two groups (0.21%). Gastrointestinal (GI) bleeding accounted 
for the majority of excess MB in WA. Rates of MB increased with age and 
were higher in WA than A for all age groups. 
Bleeding rates par 100 pt.years 
Age Group <50 50-59 60-69 >70 
A 0.19 0.36 0.74 1.24 
WA 0.41 0.77 1.28 2.16 
Conclusions: (1) MB in this selected population was low in both treatment 
groups; (2) the higher rate of MB in WA was primarily GI with no increase 
in ICH; and (3) MB rates increased with advancing age in both treatment 
groups. 
1106-I 27 Selective Inhibition of Factor Xa is More Efficient 
Than Heparin at Facilitating Coronary 
Thrombolysis in a Canine Model 
Debabrata Mukherjee, Kai Wang, Stephen G. Ellis, Mitchell Silver, 
Xiaorong Zhou, Rami Nimrod’ , Eric J. Topol, Michael A. Lincoff. C/eve/and 
Clinic Foundation, C/eve/and, Ohio, USA; ‘Biotechnology Genera/, lsrael 
Background: Despite significant advances in thrombolytic therapy and ad- 
junctive use of antiplatelet and antithrombotic therapies in the last few years, 
current thrombolytic intervention still does not achieve the goal of early, 
complete and sustained reperfusion in majority of patients. We determined 
the effect of adjunctive inhibition of factor Xa after thrombolytic therapy with 
tissue-type plasminogen activator (t-PA) in a canine model of electrically 
induced coronary thrombosis 
Methods: Fourteen dogs with electrically induced coronary thrombus 
undergoing thrombolysis with t-PA (1 mg/kg over 20 min) were randomly 
assigned to either heparin (80 U/kg bolus + 17 U/kg/hr I.V. for 90 minutes, n 
= 7) or FactoreX inhibitor (70 figs/kg bolus followed by 20 figs/kg/hour for 90 
minutes, n = 7). The dogs were observed for 180 min after thrombolysis for 
reocclusion and cyclic flow variation. At the end of the experiment, animals 
were sacrificed and infarct size determination performed using the ex vivo 
dual perfusion histochemical method. 
Results: Factor X inhibition accelerated the time to repetfusion, increased 
duration of reflow, and decreased cyclic flow variation as compared to hep- 
arin. Adjunctive treatment with factor X inhibitor also significantly decreased 
the infarct size compared to heparin use. 
Reperk&n Rate 
Heparin 
83% 
Factorex 
100% 
Tink to reflow (min) 
Reflow Duration (min) 
Cyclic Flow Variation 
Reocclusion Duration 
Infarct Area 
83.33 i 25.75 25.85 + 5.64* 
71.161- 19.70 147.57 i- 7.64* 
32.65 i 13.74 3.64 i 1.36* 
36.66 i 26.44 2.01 * 1.44s 
4.04 Lt 1.61 cm2 1 .Ol zk 0.42 cm2 
- p < 0.05 
Conclusions: In this experimental model, selective inhibition of factor Xa 
accelerated thrombolysis, increased reflow duration and decreased infarct 
size. Factor Xa inhibition may be a useful adjunct for optimal thrombolysis. 
I 1106 128 Randomized Comparison of Vasoflux, a Novel Anticoagulant, and Heparin as Adjunctive 
Therapy to Streptokinase for Acute Myocardial 
Infarction 
Ron J.G. Peters’, William SpickleP, Pierre Theroux3, Harvey White4, 
Michael Gibson5, Peter G. Molhoek6, Jack Hirsch’, J.I. Weitz7, 
Douglas Weave+. ‘Academic Medical Center. Amsterdam; 6Medisch 
Spectrum Twente, Enschede, the Netherlands; 2 Vascular Therapeutics, 
California; 5West Roxbury VA Hospital, Massachusetts; ‘Henry Ford 
Medical Center, Detroit, USA, USA; 3Montreal Heart Institute, Montreal; 
7Hami/ton Civic Hospitals Research Center, Hamilton, Canada; 4 Green 
Lane Hospital, Auckland, New Zealand 
Background: With current thrombolytic regimens for acute myocardial in- 
farction, restoration of normal coronary flow (TIMI- flow) is achieved (at 
90 minutes) after the start of treatment in only 32 (streptokinase) to 54% 
(tPA). Vasoflux is a derivative of low molecular weight heparin that catalyzes 
fibrin-bound thrombin inactivation by heparin co-factor II and inhibits factor 
IXa activation of factor X, independently of antithrombin and heparin co-fac- 
tor II. It is therefore the first factor IXa-inhibitor tested in man. The present 
dose-finding study was designed to test the hypothesis that vasoflux would 
improve the angiographic patency of the infarct-related artery in patients with 
AMI undergoing thrombolysis with streptokinase. 
Methods: In VITAL, 277 patients with acute ST-segment elevation my- 
ocardial infarction presenting within 6 hours were randomized to receive i.v. 
heparin or one of 4 i.v. doses of vasoflux: 1 mg/kg, 4 mg/kg, 8 mg/kg and 16 
mgikg in a dose escalating phase II study. Primary endpoint of the study was 
angiographic patency of the infarct related artery at 90 minutes after the start 
of therapy. 
Results: In 255 patients adequate core-laboratory assessment of TIMI 
flow grade was possible at 90 minutes. Rates of TIMI flow grade Ill with 
vasoflux (35 to 42%) were not significantly different from heparin (41%) at 
any dose. Major bleeding events were observed in 13 (p = 0.05) and 28% (p 
= 0.01) in the vasoflux dose groups of 8 and 16 mg/kg, as compared to 8% 
in the heparin group. 
Conclusions: At doses that increase bleeding risks, the addition of va- 
soflux to streptokinase and aspirin did not lead to improved patency rates as 
compared to heparin. 
) 1106-l 29 1 Enoxaparin Pharmacokinetics and 
Pharmacodynamics After Intravenous Bolus 
Administration Alone and at Initiation of a 
Subcutaneous Dosing Regimen 
Aim6 Le Liboux, Ger-Jan Sanderink, Philippe Grosjean, 
Marie-Laure Ozoux, Yvonne Le Roux, Anne Floch, Guy Montay, 
Bruno Boutouyrie, Gerald R. Rhodes. Drug Metabolism & Pharmacokinefics 
and Clinical Pharmacology, Rh6ne-Poulenc Rarer, Anton)! France 
Background: Enoxaparin (E) is the only low molecular weight heparin which 
has shown superior efficacy over heparin in large unstable angina and non-Q 
wave myocardial infarction clinical trials (ESSENCE and TIMI 11 B). In both 
studies Ewas administered at a dose of 1 .O mg/kg q12 h SC. In addition, in 
the TIMIIIB trial a 30 mg loading dose was given IV at treatment initiation. 
Methods: 16 healthy elderly volunteers (age 57 It 1.4 years) were given 
30 mg E as a single IV bolus in period 1. In period 2, they received the 
same single IV bolus and simultaneously E 1 .O mg/kg SC every 12 hours for 
4 days. The plasma pharmacokinetics of anti-factor Xa, anti-factor Ila and 
aPTT were evaluated on day 1 of both periods and day 4 of period 2. 
Results: 30 mg IV alone: Plasma clearance of anti-Xa activity was 1.15 
L/h. The distribution volume was 4.25 L. Elimination appeared monophasic 
with a mean half-life of 2.64 hours. In comparison, anti-lla activity clearance 
was 2-fold higher and the half-life 2-fold shorter than of anti-Xa activity, with a 
similar distribution volume. The AUC of anti-Xa activity was eight-fold higher 
than that of anti-lla. Renal clearance of active fragments represented 11% 
of the systemic clearances. The mean maximum prolongation of aPTT was 
23.5 s. 
30 mg IV + 1.0 mg/kg SC 912 h: 5 min after treatment initiation, anti-Xa 
activity was 0.66 f 0.23 IU/ml, comparable to minimum concentrations at 
steady-state with this regimen. Anti-factor Xa activity then increased to 1 .I6 
f 0.17 IUiml at the tmax of 3 hours. AUC, Amax and Amin of anti-Xa over 
the first dosing interval were about 90% of those at steady-state conditions 
and significantly higher than in historical controls treated with the same dose 
without an iv bolus. The apparent elimination half-life was about 7.0 hours. 
The initial increases in anti-lla activity and aPTT were about 1.7-fold higher 
than at steady-state, but then dropped within 6 hours to steady-state levels, 
which were then maintained for the next doses. 
Conclusion: The 30 mg IV loading dose allows to immediately reach 
therapeutic anti-Xa levels and steacly-state conditions. Anti-lla and aPTT are 
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higher than steady-state levels, but only for a few hours following the initial 
loading dose. 
1 1106-l 30 1 Eptifibatide Inhibits the Function of GP Ilb-llla on 
Unstimulated Platelets Without Causing Platelet 
Activation 
Lisa Nannizzi-Alaimo, Amanda L. Rychel, David R. Phillips. COR 
Therapeutics, Inc., South San Francisco, California, USA 
Background: Although it is now established that GP Ilb-llla antagonists 
improve clinical outcomes in patients with ACS and those undergoing PCI, 
recent reports suggest that certain GP Ilb-llla antagonists may induce platelet 
activation (Blood, 92, 3675; 92, 3240, 1998). The present study determined 
if eptifibatide, a potent and specific GP Ilb-llla antagonist, has platelet stim- 
ulatory activities and to characterize additional inhibitory properties of this 
drug. 
Methods: Two measurements assessed platelet activation; P-selectin 
(Psel) expression, measured by FITC-Psel antibody binding, and Ca2+ flux 
measured by Fura-2. 
Results: Eptifibatide at doses from 0.001-20 WM had no effect on Psel 
expression. In contrast, Psel expression was readily induced by TRAP. Like- 
wise, no change in Ca2+ was observed with eptifibatide to up to 10 PM, 
whereas responses to thrombin or ADP were evident. Since eptifibatide did 
not promote activation, we determined if eptifibatide inhibited adhesion of 
platelets to immobilized fibrinogen, a function of GP Ilb-llla on unstimulated 
platelets. Eptifibatide demonstrated a dose dependent inhibition of adhesion 
(ICss = 1.1 FM), with no promotion of adhesion from 0.01-20 PM. We also 
investigated whether eptifibatide reversed platelet aggregation (PA). Eptifi- 
batide at 2.7 PM, the drug concentration achieved in the PURSUIT clinical 
trial, was added to aggregates formed in response to 10 WM ADP in PRP 
using a standard PA assay. The average percent reversal in PPACK antico- 
agulated blood at 60 or 90 seconds after initiation of PA was 69 i 17% and 
61 f 15% (n = 15), respectively. 
Conclusion: This study shows that eptifibatide inhibits thrombus forma- 
tion without causing platelet stimulation. Additionally, eptifibatide may reverse 
newly formed aggregates thereby identifying an alternate inhibitory mecha- 
nism that may contribute to the observed clinical benefits. 
1 1106-l 31 ( Comparative Effects of Abciximab and lntegrilin 
on Platelets and Fibrin Formation in Native 
Non-Anticoagulated Blood Under Flow 
Conditions 
Rohit R. Arora, Bruce Lages, Thomas Hoffman, Conan K.N. Li. Columbia 
University, New York; Xylum Corporation, Scarsdale, New York, USA 
Global hemostatic evaluation of the antiplatelet and antithrombotic effects 
of GP Ilb/llla blockers in native, non-anti-coagulated blood under flow con- 
ditions is largely unavailable. Current methods utilize either anti-coagulated 
blood in which thrombin/fibrin interaction is abolished, or non-flow states 
which eliminate the platelet activation effects of high shear rates. The follow- 
ing parameters were measured using the Xylum Clot Signature Analyzer@: 
1) high shear-induced activation of platelets by flow through 100 urn diameter 
holes punched in the 500 urn diameter blood flow tubing, in which the time 
from punch to occlusion of the holes is designated as platelet hemostasis 
time (PHT); and 2) adhesion and aggregation of platelets to a collagen fiber, 
in which the time for 50% occlusion of this pathway is designated as colla- 
gen-induced thrombus formation (CITF). A third parameter measured was 
clotting time (CT), which is the time for cessation of flow in the punch channel 
due to fibrin clot formation under low shear conditions. We investigated GP 
Ilb/llla blockers Abciximab and eptifibatide, at concentrations which span the 
range for inhibition of aggregation in vitro and which simulate therapeutic 
levels. 
Abciximab (ugiml) 0 2 5 10 
PHT (set) 222 * 33 339i31* 508 f 56* 586 zk 64* 
CITF 336 zk 22 478 f 43* 762 5 37* 787 zk 53* 
CT 1064&64 1159*55 1364 zk 106* 1508 zt 128* 
Eptifibatide @g/ml) 0 208 416 832 
PHT (SW) 235 i 25 310&27* 368 i 39* 422 + 38* 
CITF 309f 10 399 zk 14* 438 + 34* 544 f 25* 
CT 1066iz44 1284 + 119 1203f74 1326f 123 
Means zt sem (n = 8) *p < 0.05 YS 0 
These results suggest that abciximab is a more potent inhibitor of shear 
induced platelet activation, collagen-induced thrombus formation, and fibrin 
clot formation than eptifibatide, even at concentrations that maximally in- 
hibit aggregation. Such measurements may have potential applications in 
establishing and monitoring clinically effective doses of Ilb/llla blockers. 
ORAL 
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856-l ST Elevation in Lead Ill Greater Than Lead II Predicts 
High Risk Inferior Wall Myocardial Infarction 
John Jue, Jacqueline Saw, Heather Abbey, Anthony Y. Fung, Karin 
S. Coyne, Allan M. Ross. USC, Vancouver BC, Canada; George 
Washington Universiw Washington DC, USA 
Background: In inferior myocardial infarction (IMI), precordial ST depres- 
sion, 2”d/3’d degree heart block and involvement of the right ventricle (RV) 
portends higher risk. As the lead Ill vector overlooks both the inferior wall of 
the LV and RV, the magnitude of ST elevation in lead Ill exceeding lead II (Ill 
> II) has been purported to predict RV infarction and proximal right coronary 
artery (RCA) involvement. We assessed the value of Ill p II in predicting the 
infarct related arterial segment, in-hospital morbidity and mortality in IMI. 
Methods: Patients with IMI and ST elevations in II, Ill and aVF from 
the Plasminogen-Activator Angioplasty Compatibility Trial (PACT) were re- 
viewed. Immediate angioplasty was performed on those with less than TIMI 
3 flow. Mortality and in-hospital complications were grouped according to the 
presence of Ill P II or its absence (Ill 5 II). 
Results: Of the 367 IMI identified, no differences were noted between 
the 2 groups in age, gender, prior MI or risk factors. Despite similar Timi flow 
and LV function, Ill z II predicted greater 30 day and 1 year mortality and 
greater in-hospital morbidity. More proximal RCA occlusions were noted in 
this group. 
ST depression Vl-V4 
pnd/3’d degree heart block 
Temporary pacemaker 
Cardiogenic shock 
Proximal RCA involvement 
% Acute PTCA 
% Final Timi 3 Flow 
LV ejection fraction 
In-hospital reinfarction 
30 day mortality 
1 year mortality (n = 362) 
Ill 5 II (n = 150) Ill > II (n = 217) P 
88 (59%) 153 (70%) 0.02 
6 (4.0%) 25 (11.5%) 0.01 
10 (6.7%) 34 (15.7%) 0.009 
3 (2.0%) 13 (6.0%) 0.07 
31 (21%) 77 (36%) 0.003 
69% 79% 0.03 
83% 82% ns 
62%(n=118) 62% (n = 165) 
1 (0.7%) 8 (3.7%) oY7 
1 (0.7%) 10 (4.6%) 0.03 
1 (0.7%) 13 (6.1%) 0.009 
After adjusting for the presence of 2nd/3rd degree heart block and ST 
depression in Vi-V4, Ill > II remained an independent predictor of 30 day 
mortality or in-hospital reinfarction, and 1 year mortality. 
Conclusion: Despite aggressive interventional therapy, the presence of 
Ill t II in inferior wall myocardial infarction predicts a high risk group with 
greater morbidity and mortality. 
4:15 D.m. 
856-2 Aborted Myocardial Infarction is a Predictor of 
Reinfarction After Successful Thrombolysis 
Marc A. Brouwer’ , Gerrit Veer?, Aart J. Karreman’, Freek W.A. Verheugt’. 
2 Free University Hospital Amsterdam: ’ Heartcenter University Hospital 
Nijmegen, The Netherlands 
Background: Since the introduction of early thrombolytic therapy (TT) my- 
ocardial infarction (Ml) can sometimes be aborted. The optimal treatment 
strategy for these patients has never been addressed in a trial; some follow 
an ischemia guided, others an invasive approach. Those in favor of the inva- 
sive approach state that these patients are at increased risk of future events. 
So far, this has never been demonstrated in a study. We therefore report 
on clinical and angiographic outcome following a conservative strategy after 
aborted myocardial infarction. 
Methods: In the APRICOT-I trial patients were treated with TT for sus- 
pected acute MI, had an angiographically confirmed open infarct related 
artery and underwent follow-up angiography after three months. In 32 pa- 
tients (11%) CK-peak value was less than twice the upper limit of normal, i.e. 
~240 U/I, indicating little or no myocardial necrosis: “aborted myocardial in- 
farction”. Outcome in these patients was compared to patients with a regular 
enzyme rise after thrombolysis (n = 249). 
Results: Eventfree survival at one year was 56% for patients with aborted 
infarction, compared to 80% for patients with a regular enzyme rise (p < 
0.005). In a multivariate analysis a CK-peak value < 240 U/I was found to be 
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an independent predictor of reinfarction within the first year after thrombolysis 
(pain, ECG and enzymes): OR = 6.1, Cl 1.36-30.10. No independent relation 
was found with reocclusion (both symptomatic and clinically silent): OR = 
1.81 Cl 0.80-4.12. However, symptomatic reocclusions - reinfarction or 
revascularization as a result of reocclusion- were more frequent in patients 
with aborted myocardial infarction: 30% vs. 7% (p < 0.0005). A CK-peak value 
< 240 U/I was independently associated with symptomatic reocclusion: OR 
= 10.4 Cl 1.8-51.2. 
Conclusion: These data suggest that patients with aborted infarction are 
at increased risk for symptomatic reocclusion, expressed as an increased 
risk for reinfarction. A clinical trial should evaluate the possible benefit of an 
invasive approach over a conservative one with respect to outcome in these 
patients. 
4:30 am. 
El : 856 3 Myocardlal Infarction During the First 72 Hours of 
Hostxtalization is a Predictor of Late-Term Mortalitv 
in Pitients Presenting With Non-ST-Elevation Acut;! 
Coronary Syndromes 
Dan J. Fintel, Sally Greenberg, Todd J. Lorenz, Michael M. Kitt. 
Northwestern University School of Medicine, Chicago, Illinois; COR 
Therapeutics, Inc., South San Francisco, California, USA 
Background: Patients presenting with non-ST-elevation acute coronary syn- 
dromes (ACS) are at high risk of adverse coronary events, both short-term 
and long-term. We analyzed data from the largest study of non-ST-eleva- 
tion ACS to date, PURSUIT, in order to determine whether the patients who 
experience myocardial infarction (Ml) during initial hospitalization (within 72 
hours) are at an increased risk of death at a later time. 
Methods: The PURSUITtrial evaluated therapy with eptifibatide in 10,948 
patients with Non-ST-elevation ACS. Ml was defined by the clinical events 
committee as a CK-MB above the upper limit of normal during the first 72 
hours of the hospitalization. We pooled the data from both the eptifibatide 
and the phcebo arms of the study, and analyzed patient mortality to 6 
months according to whether an Ml had occurred during the first 72 hours of 
hospitalization. MIS at time of enrollment were excluded from the analysis. 
Results: At 6 months, the mortality rate was 5.5% among patients who 
did not experience an Ml within 72 hours of presentation, and 18.3% among 
those who did (P = 0.001). 
Conclusion: Patients with non-ST-segment elevation ACS who suffer an 
Ml during the first 72 hours after presentation are at a significantly increased 
risk of death over the following 6 months. Therapies that reduce the risk of 
early Ml should be considered for use during hospitalization of patients with 
unstable angina to help reduce late-term mortality in this group of patients. 
4:45 p.m. 
856-4 Early ST Segment Resolution is Associated With 
ImDroved Late Survival in Patients With Infarct 
Ariery 
John K. French, Jacqueline Andrews, Samuel O.M. Manda, Ralph 
A.H. Stewart, John J.C. McTigue, Harvey 0. White. Green Lane Hospital, 
Auckland, New Zealand 
Background: Early resolution of ST segment elevation improves short-term 
outcome atier acute myocardiai infarction. However, the influence of ST seg- 
ment resolution on long-term outcome with respect to infarct artery patency, 
is not known. 
Methods and Results: The study consisted of 859 patients with tech- 
nically suitable electrocardiograms (ECGs) from 3 trials of thrombolytic and 
adjunctive therapies. ST segment resolution, and the presence of T wave 
changes, on the baseline and post thrombolytic therapy ECG were evaluated 
at a median of 167 (IQR 90, 232) minutes. TIMI flow grades were assessed 
at 3 weeks and vital status was determined at a median of 6.25 (IQR 5.0, 8.4) 
years. Absence of early 50% ST segment resolution (ST res) independently 
predicted an increased risk of late death (P < O.OOl), late cardiac death (P 
= 0.004) and failure to achieve long-term event free survival (P = 0.003) in 
all patients and late death (P = 0.003) and failure to achieve long-term event 
free survival (P = 0.008) in patients with TIMI 2 or 3 flow assessed 3 weeks 
after infarction. In patients with TIMI O-l flow, ST res was associated with 
improved late survival, compared to those without ST res (p = 0.04). Other 
ECG predictors of late mortality were the amount of baseline ST elevation (P 
= 0.001) and, in patients with an occluded artery, the presence of peaked T 
waves on the baseline ECG (P = 0.02). 
Conclusions: Failure to achieve early 50% ST resolution of maximal ST 
elevation was the most consistent ECG predictor of an adverse long-term 
outcome. This electrocardiographic parameter predicts higher risk patients 
who may require more aggressive management. 
5:00 p.m. 
I 856 5 International Differences in Acute Coronary Syndrome Outcomes are Related to Angiography 
Rates 
Anatoly Langer, Christopher P. Cannon, Shaun G. Goodman, 
Andrew Charlesworth, Carol Hill, Carolyn McCabe, Eugene Braunwald. St 
Michael’s Hospital, Toronto, Canada; Brigham and Women’s Hospital, 
Boston, MA, USA 
Background: Significant international differences in outcome are known to 
exist in the management of pts with acute coronary syndromes (ACS) and 
are thought to be related to the rates of angiography and revascularization. 
Methods: Since the value of early intervention continues to be debated, 
we analyzed the results of the OPUS-TIM1 16 trial, which studied safety 
and efficacy of orbofiban in the full spectrum of pts with ACS. Countries 
with more than 100 enrolled pts were divided based on index hospitalization 
angiographic rates. We compared composite end-point (death, Ml, urgent 
revascularization or hospitalization for recurrent ischemia and stroke), bleed- 
ing leading to study drug discontinuation, CVA or TIA. 
Results: 
Index Hospitalization Angiographic Rate 
<20% 2040% 41-60% >60% 
n=725 n=1139 n=4576 tl=3851 
1 -year composite** 13.4% 18.4% 22.0% 20.7% 
mortality 3.4% 4.3% 4.1% 3.6% 
bleeding ** 0.8% 1.6% 2.7% 5.4% 
CVAiTIA* 0.6% i .a% 1 .3% 1.9% 
*p < 0.05, **p < 0.001 
These differences persisted after multivariable analyses; compared to 
~40% angiography rate group, the composite end-point was more frequent 
in 4160% group (RR: 1.31, p = 0.0001) and in the group with >60% rate (RR: 
1.18, p = 0.018). Also similar outcome differences were seen in countries 
grouped by revascularization rates. 
Conclusion: An inverse relationship exists between angiographic or 
revascularization rates and outcome of pts with ACS; although no mortality 
difference was seen. This suggests that a widespread aggressive approach 
may not lead to optimal clinical outcome. 
515 p.m. 
/ 856 6 Risk of Arrhythmic Mortality in High-Risk Patients Does Not Change With Time Course in the First 2 
Years After Myocardial Infarction - A Secondary 
Meta-analysis 
Yee Guan Yap, Trinh Duong, Martin Bland, Marek Malik, Lars Kober, 
Stuart Connolly, Robin Roberts, Bradley Marchant, A. John Camm. St. 
George’s Hospital Medical School, London, UK 
Background: It remains speculative that patients with low ejection fraction 
(LVEF) or frequent ventricular ectopics (VE) are more likely to die of ar- 
rhythmic than non-arrhythmic cardiac death soon after myocardial infarction 
(3. 
Method: Modes of cardiac death (arrhythmic/sudden deaths (AD) vs. 
non-arrhythmic (NAD)) within 2-year period were examined on 600 deceased 
patients (443 M, age = 69 f 10 yr) with recent Ml & LVEF < 40% or frequent 
VE pooled from placebo arms of EMIAT (E), CAMIAT (C), SWORD (S), 
TRACE (T) and DIAMOND-MI (DM). To account for different recruitment 
periods between trials, time trends were investigated firstly for all studies 
from 45 d after Ml & then from onset of HI for T & DM that recruited 
patients within 2 weeks. Demographic features predictive of AD vs. NAD 
were assessed using logistic regression. 
Results: The proportion of AD vs. NAD did not vary over time from day 
45 to 2 years after MI (AD: 57% (45 d-6 m), 57% (-12 m), 55% (-18 m), 
58% (-24 m)). Data based on T & DM showed no trend in modes of early 
death (AD: 53% (O-44 d) vs. 55% (45 d-24 m)). Factors that increased risk 
of AD instead of NAD were: young age (~10 y in age: OR = 0.82, (95% Cl 
= 0.66-1.02), p = 0.05), male sex (1.75 (1.14-2.68), p = O.Oi), hypertension 
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(1.91 (1.26-2.87), p = 0.002), low baseline systolic BP (TlO% in BP: 0.84 
(0.74-0.95), p = 0.006). NYHA class l/II patients were more likely to die 
of AD than NAD compared to III/IV in the 1st month only after Ml (68 vs. 
42%, OR = 4.29 (95% Cl = 1.999.26), p = 0.04). After 1st month, risk of AD 
between NYHA groups was the same (56 vs. 57%). After adjusting for above 
variables, the proportion of AD vs. NAD were significantly different between 
studies (AD: E = 58%, C = 59%, S = 85%, T = 46%, DM = 65%, p = 0.001). 
Conclusions: In high risk post-Ml patients: 1) The risk of AD vs. NAD did 
not change up to 2 years against previous speculation; 2) A clear disparity in 
mortality pattern between trials was seen despite similar populations. 
ORAL 
El 864 Treatment in the Early Hours of Acute 
Myocardial Infarction 
Tuesday, March 14, 2000, 8:30 a.m.-IO:00 a.m. 
Anaheim Convention Center, Room 213C 
8:30 a.m. 
864-l Longer Thrombolysis Door-to-Needle Times are 
Associated With Increased Mortality in Acute 
Myocardial Infarction: An Analysis of 95,589 Patients 
in the National Registry of Myocardial Infarction 2 + 3 
Christopher P. Cannon, C. Michael Gibson, Costas T. Lambrew, Alan 
J. Tiefenbrunn, Haili Sun, Judith A. Malmgren, Paul Frederick, Nathan 
R. Every, Robert Zalenski. for the NRMI 2 and 3 Investigators; Brigham and 
Women’s Hospital, Boston, Massachusetts, USA 
Background: Increasing time to treatment with thrombolysis for acute my- 
ocardial infarction (Ml) (i.e. from Ml symptom onset and start of thrombolysis) 
has led to recommendations that all hospitals work to decrease door-to-nee- 
dle time (from hospital arrival and start of thrombolysis). However, the rela- 
tionship between door-to-needle time vs. mortality has not been examined. 
Methods: In a registry of 85,589 ST elevation Ml Pts treated with throm- 
bolysis and not transferred in from another hospital, we evaluated whether 
longer door-to-needle time is associated with increased mortality. Multivari- 
ate logistic regression was used to control for demographic and presentation 
characteristics. 
Results: Compared with patients with door-to-needle time 5 30 mins, the 
adjusted odds of death were significantly increased by 11% and 23% for Pts 
with door-to-needle times 61-90 mins (p = 0.01) and >90 mins (p = 0.0001) 
respectively (Fig). A similar analysis showed a 13-23% increase in odds of 
developing ejection fraction < 40% as door-to-needle time increased >30 
mins (p = 0.001 for each time point). 
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Conclusions: Delays in door-to-needle time were associated with an 
il-23% increase in mortality and in the development of left ventricular dys- 
function post MI. These data provide, for the first time, direct evidence of the 
need to reduce door-to-needle time to improve the chance of survival and 
OUtCOmeS DOSt AMi. 
8:45 a.m. 
864-2 Relation of Time to Treatment on Relative Effects of 
Primary Coronary Angioplasty vs. Thrombolytic 
Therapy 
W. Douglas Weaver. Primary Coronary Angioplasty Tralists Collaboration; 
NHMRC Clinical Trials Centre, Sydney Australia 
We assessed the impact of thrombolytic therapy (TT) vs PTCA on go-day 
mortality and reinfarction in 2635 patients from an individual patient data 
overview of 10 randomised trials and examined whether the relative effec- 
tiveness of these strategies was associated with the time from symptom 
onset to randomization and with the time from randomization to treatment. 
PTCA was associated with a lower risk of death at 30 days (odds ratio 
0.58, 95% Cl 0.40-0.83) or death plus nonfatal Ml (odds ratio 0.46, 95% Cl 
0.35-0.61). A longer time from symptom onset to randomization was associ- 
ated with a higher risk of death at 30 days and a larger relative reduction in 
mortality of PTCA over TT (p-value for interaction = 0.003). However, PTCA 
was associated with about 43 minutes delay compared with TT (65 mins vs 
22 mins median time from randomization) offsetting the potential maximum 
advantage of PTCA. When trials were ranked by times to treatment, there 
was a significant trend between trials with a longer time difference between 
PTCA and TT and a smaller relative treatment effect of PTCA at 30-days (p 
= 0.003). This relationship may be a partial explanation for some variability 
across the trials. 
Time from onset 
O-2 hrs 
24 hrs 
4-6 hrs 
<6 hrs 
n = 
633 
1035 
345 
271 
30-day dth (%) 
PTCA -rr 
3.9 5.2 
4.1 6.3 
3.6 11.3 
6.2 12.8 
Odds Ratio (95% Cl) 
0.73 (0.36-1.41) 
0.64 (0.46-l .ll) 
0.29 (0.11-0.74) 
0.45 (0.19-l .07) 
Conclusions: The benefit associated with PTCA therapy over TT at 
30 days appears greater for patients presenting later after symptom onset. 
The delay in PTCA compared with TT may offset some of the advantage 
of PTCA and needs to be taken into account when applying the results of 
these randomized trials to a broader community setting. Any delays in PTCA 
treatment may be more critical in patients presenting early. 
9:00 a.m. 
864-3 A Randomized Trial of Thrombolysis vs Transfer for 
Primary PTCA in High Risk AMI Patients: Results of 
the AIR PAMI Trial 
Cindy L. Grines, Carlos Balestrini, Donald Ft. Westerhausen, Jr., Timothy 
J. Hanlon, Timothy L. Logemann, Matti Niemela, Mariann Graham, William 
W. O’Neill, Lorelei L. Grines. William Beaumont Hospital Royal Oak, MI, 
USA 
Background: In the management of AMI patients, large tertiary care centers 
frequently use primary PTCA, whereas hospitals without catheterization facil- 
ities use thrombolytics. However, high risk patients have increased mortality 
despite thrombolytic therapy, suggesting a more aggressive approach may 
be warranted. 
Methods: AIR-PAM1 is a multicenter trial randomizing lytic eligible, high 
risk AMI patients (age > 70, anterior MI, Killip Class ll-lll, HR > 100 or BP 
< 100 mmHg) to receive transfer to a tertiary care center for primary PTCA 
vs thrombolysis with no routine transfer. 
Results: Despite enrollment for a 3 year interval, only 138 (32%) of the 
anticipated sample size of 430 were recruited, thus the study was terminated. 
High risk enrollment criteria included anterior Ml in 79%, age > 70 years in 
32%, Killip Class ll-lll in 25% HR > 100 in 31%, and BP < 100 mmHg 
in 31%. 62 patients were randomized to transfer for primary PTCA and 59 
patients to thrombolysis. As expected, time from randomization to treatment 
was markedly delayed in the PTCA group compared to lysis (120 l 69 vs 20 
i 16 min, p < 0.0001). Delay in treatment in the PTCA arm was largely due to 
initiation of transfer (51 f 37 min) and transport time (34 f 30 min). No patient 
died or required CPR during transfer. Primary PTCA established TIMI- flow 
in 87%. Day 30 events in PTCA and lytic treated groups include death (10.0 
vs 12.5%), recurrent Ml (1.7 vs 3.6%), and disabling stroke (0 vs 0%) were 
not significantly different. Although a 44% reduction in the combined primary 
endpoint (10.0 vs 17.9%) was observed for the PTCA group, due to inability 
to recruit the anticipated sample size, this was not a significant difference. 
Conclusions: High risk AMI patients who present to hospitals without a 
cardiac catheterization laboratory may have improved outcome when trans- 
ferred for primary PTCA, but will require further study. 
9:15 a.m. 
I 864 4 Beta Blocker Treatment for Acute Myocardial 
Infarction in Patients With Clinical Evidence of Heart 
Failure: Evidence From the GUSTO Trials 
David M. Yamada, Sorin J. Brener, Eric J. Topol. C/eve/and Clinic 
Foundation, Cleveland, Ohio, USA 
Background: Although beta blockade improves the prognosis of patients 
presenting with myocardial infarction and is generally recommended, those 
with heart failure are often excluded from such treatment. 
Methods: We studied 7685 patients enrolled in GUSTO-l, GUSTO-llb, 
and GUSTO-III who presented with myocardial infarction and in Killip class 
II-IV. Baseline variables and outcomes were determined based on whether 
or not beta-blocking agents were administered. 
Results: Of 2396 patients receiving beta-blocking drugs (31%) and 5289 
patients who received none (69%), those given beta-blocking drugs were 
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younger (mean age 64 f 11 vs 67 f IO), more likely to be smokers (73% vs 
66%) and have a history of previous percutaneous coronary revascularization 
(4.4% vs 3.2%), and were less likely to have a history of diabetes (18% 
vs 22%) and previous myocardial infarction (23% vs 29%). On admission 
they had a lower pulse (mean 79 + 17 vs 82 f 18) and higher blood 
pressure (mean systolic 130 It 24 vs 121 i 28). Women were more likely 
to receive beta blockade than were men (72% vs 68%). Patients treated 
with beta-blocking agents were significantly more likely to survive to hospital 
discharge (92% vs 70%, p < O.OOl), as well as to 30 days (92% vs 69%, p 
< 0.001) and one year (87% vs 61%, p < O.OOi), as compared to those not 
treated with beta blockade. Sustained hypotension (16% vs 30%, p < O.OOl), 
ventricular arrhythmias (7% vs 14%, p < O.OOl), and in-hospital requirement 
for pacing (6% vs 12%, p < 0.001) were all significantly less likely in those 
receiving beta-blocking drugs. 
Conclusion: In-hospital treatment with beta blockade is associated with 
improved outcomes in patients presenting with acute myocardial infarction 
who have clinical evidence of heart failure on admission. Survival advantage 
is maintained up to one year after the index event. 
9:30 a.m. 
/ 864-5 / What Should be Done Acutely for Patients With 
Noninvasive Evidence of Spontaneous Reperfusion 
in Acute Myocardial Infarction? 
Randall Marsh, Molly Wright. North Colorado Medical Center, Greeley 
Colorado, USA 
Background: Spontaneous reperfusion (SR) in ST segment elevation my- 
ocardial infarction (Ml) has been documented angiographically (TIMI 2-3 
flow) in 20-34% of patients within a 90 minute period, and acute manage- 
ment has been based on angiographic criteria. The appropiate management 
of patients demonstrating noninvasive evidence of SR (without acute cath to 
prove it), however, has not been studied. We repot-l here the inpatient clinical 
course and outcome of 26 such consecutive patients. 
Methods: We prospectively audited 46 patients presenting with acute MI 
and ST elevation between January 1998 and June 1999 who were judged 
to have SR. 20 of 46 were proved patent at emergent 60-90 minute cath 
including all patients who were electrically or hemodynamically unstable. 
The remaining 26 patients were judged to have SR based on the noninva- 
sive criteria of complete pain relief and at least 50% reduction of ST shifts 
(the same criteria as used following thrombolytic therapy). All patients were 
treated acutely with heparin, aspirin, beta blockers (if eligible), and IV NTG 
(if needed), but did not receive any other proven reperfusion intervention. 
Results: No hospital mortality occurred in this group. Mean time to pre- 
sentation was 62 f 40 minutes. Mean EF was 51 f 7%. Mean peak CPK 
elevations were 726 f 600 IlJ/L. 20 of 26 had subacute cath (24-96 hours), 
and 16 had patent vessels (TIMI 2-3 flow). Four had occlusions (2 with col- 
laterals). lschemic driven or elective intervention was carried out in 14 of this 
group. Neither patient with an occluded vessel and no collaterals required in- 
tervention. 8 of 26 patients had no measurable necrosis by CPK-MB fraction 
in spite of ST elevation on admission. 
Conclusion: We are not aware of any data on the acute management 
of noninvasive SR, but this small experience suggests that stable patients 
demonstrating noninvasive evidence of SR present early, have relatively 
small CPK increases, and may be treated acutely without thrombolytic or 
mechanical intervention. 
9:45 a.m. 
864-6 Chest Pain Emergency Units and Their Impact on 
Processes of Care and Outcome: Observations 
From the National Registry of Myocardial Infarction 
John G. Canto, Joseph P. Ornato, Rob Zalenski, William J. Rogers, Paul 
D. Frederick, Judith Malmgren, Hal V. Barron, Thomas E. Terndrup, 
Catarina I. Kiefe. for the NRMl Investigators; University of AL at 
Birmingham, Birmingham, AL, USA 
Background: Chest pain emergency units (CPEU) have been shown to be a 
safe and cost-effective method for risk-stratifying low-risk and intermediate- 
risk patients presenting with suspected acute coronary syndrome. However, 
it is unknown whether CPEUs may actually improve the process of care and 
subsequent mortality among a subset of patients with documented Ml. 
Methods: The NRMI 3 has enrolled 193,583 patients from April 1998 to 
March 1999. Transferred-in patients were excluded. Patients who presented 
to hospitals with CPEUs were compared to those who presented at hospitals 
without CPEUs with regard to their lnltlal management and outcome. 
Results: see table. 
Conclusion: In this national registry of patients with documented myocar- 
dial infarction, CPEUs were not directly associated with improved processes 
of care or lower hospital mortality. 
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CPEU (N = 25.645) No CPEU (N = 102.377) 
Mean age, years 68.4 
Non-white, % 83.3 
Women, % 39.9 
Diabetes, % 71.5 
Time-to-ls ECG, median, min 11.0 
Door-thrombolytic. median, min 39.0 
Door-balloon inflation, median, min 124.0 
Aspirin, % 85.3 
Beta-blockers, % 53.6 
Any reperfusion (eligible), % 72.0 
Crude hospital mortality, % 10.2 
Adiusted matalitv. OR * 95% Cl* 0.952 10.905-l ,002) 
68.8 
85.8 
40.6 
70.7 
11.0 
39.0 
120.0 
83.8 
51.5 
71 .o 
9.6 
Reference 
*Adjusted for demographics (age, gender, race, region, payer status), past medical his- 
tory (prior angina, MI, heart failure, PTCA, CABG, COPD, CRI, Diabetes, hypertension, 
high cholesterol, smoking, family history CAD) and presenting characteristics (chest pain, 
Q wave MI, initial ECG, Killip class) 
POSTER 
[I1261 Ischemia, Reperksion, and Myocardial 
Preservation 
Tuesday, March 14, 2000, 9:00 a.m.--11 :00 a.m. 
Anaheim Convention Center, Hall A 
Presentation Hour: 9:00 a.m.-IO:00 a.m. 
L-.-L-J 1126 101 Influence of LV Filling- on Coronary Collateral Perfusion-Pressure 
Stefano F. de Marchi, Tilmann Pohl, Martin Fleisch, Franz R. Eberli, 
Ali Garachemani, Bernhard Meier, Christian Seiler. Swiss Cardiovascular 
Center Bern, University Hospital Bern, Switzerland 
Background: In the past, coronary collateral flow was estimated using coro- 
nay wedge pressure. Coronary perfusion pressure during vascular occlusion 
is, however, dependent on aortic and central venous pressure (CVP). Addi- 
tionally, it may be influenced by the LV filling pressure, which is elevated in 
the presence of large ischemic areas receiving low collateral flow. This study 
was performed to test the hypothesis that LV filling pressure changes influ- 
ence epicardial intracoronay wegde pressure in comparison to intracoronaty 
wedge Doppler flow velocities. 
Methods: In 27 patients (pts.) with coronary artery disease, mean aortic 
(Pao), LV end-diastolic pressure (LVEDP) and intracoronay pressure (Poccl) 
as well as intracoronay Doppler flow velocity (averaged peak velocites: 
APV) distal to the stenosis to be dilated were measured during a one-minute 
occlusion. The collateral flow index (CFI) was assessed from both, pressure 
(CFlp = (Poccl-CVP)/(Pao-CVP) and Doppler measurements (CFIv = APV at 
occlusion/APV during patency). The difference between the two CFI (dCFI 
= CFlp-CFIv) was calculated. All data were obtained at IO second-intervals 
during each occlusion. The relative area at risk (AR) was assessed from the 
angiographic length of the coronary tree distal to the stenosis in relation to 
its total length. 
Results: There was a significant exponential increase of dCFl with in- 
creasing LVEDP in all pts (r = 0.55, p < 0.0001; left panel: solid line). No 
difference was found with respect to the AR size (left panel: AR < 0.4 (H), 
AR 2 0.4 (0)). In pts. with CFlv < 0.2 (D), this relation was accentuated (r = 
0.64, p < 0.0001; right panel: solid line), whereas in pts. with CFlv 2 0.2 (D), 
no such relation was found (r = 0.36, p = NS; right panel: dashed line). 
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Conclusions: Pressure- and flow velocity-derived collateral flow mea- 
surements do not differ over a wide range of LVEDP, but an increase of 
pressure-derived collateral flow index can be observed in pts. with low col- 
lateral supply when LVEDP exceeds 30 mmHg. 
) 1126-I 02 1 lschemic Mitral Regurgitation in the Setting of 
Hibernating Myocardium: Preliminary Results in 
a Porcine Model 
Tianjie Lai, Lisa V. Carl, William Dyckman, Elio Morgan, Jeff Mather, Anita 
M. Kelsey, Linda D. Gillam. Hartford Hospital, University of Connecticut 
School of Medicine, Hartford, Connecticut, USA 
Prior animal studies from this lab have suggested that hibernating my- 
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ocardium is associated with microscopic changes, ventricular dysfunction 
and remodeling that may be incompletely reversible with revascularfzation. 
However, the relation between hibernating myocardium and ischemic mitral 
regurgitation (IMR) has not been previously evaluated. This would be clini- 
cally relevant because of the controversy concerning the optimum surgical 
management of IMR. We, therefore, studied 6 pigs using our previously 
described model of hibernating myocardium. A fixed left circumflex (LCX) 
stenosis was created to reduce LCX flow by f50%. This results in re- 
gional hypokinesis without infarction. Coronary flow (CF) was measured and 
adjusted by flowmeter. Posterior wall thickening (WT,,,r), LV end-diastolic 
volumes (LVEDV), LV ejection fraction (LVEF) and LV geometry were de- 
termined by 2-D and 3-D echo at baseline and after LCX stenosis. Mitral 
regurgitation was assessed by color flow Doppler. 
Results: No pig had baseline MR. Following the creation of the LCX 
stenosis, all 6 pigs had MR. At the time of sacrifice, there was no evidence of 
myocardial infarction by TTC staining. The rate-pressure-product (RPP), CF, 
WTpost, LVEDV, LVEF and degree of MR are summarized in the following 
table: 
RPP 
Baseline LCX stenosis 
6540 f 726 7926 zt 1333 
CF (mllgimin) 0.79 zt 0.03 0.38 * 0.04* 
~posi w 4014 8 * 3* 
LVEDV (ml) 101*13 115 f 15* 
LVEF (%) 53*5 44 * 4* 
MR O/6 616 (mild = 3, mod = 3)* 
* P < 0.05 compared with baseline (paired t-test) 
Conclusions: A porcine model of hibernating myocardium in the LCX 
distribution is associated with ischemic MR. This model will be useful in 
studying the pathophysiology of ischemic MR and its response to myocardial 
revascularization. 
1 II 26-l 03 1 Warm Up Angina Protects Against lschaemia 
and Arrhythmias in the Absence of Collateral 
Flow 
Richard J. Edwards, Simon R. Redwood, Pier D. Lambiase, Roby R. Rahkit, 
Michael S. Marber. Sf Thomas’ Hospital, London, UK 
Background: Warm up angina has been used as a surrogate model of pre- 
conditioning in man. However, it is uncertain whether the improved exercise 
tolerance seen after first exertion could equally be due to the opening of 
collaterals. 
Methods: We performed three sequential Bruce Protocol exercise tests 
on 18 patients with normal LV function awaiting PTCA to an isolated LAD 
stenosis. Angina medication was stopped for 48 Hrs before. The second test 
was separated from the first by 15 mins and from the third test by 90 mins to 
control for training. Subsequently collateral flow index (CFI) was calculated 
from simultaneous recordings of balloon occlusion pressure, aortic pressure 
and coronary sinus pressure during PTCA. A total of 6 minutes balloon 
inflation was used to ensure maximal collateral recruitment. 
Results: Patients were grouped into those with collaterals n = 7 (mean 
CFI 0.2 f 0.03) and those without detectable collaterals n = 4. Four patients 
were excluded, as they had no demonstrable ischaemia ‘during the first 
exercise and three because CFI couldn’t be measured. The graphs represent 
comparisons of ischaemic parameters between Ex2 v (Exl and Ex3) within 
each group (p < 0.05). 
Conclusion: 1. There is an improvement in all ischaemic parameters and 
arrhythmias during the second test that wanes by the third test. 2. The degree 
of protection is independent of a collateral circulation, implicating ischaemic 
preconditioning as the most important mechanism. 3. Patients with collaterals 
have more severe exercise limitation. 
(MH) and to study the function-flow relationship we performed a series of 
acute and chronic experiments. 
Methods: An aseptic thoracotomy was performed in 28 dogs to surgically 
produce a tight stenosis of LAD (70%). Eight dogs died either during the 
procedure or at a later stage. The remaining 20 dogs were randomly divided 
in to chronic (group 1) or acute (group 2) protocols. The function (anterior 
wall thickening, AWT %) was determined weekly by echocardiography, and 
coloured microspheres were used for the regional flow (RF) and coronary 
reserve (CR). After placement of LAD stenosis the dogs were divided as 
follows: Group la, n = 6, 4 episodes of preconditioning (PC) followed by 40 
min of LAD occlusion then reperfusion and sacrifice at 8 weeks (wk); group 
1 b, n = 6, idem as group la with PTCA of LAD at 8 wk, sacrifice at 12 wk; 
group Ic, n = 2, 40 min ischemia without PC, sacrifice at 6 wk; group 2a, 
n = 3, PC with 40 min ischemia to study the early changes in WT, RF and 
CR; group 2b, n = 3, LAD stenosis followed by twice 10 min of epinephrine 
infusion (0.25 microg/kg/min) to study how WT and RF change during and 
after adrenergic stimulation in the presence of a significant coronary stenosis. 
Results: Our findings are summarized as follows: In the acute experi- 
ments (group 2a), LAD stenosis caused a reduction of CR with normal WT 
and RF, function was reduced after 40 min of ischemia vs baseline, BS (AWT, 
25 f 3 vs 45 f 4, p < 0.05) however RF remained unchanged. In group 2b 
after an initial increase in WT and RF with epinephrine infusion there was 
depressed AWT (22 f 4 vs 45 + 9%, p < 0.05) and RF (65% of BS). In the 
chronic studies the AWT was reduced at 8 wk (17 !I 5 vs 41 * 5%, p < 0.05) 
with subendocardial hypoperfusion (72% of BS). After PTCA of LAD AWT, 
RF and CR normalized by 12 wk. Histology was normal in groups la and b 
with a clearly defined region of transmural infarction in group Ic. 
Conclusion: Our data suggest that demand induced ischemia in the 
presence of severe coronary obstruction may be an important trigger for the 
transition from perpetual stunning to myocardial hibernation by downward 
adjustment of myocardial oxygen demand and regional flow. 
1126-l 05 The Free Radical Scavenger SOD Reduced 
Myocardial Infarct Size in Rats Breathing Clean 
Air or Exposed to Second Hand Smoke 
Bo-qing Zhu, Yi-ping Sun, Satyavardhan Pulukurthy, Tony M. Chou, Prakash 
C. Deedwania, Kanu Chatterjee, William W. Parmley, Stanton A. Glantz. 
University of California San Francisco, San Francisco, California, USA 
Background: Second hand smoke (SHS) increases myocardial infarct size 
in a rat model of ischemia and reperfusion. We hypothesized that SHS 
increases free radicals, which increase myocardial damage. 
Methods: Fifty six female Sprague-Dawley rats were randomized into 4 
groups: exposed to clean air or SHS and given SOD (free radical scavenger, 
polyethylene-glycolated superoxide dismutase 20,000 u/kg/day, IM.) or a 
placebo (normal saline, IM.) for 6 weeks. The SHS exposure chamber had a 
3.6 m3 interior volume, similar to that of an automobile sedan. Four Marlboro 
filter cigarettes were smoked every 15 min for 6 hr/d, 5 d/wk in an exposure 
chamber. After 6 wks, all rats were subjected to 17 min of left coronary artery 
occlusion and 2 hr of reperfusion. 
Results: Average air nicotine, carbon monoxide, and total particulate 
concentrations were significantly higher in the SHS chamber than control 
(1304 f 215 vs 1.4 * 0.1 wg/m3, 76 f 2.0 vs 2 f 0.6 ppm, 31 i 0.7 vs 0.4 
f 0.1 mg/m3, respectively, all p < 0.01). Plasma nicotine and cotinine levels 
were significantly higher in SHS groups (39 f 5 vs x0.01 rig/ml, 437 f 124 
vs x0.1 rig/ml, respectively, all p < 0.001). SOD levels (weight activity) of 
the kidneys in SOD groups were higher (SOD vs Control: 116 & 20 vs 81 f 
IO u/g, p = 0.08). Infarct size = infarct mass/risk area x 100%. NS = normal 
saline. 
Groups NonSHS + NS SHS + NS SHS + SOD NonSHS + SOD 
Infarct size (%) 16zk3 24 5 3 1412 6zt2 
SHS increased infarct size (p = 0.026), and SOD decreased infarct size 
(p = 0.008). However, there was no interaction between SHS and SOD (p = 
0.744). 
Conclusion: Decreasing free radicals reduced infarct size, suggesting 
that free radical injury plays a role in myocardial infarction. SOD reduced 
infarct size in rats exposed or not exposed to SHS. 
1126-l 04 Does Demand lschemia Trigger Myocardial 
Hibernation? 
Bharati Shivalkar, Willem Flameng, Monika Szilard, Sorin Pislaru, 
Marcel Borgers, Johan Vanhaecke. Deparfmenf of Cardiology, KU Leuven, 
Leuven, Belgium 
Background: To understand the onset mechanism of myocardial hibernation 
1 1126-l 06 1 Apex to Base Position of an Infarct is a Major 
Determinant of its Size in Relation to the Risk 
Zone 
Sharon L. Hale, Robert A. Kloner. Heart Insfifufe, Good Samaritan Hospital 
& University of Southern California, Los Angeles, CA, USA 
Background: Determinants of infarct size in the rabbit heart include risk zone 
size, regional myocardial blood flow (RMBF), temperature, and duration of 
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ischemia. There are other potential determinants of the size of an infarct 
within the heart, and the purpose of this study was to determine whether the 
location of the infarct in the apex of the heart versus base played a role. 
Occlusion of an anteriolateral branch of the circumflex artery in the rabbit 
produces a risk region that typically comprises most of the apex of the left 
ventricle with decreasing area involvement from apex to base. 
Methods and Results: In a retrospective study of 65 rabbit hearts (sub- 
jected to 30 min of coronary artery occlusion and 3 hr reperfusion), which had 
been sectioned into 6-8 cross-sectional slices, average risk zone comprised 
86 rt 3% of the apical slice, 68 -i- 2% of the middle slice and 39 + 2% near 
the site of occlusion at the base of the heart. If necrosis were dependent 
on risk zone alone, then infarct size (necrosis/risk zone) would not vary by 
position. However necrosis in the apex was 52 i 3% of the risk zone while 
necrosis near the base was 30 i 3% of the risk zone, p < 0.0001. To test 
if this salvage of tissue at risk near the base was due to differences in re- 
gional myocardial blood flow (RMBF), this was measured during occlusion 
in additional 4 rabbits. Average risk zone RMBF was 0.025 ml/min/g in the 
apex and 0.010 in the base, p = ns. Nor was the salvage due to differences 
in temperature. During occlusion, myocardial risk zone temperature (n = 5) 
was 38.iQC i 0.3 in the apex and 38.4 + 0.2 in the base (p = ns). 
Conclusion: Necrosis as a percent of the risk zone depends upon 
whether the risk zone is at the apex or base of the heart. This phenomenon 
is independent of collateral flow or temperature, and suggests that other as 
yet unknown factors contribute to infarct size. 
1 1126-l 07 / Depressed Tolerance to Fluorocarbon-Simulated 
lschemia in Failing Rat Myocardium Due to 
Impaired Intracellular Ca*+ Modulation 
Jiang-Yong Min, Thomas G. Hampton, Ju-Feng Wang, Joe DeAngelis, 
James P. Morgan. BIDMC/Harvard Medical School, Boston, MA, USA 
The aim of this study was to investigate the tolerance of failing myocardium 
from post-infarction rats to simulated ischaemia. 
Methods and Results: Myocardial infarction (Ml) was induced by perma- 
nent ligation of left coronary artery. Isometric force and free intracellular Ca2+ 
concentrations ([Ca*+]r, Cap+-indicator aequorin) were determined in failing 
left ventricular papillary muscles from sham-operated (Sham group, n = 7) 
and 6 weeks post MI animals after surgery (Ml group, n = 6). A ischaemic 
model was simulated using fluorocarbon immersion with hypoxia. There was 
no significant difference of developed tension (DT) in either group at baseline 
(10.3 + 1.5 mN/mm* in Sham and 9.6 f 1.1 mN/mm2 in Ml rats). After 20 
min of ischaemia, DT was depressed to 2.3 i 0.6 mN/mm* in Sham vs 
1.6 f 0.3 mN/mm2 in Ml animals (p < 0.05). During 20 min reoxygenation, 
recovery of DT remained lower in the Ml group as compared to the Sham 
group (3.5 i 0.8 vs 5.7 f 7 .I mN/mma, respectively, p < 0.01). There was 
no corresponding decrease of peak [Cas+]i in the Sham (46.8 * 8.2% of 
baseline) or Ml groups (39.4 i 7.5% of baseline) with ischaemia (p > 0.05). 
After 20 min reoxygenation, peak [Cap+], was more significantly depressed in 
the MI group (80.5 f 7.8% of baseline) compared to that in Sham rats (89.4 
i 9.4% of baseline, p < 0.05). Diastolic [Ca’+], was significantly higher in 
Ml rats compared to Sham animals at baseline (0.35 + 0.05 vs 0.28 f 0.03 
PM, respectively, p < 0.05). After 20 min reoxygenation, diastolic [Ca”+]r was 
elevated in both groups, but was higher in the Ml group (0.38 & 0.05 vs 0.32 
i 0.04 PM, p < 0.05). When fluorocarbon was then replaced by physiologic 
salt solution, DT and [Ca2+], recovered promptly to near basal values. 
Conclusion: Enhanced sensitivity to ischaemia in failing myocardium 
may be a consequence of more severe alterations in [Ca’+]i homeostasis. 
of the CRC and L-type were determined in homogenates using 3H-ryanodine 
for the CRC and 3H-PN-200 110 for the L-type as radioligands. 
Results: There is a siginificant (p c 0.05) decrease in the density of the 
CRC, during ischemia and persisting through reperfusion, whereas the Ca 
sensitivity of the CRC, the density of the L-type and the KD value of both 
remains unchanged. Table: Bmax = maximal specific binding of 3H-ryanodine 
or 3H-PN-200 110 in fmol/mg protein, means + SEM, EC& = [Ca*+] at half 
maximal 3H-ryanodine binding in 0.1 PM with the 95% confidence intervals 
(*,’ vs control p < 0.05). 
Table 
control 
ischemic (n = 13) 
postischemic (n = 12) 
CRC L-type 
Bmax Go Bmax 
101.2 i 4.2 3.2 (3.1-3.5) 58.2 f 2.5 
71.8 l 3.8X 3.4 (3.2-3.5) 53.1 f 2.6 
68.4 i 3.6’ 3.2 (3.0-3.5) 51.4 i 3.1 
Conclusion: The siginificant reduction in the density of the CRC in is- 
chemic and reperfused myocardium could contribute to the contractile dys- 
function after cardiac surgery. Since both stunning and preconditioning have 
been observed in the context of cardiac surgery, these findings suggest that 
SR dysfunction may play a role in these syndromes in man. 
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1127-l 35 Are Cardiac Risk Factors Predictive in Low Risk 
Emergency Department Chest Pain Patients Who 
Have Chest Pain? 
Arman Faroghi, Michael C. Kontos, Robert L. Jesse, Charlotte S. Roberts, 
James L. Tatum, Joseph P. Ornato. MCVNCU, Richmond, VA, USA 
Background: Prior published studies suggest that the most important vari- 
ables for identifying Emergency Department (ED) patients (pts) with MI are 
the ECG and known coronary disease, while traditional cardiac risk factors 
are of less utility. However, inclusion of high risk pts may have biased these 
conclusions. It is unknown whether this remains true in low risk ED chest 
pain pts. 
Methods: All pts undergoing ED evaluation for myocardial ischemia from 
6/94-4/98 were included. High risk pts, identified by ST elevation or de- 
pression, or a history of Ml or revascularization, were excluded. End-points 
included Ml during admission, or death, revascularization (REV) or significant 
disease (Sig Dz) (~70% stenosis) within 30 days of admission. Stepwise lin- 
ear regression was performed using the following clinical variables: gender, 
age 2 60, typical symptoms and traditional risk factors. 
Results: A total of 4512 low risk pts (68% of all chest pain pts) were 
evaluated for possible ischemia. End-points occurred in 316 pts (7.0%): Ml 
in 117 (2.6%) and death in 11 (0.2%). An additional 278 pts (6.2%) had Sig 
Dz, of whom 198 (4.4%) had REV. Odds ratios for the end-points are shown 
in the Table below. 
1126-l 08 Reduced Density of Sarcoplasmic Reticulum 
Calcium Release Channel in Human lschemic 
and Reperfused Myocarclium 
Bernd Koenigs’ , Maura Greiser’ , Hilmar Doerge’, Jorge 
F. Vazquez-Jimenez2, Peter Hanrath’ ‘Department of Cardiology; 
“Department of Thoracic and Cardiovascular Surgery, University Hospital 
Aachen, Germany 
260 Male Typical Cholesterol Diabetes Family Tobacco 
Pain History 
MI/D 2.8 1.8 4.0 “3 “3 “3 
REV 2.9 2.4 5 4.9 2.1 2.2 “3 
Sig Dz 3.1 2.1 1.9 4.7 2.4 i.5* 2.5* 
All odds ratios were significant at p < 0.01 except * (p < 0.05) 
Conclusions: Traditional risk factors do have value for predicting non-MI 
cardiac events in low risk ED chest pain pts. Risk factors should be considered 
in the initial risk assessment of these pts. 
dioplegic ischemia and rep&f&ion in biopsies of the right atrial myocaydium 
subjected to cardiac surgery. 
Methods: Biopsies of the right atrial myocardium were obtained from 
Background: Hypothermic ischemia in cardioplegia followed by reperfusion 
during cardiac surgery can cause an imbalance in intracellular calcium (Ca) 
metabolism and consequently contractile dysfunction. In this study we inves- 
tigate the density of the sarcoplasmatic reticulum release Ca channel (CRC) 
and L-tvoe Ca channel (L-tvoe) and the Ca sensitivitv of the CRC durina car- - _ 
Siu Ming Ng, Padma Krishnaswamy, Robin Morrissey, Alan Maisel. VAMC 
and UCSD, La Jo//a, CA, USA 
1127-l 36 A Critical Pathway for Chest Pain Patients 
Allows Accurate Triaging Within Ninety Minutes 
of Presentation to the Emergency Room 
25 patients (5 aortic-, 4 mitral valve replacements, 16 aortocoronary by- 
passgrafts) before aortic cross clamping (control) and during hypothermic 
ischemia (26X, 90 minutes), or after reperfusion (30 minutes). The density 
Background: Accurate and cost-effective evaluation of patients presenting 
to the Emergency Room (ER) with chest pain requires a tremendous expen- 
diture of time and resources, and poses a very significant problem from a 
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public health perspective as well as an economic and liability perspective. We 
evaluated the performance of a critical pathway which utilizes triple cardiac 
marker testing along with clinical history and ECG findings in the triaging of 
patients with possible coronary ischemia. 
Methods: 1285 consecutive patients who presented to the EA with chest 
pain were evaluated utilizing the following critical pathway: a) Point of care 
cardiac marker testing of myoglobin, troponin I, and CK-MB (Triage Cardiac, 
Biosite Diagnostics, La Jolla, CA) at presentation (time 0), 30,60, 90 minutes, 
b) Admission to the CCU for rest chest pain and ECG changes (ST elevation 
or depression), or rising marker values by 90 minutes. Outcome measures 
included: 1) Accurate triaging of patients within 90 minutes of presenting to 
the ER. 2) Sensitivity and specificity of the combination of cardiac troponin 
I, myoglobin, and CK-MB in diagnosing Ml within 90 minutes. 3) Appropriate 
triaging of patients to coronary care unit, compared to a baseline study. 4) 
Ability to safely discharge a low-risk population of patients within 90 minutes 
of presentation. 
Results: Using history and ECG changes, along with the combination 
of three markers, all myocardial infarctions were diagnosed by 90 minutes 
of arriving in the ER (sensitivity lOO%, specificity 95%). Use of the algo- 
rithm allowed a 40% decrease in CCU bed utilization compared to baseline 
sampling. In patients who were “marker” and ECG negative, 90% were dis- 
charged home before or at the 90 minute time point, with only one subsequent 
Ml (0.2%) over the next 30 days. 
Conclusions: This simple, yet aggressive, algorithm, allows accurate 
triaging of patients within 90 minutes of presenting to the emergency room 
with chest pain. This pathway, which utilizes high risk features from history 
and ECG, along with rapid, point of care testing of a panel of myocardial 
markers, has the advantage of being simple to follow, inexpensive, and 
available to any emergency room or urgent care clinic. 
I 1127 137 Chest Pain and Myocardial Infarction: Is it Time 
to Redefine the Classical Clinical Presentation? 
Observations from the NRMI 2 
John G. Canto, Michael G. Shlipak, William J. Rogers, Judith A. Malmgren, 
Paul D. Frederick, Costas T. Lambrew, Joseph P. Ornato, Catarina I. Kiefe. 
For the Ni?M/ Investigators; The University of Alabama at Birmingham, 
Birmingham, AL, USA 
Background: Patients with acute myocardial infarction (Ml) may not exhibit 
the hallmark symptom of chest pain (CP), though the extent to which this 
phenomenon may occur is largely unknown. 
Objective: To determine the frequency that patients with documented 
acute Ml lack CP, and to evaluate the clinical predictors, hospital treatment 
and outcome associated with this presentation. 
Methods: Patients with and without CP in a national cohort of Ml were 
compared with regards to their presenting characteristics, treatments and 
outcome. Logistic regression models were developed to determine the pre- 
dictors associated with the lack of CP and subsequent outcome in this study 
population. 
Results: One-third of all patients diagnosed with acute Ml did not have 
CP upon initial presentation to the hospital (n = 142,445) and two-thirds 
presented with CP (n = 292,432). These patients were frequently much 
older, female, non-White, with a higher prevalence of diabetes and prior 
heart failure. MI patients who lacked CP, were significantly more likely to 
delay before presenting to the hospital (7.9 vs 5.4 hrs, p < 0.001). After 
arriving at the hospital, these patients were less likely to be diagnosed with 
Ml at the time of admission (22.2 vs 50.3%, p < O.OOl), and were less likely 
to receive therapies known to improve hospital survival such as thrombolysis 
(18.7 vs 56.4%, p < O.OOl), primary angioplasty (6.2 vs 16.6%, p < O.OOl), 
any reperfusion if eligible (25.3 vs 74.0%, p < O.OOl), aspirin (60.4 vs 84.5%, 
p < O.OOl), beta-blocker therapy (28.0 vs 48.0%, p < O.OOl), or heparin (53.4 
vs 83.2%, p < 0.001). Furthermore, they were less likely to receive a timely 
ECG (31.8 vs 15.6 min, p < 0.001) or receive timely reperfusion strategies 
when eligibility criteria were met (difference in mean time to thrombolysis - 
74.4 min and primary PTCA - 110.4 min, p < 0.001 respectively). Lastly, 
Ml patients who lacked CP had over a two-fold increased risk of hospital 
death than their counterparts who presented with CP, which persisted after 
adjusting for comorbidities and clinical presentation (OR = 2.21, 95% Cl = 
2.19-2.23). 
Conclusion: Ml patients who lacked CP on initial presentation represent 
a large segment of the Ml population, who are at increased risk for patient 
delay, less aggressive treatments, and worse hospital survival. 
I 1127 138 Impact of an Emergency Department Cardiac 
Clinical Decision Unit on a Population of 
Patients With Episodic Chest Discomfort 
Shalin S. Shah, Glenn F. Tokarski, James K. McCord, Nabil E. Khoury, 
Kristin B. McCabe, Robert J. Morlock, Husam Noor, Peter A. McCullough. 
Henry Ford Heart and Vascular Institute, Henry Ford Hospital, Detroit, 
Michigan, USA 
Background: Several small studies and one randomized trial have shown 
that emergency department (ED) chest pain units can decrease the number 
of hospital admissions for chest pain without increased risk. 
Methods: This quasi-experimental time series study was designed to 
evaluate the population impact of a cardiac clinical decision unit (CDU) in 
the urban ED of an integrated health system. All patients seen for chest dis- 
comfort who underwent an electrocardiogram and had at least one creatine 
phosphokinase measurement were taken from a 6-month period before and 
after the CDU opened (pre-CDU, post-CDU) allowing for a 6-month start-up 
period. 
Results: Patients in the pre-CDU (n = 1831) and post-CDU (n = 2505) 
period had similar baseline characteristics: age 60 & 16 vs 60 + 18, female 
47% vs 48%, and African American 77% vs 73%, respectively, p = ns for all. 
In the post-CDU group, 404/2505 (16%) were admitted to the CDU. Rates of 
AMI were similar in the two periods, 21% and 20%, p = 0.41. Mortality was 
5% in both groups, p = 0.91. The overall effect of the CDU was a reduction 
in hospital admissions from 81% to 67%, but an increase in ED repeat visits 
from 5% to IO%, p i 0.01 for both. There was no overall impact on mean 
LOS of 5.7 days in each group, p = 0.50. 
Conclusion: Chest pain units impact the care pathway of a minority of 
chest pain patients. This study, as well as randomized trial data, indicates 
that chest pain units reduce the overall number of patients admitted with 
chest pain. However, there appears to be a tradeoff between a reduction 
in hospitalizations and doubling in the number of repeated ED visits for 
the same problem. Our system has responded to these results by creating 
CDU discharge pathways, which include office-based risk factor analysis and 
evaluation of non-cardiac sources of pain. 
1 1127-l 39 1 Marked Delay in Presentation of Native American 
Patients With Acute Myocardial Infarction 
Eric A. Brady, Justin L. Sewell, Wanda Zziwambazza, Phyllis Morez, 
Yvette Roubideaux, Laura Koepke, Betsy Painter, James M. Galloway. 
Native American Cardiology Program, University of Arizona, Tucson, 
Arizona, USA 
Background: Prior studies have suggested a significant delay in presen- 
tation of Native American (NA) and other minority patients suffering acute 
myocardial infarction (AMI). However, these studies have not examined the 
unique presentations of rural NA patients, The Native American Cardiology 
Program (NACP) of the Indian Health Service serves a diverse population of 
rural NA. We prospectively studied these patients and their presentations to 
better define this problem in hopes of identifying areas for intervention. 
Methods: Twenty-five consecutive NA patients with AMI were evaluated 
at rural facilities and transferred to NACP from February through August 
1999. Trained auditors interviewed each patient at the time of presentation 
and obtained data including demographics, ECG findings, patient symptoms, 
complications, laboratory and cardiac catheterization results if performed. 
Translation services were utilized if necessary. 
Results: Sixteen of 25 patients (64%) presented to the ER within 12 
hours of symptom onset; average delay 227 minutes. Three patients (12%) 
presented between 12 and 24 hours and five patients (20%) presented >24 
hours following symptom onset. One patient suffered a cardiac arrest and 
died. Sixteen of 25 (64%) patients did not receive thrombolytic therapy, 7/16 
(44%) due to accepted contraindications and 9/16 (56%) due to delay in pre- 
sentation. Seven of these 9 patients (78%) gave their own misinterpretation 
of symptoms as the reason for delayed presentation. The average distance 
to the presenting medical facility was 19.7 miles with negligible difference for 
those presenting within 12 hours (15.0 miles) vs. those presenting >24 hours 
(19.0 miles). A majority of patients utilized privately owned vehicles as their 
mode of transport to medical facilities (67% of patients arriving ~12 hours 
vs. 87.5% of those >I2 hours). 
Conclusions: These data demonstrate a marked delay in presentation of 
rural NA patients with AMI. Misinterpretation of symptoms was the predom- 
inant cause of delay. Distance and transportation to medical facilities were 
not significant issues. Further study is required to support these preliminary 
findings. If confirmed, a program of community-based education should result 
in increased candidacy for thrombolytic therapy and improved outcomes. 
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I. 1127 140 Angiographic Manifestations of Coronary Artery Disease Presenting as Acute Coronary 
Syndrome in Patients With Cocaine Abuse 
Yasser Salem, Omar Almousali, Wajahat Mirza, Siva Gummadi, 
Riyaz Nomani, Sandeep Khosla. Mount Sinai Hospital/Chicago Medical 
School, Chicago, Minois, USA 
Background: To evaluate the angiographic spectrum of coronary artery 
disease associated with cocaine abuse. 
Methods: Coronary angiograms of 27 consecutive patients (mean age 
42, range 31-56, Females 22%) with cocaine abuse were retrospectively 
analysed. All patients presented with Acute Chest Pain (ACP) temporally 
related to cocaine abuse (mean time from abuse 13.2 hrs, range 1-72 hrs). 
The route of abuse was smoking 84%, lntranasal 13% and IV 3%. The clinical 
presentation was Rest angina (60%), NQMI (22%), QMI (3%) and worsening 
stable angina (15%). Electrocardiographic manifestations were new T-wave 
changes (67%), ST-segment depression (4%), ST-segment elevation (11%) 
and non-diagnostic ECG changes (18%). Duration of cocaine abuse was >5 
years (56%): c5 years (37%) and ~1 year (7%). 
Anoiooraphic Findina LAD LCX RCA -_, 
Normal 12 (44%) 18 (67%) 17 (63%) 
Diameter Stenosis < 50% 6 m.?%~ 2 17%) 4 115%) 
Diameter Stenosis > 50% 5 ii9%j 5 (i9k) 4 iiwj 
Normal and cTIMI-3 Flow 4 (15%) 2 17%1 2 (7%) 
Results: Five Patients (18%) were treated using vasodilators due to 
sluggish coronary flow, 4 (15%) using coronary stenting, 2 (7%) using PTCA 
and 1 (4%) using CABG (All with 100% procedural success). Two of the 4 
patients that underwent coronary stenting continued to abuse cocaine, did 
not take antiplatelet therapy and returned on days 4 and 5 with subacute stent 
thrombosis. Both patients were successfully revascularized using coronary 
angioplasty. 
Conclusions: 1) ACP related to Cocaine abuse can be associated with 
obstructive coronary artery disease requiring revascularization (7/27 = 26%), 
non-obstructive CAD (6/27 = 22%), sluggish coronary flow without obstruc- 
tive CAD (4/27 = 15%) or normal coronary angiographic flow 2) Cocaine 
abuse may result in higher incidence of subacute stent thrombosis following 
coronary stenting. 
L-4 1127 141 Is Exercise Stress Testing Alone Useful in Patients With Cocaine Associated Chest Pain? 
Michael C. Kontos, Joseph P. Ornato, Robert L. Jesse, James L. Tatum. 
MWVCU, Richmond, VA, USA 
Background: After exclusion of MI, stress testing is often performed for 
further risk stratification. There is little data on the value of stress testing in 
pts evaluated for cocaine-associated chest pain who have Ml excluded. 
Methods: Pts evaluated in the Emergency Department for chest pain after 
cocaine use who did not have Ml and who subsequently underwent stress 
myocardial perfusion imaging (MPI) comprised the study cohort Significant 
disease was defined as 250% stenosis. 
Results: A total of 133 pts (mean age 37 i 7) underwent stress MPI 
(exercise in 111, dipyridamole in 17 and dobutamine in 5) a mean 2 f 3 days 
after ED evaluation. Only 64% of pts who exercised reached 85% PMHR. 
Pharmacologic stress MPI was required in 22 (17%) (4 pts uninterpretable 
ECG, 18 inability to exercise). The only positive stress ECG occurred in apt 
who had dobutamine stress. Reversible perfusion defects were present in a 
minority of pts (11%) (Table). Seven of the 11 pts who underwent angiography 
had significant disease, of whom 6 had reversible defects and 1 had a fixed 
defect. 
All Stress (N = 133) Exercise (N = Ill) Pharmacologic (N = 22) 
Normal 105 (79) 95 (86) 10 (46) 
Reversible 8 (6) 5 (5) 3 (14) 
Fixed 13 (IO) 8 (7) 5 (23) 
Fixed + reversible 7 (5) 3 (3) 4(13) 
numbers in parentheses indicate percentages 
Conclusions: EGG and scintigraphic evidence of inducible ischemia are 
uncommon among pts with cocaine chest pain when Ml has been excluded. 
Stress MPI is the preferred stress modality in this group of pts, since the 
exercise ECG alone has low sensitivity and a significant proportion of pts 
require pharmacologic stress. 
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1128-I 27 Smoking Cessation Reduces Mortality After 
Coronary Artery Bypass Surgery: A 20-Year 
Follow-tip Study - 
Ron T. van Domburg, Karin Meeter, Dorien F.M. van Berkel, Rolf 
F. Veldkamp, Lex A. van Herwerden, Ad J.J.C. Bogers. Thoraxcenter, 
University Hospital Dijkzgf, Rofferdam, The Netherlands 
Background: Cigarette smoking is one of the known major risk factors of 
coronary artery disease. However, the influence of smoking cessation on 
mortality after coronary artery bypass surgery (CABG) has still not been 
established clearly. 
Methods: One thousand and forty-one patients underwent CABG surgery 
between 1971 and 1980. The pre-operative and post-operative smoking 
habits of 985 patients (95%) could be retrieved and were analysed in a 
multivariate Cox analysis. 
Results: The median follow-up was 20 years (range 13-26 years). Smok- 
ing status before surgery did not entail an increased risk of mortality: patients 
who had smoked before surgery and those who had not smoked in the year 
before surgery had a similar probability of survival. However, smoking ces- 
sation after surgery was an important independent predictor of a lower risk of 
death and coronary reintetvention during the 20-year follow-up when com- 
pared to patients who continued smoking. In analyses adjusted for baseline 
characteristics, the persistent smokers had a greater relative risk of death 
(RR 1.68; 1 1.33-2.13) and cardiac death (RR 1.75; 1.30-2.37) as compared 
to patients who stopped smoking for at least 1 year after surgery. The esti- 
mated benefit of survival for the quitters increased from 3 percent at 5 years 
to 14 percent at 15 years. The quitters were less likely to undergo repeat 
coronary reintervention (RR 1.41; I .02-l .94). 
Conclusions: Patients who continued to smoke after coronary bypass 
surgery had a greater risk of death than patients who stopped smoking. They 
also underwent repeat revascularization procedures more frequently. 
/ 1128 128 Simply Counting the Number of Risk Factors Provides an Estimate of the Mortality Rate of the 
Projected Coronary-Bypass Surgery 
Victor Parsonnet, Alan D. Bernstein. Newark Beth Israel Medical Cenfec 
Newark, New Jersey USA 
Background: While considerable attention has been devoted to risk stratifi- 
cation in retrospective evaluation of the quality of care in cardiac surgery for 
large patient (pt) cohorts, a simple method is needed for estimating the risk of 
surgery both for pt cohorts and for assisting patients, families, and surgeons 
in estimating the risk of the proposed surgery on an individual basis. 
Methods: The relationship between the number of preoperative risk fac- 
tors, independent of precisely which factors were present, and the observed 
rate of in-hospital surgical mortality among 20,325 patients who underwent 
aottocoronaty-bypass (ACB) surgery in New Jersey during 1996 and 1997 
was examined. Risk-factor prevalence was calculated for 44 factors, and 
observed mortality rates and 95% binomial confidence intervals (Cl.) were 
computed. Two thirds of the pt records were chosen as a training set by pseu- 
dorandom selection. Logistic regression was performed with the training set 
to evaluate the factor count as a predictive index, and receiver operating 
characteristic (ROC) curves were plotted for the training set and for a test set 
consisting of the remaining records. Weibull analysis was used to calculate 
the correlation between the factor counts and the observed mortality rates. 
Results: The observed mortality rates were highly correlated (r* = 0.982) 
with the factor counts, and ROC areas were 0.769 for the training set and 
0.748 for the test set. These results were plausible because the risk-factor 
prevalences were not distributed uniformly, but varied widely, from 0.01% for 
active AIDS to 72% for hypertension 
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Risk 
Factors 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
>lO 
% of % 95% 
Pts Mortality C.I. 
3.4 0.4 0.1-1.3 
12.3 0.5 034.9 
18.9 1.0 0.8-1.4 
20.4 1.8 1.5-2.3 
16.5 3.0 2.5-3.7 
12.0 4.0 3.3-4.9 
17.4 7.6 6.3-9.1 
4.4 9.1 7.3-11.1 
2.4 12.7 9.9-16.0 
1.2 19.1 14.3-24.8 
0.7 19.3 13.0-26.9 
0.6 24.4 17.1-33.0 
Conclusion: Counting apt’s risk factors provides an easy way to estimate 
the risk of surgical mortality in ACB at the bedside. 
1128-l 29 Prognostic Importance of Pulse Pressure in 
Coronary Artery Disease Patients Undergoing 
Revascularization: Results From the Bypass 
Angioplasty Revascularization investigation 
(BARI) 
Michael J. Domanski, Kim Sutton-Tyrrell, Gary F. Mitchell, Ping Guo, David 
P. Faxon, Bertram Pitt, George Sopko. The SARI Investigators; National 
Heart, Lung, and Blood Insfifufe, Bethesda, Maryland, USA 
Background: An association between increased vascular stiffness, as evi- 
denced by increased pulse pressure (PP) (calculated from sphygmomano- 
metrically determined systolic and diastolic pressure), and adverse cardio- 
vascular events has been demonstrated in patients with congestive heart 
failure, systolic hypertension and following myocardial infarction (Ml). The 
association of PP & outcome Following coronary revascularization has not 
been examined. 
Methods: We studied the prognostic significance of PP & mean arte- 
rial pressure (MAP) in 3,387 patients with coronary artery disease entered 
into the Bypass Angioplasty Revascularization Investigation (BARI) trial and 
registry. 
Results: Before revascularization, mean PP was 54 mm Hg & mean 
MAP was 94 mm Hg. There was a significant association of increased PP 
(p i 0.001) with history of hypertension, female sex, diabetes, & older age 
as well as an inverse association with history of prior Ml. Prior beta-blocker 
& aspirin use were associated (p < 0.05) with reduced PP while diuretics 
& angiotensin converting enzyme inhibitors were associated with increased 
PP. Similar associations were seen for MAP. Using a Cox model, PP was 
significantly associated with time to death (p = 0.033) after controlling for 
MAP, age, smoking, male gender, diabetes history, congestive heart failure, 
as well as drug use including ACE inhibitors, diuretics & digitalis. Each 10 
mmHg increment in PP was associated with a relative risk of 1.08 (95% 
confidence interval 1.07, 1 .I 5). There was no significant association of PP 
or MAP with the endpoints of angina or repeat revascularization. 
Conclusion: Increased arterial stiffness, as evidenced by increased pulse 
pressure, is an easily determined, independent predictor of mortality in coro- 
nary artery disease patients who undergo revascularization. 
I 1128 130 Characterization of Diabetics Who Undergo Coronary Revascularization 
Jennifer Carreiro, Susan X. Lin, Craig Fi. Smith, Mehmet C. Oz, 
Windsor Ting. Columbia Univefsifx New York, New York, USA 
Background: Previous studies have demonstrated that cardiopulmonary 
bypass (CPB) contributes to end organ dysfunction which is common among 
diabetics who undergo coronary revascularization (CABG). The purpose of 
this study was to characterize the incidence of complications among diabetic 
patients undergoing CABG. 
Methods: A retrospective multi-center analysis was performed on 73,683 
patients who underwent CABG between 1993 and 1996 by 179 surgeons at 
32 hospitals. 
Results: A history of diabetes requiring oral hypoglycemic agents or 
insulin was present in 27% of all CABG patients, and was significantly higher 
in females (36% vs. 23%, p < 0.001). There was no difference in the mean 
age of diabetics and non-diabetics (65 f IO). Preoperative risk factors that 
were significantly higher in diabetics include history of hypertension (76% 
vs. 64%, p < O.OOl), heart failure (17% vs. 9.1%, p < 0.001) and prior 
myocardial infarction (21% vs. 16%, p < 0.001). Hospital mortality following 
CABG is significantly higher among diabetics (3.7% vs. 2.1%, p < 0.001). 
Diabetic patients have significantly higher incidence of pert-operative stroke 
(2.0% vs. 1.3%, p < 0.001) respiratory failures (4.7% vs. 2.7%, p < 0.001) 
and renal failure (1.2% vs. 0.6%, p < 0.001). No differences were found 
in transmural myocardial infarction, gastrointestinal bleed, or post-operative 
bleeding. 
Conclusion: The data supports an association between diabetes and 
end organ failure. Future studies should investigate whether off-pump CABG 
can reduce these complications that are prevalent among diabetics. 
/ 1128 131 Neurophysiological Changes and Psychosomatic Outcome After Minimallv 
Invasive and Conventional Coronary Artery 
Bypass Grafting 
Vassilios Gulielmos’, MS. Damians, Hans-Martin Dill’, Markus Eller’, 
Sebastian Thiele’, B. Vatankhahs, W. SauteP, V. Koellner*, 
Stephan Schueler’ 7 Cardiovascular Insfifufe, University of Dresden; 
2Deparfmenf for Neurology and for Psychosomafic Medicine, Dresden, 
Germany 
Objective: Minimally or less invasive novel techniques for coronary artery 
bypasss grafting (CABG) have been introduced to reduce neurological se- 
quelae and psychosomatic disorders. 
Methods: In a prospective randomized trial 4 groups were compared: 
10 patients (pts; age: 59.6 f 11 .O years) were operated using median ster- 
notomy (MS) and cardiopulmonary bypass (CPB); 10 pts (age: 65.7 f 11.1 
years) recieved off pump procedures through MS; IO pts (age: 60.4 f 10.7 
years) were treated using CPB through a minithoracotomy (MT) and IO pts 
(age: 63.8 f 11.3 years) recieved off pump procedures through a MT. All pts 
had singel vessel CAD. Demographical data and underlying diseases were 
comparable. Clinical and biochemical neurological and psychosomatical as- 
sessment was performed. 
Results: All pts received LIMA-bypass to LAD and there were no major 
complications. Near infrared spectrography showed cerbral oxygen satura- 
tion (rS02) decrease 120% during CPB. One pathological EEG occurred 
in each group using off pump surgery. Minor transient clinical neurological 
alterations were found in all groups. Neuron specific enolase significantly 
increased on day 1 after operation in CPB-procedures. In pts undergoing 
MS posttraumatic stress disorders (PTSD), visual analog scale and behavior 
rating scale values were higher (p < 0.05). Six minutes walking distance on 
postoperative day 4 was longer after MT (p < 0.05). 
Conclusions: The moderate decrease of rS02 and biochemical changes 
found with CPB are not associated with clinical neurological and EEG se- 
quelae. The use of MS is related to more PTSD and significantly higher pain 
rates. Pts receiving MT reveal a shorter and faster convalescence. 
1 1128-l 32 1 Beating Heart Versus Conventional Reoperative 
Coronary Artery Bypass Grafting for Single 
Vessel Coronary Artery Disease 
Paul J. Corso, Sotiris C. Stamou, Albert J. Pfister, Mercedes K.C. Dullum, 
Steven W. Boyce, Ammar S. Bafi, George Dangas, Jorge M. Garcia. 
Washington Hospital Center, Washington DC, USA 
Background: Reoperative (redo) coronary artery bypass grafting (CABG) 
with cardiopulmonary bypass (On-pump) is associated with a higher morbidity 
and mortality, in comparison with first time CABG. It is unknown, however 
whether an off cardiopulmonary bypass approach (Off-pump) may yield an 
improved clinical outcome over conventional On-pump redo CABG. 
Methods: We compared the pen-operative outcome of single vessel On- 
pump redo CABG (n = 41) versus beating heart single vessel Off-pump redo 
CABG (n = 91) performed from January 1989 to July 1999. The two groups 
were similar with respect to baseline characteristics and risk stratification: 
Parsonnet score was 26 f 9 for On-pump versus 24 f 9 for Off-pump patients 
(p = NS). 
Results: Comparative analysis is summarized in table. 
First time Redo CABG 
On-pump Off-pump P 
35 (85) 79 (87) NS 
Postoperative transfusions 24 (58j 25 i27j 0.001 
Operative time (hours) 4fl 3fl 0.04 
Prolonged ventilation 7(17) 4 (4) 0.03 
Postoperative atrial fibrillation 12 (29) 13(14) 0.04 
Postoperative stay, (days) a*4 6+2 <O.OOl 
In-hospital mortally 4(10) l(l) 0.03 
Values are expressed as mean i SD, or as n (%), 
Conclusion: Single-vessel Off-pump beating heart redo CABG can be 
performed with a lower operative morbidity and mortality, and an abbreviated 
hospital stay in comparison to conventional On-pump redo CABG. 
JACC February 2000 
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1128 133 lnducibility of Ventricular Tachycardia After Dor 
Mina K. Chung, Robert A. Schweikert, Michael Firstenberg, Tiffany Buda, 
Andrea Natale, Fredrick J. Jaeger, Mark J. Niebauer, Patrick J. Tchou, 
Randall C. Starling, James B. Young, Nicholas Smedira, Patrick 
M. McCarthy. C/eve/and Clinic Foundation, C/eve/and, Ohio, USA 
Left ventricular infarct resection has been performed in conjunction with 
coronary bypass surgery in patients with ischemic cardiomyopathy and heart 
failure. Because of the potential risk for ventricular arrhythmias that might 
remain in these patients despite infarct resection, we prospectively performed 
electrophysiologic testing (EPS) in patients prior to discharge and compared 
the rate of ventricular tachycardia (VT) induction with that of patients with 
coronary artery disease undergoing EPS for risk stratification. 
Methods: EPS was performed on patients after the Dor procedure and 
patients with CAD and nonsustained VT (Control). The EPS protocol con- 
sisted of programmed ventricular stimulation using up to 3 extrastimuli at 2 
paced cycle lengths (PCL) and 2 right ventricular sites, 4 extrastimuli at PCL 
350, 400, and 600 ms, and long-short coupling intervals. 
Results: From July 1997 to August 1999, 80 patients underwent the 
Dor procedure. Of these, 33 underwent EPS. Dor patients had lower left 
ventricular ejection fraction (23 i 7 vs. 29 f IO%, p < 0.001) and tended 
to be younger (age 62 i 8 vs. 65 i 10 years, p = 0.088). VT was induced 
in 12/33 (45%) of Dor patients and 116/236 (49%) of Control patients, p = 
0.17. The mean VT cycle length in the 13 VTs induced was 268 + 54 ms 
with 9 RBBB and 4 LBBB morphology tachycardias. No ventricular fibrillation 
was induced. All 12 patients who had inducible VT underwent implantation 
of an implantable cardioverter-defibrillator (ICD). ICDs were also implanted 
in 3 patients with preoperative sustained ventricular arrhythmias and in 2 
for postoperative sustained VT/ventricular fibrillation and 1 for syncope with 
symptomatic nonsustained VT. 
Conclusions: Patients undergoing the Dor procedure appear to have 
a rate of ventricular tachycardia inducibility similar to that of patients with 
CAD and MADIT indications for risk stratification. Prophylactic ICD implan- 
tation in the post-Dor procedure patients with inducible VT may yield similar 
imorovements in survival. 
1128-I 34 Marked Superiority of Clopidogrel Versus 
Aspirin in Patients With a Historv of Previous 
Cardiac Surgery 
Deepak L. Bhatt, Alan T. Hirsch, Derek P. Chew, Peter Ringleb, 
Werner Hacke, Eric J. Topol. Cleveland Clinic, Cleveland, Ohio, USA 
Background: Following coronary artery bypass surgery, patients have a 
high rate of recurrent ischemic events. We sought to determine whether the 
ADP receptor antagonist clopidogrel would be more effective than aspirin in 
preventing ischemic events in this patient population. 
Methods: Without any double counting of events, the rates of vascular 
death, MI, all-cause stroke, and rehospitalization for ischemic events (angina, 
transient ischemic attack, limb ischemia) or for bleeding were determined for 
the 1480 patients with a history of cardiac surgery randomized to either 
clopidogrel or aspirin in the CAPRIE study, 
Results: The composite event rate per year was 22.3% in the 705 pa- 
tients randomized to aspirin and 15.9% in the 775 patients randomized to 
clopidogrel, p = 0.001. The risk reduction was also seen in each of the individ- 
ual endpoints examined, including a 42.8% relative risk reduction in vascular 
death in patients on clopidogrel versus aspirin, p = 0.030. While clopido- 
grel therapy was efficacious in the entire CAPRIE population, patients with 
previous cardiac surgery derived particular benefit, p-value for interaction 
between clopidogrel therapy and cardiac surgery = 0.015. In a multivariate 
model incorporating baseline clinical characteristics, clopidogrel therapy was 
independently associated with a decrease in vascular death, Ml, stroke, and 
rehospitalization for ischemia or bleeding in patients with a history of car- 
diac surgery, with a 31.2% relative risk reduction (95% confidence interval of 
15.8% to43.8%), p < 0.001. 
Conclusion: Compared with aspirin, clopidogrel therapy results in a dra- 
matic reduction of the elevated risk for recurrent ischemic events seen in 
patients with a history of previous cardiac surgery, with a decreased risk of 
bleeding. 
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/ 871 New Insights Into Pathophysiology of 
lschemic Syndromes 
Tuesday, March 14,2000, IO:30 a.m.-Noon 
Anaheim Convention Center, Room 207A 
lo:30 a.m. 
871-I The Impact of Direct Percutaneous Myocardial Laser 
Revascularization (Biosense DMR’“) on Myocardial 
Perfusion and Function as Assessed by Gated 
SPECT Myocardial Perfusion imaging: Results of the 
Phase I Multicenter DMR Trial 
Robert C. Hendel, Ran Kornowski, Scott Leonard, Martin B. Leon, Robert 
0. Bonow. Northwestern University Medical Center, Chicago, IL; 
Washington Hospital Center, Washington, DC, USA 
Background: Alternative treatment strategies, including percutaneous direct 
myocardial revascularization (DMR), are currently being explored for patients 
who are not ideal candidates for traditional coronary revascularization with 
PTCA or CABG. This substudy oi the multicenter phase I trial of Biosense 
DMR’” sought to examine the impact of laser revascularization on myocardial 
perfusion and function as assessed by tomographic (SPECT) radionuclide 
perfusion imaging. 
Methods: Adenosine dual isotope stress-rest-redistribution SPECT imag- 
ing was performed before (baseline) and after DMR (30 d and 6 mo). These 
data were submitted to a central core laboratory for blinded, uniform process- 
ing and interpretation. A 20 segment semiquantitative visual analysis was 
performed, as was an automated quantitative analysis. The gated SPECT 
data were used for calculation of the left ventricular (LV) ejection fraction. 
Results: The visual summed stress scores failed to show differences in 
baseline and the 30 d study in 60 pts (19.8 vs 18.9; p = ns) or in the 6 
mo SPECT study for 47 pts (19.2 vs 18.8; p = ns). Similar findings were 
noted for the summed rest and summed redistribution scores. A blinded, 
visual side-by-side comparison of the perfusion data also failed to reveal 
a treatment effect. Quantitative analysis confirmed the lack of an effect 
on myocardial perfusion. When regional perfusion data was correlated to 
the lased region, no effect on perfusion was noted with DMR therapy. No 
significant change in LV function was noted from baseline to 30 d in 38 pts 
(42% vs 44%; p = 0.15) or from baseline to 6 mo in 22 pts (42% vs 45%: p = 
0.05). 
Conclusion: SPECT perfusion imaging fails to document changes in 
myocardial perfusion following DMR, although minor improvement in LV 
function is noted. The mechanism for clinical improvement after DMR is 
therefore not apparent but appears unrelated to improvement in myocardial 
blood flow. 
lo:45 a.m. 
871-2 Adenosine and Microvascular Dysfunction: 
Increment in Coronarv Flow (TIMI Frame Count) in 
Men With Microvascuiar Angina 
Jose G. Diez’ , M.J. Lievano, Mihai Croitoru’ , James J. Ferguson’ Hospital 
Universitario San Rafael, Bogota, Colombia; ‘St. Luke’s Episcopal 
Hospital/The Texas Heart Institute, Houston, TX, USA 
Background: Patients with microvascular dysfunction have inadequate and 
slow coronary flow despite normal epicardial coronary arteries. This finding 
has been associated with angina-like chest pain, some with evidence of 
ischemia. Microvascular angina (MVA) has been grouped within the hetero- 
geneous coronary Syndrome X among with abnormal pain perception and 
sympathovagal imbalance. Patients with MVA have evidence of endothelial 
dysfunction with intracoronary acetylcholine and by brachial hyperemia test- 
ing. Adenosine increases arterial endothelial cell nitric oxide (NO) through 
adenosine A2a receptors. By increasing NO, adenosine might be expected 
to cause vasodilatation and improve coronary flow in patients with MVA. 
Objective: To evaluate the effect of intracoronay adenosine (ICA) on 
coronary flow in patients with MVA, as measured by changes in TIMI frame 
count (TFC). 
Design: Prospective, open-label study; blinded analysis of TIMI frame 
count. 
Method: Patients referred for angiography due to typical chest pain, 
and/or ECG changes suggestive of ischemia, and/or abnormal perfusion 
study in whom no atherosclerotic epicardial coronary disease was found and 
who had impaired coronary flow by angiography. Qualifying patients under- 
went administration of ICA, with pre and post TIMI frame count measurement. 
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Results: Thirteen vessels (9 RCA and 4 LAD) in ten male patients were 
evaluated. In the LAD the mean pre-ICA TFC was 46.2, and the mean 
post-ICA TFC was 27.2. In the RCA the mean pre-ICA TFC was 34, and the 
mean post-ICA was 22.3. The mean TFC change was 19 for the LAD, and 
11.7 for the RCA. 
Conclusion: lntracoronary adenosine administration improves TIMI frame 
count measurements in male patients with microvascular angina. This may 
result in enhancement of otherwise impaired endothelial function in these pa- 
tients, with improved endothelial cell NO production mediated by adenosine 
A2a receptors. 
11:OOa.m. 
El 871 3 Syndrome X: lschemic or Not lschemic Disease? 
New Insights With Exercise Echo-Doppler Evaluation 
Faust0 Rigo, Bruno De Piccoli, Valeria Cutaia. Umberto PHospital Venice, 
ltaly 
Background: Increasing evidence suggests that myocardial ischemia is 
uncommon in patients having syndrome X (SdrX) that is characterized by 
chest pain and ST depression on the stress Ecg despite normal coronary 
angiograms. 
Methods: In order to verify the mechanism responsible for symptoms 
and ecg alterations, we evaluated 34 patients with SdrX, 25 female and 9 
male, mean age 54 i- 8 years, with Exercise Echo-Doppler utilizing upright 
cycle-ergometry standard and 29 matched healthy control subjects (Ctr). 
We calculated LVMI (gdm’) WMSI, EDLV (Ml/m*), EF (%), and the peak 
and mean gradient (PG, MG = mmHG) with CW-Doppler in LVOT at basal 
(b) and peak test (p). All patients underwent TC-MIBI SPECT and coronary 
angiography. 
Results: A significant statistical difference was found only for the following 
parameters: 
LVMI WMSI D EDLV ~7 ESLV a EFo MGo PG D 
SdrX 92*15 1.1 * 0.05 56f9 16zk4 72 * 9 2317 49fll 
ctr 78zk19 1.05 rt 0.04 51 * 11 19*7 62 + 8 4 * 0.3 13f5 
0 “S ns ns ns 0.05 0.001 0 nn3 
The MIBI-SPECT showed reversible perfusion defects in 10134 pts with 
SdrX despite normal coronary angiography in all the pts. We foud a good 
correlation between the magnitude of ST depression at peak and the left 
ventricular functional gradient (r = 0.86; p < 0.001) in LVOT at the peak test. 
The chest pain was present in 25/34 pts (73%) at the peak of exercise and 
this finding well correlated with gradient in LVOT (p = 0.001). 
Conclusion: All the pts with syndrome X showed a “supernormal” in- 
otropic reaction with a hyperkinetic behaviour of left ventricle that induced a 
functional variable sistolic gradient in LVOT. We believe that the appearance 
of ST depression as well as chest pain in pts with syndrome X could be 
explained by an abruptly increasing of pressure on regional endocardial sur- 
face, expression of an augmented sympathetic activity rather than ischemic 
mechanism. 
11:15a.m. 
1 871-4 1 Coronary Flow Reserve Predicts Mortality in 
Patients With Suspected Myocarclial lschemia and 
Normal Coronary Arteries 
David S. Marks, Surendra B. Gudapati, Jennifer Wailer, Jan L. Houghton, L. 
Michael Prisant, Albert A. Carr, E. Brooke Weir, 
Caroline diDonato-Gonzalez. Medical College of Georgia, Augusta, 
Georgia, USA 
Background: Patients (Pts) with the clinical diagnosis of ischemic heart dis- 
ease without significant epicardial stenoses (SX) are a poorly understood, 
heterogeneous population. Prior reports suggest long-term survival is excel- 
lent but are limited in ability to differentiate risk among this group. The utility 
of assessing microvascular dysfunction by coronary flow reserve (CFR) in 
predicting long-term functional status of Pts with SX is unknown, 
Methods: A cohort of 172 Pts were classified as normal (NI) CFR (~3.0, 
N = 109) or abnormal (Abn) (CFR < 3.0, N = 63) were followed longitudinally 
(F/U = 8.43 f 1.74 years). Survival was confirmed by telephone contact; 
death was confirmed by National Death Registry and death certificate. Ka- 
plan-Meier analysis was utilized to test for survival. 
Results: Abl CFR predicted all cause (p = 0.0036) and cardiovascular 
death (p = 0.0012). Overall survival was not predicted by gender, race, history 
of hypertension, or left ventricular mass (see figures). 
Conclusion: Although SX traditionally carries a benign prognosis, CFR 
testing predicted increased morality in this cohort. Further investigation is 
required to investigate the mechanisms of this important finding. 
Cardiovascular Survival by CFR 
11:30a.m. 
1 871-5 ] Increased Adhesion Molecules Levels in Patients 
With Chest Pain and Normal Coronary Arteriograms 
Emmanouil G. Zouridakis, Dimitris Tousoulis, George Asimakopoulos, 
Homeyra Homaci, Nabeel Ahmed, Graham J. Davies, Juan Carlos Kaski. 
Cardiology Units, Hammersmifh Hospital Imperial College School of 
Medicine; St George’s Hospital Medical School, London, UK 
Background: The pathogenesis of angina in patients with angiographically 
normal coronary arteries (CPNA) remains unclear, however, endothelial mi- 
crovascular dysfunction appears to play a role. A chronic inflammatory pro- 
cess with leukocyte activation and adhesion to vascular endothelium may 
lead to vascular dysfunction. The aim of this study was to test whether 
markers of endothelial activation i.e. intracellular and vascular cell adhesion 
molecules (ICAM-I and VCAM-1) are increased in CPNA patients. 
Methods: We studied 21 patients (6 men; mean age: 56 i 9 ys) with 
exertional angina, positive response to exercise stress testing and completely 
normal coronary angiograms (CPNA), 36 patients (34 men; mean age 62 i 
9 ys) with chronic stable angina and documented coronary artery disease 
(CAD) and 11 healthy volunteers (8 men; mean age 49 f 14 ys) (Control). 
Circulating ICAM- and VCAM-1 plasma levels were measured in all subjects, 
using commercially available ELISA methods. 
Results: ICAM- levels were significantly higher in CPNA patients com- 
pared to controls and similar to those of CAD patients. VCAM-I levels were 
also higher in CPNA and CAD patients than in controls 
ICAM- (ngiml) 
CPNA (n = 21) CAD (n = 36) Control (n = 11) 
362 i 22* 328 f 26* 225 5 29*$ 
VCAM-I (nglml) 656 f 43 626 + 42 551 zlc 60 
*CPNA vs Control p < 0.05, *CAD vs Control p < 0.05 
Conclusions: Our findings indicate that chronic inflammation with en- 
dothelial involvement, as suggested by increased cell adhesion molecules 
levels, is present in patients with angina and normal coronary angiograms. 
The precise role of these findings in the pathophysiology of this condition 
deserves further investigation, 
11:45a.m. 
I 871 6 Is Impaired Myocardial Collateral Development due to Angiogenic Growth Factor Deficiency or a 
Resistance to Growth Factor Stimulation? 
Pier D. Lambiase, Richard J. Edwards, Simon R. Redwood, Michael 
M. Webb-Peploe, Jeremy M. Pearson, Clifford Bucknall, Michael S. Marber. 
St Thomas’ Hospital, London, UK 
Background: The factors causing the variation in myocardial collateral de- 
velopment in patients even with similar patterns of coronary artery disease 
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are poorly understood. inadequate collateral formation may be due to a 
deficiency in local angiogenic growth factor (GF) production or an intrinsic 
resistance of the myocardium to GF stimulation. 
IO:45 a,m. 
Methads: 8 patients (62 f 5 years) with stable angina due to isolated 
LAD disease underwent 2 balloon inflations of >I 80s each separated by 5 
min reperfusion. Balloon occlusion pressure was measured with an 0.014’ 
pressure wire positioned distal to the balloon. Collateral flow index (CFI) was 
calculated from simultaneous measurements of coronary sinus (CS) and 
mean aortic pressure. Serum was collected from the CS at baseline and at 
the end of the second inflation. The serum relative mitogenicity (RMit) was 
determined employing a3H thymidine incorporation assay in human umbilical 
vein endothelial cells and is expressed relative to standard serum. Myocardial 
ischaemia was assessed by the greatest degree of ST shift recorded from 
intracoronary and surface ECG during balloon occlusion. 
873-2 Functional Capacity Following Emergency 
Revascularization in Cardiogenic Shock Patients: 
Preliminary Results From the SHOCK Trial 
Lynn A. Sleeper, Thierry H. LeJemlel, Emilie Godfrey, Nancy Avis, Michael 
H. Picard, Vladimir Dzavik, Deborah Tormey, Judith S. Hochman. For the 
SHOCK Investigator..; New England Research Institutes, Watertown, 
Massachusetts; St. Luke’s/Roosevelt Hospital, New York, New York, USA 
Results: 3 patients had CFI > 0.25 and 5 had inadequate collateral 
support; (CFI < 0.25). The maximal RMit in patients with a CFI < 0.25 was 
twice that in patients with CFI > 0.25 (7.3 Z+Z 1 vs 3.7 f 0.5 p = 0.04). Baseline 
RMit was 2.7 fold higher in the CFI c 0.25 group (7.6 f 1 .I vs 2.8 i 1.3 p = 
0.06). However, when normalized for the degree of ischemia during PTCA, 
the post ischemic serum RMit was 10.7 fold higher in the CFI > 0.25 group 
(8.6 i 4.4 vs 0.8 f 0.1 p = 0.03). 
Background: The multicenter randomized SHOCK Trial evaluated the im- 
pact of emergency revascularization (ERV) vs. initial medical stabilization 
with possible late revascularization (IMS) in 302 patients with acute myocar- 
dial infarction (Ml) complicated by cardiogenic shock. The primary endpoint 
was 30-day mortality and there was no difference by treatment group (P = 
0.11). At 12 months, preliminary data show an ERV survival benefit (45% vs. 
30% in IMS, P = 0.011). 
Methods: Secondary endpoints included functional capacity at 6 and 12 
months post-Ml. 
Conclusion: 1. The myocardium of patients with CFI > 0.25 produces 
significantly more mifogenic serum during during balloon occlusion compared 
to those with inadequate collaterals when corrected for the degree of ischemic 
stress. 2. These preliminary findings suggest inadequate collateral formation 
may result from impaired GF production for a given ischemic stress. 
ORAL 
I a73 Complications of Acute Myocardial Infarction 
Tuesday, March 14, 2000, IO:30 a.m.-Noon 
Anaheim Convention Center, Room 213C 
IO:30 a.m. 
III 873 1 Right Ventricular infarction Complicated by Cardiogenic Shock: Observations and Implications. 
The NHLBI SHOCK Registry 
Results: New York Heart Association (NYHA) Class at 6 months post-MI 
(n = 92 with 1 year followup, 96% complete) was 55% Class I; 17% Class 
II; 12% Class Ill; 15% Class IV but did not differ by treatment group (75% 
of ERV vs. 70% of IMS in NYHA Class l/II). Among patients with functional 
capacity data at 6 months, one year survival post-Ml was 89% with no 
difference by treatment group (Table; P = 0.19). The interaction between 
treatment modality and functional class (FC) was not significant (P = 0.23), 
but following ERV, one-year survival is similar for patients in Class l/II (95%) 
and Class III/IV (86%). In contrast, in patients randomized to IMS, one-year 
survival is correlated with FC (96% survival in Class l/II vs. 55% survival in 
Class Ill/IV). 
12-month Survival 
6.ma. NYHA Class l/II 
6.mo. NYHA Class Ill/IV 
All patients 
ERV IMS 
(n = 55) (n = 37) 
95% 96% 
86% 55% 
93% 84% 
Alice K. Jacobs, Jane A. Leopold, Sharada Modur, Lisa A. Mendes, 
Robert forman, E. Scott Monrad, Ravin Davidoff, Eric Bates, Jean Boland, 
Judith S. Hochman. Boston Medical Center, Boston, MA, USA 
Conclusions: Over two-thirds of cardiogenic shock survivors, regardless 
of treatment, have a preserved functional capacity six months post-Ml. Shock 
patients randomized to IMS who are Class III/IV at 6 months have the worst 
outcome. The association between FC and outcome is not observed in 
patients who undergo ERV. 
11:OO a.m. 
To determine the characteristics and outcome of patients with acute Ml 
complicated bycardiogenic shock (CS) due to right ventricular (RV) infarction, 
46 patients with predominant RV CS were compared with 884 patients with 
LV CS in the SHOCK Registry. Isolated RV CS was defined by clinical criteria. 
Clinical characteristics and treatments are shown: 
/ 873 3 Incidence, Risk Factors and Clinical Outcome of Stroke After Acute Myocardial Infarction in Clinical 
Practice 
Age (YN 
Male (%) 
Anterior MI (%) 
Prior MI (%) 
Heart rate (bpm) 
Cl (Umin) 
Lytic RX (%) 
PTCA (%) 
IAB 
Single vessel disease (%) 
Median hrs. MI to CS 
RV cs LV cs p value 
65.1 + 12.0 68.5 + 12.t 0.076 
52.2 63.6 0.121 
11.4 58.8 <O.OOl 
27.3 40.1 0.113 
63.9 i 24.9 95.2 & 25.7 0.019 
2.0 + 0.6 2.1 * 0.8 0.825 
50.0 34.4 0.039 
47.8 32.8 0.038 
50.0 52.6 0.764 
65.0 22.2 <0.0001 
2.9 6.2 0.002 
Harm Wienbergen, Rudolf Schiele, Anselm K. Gitt, Steffen Schneider, 
Tobias Heer, Jochen Senges. For the M/R and M/TRA Study Group; 
Herzentrum Ludwigshafen, Department of Cardiology, Germany 
Background: We analyzed incidence, predictors and mortality of stroke 
(hemorrhagic and ischemic) after acute myocardial infarction (AMI) in clinical 
practice in Germany. 
In-hospital mortality was similar (54.4 vs 60.8%) with (45.8 vs 39.9%) or 
without (63.6 vs 78.3%) revascularization between RV and LV CS groups 
respectively and multivariate analysis revealed RV (in comparison to LV CS) 
was not independently correlated with mortality (Odds ratio 0.925, 95% Cl 
0.466, 1.835). Despite less anterior Ml and more single vessel disease, lytic 
therapy and PTCA in RV patients, mortality rate is high and similar to LV CS 
patients. Although the impact of revascularization appears to be similar for 
RV and LV CS, mortality is high when RV CS is diagnosed and strategies to 
improve outcome in this high risk subset appear warranted. 
Methods: MITRA and MIR are two large German registries investigating 
treatment modalities for patients with AMI. From 6/94 to 2/98 22764 AMI- 
patients were consecutively included in the MITRA and MIR registries. A 
follow-up was performed after 1.5 years in the MITRA registry. 
Results: 259 (1 .l%) of the patients with AMI developed a stroke after 
hospital admission. These patients were 6 years older and had a higher rate 
of comorbidity including diabetes mellitus, previous stroke and previous AMI 
than patients without stroke. In a logistic regression model, previous stroke 
was the strongest predictor of stroke after AMI. Age P 70 years, heart failure 
and heart rate > IOOimin were independent predictors of posttherapeutic 
stroke. There was a trend without statistical significance, that thrombolysis 
was associated with a higher risk of stroke. 
Stroke No stroke OR 
~95%cw 
Previous stroke (%) 11.6 1.1 9.3 (6.0-14.2) 
Age > 70 years (%) 61.4 40.8 1.7 (1.3-2.3) 
Heart failure (%) 23.2 9.4 1.6 (1.2-2.2) 
Heart rate > lOO/min (%) 30.9 22.9 1.4 (1.1-1.9) 
Thrombolvsis (%I 33.2 40.5 1.3 (0.961.7) 
*Multivariate odds ratio and 95% confidence interval for the risk of occurrence of post- 
therapeutic stroke 
The hospital mortality of patients with stroke after AMI was as high as 
45.9% versus 14.8% of patients without stroke. The additional long-term 
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mortality of patients with posttherapeutic stroke after 1.5 years was 30.8% 
versus 11.5% of patients without stroke. 
Conclusions: In clinical practice the rate of stroke after AMI is 1.1% 
(hemorrhagic and ischemic). Previous stroke was the strongest predictor 
of stroke after AMI. Stroke after AMI has a poor prognosis short-term as 
well as long-term Nearly half of the patients with posttherapeutic stroke died 
in-hospital, another l/3 of patients died within the next 18 months. 
11:15 a.m. 
El 873 4 Benefit Versus Bleeding Complications After Thrombolysis for Acute Myocardial Infarction in 
Patients With History of Gastroduodenal Ulcers 
Anselm K. Gitt, Alexandra Ch. v. Bubnoff, Rudolf Schiele, 
Harm Wienbergen, Frank Fischer, Jochen Senges. Herzzentrum 
Ludwigshafen, Cardiology: Germany 
Background: The history of gastroduodenal ulcers (GU) is still a relative 
contraindication against thrombolysis in acute myocardial infarction (AMI) 
because of possible bleeding complications. Thrombolysis therefore is often 
withheld despite the possible benefit on mortality. 
Methods: In two German registries (MITRA = Maximal Individual Ther- 
apy of AMI; MIR = Myocardial Infarction Registry) out of 21416 consecutive 
patients with AMI 839 (4%) had a history of GU. Differences in gastroin- 
testinal bleeding rate and mortality were analysed in patients who received 
thrombolysis, primary PTCA or no recanalisation therapy. 
Results: Patients with AMI and history of GU did receive an acute re- 
canalisation therapy in 41% (Thrombolysis 31%, PTCA 10%). These patients 
were younger than the GU-patients without recanalisation therapy (63 vs 69 
years, p < 0.001). The number needed to treat to save one life (NNTL,~,) was 
IO in the Thrombolysis and the PTCA group whereas the number needed 
to treat to provoke one gastrointestinal bleeding (NNTG,~) was 40 for the 
Thrombolysis and 65 for the PTCA group. 
Thrombolysis 
n=261 
GI-Bleeding 5.3%* 
Transfusion 1.1% 
Hospital Mortality 8.8%” 
*p < 0.05 as compared to no reca. 
PTCA 
n = 80 
1.3%* 
0% 
8.7%* 
No Rem 
rl=498 
2.8% 
1 .4% 
18.9% 
Conclusion: Thrombolysis of AMI in patients with history of GU is as- 
sociated with a reduction of hospital mortality. Gastrointestinal bleeding was 
observed more often aider thrombolysis (NNTGI~: 40), but none was fatal. 
The beneficial effect of thrombolysis on hospital mortality exceeds the risk of 
gastrointestinal bleeding. 
11:30 a.m. 
El 873 5 Recurrent lschemia and Clinical Outcome After Thrombolvsis for Mvocardial Infarction: 
Observatibns FrominTlME II 
Wayne Warnica, Elliott M. Antman, Robert Wilcox, Carolyn McCabe, 
Karl Neuhaus, Eugene Braunwald. Universifyof Calgary, Calgary, AB, 
Canada; Brigham and Women’s Hospital, Boston, MA, USA 
Background: Recurrent ischemia (Ret Isch) after myocardial infarction (Ml) 
is associated with poor prognosis. The prevalence of and early clinical out- 
comes following Ret lsch after thrombolytic therapy have not been well de- 
scribed. 
Methods: InTIME II, a multinational study, compared tPA to the bolus 
thrombolytic nPA in pts < 6 h from Ml. Ret lsch (angina 2 IO min in-hospital 
or requiring re-hospitalization, emergency revascularization in-hospital or by 
30 days, and recurrent Ml by 30 days) occurred in 3413 (22.7%) of 15,059 
patients. 
Results: There was no difference between tPA and nPA in Ret Isch. 
Clinical events within 30 days (d) of the qualifying Ml were compared in 
those with and without Ret Isch. 
Events ( 30 d (%) 
N= 
Death (D) 
D/MI 
DIMliEmerg Revasc 
Severe CHF 
ICH 
D/MI/CHF/Stroke 
Any Revasc 
Maior Bleed 
Ret lsch No Ret lsch Total 
3413 11646 15059 
9.3 6.0 6.7 
28.5 6.0 11.1 
48.1 6.0 15.5 
4.4 1.8 2.4 
0.6 1.1 1 .o 
31 .o 7.7 1.3 
50.6 19.0 26.2 
1.1 0.4 0.5 
P 
<O.OOl 
<O.OOi 
<O.OOl 
<O.OOl 
0.0199 
<O.OOi 
<O.OOl 
<O.OOi 
No differences were seen in total stroke, disabling, and non-fatal strokes. 
Conclusions: Despite receiving thrombolysis ~6 h from MI, nearly one 
quarter of patients develop Ret lsch within 30 d. When Ret lsch occurs 
after thrombolysis, it is associated with a very high risk of early morbidity and 
mortality. This emphasizes the need to identify predictors of Ret lsch and 
effective management strategies when it develops. 
II:45 a.m. 
1873-6 1 Temporal and Regional Differences in Therapy for 
Reinfarction Following Thrombolysis: Results From 
GUSTO I and ASSENT II 
Michael P. Hudson, Gabriel I. Barbash, Christopher B. Granger, 
Yochai Birnbaum, Katrijn Houbracken, Karen S. Pieper, E. Magnus Ohman, 
Eric J. Topol, Robert M. Califf, Frans Van de Werf. Duke Clinical Research 
Institute, Durham, NC, USA; Sourasky Medical Center, Tel-Aviv, Israel 
Background: Reinfarction occurs in 4% of acute myocardial infarction pa- 
tients following thrombolysis and leads to increased morbidity and mortality. 
Therapies for reinfarction have not been systematically studied and include 
1) conservative management, 2) readministration of thrombolytic therapy, 3) 
emergent revascularization (PTCA and/or CABG). 
Methods: We explored mortality and stroke outcomes as well as the 
temporal and regional variation of different therapies for reinfarction in the 
GUSTO I (n = 41,021) and ASSENT II (n = 16,950) trials. 
Results: The incidence of reinfarction was 3.9% in GUSTO I and 4.1% in 
ASSENT II. In patients with reinfarction, 30-day mortality was 18% (GUSTO 
I) and 17% (ASSENT II). Overall stroke rates among reinfarction patients 
were 1.8% in GUSTO I and 1 .O% in ASSENT II. Intracranial bleeds occurred 
in (0.3%, l.l%, 0%) in the Conservative, Rethrombolysis, and Emergent 
Revascularization groups in GUSTO I and (O%, 0.3%, 1 .I%) in ASSENT II, 
respectively. Treatment strategies for reinfarction differed by region and trial 
as shown in the table. 
Conservative Mgmt. 
Fieadm. Thrombolytic 
Emergent Revasc. 
GUSTO I (1990-93) ASSENT II (1997-98) 
us Non-US us Non-US 
40% 42% 34% 35% 
39% 53% 18% 42% 
22% 5% 48% 23% 
Conclusions: A worldwide shift towards emergent revascularization and 
less frequent readministration of thrombolytic therapy was observed. Despite 
this change in treatment strategy for reinfarction, one-third of affected patents 
still receive conservative therapy and high mortality persists. 
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1148-l 35 Echocardiographic Determinants of Prognosis 
After Acute Ml: Beyond Ejection Fraction 
Mohsin Alam, Fareed Khaja, Steven Borzak, George Devine, Lois Graham, 
Sidney Goldstein, Hani Sabbah. Henry Ford Heart & Vascular Institute, 
Detroit, Ml, USA 
Background: Previous studies have shown depressed left ventricular ejec- 
tion fraction to be associated with poor prognosis after acute Ml, but hyperdy- 
namic non-infarcted segments may confound ejection fraction measurement. 
Methods: to assess the prognostic value of other measures of left ventric- 
ular systolic function, diastolic function, and shape changes, we performed 
a 2-D echocardiographic (echo) study in 490 consecutive patients with first 
acute Q and non-Q MI. All echo studies were performed with 48 hr of ad- 
mission. Ml complications including mortality (n = 54) and congestive heart 
failure (CHF n = 113) up to a median follow-up interval of 2 years were 
correlated with echo variables. 
Results: Measures of LV performance were independently associated 
with adverse outcomes by multivariate analysis (see table) 
Depressed left ventricular ejection fraction (<35%), after adjustment for 
LV score index and diastolic sphericity index, was not significantly associated 
with either mortality or CHF. 
Conclusion: Echo-doppler parameters of left ventricular score index, 
diastolic sphericity index and mitral deceleration time obtained with 48 hours 
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Echo variable 
LV mm index > 2 
Mortality RR 
1.9 
P value 
0.03 
CHF RR 
2.3 
P value 
0.001 
DT < 160 msec- 0.8 0.3 2.1 0.002 
LV sphericity 5 1.6 1.8 0.03 1.6 0.01 
RR = adjusted relative risk, DT = mitral deceleration time, LV = left ventricular 
of first acute MI are better predictors of late mortality and CHF than ejection 
fraction 
i-i 1148 136 Different Circadian Pattern in the Onset of Acute 
Myocardial Infarction in African-Americans 
Rajesh Sachdeva, Sanjay Dogra, Donald McMahon, Faiq SM. Akhter, 
Anekwe E. Onwuanyi. Harlem Hospital Center, Columbia University, New 
York, New York, USA 
Circadian variation in the occurrence of Acute Myocardial Infarction (AMI) 
has been widely reported albeit in predominantly non African-American (AA) 
populations with a peak incidence in the morning hours. This has been partly 
attributed to the effects of activation of the sympathetic nervous system 
(SNS). The activation of SNS has been reported to be different in AA with 
regards to blood pressure (BP). Nocturnal dip in the BP occurs less frequently 
in Blacks compared to Whites. We performed this study to determine whether 
there is a circadian variation in the occurrence of AMI in AA. 
Methods: Retrospective chart review of AA patients discharged with the 
final diagnosis of AMI from Jan. 1993 to Dec. 1996 was performed. The time 
of onset of symptoms (chest pain) was used in combination with CK-MB 
elevation to ascertain the time of onset of infarction. Of 197 patients chart 
reviewed 84 met the criteria for analysis. The mean age was 61 & 13.6 years, 
range 33 to 93 years; 50 were men with mean age 58.7 i 11.9 yrs. Mean 
age for women was 64.4 i 15.3 yrs. 
Results: The distribution of AMI by time of onset is shown by the graph: 
20 
15 
Li 
B 
10 
LL 
5 
Conclusion: A lower frequency of AMI was observed m me morning 
hours with peak occurrence at night hours. Whether this pattern is related to 
the reported lack of nocturnal dip in blood pressure in blacks remains to be 
determined. 
1148-l 37 Time Course of Early Elevation of Tissue 
Inhibitor of Matrix Metallooroteinase 1 (TIMP-11 
Following Acute Myocard/al Infarction ’ ’ 
Andrew D. McGavigan, M. Mitchell Lindsay, Paul R. Maxwell’, Francis 
G. Dunn. Departments of Medical Cardiology and ‘Biochemistry, Sfobhill 
Hospital. Glasgow, UK 
Background: Ventricular dilatation and remodelling are adverse prognostic 
indicators following acute myocardial infarction (AMI). Fibrosis is the major 
structural remodelling process and is the product of a dynamic flux be- 
tween synthesis and breakdown of collagen, Serological markers may be a 
useful non-invasive tool in monitoring dynamic changes of remodelling. We 
therefore investigated the changes in plasma levels of TIMP-1, a marker of 
inhibition of collagen degradation, following acute myocardial infarction. 
Methods: 15 patients presenting with suspected AMI were recruited to 
the study (6 anterior, 6 inferior and 3 site uncertain). All presented within 8 
hours of the onset of pain with one exception. Intravenous thrombolysis was 
administered in 11115 of the patients. Plasma TIMP-I was measured using 
a two step sandwich ELISA assay on sequential blood samples taken on 
admission, at 12 hours, 24 hours, then on days 2, 3, 4, and 30. 
Results: All patients, with one exception, had elevated plasma TIMP-I 
on admission compared with normal range (~280 rig/ml)-mean 959 ngiml 
(SEM 186, range 223-2415). Levels rose further within 24 hours and mean 
peak TIMP-I level was 2204 f 256 (range 924-4450). The rise from ad- 
mission to peak was significant (p < 0.05). By 30 days, levels had fallen 
substantially, mean 521 rt 64, range 189-903 (p < 0.05), although many 
remained persistently elevated above normal. 
Plasma TIMPI 
Mean @g/ml) 
SEM 
Range 
OIA 12h 24h Day 2 Day 3 Day 4 Day 30 
961 1331 1301 1203 999 907 521 
186 277 311 235 163 140 64 
223- 378- 441- 420- 273- 221- 189- 
2415 2520 4450 3570 2226 1911 903 
Conclusions: This study demonstrated a rapid rise and plateau of plasma 
TIMP-1 following AMI before returning towards baseline 30 days after the 
index event, suggesting a role for inhibition of collagen degradation in ven- 
tricular remodelling. Elevated levels on admission may reflect peri-infarction 
ischaemia. The rapid rise suggests that remodelling begins early following 
AMI which may have important implications with regard to the timing of 
initiation of cardioprotective strategies. 
1148-l 38 Serial Changes of Plasma Tissue Factor and 
Tissue Factor Pathway Inhibitor After Primary 
Angioplasty for Acute Myocardial Infarction 
Seiji Hokimoto, Hidso Ogawa’ , Hirofumi Soejima’ , Taro Saito, Katsuo Noda, 
Yasushi Moriyama, Fumiyuki Ishibashi, Shuichi Oshima. Kumamofo Central 
Hospifal, Kumamoto; ‘Kumamoto University: Kumamoto, Japan 
Background: Tissue factor (TF) is the primary initiator of the extrinsic coag- 
ulation cascade. Tissue factor pathway inhibitor (TFPI) is the major physio- 
logical inhibitor of TF. 
Methods: To examine the relation between TF and TFPI in acute my 
ocaridial infarction (AMI), we measured the plasma TF and freeTFPl antigen 
levels at admission, 4 hrs, 8 hrs, 24 hrs, 3 days and 7 days after successful 
PTCA in 26 consecutive patients with AMI (15 men and 11 women; mean 
age, 69 yrs). All patients were injected 10,000 U heparin on admission and 
drip infusion of heparin was continued at 10,000 U/day for 3 days. 
Results: As shown in table, plasma TF level already had been increased 
at the time of admission compared with control subjects (248 & 12 vs 177 
f 37 pgiml, p < 0.01) and decreased, thereafter, increasing at 3 days and 
reaching the same level as admission at 7 days. On the other hand, plasma 
TFPI was significantly increased on admission compared with controls (24.3 
f 3.1 vs 17.7 f 5.4 rig/ml, p c 0.01) and reached the peak level of 207 * 13 
rig/ml at 4 hrs after admission. Thereafter, TFPI level decreased but was still 
higher at 7 days than that of control. 
on admission 4 hrs 8 hrs 24 hrs 3 days 7 days 
TF 248 + 12 225i 13* 215 i 15* 21oi11* 225 * 15” 245i13 
TFPI 24 zk 3 207i 13’ 105+15# 49*10 35 * 7 32 i 5 
‘, #; p < 0.01 vs on admission, respectively, Data as Mean f SEM 
Conclusions: We demonstrated the serial changes of TF and TFPI in 
AMI, both levels were increased in the acute and sub-acute phase. Since 
the presence of thrombus on disrupted atherosclerotic plaque has been 
documented in AMI, it is possible that the specific inhibitor of TF by TFPI may 
reduce the thrombogenicity at the balloon-dilated site after primary PTCA for 
AMI. 
L-.-IL 1148 139 Different Time Frames for the Occurrence of 
Elevated Levels of Cardiac Troponin T and CRP 
in Patients With Acute Myocardial Infarction 
Robbert J. de Winter, Johan C. Fischer, Thyra de Jongh, Jan P. van 
Straalen, Rudolph W. Koster, Radha Bholasingh, Gerard T. Sanders. 
Academic Medical Center, University of Amsterdam, The Netherlands 
Introduction: Myocardial damage leads to a release of cardiac Troponin 
T (cTnT) and also induces an increase in CRP. Both an abnormal cTnT 
and an abnormal CRP are important independent prognostic indicators in 
patients with acute coronary syndromes. Therefore, to establish optimal 
timepoints for their measurement in acute myocardial infarction (AMI), we 
investigated the possible existence of differences in release characteristics 
of both parameters, 
Methods: 78 Patients (pts) with a severe AMI (characterized by CK-MB,,,, 
> 120 fig/L within 24 hours and ~7.5 pg/L (= URL) on admission) were in- 
cluded. cTnT was measured with the ES-300 ELISA (Roche, Germany, URL 
= 0.1 fig/L). CRP was measured with a nephelometric assay (Dade, Ger- 
many, URL = 5 mg/L). The cumulative proportion (C%) of patients with an 
abnormal cTnT and CRP was calculated. 
Results: see table. Only 4 pts of this population with severe AMI had an 
elevated CRP at t = 3 hrs (of which 3 pts had a [CRP] < 8 mg/L). At 6 hrs 
after onset of symptoms cTnT and CRP are elevated in 82% and 31% of pts. 
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Time after event 
(hours) 
t=3 
t=6 
t=12 
t=24 
E % pts with [cTnT] 
>O.l /.LgiL 
38 
82 
100 
100 
X % pts with [CRP] 
>5 mg/L 
12 
31 
54 
82 
respectively. Considering all timepoints, it was noted that the levels of cTnT 
became elevated within a much smaller time frame than those of CRP. 
Conclusion: This result indicates a different behaviour of cTnT and CRP 
in patients with acute myocardial infarction: elevation of cTnT occurs within 
a much smaller time frame than elevation of CRP. This has implications for 
the timing of the measurements of cTnT and CRP for prognostic purposes. 
1148-I 40 Soluble Matrix Metalloprotease (MMP)-9 Levels 
in Systemic and Coronary Circulation in Patients 
With Variant Angina and Acute Coronary Artery 
Syndrome (ACS) 
Ji Won Son, Kwang Kon Koh, Wan Kim’, Min Soo Sohn, Eak Kyun Shin. 
Cardiology, ‘Clinical Pathology, Gachon Medical School, Inchon, Korea 
Atherosclerotic plaques prone to rupture show induction and activation of 
MMP-9 in vascular smooth muscle cells and infiltrating macrophages. Syn- 
thesis of MMP-9 has been reported in patients (pts) with unstable angina, 
suggesting a pathogenic role of MMP:9 in the development of ACS. We ex- 
amined plasma levels of MMP-9 (rig/ml) in order to investigate the changes 
during acute ischemic events caused by ergonovine stimulation in pts with 
control (C) and proven variant angina (VA) and atrial pacing in pts with stable 
exertional angina @A), and in pts with acute myocardial infarction (AMI). A 
group (10 pts) of age and sex matched controls were studied for comparison. 
We withdrew blood from coronary sinus (CS) and aortic root (Ao) before and 
after inducible ischemia and from venous blood in pts with AMI. There was 
a significant increase of MMP-9 levels in pts with AMI compared with other 
groups (P = 0.005 by ANOVA on Ranks). However, there were no significant 
differences among C, VA, and SA before and after. Higher levels of MMP-9 
in AMI indicate that MMP-9 may play an important role via plaque rapture in 
rite onset of AMI. In contrast, MMP-9 may not be important in causing acute 
ischemic events in pts with VA or SA. suggesting different mechanisms from 
AMI. 
Control VA SA AMI 
Before After Before After Before After 
CS 48f12 47zt12 93zb49 77&43 140&202 132+210 
A0 45119 62152 74zt23 95i43 103zki51 84584 267zt291’ 
CS-Ao 3 zt 8 -15dc49 2Odc48 -18f29 38h59 48 ~b 127 
Data = mean + SD. “P = 0.005 by ANOVA and P < 0.05 by post-hocvs C, VA, SA 
Ll.--l 1148 141 Evaluation of Cardiac Troponin I Kinetics Profile in Patients With Acute Coronary Syndrome 
S.H. Baird, T.G. Trouton, M. Ryan, P. Auld, C. Wilson. Department of 
Cardiology, Antrim Area Hospital, Co. Anfrim, UK 
Objectives: To evaluate the release and elimination kinetics of cardiac Tro- 
ponin I (cTnl) in patients with acute coronary syndrome (ACS). 
Method: We studied 40 consecutive patients with ACS whose onset of 
maximal chest pain (time 0) was less than six hours prior to admission. Serum 
cTnl was measured on admission and then six hourly from time 0 until 24 
hours at which time, if the routine clinical 12 hr cTnl sample was elevated 
(cTnl 2 0.5 pg/L), further samples were taken every 12 hours up until 72 
hours and then regularly until cTnl levels returned to normal. 
Results: The moan delay time from onset of maximal chest pain to 
admission was3.1 (SEM & 0.2) hours. Elevated cTnl levels were detected in 
27 out of the 40 patients and of these 25 had a discharge diagnosis of ACS, 
the remaining 2 patients were diagnosed as having myocarditis. Of these 
25 patients 9 had a maximal cTnl rise less than 25 @g/l, 8 had a maximal 
cTnl rise of between 25 and 150 kg/l and 8 had a maximal rise above 150 
pg/l. The sensitivity of cTnl measurements taken prior to the 5 hour time 
point was 52% reaching 93% for the 6 hour sample and 100% for 12 hours; 
the mean maximal elevation was reached in 17.5 (SEM f 1.6) hours. The 
release kinetics of cTnl in patients given thrombolysis (n = 11) compared to 
those who were not (n = 14) was not statistically significantly different, cTnl 
was eliminated with zero order kinetics with a half life of 23.3 (SD f 1.3) 
hours, the mean elimination time was 187.6 (SEM f 19) hours. Of the 13 
patients in whom the 12-hour clinical cTnl sample was not elevated all other 
samples taken were also not elevated. 
Conclusion: The measurement of cTnl to provide optimal sensitivity 
should be delayed until 6 to 12 hours after the onset of maximal chest pain. 
If accurate assessment of peak elevation is required this should be delayed 
until 17 hours from the onset of maximal chest pain. 
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/ 1149 67 Inflammatory Markers Fail to Predict Three Month Outcome in Unselected Patients With Chest Pain 
Presumed Secondary to Myocardial lschemia 
Graham S. Hillis, Carol Terregino, Pamela Taggart, Ning Zhao, 
Anthony Killian, William C. Dalsey, Antoinette Mangione. Albert Einstein 
Medical Center, Philadelphia, Pennsylvania; Cooper Hospital/university 
Medical Center, Camden, New Jersey: USA 
Background: Elevated C-reactive protein (CRP) levels predict an adverse 
outcome in selected patients with an acute coronary syndrome (ACS). 
Whereas CRP is a non-specific inflammatory marker, soluble intercellular 
adhesion molecule-l (slCAM-1) levels reflect inflammation within the vascu- 
lar tree. We hypothesised that plasma slCAM-I levels would be of prognostic 
value in unselected patients with chest pain. 
Methods: One hundred and twenty three consecutive patients with 
chest pain, thought clinically to represent myocardial ischemia, were stud- 
ied prospectively. Subjects with conditions that affect slCAM-I levels were 
ineligible and 4 patients who had such conditions diagnosed during their 
admission were excluded. Cardiac troponin I (cTnl), creatine kinase-MB,,,,, 
CRP and slCAM-I were assayed at presentation. Positive levels were de- 
fined prospectively as 20.2 rig/ml, >5 rig/ml, >I mg/dl and 2260 rig/ml 
respectively. Patients were followed up for 3 months and serious cardiac 
events (SCEs) - defined as cardiac death, myocardial infarction, coronary 
revascularisation and readmission with an ACS - were recorded. 
Results: Complete follow up data was available on 108 patients, of whom 
35 (32%) patients experienced an SCE. Cardiac Tnl was the only independent 
predictor of a patient having a SCE during follow up (p < 0.001). 
Conclusion: Neither of the inflammatory markers tested were predictive 
of early outcome in unselected patients with chest pain. In contrast, cTnl is a 
powerful predictor of early SCEs in such patients. 
1149-68 C-Reactive Protein as a Useful Marker for Acute 
Coronary Syndrome Manifested With Acute Chest 
Pain 
Ting-Hsing Chao, Yi-Heng Li, Wei-Chuan Tsai, Chih-Hsien Chi, 
Liang-Miin Tsai, Shih-Hung Chan, Li-Jen Lin, Jyh-Hong Chen. National 
Cheng Kung University Hospital, Jainan, Taiwan, ROC 
Background: C-reactive protein (CRP) and cardiac troponin I (cTn-I) have 
been reported to be increased in acute coronary syndrome (ACS) but their 
roles in diagnosis of ACS is not well defined. We hypothesized that CRP 
could be a useful marker for ACS in patients (pts) with acute chest pain 
(ACP). 
Methods: We prospectively evaluated 214 consecutive eligible pts with 
ACP presented at our emergency room within 4 hours after chest pain onset. 
Subjects with clinical conditions affecting CRP were excluded. Serum levels 
of CRP and cTn-I were measured at 4, 8, 12, 12-24 h after onset. Study 
subjects were divided into two groups based on the final diagnosis: group I 
(n = 124, age 63 f 13 y), ACS; group 2 (n = 90, age 57 f 13 y), non-ACS. 
The optimal cutoffs of both serum markers were determined by the receiver 
operating characteristic (ROC) methodology. 
Results: The peak levels of CRP and cTn-I were significantly higher 
in group 1 than those in ACSroup 2 (1.2 f 1.4 vs 0.7 i 1.7 mg/dL, p = 
0.01; 21.8 f 32.1 vs 0.8 & 1 .O kg/L, p < 0.001). By ROC curve analyses, the 
optimal levels of CRP and cTn-I for the discrimination of ACS were 0.4 mg/dL 
and 1.2 fig/L (areas under curves were 0.844 and 0.825, respectively). The 
ratios of sensitivity and specificity of the CRP and cTn-I were 92%:78% and 
71%:93%, respectively. In the early stage (<4 h), the serum level of CRP 
was more sensitive than those of cTn-I with lower specificity (sensitivity: 81% 
vs 15%; and specificity: 82% vs 93%). When initial ECGs were added for 
parallel analyses in the early stage (ECG or CRP ~4 h, ECG or cTn-I 44 h), 
the sensitivities of CRP and cTn-I were increased markedly (97% and 76%) 
with a small change of specificity (80% and 91%). 
Conclusion: In pts with ACP, CRP is a sensitive marker for detecting 
ACS and cTn-I is less reliable because of low sensitivity, especially in the 
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early stage. With adjunct usage of ECG criteria, the screening power of the 
early CRP level for ACS is increased markedly with minimal influence on the 
specificity. CRP level may be a useful tool in addition to ECG criteria in the 
early diagnosis of ACS. 
1149-69 Elevated Levels of C-reactive Protein in Pts With 
Acute Myocardial infarction are a Predictor of 
Mortality and Heart Failure But Not of New 
Coronary Events 
Carlo Schweiger, Gianna Fabbri, Claudio Fresco, Donata Lucci, 
Piera Merlini, Paolo Mocarelli, Ernest0 Murena, Silvio Siciliano, Aldo 
P. Maggioni. On behalf of LATlN Investigafors, ANMCO Research Center, 
Florence, Italy 
While elevated levels of C-reactive pro?ein (CRP) were shown to be associ- 
ated with a worse outcome in pts with unstable angina, their prognostic role 
in pts with AMI has not been well described. Further it is unclear if this inflam- 
matory marker is independently associated with new ischemic events or with 
pump complications. We assessed the prognostic role of CRP levels mea- 
sured the morning after the admission in 1157 pts with AMI, within 12 hours 
from pain onset, in 59 Italian CCUs. We excluded from the analysis pts with 
(a) a recent episode (within 1 month) of an inflammatory/infective disease; 
(b) a recent (within 2 months) hospitalization for any reason. A multivariate 
analysis was performed to identify the 3-month independent predictors of: a) 
total mortality; b) the combined measure of death, reAMI or post Ml angina; 
c) the combined measure of death or congestive heart failure (HF). In the 
multivariate model CRP levels were considered in quartiles. 
Baseline characteristics were: mean age 63 f 12, female gender 23%, 
history of diabetes 17%, prior AMI 12%, angina in the 48 hours preceding the 
admission 36%, Killip class at entry >I 21%, anterior Ml 39%, reperfusion 
therapy (thrombolysis or primary PTCA) 65%. Mean CRP levels were 29.2 
i 36.8 &mL. At the 3-month follow-up, death occurred in 68 pts (6%), the 
combined event rate of death, AMI or recurrent angina in 353 (31%), death or 
HF in 215 (19%). While CRP serum concentrations were not independently 
associated with total mortality or death plus recurrent ischemic events, the 
risk of death plus congestive HF increased with increasing levels of CRP. 
Multivariate analysis confirmed that to have CRP levels in the highest quartile 
(>34.2 &mL) is an independent predictor of 3-month death or HF (OR 
2.16, 95% Cl 1.29-3.61). Other independent predictors of death + HF were 
age (OR 1.07, 95%CI 1 .OS-1.09); history of diabetes (OR 1.66, 95%CI 
1.10-2.51); Killip at entry >I (OR 2.57, 95%CI 1.78-3.71); high HR (OR 
1.02, 95%CI 1.01-1.03); low SBP (OR 1 .Ol, 95%CI 1.00-l .02); large Ml (CK 
peak more than 6-fold the upper normal value) (OR 2.66, 95%CI 1.80-3.95). 
In conclusions, elevated CRP in pts with Ml correlates more with infarct 
extent and pump complications than with recurrent ischemic events. 
I 1149- / 0 C Reactive Protein and Cardiac Troponin I as Predictors of Major Cardiac Events in Patients 
With Unstable Angina 
S.H. Baird, T.G. Trouton, M. Ryan, P. Auld, C. Wilson. Department of 
Cardiology, Antrim Area Hospital, Co. Anfrim, UK 
Objectives: To evaluate the ability of serum C reactive protein (CRP) and 
cardiac Troponin I (cTnl) measurements to produce risk stratification in pa- 
tients admitted with unstable angina. 
Methods: We studied 282 consecutive patients admitted to the coronary 
care unit with the clinical diagnosis of unstable angina and subsequent 
normal series of creatine kinase (CK)/CKMB (CK 4 200 lu/L or CKMB 
< 6%). CRP was measured on admission and serum cTnl measured at 
12 hrs from maximal chest pain, their ability to identify high and low risk 
patient sub-groups was assessed by determining the accuracy with which 
they predicted subsequent major cardiac events (death, Ml) during 90 days 
follow-up. 
Results: One hundred and eighty three patients with a positive CRP (13 
mg/L) had a risk of a major cardiac event during 90 days follow-up of 4.4% 
compared to 3.0% (p = NS) in those with a negative CRP (n = 99). Eighty 
one patients with a positive cTni (10.5 @g/L) had an event rate of 11.1% 
compared to 1.0% (p = 0.0001) in those with a negative cTnl (n = 199). 
Fifty-nine patients with both a positive CRP and cTnl had an event rate of 
10% compared to 2.2% (p = 0.005) in those patients with either one or both 
CRP and cTnl negative (n = 223). 
Conclusion: The measurement of cTnl in patients with unstable angina 
significantly improves risk stratification, the addition of a positive CRP does 
not add further diagnostic benefit. CRP on its own in this study failed to 
orovide accurate risk stratification. 
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1150-71 Prior Bypass Surgery Protects the Diabetic 
Patient in the Settino of Spontaneous Q-Wave 
Myocardial infarction 
Manuel S. Lombardero, Katherine M. Detre, Bernard R. Chaitman, 
George Sopko, Maria Mori Brooks, Regina M. Hardison, Robert L. Frye. 
University of Pittsburgh, Pittsburgh, PA: St. Louis University Medical Centec 
St. Louis, MO, USA 
Background:The Bypass Angioplasty Revascularization Investigation (BARI) 
reported in 1995 that treated diabetic patients had better 5-year survival fol- 
lowing an initial strategy of CABG surgery compared to angioplasty. The aim 
of this study is to investigate the role of myocardial infarction (Ml) in this 
survival difference. Previous studies have demonstrated better prognosis 
following CABG compared to medical therapy among patients with MI. It is 
also known that mortality following Ml is considerable higher among diabetic 
patients compared to non-diabetic patients. 
Methods: Patients used in this analysis include all BARI patients who 
were eligible for randomization (N = 4,107, 445% actually randomized). This 
analysis focuses on the occurrence of myocardial infarctions which meet the 
most stringent definition of Q-wave myocardial infarction (QMI), based on 
either the Minnesota code interpreted by a BARI Central EGG Laboratory, 
or an independent Mortality and Morbidity Classification Committee. QMls 
analyzed excluded those that were suspected of being “procedure induced” 
due to their temporal proximity (57 days) to a previous revascularization 
procedure. At the average follow-up time of 5.5 years vital status was ascer- 
tained in 98% of the patients. For patients who never experienced a QMI, 
mortality rates were estimated from the time of the initial revascularization; 
otherwise, they were estimated from the time when the QMI occurred. 
Results: The mortality for 641 treated diabetic patients in BARI is shown. 
For these patients, the reduction of 5-year mortality due to CABG (17% with 
prior CABG vs 80% with only PTCA) is much more dramatic following QMI 
than that found in the absence of QMI (16% vs 22%, respectively). Among the 
2,962 non-diabetic patients in BARI no protection from CABG was evident in 
either the setting of QMI @-year mortality rates 30% for CABG vs 27% for no 
CABG, NS) or no QMI (7% vs 6%, NS). 
Conclusion: It appears that the protective effect of CABG in BARI diabetic 
patients is most prevalent in those who sustained a severe nonprocedural 
myocardial infarction. 
1 1150-72 1 Seasonal Variation of Myocardial Infarct Size in 
Humans 
Robert A. Kloner, Sutapa Das, W. Kenneth Poole, James Muller, Christopher 
P. Cannon, Eugene Braunwald. Good Samaritan Hospital, University of 
Southern California, Los Angeles, CA; Research Triangle Institute, 
Research Triangle Park, NC; Massachusetts General Hospital, Boston MA; 
Brigham and Womens Hospital, Harvard Medical School, Boston MA, , USA 
Background: Recent population-based studies have repotted seasonal vari- 
ation in cardiac death. Whether the size of a myocardial infarction (Ml) varies 
with seasons is unknown. 
Methods: In a hypothesis-generating analysis we examined two databases 
of large multicenter Ml studies, the MILIS study (primarily a non-reperfu- 
sion study) and the TIMI- study (a thrombolytic-based study), to determine 
whether Ml size (based on CK analysis) fluctuated with seasons. 
Results: In the MILIS study (n = 852) Ml size assessed by mean CK-MB 
index was 15.8 infarct size index (ISI) units during winter (December, January, 
February), 16.7 during the spring (March, April, May), and lowest during the 
summer (June, July, August) at 13.0 and autumn (September, October, 
November) at 13.5 (P = 0.041 for summer versus the rest of the year; P = 
0.009 for summer versus spring). In the TIMI- study (n = 400), the estimate 
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of MI size determined by CK-MB averaged over 14 time points also revealed 
the smallest MI size during summer (101 CK-MB U/L) versus winter (IIZ), 
spring (138) or autumn (134), (P = 0.082 for summer versus the rest of the 
year; P = 0.055 for summer versus spring). In both studies, estimates of 
infarct size were smallest during the summer months. 
Conclusions: There is a seasonal variation in the size of myocardial 
infarction such that reperfused and non-reperfused MIS exhibit the smallest 
size during the summer. Seasonal variation is therefore a new, previously 
unrecognized determinant of the amount of necrosis that occurs with MI in 
patients. 
1 ii 50-73 1 Incidence and Prognosis of Non-Q Wave MI in the 
Thrombolytic Era: Insights From ASSENT II 
Yuling Fu, Shaun Goodman, Wei-Ching Chang, Aiala Barr, Maritza Lagos, 
Pushpa Jagasia, Frans Van de Werf, Christopher Granger, Paul 
W. Armstrong. For the ASSENT /I Investigators, University of Alberta, 
Edmonton, Alberta, Canada 
We performed systematic ECGs amongst acute ST elevation myocardial 
infarction (Ml) patients in ASSENT- II (TNK vs t-PA; overall 30-day mortality 
6.17%) in order to evaluate the incidence and temporal evolution of non-Q 
wave MI and its impact on survival. 
The table shows the incidence of Q vs non-Q wave Ml and associated 
short-term mortality rates for those patients surviving to hospital discharge 
in whom 3 ECG’s free of LBBB and other confounders were available at 
baseline, 24-48 hours and hospital discharge. Amongst 10,665 such pa- 
tients, there was a conversion of 11.7% patients from Q to non-Q wave Ml 
and 28.4% from non-Q to Q wave Ml between 24-48 hours and hospital 
discharge. 
Q wave MI Non-Q wave MI 
Incidence 30-d mortality Incidence 30 d mortality 
24-48 hours 8671 (81.3%) 1.9% 1994 (18.7%) 2.1% 
Hospital discharge 8224 (77.1%) 1.3% 2441 (22.9%) 4.0%* 
Higher mortality in non-Q Ml patients at discharge (* p < 0.001) was due 
to excess mortality (6.2% in patients who crossed over from Q to non-Q as 
opposed to 1.4% in patients from non-Q to Q wave Ml). These data from 
the thrombolytic era highlight the dynamic nature of non-Q wave develop 
ment, and demonstrate that the timing of its ascertainment after AMI has an 
important impact on its incidence and short-term prognostic significance. 
I 1150 74 Prior Ml or Angina and the Risk From Acute Myocardial Infarction: Observations From InTIME 
II 
Robert Wilcox, Andrew Charlesworth, Elliot Antman, Eugene Braunwald, 
Karl Neuhaus. Nottingham University Hospital, Nottingham, UK; Brigham 
and Women’s Hospital, Boston MA, USA; Kassel, Germany 
Background: The InTIME- trial compared single bolus lanoteplase with 
accelerated alteplase. Of 14082 randomised patients, 71% had no prior 
myocardial infarction (Ml) or angina (A). They were younger (59 v 64 yrs), 
had a lower prevalence of hypertension (25 v 34-47%), diabetes (12 v 
16-22%) and Killip class II-IV on admission (10 v 15-24%) than patients 
with prior Ml (7%), A (13%) or both (8%). Despite a higher index acute Ml 
(97% v 90-94%) they had significantly less heart failure (8 v 11~17%) and 
30 day mortality (5 v g-12%). 
Results: 
MI/A MI A Neither 
30 d death 11.9 7.7 9.6 5.2 
Total stroke 1.7 2.0 2.5 1.5 
ICH 0.7 1.0 1.4 0.9 
30 d death + disabling stroke 12.1 8.2 10.3 5.6 
Recurrent MI 7.9 6.9 5.7 4.6 
30 d death + RMI 17.2 13.7 14.1 9.2 
Emerg revasc 6.0 6.1 4.7 5.6 
Elective revasc 14.6 21 .o 16.0 19.0 
After mulltivariate adjustment for 14 significant prognostic demographic 
and risk factors the relative risk of death was significantly increased for Ml & 
A (1.56), Ml (1.47) and A (1.42) compared to those patients with no history. 
Conclusions: Prior Ml or angina significantly increases the rate of death 
and serious clinical events in patients with AMI who are eligible for thrombol- 
ysis for reasons other than known risk factors. 
1 1150-93 1 Prevalence of Coronary Artery Disease in Black 
and White Patients With Acute Myocardial 
Infarction 
Russell F. Kelly, Ahmed S. Hashim, Joseph E. Parrillo, James E. Calvin. 
Rush-Presbyterian-St. Luke’s Medical Center and Cook County Hospital, 
Chicago, IL, USA 
Background: Studies have suggested that black patients undergoing coro- 
nary angiography may be less likely to have significant coronary artery 
disease (CAD). The purpose of the present study was to compare the preva- 
lence of CAD in black and white patients undergoing angiography after acute 
myocardial infarction (Ml). 
Methods: A total of 426 black and white patients undergoing angiography 
at an inner-city public hospital after a recent Ml were studied. The preva- 
lence of significant CAD (>50% stenosis in a major vessel) were compared 
between blacks and whites, and multivariate regression analysis was per- 
formed to determine whether race was a significant independent predictor of 
CAD. 
Results: More black Ml patients than white patients were female (45% 
vs 27%, p = 0.01) and hypertensive (71% vs 44%, p < 0.001); age and other 
CAD risk factors were similar. Black patients were significantly less likely 
than whites to have CAD (78% vs 90%; OR 0.38, 95% Cl 0.17-0.87; p = 
0.02). On multivariate analysis, black race remained significantly associated 
with a lower likelihood of CAD after adjustment for age, gender, and other 
CAD risk factors (OR 0.32; 95% Cl 0.14-0.73; p < 0.01). 
blacks 
whites 
no CAD 
22% 
10% 
1 vessel 
33% 
40% 
2 vessel 
19% 
26% 
3 vessel 
23% 
16% 
left main 
3% 
9% 
Conclusions: Black patients undergoing coronary angiography after re- 
cent Ml were significantly less likely than whites to have significant CAD, 
even after adjustment for differences in baseline clinical characteristics. The 
reasons for the lower prevalence of CAD in blacks with Ml remain unknown. 
I 1150 94 Timing of Cardiogenic Shock is an Independent Predictor of Outcome 
Israel M. Barbash’, Alexander Battlera, Solomon Behars, Shmuel Gottlieb3, 
Valentina Boyko3, David Hasdai3, Ruben llia’ , Jonathan Lear’ For The 
Israeli Thrombolytic Survey Group; ‘Cardiology Department, Soroka 
Medical Center, Beer-Sheva; ‘Cardiology Department, Rabin Medical 
Center; 3Neufeld Cardiac Research Institute, Tel-Hashomer, Israel 
Background & Methods: To evaluate the incidence, significance and out- 
come of cardiogenic shock (CS) before vs. after hospital admission, we 
analyzed data of 4304 consecutive acute myocardial infarction pts admitted 
to 26 CCU’s in Israel during 1992-i 996. Of them, 180 pts (4.2%) developed 
cs. 
Results: 100 CS pts (56%) developed shock before admission. 
Shock before Shock after P 
Admission Admission 
Aae (vrs * SD) 
n=100 n = 80 
69fl2 73f 11 0.02 _._ 
Females 38% 54% 0.04 
Diabetes 43% 45% 0.79 
Hypertension 38% 55% 0.02 
Previous MI 35% 43% 0.30 
Ant. Ml 54% 53% 0.92 
Thrombolysis 23% 43% 0.005 
Angiography 22% 15% 0.23 
PTCA 21% 9% 0.02 
Mortality 
7-day 61% 79% 0.01 
30.day 71% 89% 0.004 
1 -year 75% 95% <O.OOl 
After multiple adjustments, CS before admission (OR = 0.20, 95%CI 0.05-0.56), and 
PTCA (OR = 0.23, 95%CI 0.08-0.61) were strongly associated with a better l-year sur- 
vival. 
Conclusions: In contrast to current knowledge and results of clinical trials, 
our national registry indicates that half of the CS pts develop shock before 
hospital admission. We found variations in characteristics, management and 
outcome of CS before vs. after admission. Pre-hospital shock and PTCA 
were associated with improved survival. 
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p-? 1150 95 Angiographic Characteristics Associated With the 
Development of Q-Wave Myocardial Infarction 
Sabina A. Murphy, James de Lemos, C. Michael Gibson, Colin Hynes, 
Timothy Saunders, Rebecca Mesley, Robert Zemble, Susan J. Marble, 
Carolyn H. McCabe, Elliot M. Antman, Eugene Braunwald. Forfhe T/A0 
Study Group, University of California San Francisco, Brigham & Women’s 
Hospital, Boston, USA 
Background: Without lytic therapy, patients with non-Q-wave MIS have pre- 
viously been shown to have lower mortality rates than patients with Q-wave 
MIS. The goal of this study was to examine the angiographic differences 
between non-Q-wave MIS and Q-wave MIS following thrombolysis. 
Methods: Angiography was performed 90 minutes after thrombolytic 
administration in the TIMI 14 trial (tPA vs low dose lytic + abciximab). The 
development of a Q-wave Ml was assessed by the clinical investigator. The 
cineframes required for contrast to first reach distal landmarks (Corrected 
TIMI Frame Count, CTFC) and other angiographic features were assessed. 
Results: The qualifying Ml developed into a Q-wave Ml in 64% of patients 
in TIMI 14 (5631878). Angiographic features of the two syndromes are shown 
below: 
Q-wave MI Non-Q-wave MI P-ValUe 
CTFC (frames) 5!&3* 35.1 45.5 * 30.7 0.009 
TIMI Grade 3 Flow (%) 54.4 66.3 0.001 
90 min. ejection fraction (%) 54.6 + 14.5 59.5 * 14.1 0.0009 
Presence of thrombus (%) 34.4 26.8 0.03 
Presence of collaterals (%) 16.0 17.3 0.64 
!-AD infarct (%) 36.4 41.0 0.17 
Mortalitv at 30 davs (%) 3.5 3.8 0.85 
Reinfar&ian at 3d days (%) 2.7 2.2 0.69 
Conclusion: At 90 minutes following thrombolytic therapy with or without 
abciximab, coronary blood flow was slower and ejection fractions were lower 
in patients who developed Q-wave MIS in TIMI 14. However, the 30 day 
clinical outcomes of patients who sustained a Q-wave Ml in the modern 
thrombolytic era were similar to those who did not evolve a Q-wave MI. 
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/ 1151-96 [ Depression Following Acute Coronary Syndrome 
is Associated With a High Risk for Recurrent 
Acute lschemic Cardiac Events 
Tasneem Z. Naqvi, Syed A. Naqvi, Haider A. Sadeghi-Razlighi, 
Noel Bairey-Merz, Bojan Cercek, Peter Panzarino Jr.. Cedars-Sinai Medical 
Center, UCLA School of Medicine, Los Angeles, CA, USA 
Background: We examined the effect of depression on rate of recurrent 
acute ischemic cardiac events and the effect of treatment of depression on 
recurrent acute cardiac ischemic events following unstable angina (UA) or 
acute myocardial infarction (MI). 
Methods: We assessed the prevalence of depression by a mailed Zung 
Self Assessment Questionnaire two weeks post discharge for UA or Ml. 
Depressed patients (pt) were offered treatment in a 4 month randomized 
study involvitig psychotherapy with or without Paxil. 
Results: A total of 253 pts (68 * 14 years) were sutveyed. The response 
rate was 67% overall (n = 166). Depression was present in 70 patients and 
was equally prevalent in males and females (48 vs 51%). Depressed patients 
tended to be older (71 i 13 vs. 57 f 14 years, P = 0.078), however, there 
was no difference in history of previous Ml, diabetes mellitus, hypertension, 
smoking, or history of cardiac revascularization in the two groups. There 
was similar use of cardiac catheterization, severity of angiographic coronary 
artery disease, use of aspirin, beta-blocker, ACE inhibitor and lipid lowering 
therapy and left ventricular ejection fraction (0.47 * 0.11 vs 0.49 * 0.17) at 
the initial admission for UA or Ml in depressed and non-depressed patients. 
Follow-up period was 9 f 4 months in depressed and 9 f 5 months in non- 
depressed patients. 12/70 depressed patients participated in the randomized 
treatment. The incidence of readmission for acute MI or UA during follow-up 
was significantly higher in the untreated depressed patients (31.5%) vs non- 
depressed patients (13.8%) or depressed patients on treatment (8.3%, p = 
0.02, 2 x 3 chi square table). 
Conclusion: 1) The prevalence of depression following acute UA or Ml 
is substantial; 2) Depressed patients have a significantly higher incidence for 
recurrent acute ischemic cardiac events compared to nondepressed patients 
despite similar co-morbidity and 3) Preliminary results suggest that treatment 
of depression following UA or Ml may reduce further acute ischemic cardiac 
events. 
I 1151 97 Prior Aspirin Use is a Univariate, but NOT a 
Multivariate Predictor of 1 Year Mortality in 10,302 
Patients With Acute Coronary Syndromes: 
Results From OPUS-TIM1 16 
Peter J. Sharis, Christopher P. Cannon, Carolyn H. McCabe, 
Andrew Charlesworth, Eugene Braunwald. Brigham and Women’s Hospital, 
Boston, MA, USA 
Background: Prior studies have suggested that patients who develop un- 
stable angina while taking aspirin (i.e. prior ASA users) are at higher risk of 
recurrent events than patients who develop unstable angina de novo. 
Methods: To address this issue in the full spectrum of acute coronary 
syndromes, we used the OPUS-TIM1 16 database (N = 10,302). We evaluated 
mortality and composite events (death, Ml, recurrent ischemia, or stroke), 
and used multivariate (MV) analysis to control for differences in baseline 
characteristics. 
Results: Prior ASA users were older (63 vs. 59 yrs), had more frequent 
evidence of prior coronary disease (Ml, angina, coronary bypass, surgery). 
(all p 5 0.001) One year outcomes are shown: 
Prior ASA No Prior ASA MV Odds ration (95% Cl) 
Death 4.9 3.4 0.99(0.77-1.27) 
Death/Ml 10.8 6.8 1.12 (0.94-1.34) 
Composite 25.3 17.7 1.05 (0.94-I .18) 
In a Multivariate analysis, however, prior ASA use was not a significant 
predictor of death or recurrent events, whereas age, prior MI, congestive 
heart failure, peripheral vascular disease, diabetes and other risk factors 
were. 
Conclusions: Although prior aspirin users who develop ACS have higher 
event rates, this appears to be a marker of prior cardiovascular disease and 
not an independent prognostic factor. Since prior aspirin use appeared to 
reduce the severity of the presenting illness, development of ACS on aspirin 
is not necessarily a “failure” of aspirin therapy or an indicator of “aspirin 
resistance”. Further platelet testing is needed to determine whether “aspirin 
resistance” relates to prior aspirin use in patients presenting with ACS. 
/ 1 i 51-98 ] Comparison of Antiplatelet Effects of Clopidogrel, 
Aspirin and Their Combination in Patients 
Following Myocardial Infarction 
Khatereh Moshfegh, Maurice Redondo, Friedgard Julmy, Walter 
A. Wuillemin, Mathias U. Gebauer, Andre Haeberli, Beat J. Meyer. 
University Hospital Bern, Switzerland 
Background: We compared the influence of clopidogrel (C), aspirin (A), or 
their combination (A + C) on platelet aggregation and activation. 
Methods: 30 patients who survived a myocardial infarction were consec- 
utively given 7-days treatments with 100 (300) mg A, 100 (300) mg A + 75 
mg C, and 75 mg C alone after washout periods. Antiplatelet effects of C 
and/or A on aggregation and P-selectin expression were measured following 
stimulation with various agonists using aggregometer and flow cytomety. 
Results: 
Platelet Activation (P-selectin) 
ADP (10 uM) Thr 10.1 U/L) 
Platelet Aggregation 
ADP (6 uM) Cal (4 ua/mL) .._ 
A 100 19.0& 1.6 55.0 * 2.7 44.7 * 2.9 36.5 + 4.2 
c75 7.0 5 0.6* 41.3 + 2.7* 24.6 i3.3* 59.3 i 5.1* 
AlOO+C75 6.8 4 0.7* 36.5 F 3.6* 26.6& 2.7* 16.4i 2.4*# 
Data presented as mean i SEM. Wilcoxson signed rank test: P < 0.05, *A vs C or A + 
C, ‘C vs A + C. Thr indicates thrombin; Cal, collagen. 
The combined treatment of A + C increased the ED50 (Half-maximal 
aggregation) of collagen-induced aggregation significantely, compared to 
treatment with A (5.5 & 1.5 to 22.4 f 4 Kg/ml, P < 0.001). In addition, when 
75 mg C was combined with 100 mg A or 300 mg A, the effects on ADP- or 
collagen-induced aggregation were similar at both A doses. 
Conclusion: Clopidogrel compared to aspirin produces a reduction of 
platelet activation. The combination of clopidogrel and aspirin at a dose of 
100 mg or 300 mg is more effective than the monotherapies in inhibiting 
collagen-induced aggregation, confirming additive antiplatelet effects seen 
in animal studies. This therapeutic strategy is currently tested in several 
clinical trials 
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1 1151-99 1 Aspirin 300 mg Daily After Successful 
Thrombolysis Prevents Reocclusion of A < 90% 
Infarct Related Stenosis 
Marc A. Brouwer’ , Gerrit Veer?, Aarl J. Karremans, Freek W.A. Verheugt’ 
*Free University Hospital Amsterdam; ’ University Hospital Nvmegen, The 
Netherlands 
Background: Despite a marked reduction in clinical events after acute my- 
ocardial infarction (Ml), aspirin has so far not been shown to reduce reocclu- 
sion after successful thrombolysis. A previous unadjusted analysis, however, 
suggested a possible effect of aspirin in patients with a < 90% infarct related 
stenosis, which prompted for a multivariate analysis. 
Methods: In APRICOT 1 (Antithrombotics in the Prevention of Reocclu- 
sion after Coronary Thrombolysis) 248 patients had thrombolysis for acute 
Ml with an open vessel at angiography < 48 hours after thrombolysis and a 
follow angiography at three months. From 1987-l 991 they were randomized 
to either aspirin, coumadin or placebo. Seventy percent of patients (173/248) 
had a stenosis < 90%. 
Results: For patients with a < 90% stenosis, aspirin showed a marked 
reduction in reocclusion rate when compared to placebo: 17% vs. 32%, p = 
0.08. The unadjusted relative risk for reocclusion for these patients on aspirin 
is 0.55 (Cl 0.28-l .09). In a multivariate stepwise regression analysis, the odds 
ratio (OR) for reocclusion in patients on aspirin was 0.41 (Cl 0.16-1.03). 
In addition, lesion morphology turned out as a rather strong independent 
predictor of reocclusion: OR, smooth lesion = 3.79 (Cl 1.45-9.89). This in 
contrast to the results of a multivariate analysis on the entire APRICOT 
population (including those with a >90% stenosis), where lesion morphology 
and antithrombotic regimen were not found to predict reocclusion. 
Conclusion: Aspirin markedly reduces the risk of reocclusion in patients 
with a x90% stenosis after successful thrombolysis for acute MI. The fact 
that lesion morphology and the antithrombotic regimen are not predictive 
in the entire Ml population demonstrates the strong association of a >90% 
stenosis with reocclusion. 
L--L-l 1151 100 Clinical Predictors of Poor Outcome in Women Recovering From Acute Coronary Syndrome 
Faris Al-Khalili, Sarah P. Wamala, Bertil Svane, Kristina OrthGomer, 
Lars Ryden, Karin Schenck-Gustafsson. Department of Cardiology: Division 
of Preventive Medicine-Department of Public Health Sciences and 
Department of Thomcic Radiology Karolinska Hospital and Karolinska 
Institutet, Stockholm, Sweden 
Background: Although coronary heart disease is a major health problem for 
women, there is unsufficient data on the prognostic importance of various 
risk factors and clinical parameters in female patients with acute coronary 
syndromes. 
Methods: All women 565 years, hospitalised for acute coronary syn- 
dromes in the greater Stockholm area from 1991 to 1994 were recruited. 
Comprehensive clinical screening was performed 3-6 months after the index 
event. Recurrent cardiac events defined as total mortality, cardiac death and 
non-fatal myocardial infarction (Ml) were monitered for 5 years. 
Results: Total number of patietns was 335, mean age was 56 f 7 yr. 
Unstable angina pectoris was documented in 63% and myocardial infarction 
(Ml) in 37% of patients. There were 14 deaths (9 cardiac) and 17 patients 
with recurrent Ml druing the follow-up period. After adjustment for age, the 
following among other parameters, were found to be related to adverse 
outcome: a history of Ml at index event (Hazard ratio (HR) 9.13, 95%Cl = 
3.09-26.99), history of diabetes mellitus (HR 4.13, 95%CI 1.68-10.17) left 
ventricular dysfunction (HR 3.94, 95%CI 1.52210.17) s-triglycerides >2.0 
mmol/l (Hi? 2.46, 95%CI 1.07-5.63) and s-HDL-choletesterol 51 .O mmol/l 
(HR 1.80, 95%CI 0.75-4.33). In multivariate statistical models all above but 
triglycerides remained as significant predictors of adverse outcome. 
Conclusion: History of Ml, diabetes mellitus, left ventricular dysfunc- 
tion and high s-triglyceride levels in women <66 yr with acute coronary 
syndromes were predictors of adverse cardiac prognosis. The presence of 
these variables implicate aggressive coronary investigation, intervention, and 
follow-up in an attempt to improve prognosis. 
ORAL 
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2:00 bm. 
881-I Plaque Sites That Exhibit Apoptosis and Predispose 
to Thrombosis are a Target for Abciximab 
Gerhard Bauriedel, Rene Andrie, Bob Jordan, Berndt Liideritz. Dept. of 
Cardiology, University of Bonn, Bonn, Germany 
Background: Plaque rupture and subsequent thrombosis are key events in 
the onset of acute coronary syndrome. Recent work on vulnerable human 
atheroma revealed high apoptosis that may lower smooth muscle cell density 
and restrict macrophage infiltration. Also, apoptosis apparently confers a pro- 
coagulant activity to the cells concerned. To further establish this concept, the 
present ex vivo study compares the expression of CPP-32 (caspase-3) a cell 
death effector, and that of tissue factor (TF), a primary initiator of coagulation, 
in atheroma from patients with unstable or stable angina. Also, we studied the 
pattern of plaque sites targeted by the platelet glycoprotein Ilb/llla antagonist 
abciximab, to assess the therapeutic potential attributable to a blockade of 
prothrombotic intimal elements, in addition to known anti-platelet effects. 
Methods: Atherectomy samples from 40 primary coronary lesions were 
analyzed (25 patients with acute coronary syndrome, group 1, and 15 patients 
with stable angina, group 2). Detection of CPP-32 (Dako) and TF (Am. Diagn.) 
was performed by immunhistochemistry using the APAAP technique. The 
murine 7E3 IgG antibody was from Centocor Inc. Signals were quantified by 
histomorphometric analysis. 
Results: Mean cell densities were similar with 294 i 34 (x + SEM) 
cells/mm2 in group 1 and with 311 i 38 cells/mm2 in group 2 (p = 0.91). 
Apoptosis signalled by CPP-32 was more frequently (p < 0.005) found in 
group 1 (Ii i 2% of intimal cells) than in group 2 (4 f 1%). Predilection sites 
were areas with macrophages/foam cells or sparse cellularity. Concordantly, 
mean expression of TF was higher (p = 0.02) in group 1 (6.4 f 1.3%) than in 
group 2 (3.5 f 0.8%). TF signals were bound to cells or apoptotic microvesi- 
cles and were predominantly located in areas with thrombi, necrosis, sparse 
cellularity or foam cells. TF and CPP-32 showed a significant correlation (r = 
0.41, p < 0.05). As expected, signals of abciximab (7E3) were observed in 
thrombus segments, but also in intimal subendothelial and foam cell areas. 
Quantitatively, expression differed (p < 0.05) between groups 1 and 2 (2.2 + 
0.4% vs. 1.2 + 0.3%). 
Conclusion: The present study suggests that thrombogenesis in hu- 
man atheroma coincides with (macrophage) apoptosis, the more with acute 
coronary syndrome compared to stable angina. Abciximab may directly in- 
terfere with the intimal microecology and antagonize its procoagulant activity 
beyond platelet inhibition. Our data further substantiate the varied role of 
intimal apoptosis and underscore the unique value of specific glycoprotein 
Ilb/llla antagonists to attenuate its sequelae. 
2:15 p.m. 
881-2 Factors Influencing Outcome and Degree of Benefit 
With GP llblllla Inhibition in Patients With 
Non-ST-Elevation Acute Coronary Syndromes 
Marc S. Sabatine, Steven Snapinn’, Pierre Theroux’, Ik-Kyung Jang. 
Massachusetts General Hospital, Boston, MA; ‘Merck Research 
Laboratories, West Point, PA, USA; *Montreal Heart Institute, Montreal, 
Canada 
Background: There is wide variation in both clinical outcome and use of 
GP Ilb/llla inhibitors in patients (Pts) with UAINQWMI. A method to identify 
which Pts are at highest risk and derive the greatest benefit from GP Ilb/llla 
inhibitors would allow more appropriately tailored therapy. 
Methods: We retrospectively examined the relationship between present- 
ing characteristics, outcome and degree of benefit achieved with tirofiban in 
PRISM-PLUS. 
Results: Multivariate analysis revealed 4 independent risk factors for the 
composite endpoint of death, Ml or refractory ischemia at 7 days: prior aspirin 
use, prior beta-blocker use, prior CABG and ST& Compared to Pts with O-l 
risk factors, Pts treated with heparin with 2 risk factors had nearly 2x and 
Pts with 34 risk factors >3x the rate of clinical events (p < 0.001). For 
Pts with 3-4 risk factors (grouped because few patients had 4 risk factors), 
the addition of tirofiban was associated with a 45% relative reduction in the 
composite endpoint (p < 0.0005). 
Conclusion: Prior aspirin use, prior beta-blocker use, prior CABG, and 
ST& upon presentation are independent risk factors for adverse outcomes 
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in Pts presenting with UAINQWMI. The addition of tirofiban is particularly 
beneficial in Pts with multiple (53) risk factors. 
2:30 p.m. 
881-8 Increased Mortality With Oral Glycoprotein Ilb/llla 
Antaaonists: A Pooled Analvsis of the Larae Scale 
Oral Glycoprotein Ilb/llla Trials 
Derek P. Chew, Deepak L. Bhatt, Eric J. Topol. Cleveland Clinic foundation, 
Cleveland, Ohio, USA 
Background: Despite the success of intravenous glycoprotein Ilb/llla in- 
hibitors in patients with acute coronary syndromes and those undergoing 
coronary interventions, attempts to extend the benefits of this form of potent 
platelet inhibition with oral therapy have produced no clear benefits. 
Methods: We assessed the three large scale phase Ill trials with ad- 
equate power to detect differences in mortality. The EXCITE trial studied 
post-angioplasty patients while OPUS and SYMPHONY enrolled those with 
acute coronary syndromes. Studies with both xemilofiban and orbofiban in- 
cluded co-treatment with aspirin, while the study with sibrafiban did not. As 
each study included a low and high dose arm, we pooled the results of the 
active arms in each study. Duration of administration and/or follow up varied: 
180 days for EXCITE: and 90 days in SYMPHONY; 30 days for OPUS. 
Results: There was a consistent trend towards increased mortality in pa- 
tients randomized to treatment with each oral glycoprotein Ilb/llla antagonist 
in the studies, as indicated by the p-value of 0.62 with the Breslow-Day test 
for odds ratio heterogeneity. Pooled analysis of the three studies provides a 
total patient population of 26,703 and demonstrates a statistically significant 
increase in mortality for the duration of follow up. (Placebo: 1.4% versus any 
oral glycoprotein Ilb/llla antagonists: 1.6%, p = 0.023. Odds ratio: 1.27. 95% 
Cl.: 1.03-I 56) 
Death 
Conclusions: The use of oral glycoprotein llbillla antagonists for long 
term platelet inhibition is associated with an increase in mortality. These 
results raise concerns of an unanticipated pro-thrombotic effect with these 
agents that requires elucidation. 
2:45 0.m. 
881-e Thrombocytopenia, Bleeding and Thrombotic 
Events With Oral Glvcoprotein Ilb/llla Inhibition: 
Results From OPUS~TI~I 16 
Stephanie A. Coulter, Christopher P. Cannon, Richard A. Cooper, Carolyn 
H. McCabe, Richard Aster, Andrew Charlesworth, Allan M. Skene, 
Eugene Braunwald. Brigham and Women’s Hospital, Boston, 
Massachusetts, USA 
Background: Thrombocytopenia (iPIts) occurs in ~1% of patients treated 
with glycoprotein Ilb/llla inhibitors, however outcomes in these patients are 
not well characterized, especially with oral agents. 
Methods: We examined this relationship in 10,277 patients with acute 
coronary syndromes in the OPUS-TIM1 16 trial of orbofiban plus aspirin vs. 
aspirin alone (treatment approx. 1 year). 
Results: The 30-day rate of SPlts (&O,OOO cells/dl) was 0.7% for or- 
bofiban vs. 0.1% for placebo (p c 0.001). Beyond 30 days, both aspirin alone 
and orbofiban had rates of 0.1% (p = NS). Median time to onset of &Pits was 
10 days post orbofiban. Initial results suggest an immune-mediated cause. 
Among these 49 patients with J.Plts < 30 days, higher rates of both bleeding 
and cardiac events were seen (all p < 0.001). Following the onset of iPIts, 
the median time to a bleeding event was 1 day, and time to a composite 
event (Death, Ml, recurrent ischemia, or stroke) was 4 days: 
1 year events 
Death 
Composite 
Major Bleed 
ICH 
JPlk 
14.3% 
34.7% 
20.8% 
4.3% 
No LPI& 
3.9% 
20.5% 
3.3% 
0.1% 
Multivariate Odds Ratio 
2.85 (p = 0.012) 
1.91 (p = 0.006) 
4.25 (p < 0.0001) 
Conclusions: Avery small %of patients treated with oral Ilb/llla inhibitors 
develops JPlts, usually in the first month. Of these, the risk of a thrombotic 
or bleeding event is higher compared with those without JPlts. This pat- 
tern is similar to that for intravenous Ilb/llla inhibitors as well as heparin. 
suggesting the pathophysiology may relate to a more general Drug-Induced 
Thrombocytopenia +/- Thrombosis (DITT) Syndrome. For patients treated 
with oral agents, frequent screening for &Plts is suggested for up to 30 days, 
and less often thereafter. Among patients who develop &PI&, careful clinical 
monitoring and care is suggested for at least 4-5 days post onset of &Pits. 
Our data also support the need for a test to screen for antibodies related to 
developing APIts. 
3:00 p.m. 
881-5 How Important is IJnfractionated Heparin as 
Adjunctive Pharmacotherapy With GPllbIllla 
Antagonists in Acute Coronary Syndromes? 
Richard C. Becker, Frederick A. Spencer, You Fu Li. University of 
Massachusetts Medical School, Worcester, Massachusetts, USA 
Background: The pharmacologic approach to patients with acute coronary 
syndromes receiving GPllbillla antagonists frequently includes unfraction- 
ated heparin (UFH); however, its contribution to the overall antithrombotic 
potential of FDA-approved agents has not been determined. 
Methods: In a series of invitro experiments, abciximab (140 FM), tirofiban 
(42 NM), and eptifibatide (333 PM), either alone or in combination with 
UFH (1 U/ml), was added to washed platelets (from pooled normal donors) 
suspended in buffer. Maximum thrombin generation (F1.2) was quantitated 
by ELISA following platelet activation with collagen (10 fig/ml) and TRAP (15 
PM). All experiments were performed in triplicate. 
Results: Each of the GPllb/llla antagonists reduced platelet-dependent 
thrombin generation (range 24545.2%). The percent reduction, absolute 
difference (in thrombin generation) with/without UFH and the relative reduc- 
tion with UFH are summarized: 
Drugs Max Thrombin 
Generation’ 
i% reduction) 
Difference 
with or without UFH 
ml 
Relative 
Reduction 
1%) 
Abciximab 
Abciximab + UFH 
Tirofiban 
Tuofiban + UFH 
Eptifibatide 
Eotifibatide + UFH 
45.2 3.8 8.0 
49.0 
31.1 16.9 35.2 
48.0 
24.5 13.5 35.5 
38.0 
*compared with activated platelets and no drug 
Conclusions: In concentrations achievable within plasma after standard 
dosing, UFH facilitates the antithrombotic potential of GPllb/llla antagonists. 
The enhancing effect is 4-fold greater with tirofiban and eptifibatide than ab- 
ciximab, suggesting that the overall clinical importance of UFH as adjunctive 
pharmacotherapy may differ among the agents. 
3:15 p.m. 
(881-61 Costs and Effectivitv of Treatment With Tirofiban in 
I Patients With Unstable Angina - Results From the 
PRISM Trial 
Christopher Heeschen, Christian W. Hamm, Ariane Due, 
Lukas Langenbrink, Harvey White. Stanford University School of Medicine, 
USA; KerckhofHJinic, Bad Nauheim, Germany; Green Lane Hospital, 
Auckland, New Zealand 
In 3232 patients with unstable angina enrolled in the PRISM trial, the platelet 
glycoprotein Ilb/llla receptor antagonist tirofiban demonstrated a reduction of 
primary endpoints. We investigated the cost effectiveness ratio according to 
reduction of cardiac events (death, AMI), necessity for coronary intervention, 
and duration of hospitalization. 
Methods: To assess costs and effects of tirofiban, the database of the 
PRISM trial, enrolling patients with unstable angina, was combined with unit 
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cost data. Effects are expressed in terms of event-free survival at 30-day fol- 
low-up. Three definitions were used: 1.) AMI-free survival, 2.) adding revascu- 
larization, and 3.) adding major bleeding as events. Estimated costs include 
revascularization, associated complications and hospitalization. Additional 
subgroup analysis of high-risk patients was performed among patients with 
either troponin I (Tnl) levels above 1 .O Kg/L or troponin T (TnT) above 0.1 
d-. 
Results: For AMI-free survival, the absolute difference at 30-day follow-up 
was 1.3% (94.2% vs. 92.9%; tirofiban vs. heparin; P= 0.11). Apart from the 
additional costs for tirofiban, there were no differences in amounting costs ($ 
6,458.-versus $ 6,625.-; P= 0.72). The incremental costs per gained event 
free survivor were estimated at $ 68,062.-. Far more favorable results were 
observed for the limited use of tirofiban in high-risk patients with elevated 
troponins (Tnl: 28.1%; TnT 28.9%). For Tnl-positive patients, the absolute 
difference in AMI-free survival at 30-day follow-up was 8.7% (95.7 versus 
87.0%; P < 0.001). Excluding the additional costs for tirofiban, the amounting 
costs for Tnl-positive patients receiving tirofiban were lower as compared 
to patients receiving heparin ($ 8,613.- versus $ 9,197.-; P = 0.04). For 
such Tnl-positive patients receiving tirofiban, costs per gained event free 
survivor were estimated at $ 8,941.-. Similar results were obtained for TnT 
measurements. 
Conclusions: Treatment with tirofiban of patients with unstable angina 
according to the PRISM inclusion criteria can be considered cost effective in 
troponin-positive patients only. 
POSTER 
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1 1172-I 01 1 Do Transplanted Cardiomyocytes Augment 
Global Left Ventricular Function in Infarcted Rat 
Heart? 
Ernst R. Schwarz, Sharon L. Hale, Robert A. Kloner. Hearf tnstifufe, Good 
Samaritan Hospital, University of Southern California, Los Angeles, 
California, USA 
Background: There is controversy whether transplanted cardiomyocytes 
within infarcted tissue contribute to cardiac function. 
Methods and Results: In 33 Sprague-Dawley rats the left coronary artery 
was occluded to create myocardial infarction. Four weeks later, transthoracic 
echocardiography using a 7 MHz pediatric tranducer demonstrated visible 
wall motion abnormalities following myocardial infarction in all animals. End- 
diastolic diameter was 0.66 f 0.03 cm, end-systolic diameter was 0.41 & 
0.03 cm, and fractional shortening was 37.7 f 2.8% (x f SEM). At p4 weeks 
following myocardial infarction, small tissue fragments of fetal cardiac tissue 
(n = 22) were transplanted by advancing the fragments into a pouch created 
within the infarcted scar tissue in the hearts. Control infarcted animals (n = 
11) were sham operated. Four weeks after cardiomyocyte transplantation, 
end-diastolic diameter was 0.68 & 0.04 cm, end-systolic diameter was 0.45 
k 0.04 cm, and fractional shortening was 35.9 i 2.3% (not significant versus 
baseline). In control animals, there was also no improvement of function four 
weeks after sham operation. Histologic analysis (hematoxyllin-eosin stain 
ing, alpha actin staining) and fuorescence microscopy revelaed large nuclei 
suggestive of transplanted fetal cardiomyocytes in transplanted hearts but 
not in controls. 
Conclusions: By means of echocardiography, left ventricular function 
was not significantly improved following cell transplantation in infarcted rat 
heart, suggesting that transplantation of tissue fragments of cardiomyocytes 
is insufficient to accomplish host-associated contractile function. 
1172-I 02 Serial Versus Single-One-Point Cardiac Troponin 
T Measurements for Estimation of Mvocardial 
Infarct Size - A Histoanatomical Study in 
Experimental Myocardial Infarction 
Evangelos Giannitsis, Andrew Remppis, Philipp Ehlermann, 
Tobias Greten’ , Patrick Most, Margit Muller-Bardorff, Hugo A. Katus. 
Departments of Medicine II, Medical University of Luebeck; ‘Heart Center 
LahrBaden, Germany 
We sought to estimate non-invasively the infarct size after LAD ligation in 
non reperfused myocardium by use of cardiac troponin T (cTnT) serum levels 
and to provide a practical and cost-effective algorithm for clinical practice. 
Methods: 20 beagle dogs underwent LAD ligation. Blood samples were 
collected serially prior to the procedure and 2, 4, 10, 16, 22 and 30 hours 
thereafter, and daily until sacrifice of the animals. Explanted hearts were 
incubated with triphenyltetrazoliumchloride (TTC), the demarkated infarct 
area was cut out and weighed. Relative infarct weight was correlated with the 
findings of serum levels of cTnT in serial samples and at different single-time 
points. 
Results: 16 dogs were finally analysed. Relative infarct weight amounted 
to 16.0 rt 5.9%. Peak cTnT levels (14.10 * 4.71 pgll) were reached after 
110 + 21 h (range 48-144 h). When relative infarct weight was correlated 
with serial measurements of cTnT, a significant correlation was seen for peak 
cTnT levels (p c 0.0001; r = 0.83) and cumulative (area under the curve) 
cTnT levels (p < 0.002; r = 0.72). When single one point measurements of 
cTnT were regarded, the sample taken 96 hours after LAD ligation showed 
best correlation (p < 0.005; r = 0.69). 
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Conclusions: Peak and cumulative cTnT levels are excellent estimates 
of infarct size in non-reperfused experimental myocardial infarction. For clin- 
ical practice, infarct size may be estimated reliably with single-one-point 
measurements close to peak levels (96 hours) 
I 1172 103 Lower Prevalence of Specific Allele at the DRBl 
MHC Class II Locus (DR3) in Young Myocardial 
Infarction Patients Compared to Older Subjects 
Giovanni Sperti, Cinzia Varlotta, ltalo Porto, Nicoletta Todaro, 
Sonia lacovella, Willy van de Greef, Ermenegildo De Ruvo, Marco Testa, 
Maurizio Genuardi, Giovanni Neri, Attilio Maseri. lnsfitutes of Cardiology 
and Genetics, Catholic University: Rome, Italy 
Background: A family history of myocardial infarction (Ml) is a major in- 
dependent risk factor for MI. Increasing evidence suggests a role for the 
immune/inflammatory system in the pathogenesis of acute coronary syn- 
dromes. Specific alleles at the DRBI MHC class II locus are associated with 
several diseases which share an altered immune/inflammatory response. 
We have tested the hypothesis that young subjects with Ml have a higher 
prevalence of these alleles compared with older patients. 
Methods: We tested 44 patients consecutively enrolled in our clinical 
database with a documented diagnosis of Ml as first presentation of coro- 
nary artery disease occurred at an age 5 40. They were compared with 
40 consecutive patients with Ml occurred at an age 2 40. Genomic DNA 
extracted from peripheral blood was amplified with two sets of primers iden- 
tifying one specific region of locus DRBl along the second exon. 32 specific 
alleles were recognized by PAGE of the eteroduplex formed by the DNA from 
PCR amplification and the DNA derived from standard cell lines. 
Results: The two groups did not significantly differ for the prevalence 
of smoking (86.6% vs 76.5%), hypercholesterolemia (36.4% vs 50%), hy- 
pertension (27.3% vs 38.2%), diabetes (9.1% vs 11.7%). Because of the 
large number of alleles involved in a relatively small number of patients, no 
significant difference in the prevalence of a single allele was noted. However, 
when the allele groups corresponding to the same serological specificity were 
compared, there was a significantly lower frequency of DR2 specificity in the 
540 group (5% vs 22%, 2 vs 10 patients, p < 0.01) than in young patients. 
Conclusion: MHC genotype might predispose to an altered immune/ 
inflammatory response to various stimuli and play a role in early onset Ml. 
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\ 1172-l 04 1 Animation of Mechanical Complications in 
Experimental lschemic Heart Disease: A New 
Technique for 3-D Cardiac Imaging 
Benjamin M. Jackson, Joseph H. Gorman III, Robert C. Gorman, Ivan 
S. Salgo, I. Henry Edmunds, Martin G. St. John Sutton. Hospital of the 
Unfversify of Pennsylvania, Philadelphia, Pennsylvania, USA 
Background: Dynamic three-dimensional geometric distortions of the left 
ventricle associated with myocardial &hernia and infarction are poorly un- 
derstood. These distortions lead to complications of ischemic heart disease, 
such as acute and chronic ischemic mitral regurgitation (IMR) and apical 
aneurysm formation, 
Methods: Using animations, we have analyzed data obtained with so- 
nomicrometry array localization (SAL) in ovine models of acute and chronic 
ischemic mitral regurgitation and apical LV aneurysm. We have developed 
the ability to animate the three-dimensional position data obtained using SAL. 
In essence, we have used animations to formulate hypotheses concerning 
the pathogenesis of these diseases, and then confirmed and quantified the 
hypothesized changes in left ventricular function by analyzing data quantita- 
tively. 
Results: (i) In both acute and chronic IMR, the movements of the papillary 
muscles relative to each other and to the annulus are easily and immediately 
understood using animations. The changes in direction and velocity of motion 
are recognized, while in static images, only changes in position at discrete 
times are appreciated. (2) In IMR, the ability to rotate the ongoing animation 
36Oearound perpendicular axes and the ability to impart some sense of depth 
to the data allowed an appreciation both of the shape of the mitral annulus, 
and of the rotation of papillary muscles around a left ventricular axis. (3) 
In left ventricular apical aneurysm, animations demonstrate paradoxical wall 
motion in systole and hints at a “border zone” of uninfarcted myocardium 
being chronically drawn into the aneurysm. 
Conclusions: SAL allows measurement of cardiac dynamics - and their 
chronic changes over weeks or months -with precise spatial and time resolu- 
tion. However, analysis of the resulting data has been hindered by an inability 
to present it in a visually compelling - and therefore intuitive - manner. (In 
contrast, MRI, CT, and ultrasound present data in an inherently intuitive and 
easily-understood visual format, but are presently incapable of comparable 
time resolution or chronic study.) We will present individual examples of these 
visual representations, and discuss how they have directed our more exact 
quantitative analysis of position and cord length data. 
/ 1 ‘I 72 105 Insulin-Like Growth Factor-l and II Preserve Myocardial Structure in Post-Infarct Swine 
Arkady Kotlyar, David Castel, Zvi Vered, Yuval Heled, iris Goldberg, 
Dvora Nas, Eduard Fridman, Zehava Chen-Levy, David Hasdai, 
Naphtali Savion, Michael Eldar. Mickey Scheinowitz. G/Aviv UniversifL: 
lsraei 
Background: Insulin-like growth factor (IGF) I and II improve myocardial 
function following coronary occlusion in different animal models. We investi- 
gated the mechanism of improved myocardial function following IGF-I and II 
administration in acute myocardial infarction (Ml). 
Methods: Female pigs (25 i 5 kg) were subjected to acute microem- 
bolization Ml using 75-150 fi affigel blue beads. The beads contained and 
slowly released either 150 pg of IGF-I (n = 6) IGF-II (n = 6) or saline (n = 
6). Myocardial function was assessed echocardiographically during 4 weeks 
post-Ml and after dobutamine administration, and serum cardiac troponin 
I concentration was measured before, immediately post and 3 h post-Ml. 
Excised hearts were analyzed for actin, desmin, blood vessel density and 
DNA laddering in infarct, border and normal myocardium. 
Results: Myocardial function of the infarct related area of IGF treated, but 
not of control animals, significantly improved during the 4 week follow-up (p = 
0.01). Following dobutamine administration regional myocardial wall motion 
significantly improved in IGF-I compared to IGF-II animals (p = 0.05) both 
being better than control (p = 0.03). IGF-I and II groups had lower serum 
cardiac troponin I concentration (p = 0.001) more actin in the border (p = 
0.01) and infarct (p = 0.0001) areas, and reduced DNA laddering (23.3 f 
8.5%-IGF-I) and (33.3 & 8.3%-IGF-II) in the infarct area as compared to 
control (p < 0.05). IGF groups had more blood vessels in the border (p = 
0.04) and infarct (p = 0.003) areas than control. 
Conclusion: Both IGFs improved myocardial function, which was asso- 
ciated with preservation of myocardial structure in the infarct-related area. 
The effect of IGF-I was more potent than IGF-II. 
/ 1172-I 06 1 Tenascin-X and Cardiac Sympathetic Nerve 
Growth 
Angela C. Lai, Kurt Wallner, Ji-Min Cao, Masaaki Yashima, 
Toshihiko Ohara, Michael C. Fishbein, Hrayr S. Karagueuzian, 
Peng-Sheng Chen. Behrooz Sharifi Division of Cardiology Department of 
Medicine, Cedars-Sinai Medical Center, and UCLA, Los Angeles, CA, USA 
Background: Sympathetic nerve sprouting after myocardial infarction (Ml) 
may contribute significantly to the occurrence of ventricular arrhythmia and 
sudden cardiac death. Tenascin-X (TN-X), a matrix protein known to be 
associated with nerve growth in central and peripheral nerves, may also play 
a role in cardiac nerve sprouting after Ml. The purpose of the present study 
was to test the hypothesis that TN-X is present in newly generated (sprouted) 
cardiac nerves. 
Methods: lmmunohistochemical staining techniques were used to identify 
nerves in 5 km serial sections from 15 dogs with Ml containing both infarcted 
and normal myocardial tissues. Among the 15 dogs, 8 also received nerve 
growth factor (NGF) infusion to the left stellate ganglion. The time between Ml 
to tissue harvest averaged 35.7 * 14.4 days. Tyrosine hydroxylase (TH) stain 
was used to identify sympathetic nerves, and Growth Associated Protein 
43 (GAP 43) was used to identify growing nerves. Monoclonal antibody 
developed in our laboratories was used to identify TN-X. 
Results: Nerves were evident in both the infarcted and non-infarcted 
areas in all dogs. Nerves are most abundant around blood.vessels. A total of 
72 slides were examined. A total of 313 nerves (normal regions 131; infarct 
regions 12; border zones 19; around blood vessels 151) stained positive for 
both GAP43 and TH, indicating sympathetic nerve sprouting after MI. For 
every nerve that stained positive in both the TH and GAP43, there was also 
a positive stain for TN-X. 
Conclusions: There is a co-localization of TN-X, GAP43 and TH in dogs 
after Ml. These results suggest that TN-X is important in cardiac sympathetic 
nerve sprouting after Ml. 
L-L 1172 107 Quantitative Echocardiographic Assessment of 
Border Zone Distribution in an Acute Infarct 
Model 
Ivan S. Salgo, Joseph H. Gorman, Robert C. Gorman, Benjamin 
M. Jackson, Frank W. Bowen, Theodore T. Plappert, L. Henry Edmunds, 
Martin G. St. John Sutton. Univ. of Pennsylvania, Philadelphia, PA, USA 
Background: Adjacent to an acute infarction, a border zone has been de- 
scribed that is normally perfused but mechanically dysfunctional. In this study, 
we identify and quantify the border zone using contrast echocardiography in 
a sheep model of non-collateralized acute infarction. 
Methods: An acute posterior infarction of the left ventricle was created 
in four sheep. Contrast echocardiography was employed to determine both 
perfusion and wall thickening using a short axis plane at the midpapillary level. 
0.1 cc of echo contrast agent (Optison, Mallinckrodt) was injected directly into 
the aortic root. Standard wall motion and second harmonic perfusion images 
(SONOS 5500, Hewlett Packard) were analyzed using specialized software 
developed by our group. Wall thickening and pixel intensity (perfusion) were 
segmented radially over 360’. The extents of the wall thickening abnormality 
and perfusion deficit were determined and the border zone was computed 
as the difference. 
Results: 
Sheep Septal Perfusion Lateral 
Border Zone Defect Border Zone 
1 38” 116P 19” 
2 39” 129’ 34’ 
3 35” 108” 44” 
4 28’ 152” 39’ 
M&Xl 35s 126” 34” 
Standard Deviation 5” 19” 11” 
Conclusion: The extent of normal, border zone and infarcted myocardium 
can be quantified using contrast echocardiography. Further studies employ- 
ing this technique will help elucidate the contribution of the border zone to 
post infarction left ventricular remodeling. 
] 1172-I 081 Postischemic Apoptosis and Functional 
Recovery After Angiotensin II Type 1 Receptor 
Blockade in the Isolated Working Rat Heart 
Sorin Musat-Marcu, Rohit Moudgil, Bodh I. Jugdutt. University of Alberta, 
Edmonton, Alberta, Canada 
Background: Apoptosis contributes to left ventricular (LV) dysfunction after 
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ischemia-reperfusion (IR). We hypothesized that angiotensin II type I receptor 
blockade (ARB) inhibits apoptosis after IR. 
Methods: We studied the relation between postischemic recovery of 
function (LV developed pressure) and the apoptotic index (TUNEL assay) 
in isolated working rat hearts with IR (25 min ischemia, 40 min reperfusion) 
after pre-treatment with ARBs losartan and UP 269-6 for 1 to 3 weeks. 
Results: The ARES produced a wide range of functional recovery during 
reperfusion and reduced the apoptotic index. The relation between functional 
recovery and apoptosis was ‘bell-shaped’. This was likely due to energy 
requirements of the apoptotic cascade: at low (O-IO%) levels of recovery 
(i.e. low flow), little apoptosis was detectable; in the 1 O-50% range (more 
energy available), more apoptosis was detectable; in the 50 to 90% range 
(beyond the nadir), the number of truly apoptotic cells was lower or the ceils 
had passed the detectable stage. 
O’,W , ~ , 
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Conclusion: ARBs flatten the relation between functional recovery and 
apoptosis after IR, implying an ARB-induced inhibition of apoptosis. 
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I 1173 132 Quantitative Angiographic Measurement of Absolute Coronary Blood Flow 81 Its Relation to 
Mortality in Acute Myocardial Infarction 
G. Michael Gibson, Rebecca Mesley, Timothy Saunders, Colin Hynes, 
Sabina Murphy, Robert Zemble, Susan J. Marble, Carolyn H. McCabe, 
Elliott M. Antman, Eugene Braunwald. for the T/M/ Study Group, University 
of California San Francisco, Brigham & Women’s Hospital Boston, USA 
Background: There is a need to estimate absolute coronary blood flow on 
diagnostic coronary arteriograms without instrumenting the lesion to pro- 
vide prognostic information. We hypothesized that higher flow rates (ccimin) 
following thrombolytic administration as estimated by quantitative coronary 
angiography (QCA) would be related to lower mortality in the acute Ml setting. 
Methods: QCA was used to estimate the absolute volume of the epicardial 
artery (cc), & the TIMI Frame Count (TFC) + 30 was used to measure the 
time (set) for dye to fill the volume of artery to yield flow in cc/set (then 
multiplied by 60 to yield cc/min). QCA Flow was estimated in views that 
minimized foreshortening in 707 culprit arteries from the TIMI 14 (ReoPro + 
low dose lyric) trial and in 101 normal pts. without Ml. A flow of 0 cc/min was 
imputed to occluded arteries in analyses involving open &occluded vessels. 
Results: QCA Flow in normal arteries in the absence of acute Ml was 
80.9 + 64.7 cc/min (n = 101). For patent + occluded MI arteries combined, 
QCA flow was 35.4 & 37.7 ccimin (n = 880, p < 0.0001 vs normal), & in open 
acute Ml arteries was 45.5 & 37.0 cc/min (n = 685, p < 0.0001 vs normal). 
In an analysis restricted to open arteries, the 90 min. QCA Flow in pts. who 
died in hospital was 55% of that in pts. who survived (25.8 * 16.9 cc/min, 
n = 11 vs. 46.1 i 38.7 cc/min, n = 532, p = 0.04) & the QCA Flow of all 
pts. who died in hospital (open & closed) was 40% of survivors (14.2 f 18.0 
ccimin, n = 20 vs. 35.7 i 39.1 cc/min, n = 687, p = 0.004). QCA flow was a 
multivariate predictor of in hospital mortality (p = 0.02) in a model controlling 
for age, Ml location & gender. 
Conclusions: Quantitative coronary angiography and the TIMI frame 
count can be used together to integrate velocity and volume measurements to 
yield estimates of coronary blood flow in cc/min from a diagnostic arteriogram. 
These methods could be automated to provide on-line estimates of absolute 
coronary blood flow in the cardiac catheterization laboratory. Reduced QCA 
flow is both a univariate and multivariate correlate of mortality in acute MI. 
[ 1173-l 31 1 Reperfusion Therapy Among Paced Patients 
With Acute Myocardial Infarction 
Saif S. Rathore, Kevin P. Weinfurt, Bernard J. Gersh, William J. Oetgen, 
Kevin A. Schulman, Allen J. Solomon. Georgetown University Medical 
Center, Washington, DC, Mayo Foundation, Rochester, MN; Delmarva 
Foundation for Medical Care, Easton, MD, USA 
Background: Current ACC/AHA guidelines recommend reperfusion therapy 
(RT) for patients with left bundle branch blocks during myocardial infarction 
(Ml), but make no recommendation for the treatment of paced patients, de- 
spite similar EKG features. Therefore, we undertook an exploratory analysis 
to examine the benefit of RT among paced acute Ml patients. 
Methods: Using data from the Cooperative Cardiovascular Project, we 
evaluated paced Medicare beneficiaries age 65 years and older treated for an 
acute MI between 1994-1996 (n = 1,954) for receipt of RT (thrombolysis or 
primary angioplasty [PTCA]) within 12 hours of admission. The association of 
RT and mortality at 30 days and long-term follow up (mean = 473 days) was 
first evaluated by unadjusted logistic regression model and Cox proportional 
hazards model respectively. Analyses were repeated adjusting for clinical 
factors, patient demographics and treatment contraindications. Propensity 
modeling was employed in both logistic regression and Cox proportional 
hazards modeling in order to adjust for non-randomization of patients to RT. 
Results: 171 (8.8%) of paced patients received RT; 70 (3.6%) by PTCA 
and 101 (5.2%) by thrombolytic agents. RT patients had similar 30-day 
mortality (26.3% vs. 25.7%, p = 0.87), but lower one-year mortality (38.6% 
vs. 48.0%, p = 0.012) compared to non-RT patients. Unadjusted risk of 
mortality was comparable to non-RT patients at 30 days (OR: 1.03, 95% 
Cl: 0.72, 1.47), but lower at long-term follow-up (HR: 0.70, 95% Cl: 0.56, 
0.88). Multivariate adjustment indicated no RT benefit at 30-days (OR: 1.12, 
95% Cl: 0.73, 1.71) or long-term follow-up (HR: 0.87, 95% Cl: 0.69, 1 .lO). 
Of note, patients undergoing primary PTCA had no risk reduction at 30-days 
(OR: 0.67, 95% Cl: 0.34, 1.34) but experienced a mortality risk reduction at 
long-term follow-up (HR: 0.60, 95% Cl: 0.40, 0.88). 
Conclusions: Preliminary analysis indicates paced acute Ml patients do 
not appear to benefit from thrombolytic therapy, though our data suggest 
there may be an important role for primary PTCA in the treatment of this 
population. 
1173-l 33 Time Course and Prognostic Implications of 
QT-Interval Dynamicity and Variability After 
Successful Reperfusion by Primary PTCA 
Hendrik Bonnemeier, Franz Hartmann, Uwe K.H. Wiegand, Gert Richardt, 
Hugo A. Katus. Medical University Luebeck, Germany 
Background: Although early recanalization of the infarct related artery is 
an established therapy in acute myocardial infarction (AMI), a substantial 
number of patients (pts) is still threatened by malignant artythmias, which 
may be caused by an inhomogeneity of ventricular repolarization. 
Methods: Temporal fluctuations of ventricular repolarization were studied 
prospectively in 97 consecutive pts with a first AMI by continuous beat-to-beat 
QT-interval measurement during and after successful primary PTCA (TIMI 
2 and 3). QT-interval dynamicity (Qtdy) and variability (QTv) was performed 
from 24-hour Holter monitoring, which was initiated at hospital admission. 
Results: Reperfusion caused a significant decrease of parameters of 
QTdy and QTv (p < 0.001) and a continuous increase of mean RR-interval, 
whereas in 15 pts with major arrhythmic events (MAE) in the one-year 
follow-up, defined as sudden cardiac death, VF or sustained VT, parameters 
of QTdy remained stable or even increased after successful reperfusion. 
Furthermore 24-hour mean values of QTv were significantly higher in pts 
with MAE (QTcSD; 26.7 & 2.9 vs. 25.4 & 2.2 ms; p i 0.05). 
ms 470 , QTc dynamicity 
Conclusions: Reduction of QTdy and QTv apter successful reperfusion, 
indicating a more stable electrical substrate, may be a previously unreported 
cardioprotective mechanism of PTCA in AMI. In those pts with MAE, a persis- 
tent abnormality of QTdy apter successful reperfusion may be regarded as 
an electrophysiological correlate of insufficient microvascular reperfusion, re- 
sulting in enhanced susceptability for ventricular arrhythmias. These findings 
support the potential clinical importance of temporal repolarization instability 
after AMI. 
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I 1173 134 Effects of Primary PTCA on Time Course of Heart Rate Variability in Acute Myocardial 
Infarction: Early Versus Late Reperfusion 
Hendrik Bonnemeier, Franz Hartmann, Uwe K.H. Wiegand, Ralph Tolg, 
Hugo A. Katus, Gert Richardt. Medical Universify Luebeck, Germany 
Background: Effective treatment of acute myocardial infarction (AMI) effects 
cardiac autonomic nervous activity, However, almost no data is available on 
the effects of early and delayed coronary artery reperfusion on the time 
course of heart rate variability (HRV) in the acute phase of infarction. 
Methods: We prospectively enrolled 123 consecutive patients (pts) with 
a first AMI (29 female, 94 male). All pts underwent primary PTCA. Successful 
reperfusion (TIMI 2 and 3) was achieved in less than 12 hours from pain onset 
in 102 pts (0) and in more than 12 hours in 21 pts (0). Time and frequency 
domain HRV was measured from 24-hour Holter monitoring, which was 
initiated at admission. 
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Results: Mean RR-interval significantly increased after PTCA. Repetfu- 
sion (N) immediately caused a transient depression, followed by a significant 
increase of vagus associated parameters (HF, SDNNi, rMSSD, pNN50). 
Quantitative markers of sympathetic predominance and sympathovagal bal- 
ance (SDANN and LFiHF-ratio) continuously decreased within the observa- 
tion period. In pts with reperfusion > 12 hours after pain onset the characteris- 
tic biphasic course of HRV and the marked increase of mean RR-interval was 
absent. Furthermore, in these pts all parameters of HRV were significantly 
lower than in pts with early reperfusion. 
Conclusions: Timely successful reperfusion leads to a biphasic effect on 
cardiac autonomic tone, characterized by a transient suppression followed 
by a significant activation of the vagal tone, as well as an attenuation of 
sympathetic predominance. Recovery of HRV may contribute to the benefits 
of early repelfusion by primary PTCA. 
1173-l 35 Angiographic Myocardial Blush Grade Relates to 
Intravenous Mvocardial Contrast Echo and 
Coronary Flow Reserve for Assessment of 
Reperfusion After Myocardial Infarction 
Wolfgang Lepper, Rainer Hoffmann, Otto Kamp’ , Andreas Franke, Care1 
C. de Cock’, Harald P. Kuehl, Gert J. Siesverda’, Uwe Janssens, Cees 
A. Visser’ , Peter Hanrath. Universify Hospitals of Aachen, Germany; 
‘Amsterdam, The Nefheriands 
Background: The angiographic myocardial blush grade (MEG) has been 
proposed for assessment of microvascular integrity after angioplasty for 
acute myocardial infarction. 
Methods: To compare MBG with other parameters of microvascular in- 
tegrity we determined MBG immediately and 24 h following primary PTCA 
and stent placement in 25 patients with first myocardial infarction and com- 
pared the results with i.v. myocardial contrast echocardiography (MCE) and 
coronary flow reserve (CFR) at 24 h. MBG was graded 1: no or minimal blush; 
2: moderate blush; and 3: normal blush. I.v. MCE was performed using in- 
termittend harmonic imaging (Sonazoid @, Nycomed-Amersham). The total 
endocardial border length of the contrast defect 24 h after revascularization 
was measured in the apical 2- and 4-chamber view. CFR was measured 
using a Doppler guidewire and intracoronary adenosine (12-18 fig) in the 
infarct related artery. In addition, MBG was related to regional (RI) and global 
wall motion index (GI) at 4 week follow-up. 
Results: MBG improved in 2/25 pts within the first 24 h. 
MBG at 24 h 1 (n = 8) 2 (n = 7) 3(n=10) P 
MCE at 24 h (mm) 144154 58 * 58 f3*17 0.0002 
CFR at 24 h 1.56 i 0.38 1.89 zk 0.24 2.13 i 0.63 0.0591 
RI after 4 weeks 2.67 + 0.33 2.00 * 0.59 2.00 * 0.47 0.0104 
GI after 4 weeks 1.97 i 0.30 1.44 * 0.26 1.40 i 0.23 0.0003 
Conclusion: Assessment of myocardial reperfusion by MBG is strongly 
related to i.v. MCE and CFR as other techniques to assess microvascular 
integrity. 
1 1173-l 36 1 Comparison of a 60 vs 90 Minute Measurement 
of ST-segment Resolution After Thrombolytic 
Therapy 
James A. de Lemos, Roll Schroder, Elliott M. Antman, Carolyn H. McCabe, 
Andrew Charlesworth, Robert P. Giugliano, Karl L. Neuhaus, 
Eugene Braunwald. Brigham and Women’s Hospital, Boston MA, USA 
Background: Complete (~70%) ST resolution (STRES) 90-180 minutes af- 
ter thrombolytic therapy identifies patients with successful myocardial reper- 
fusion who are at low risk for subsequent mortality. We evaluated the prog- 
nostic utility of an earlier (60 minute) measurement of STRES. 
Methods: In 1664 patients with ST-elevation Ml from the InTime II trial, 
a baseline ECG was recorded immediately prior to thrombolysis. Sites were 
prospectively assigned to perform either a 60 or 90 minute follow-up ECG. 
The % STRES from baseline to follow-up was categorized as complete 
(?70%), partial (30-<70%), or none (~30%). 
Results: At 60 minutes, 33% of patients had complete STRES, vs 42% 
at 90 min (p = 0.002). Clinical outcomes are shown in the table below. 
<30% 30-c70% >70% I) trend 
60 Min STRES 
”  337 268 295 
Death In-Hospital % 6.2 3 1.4 
Death/CHF In-Hosp % 21.4 17.5 8.5 
Death 30 days % 7.7 4.5 1.7 
Death 1 “ear % 10.7 7.5 2.7 
90 Min STdES 
n 
Death In-Hospital % 
DeathiCHF In-Hosp % 
Death 30 davs % 
Death 1 yea; % 
203 243 
7.9 5.3 
21.7 16.5 
8.9 5.3 
11.3 7.4 
318 
2.8 
9.7 
3.1 
4.7 
0.004 
<O.OOl 
0.002 
<O.OOl 
0.03 
<O.OOl 
0.02 
0.02 
Conclusions: Although complete STRES was seen less frequently at 
60 than 90 minutes, STRES demonstrated similar prognostic utility at both 
timepoints: at 60 minutes a 4.5 fold gradient of mortality risk was seen 
between patients with no STRES vs those with complete STRES. These 
findings suggest that an early (60 minute) determination of STRES may be 
important both for clinical practice and for the design of future thrombolytic 
trials. 
1173-i 37 Impact of Nitrate Administration on the TIMI 
Frame Count and TIMI Flow Grades in the 
Setting of Acute Myocardial Infarction 
Rebecca Mesley, Martin Aldrich, Jill Swanson, Sabina Murphy, Colin Hynes, 
Timothy Saunders, Robert Zemble, Susan J. Marble, Carolyn H. McCabe, 
Christopher P. Cannon, C. Michael Gibson. For the T/Ml Study Group, 
University of California San Francisco, Brigham & Women’s Hospital, 
Boston, USA 
Background: The goal of this study was to examine the impact of vasoactive 
drugs on the corrected TIMI Frame Count (CTFC) and TIMI flow grades in 
acute MI. 
Methods: Drug &flow data were obtained from patients in TIMI 4, IO, & 14. 
Results: Neither calcium channel blocker (n = 1,607), ACE inhibitor (n = 
1,608), nor beta blocker (n = I,51 9) use were associated with a significant 
difference in the culprit CTFC at 90 min. after lytic administration. However, 
IV nitroglycerine (TNG) (but not PO TNG) was associated with a slowing 
of the CTFC in patent vessels: 39.5 & 27.8 (n = 449) vs 32.7 f 16.8 (n = 
197) (p = 0.002). In a multivariate model, IV TNG tended to be associated 
with a 4.8 frame slowing (p = 0.13) after controlling for pulse, systolic blood 
pressure and stenosis severity. IV TNG was also associated with a lower 
rate of TIMI 3 flow (57.1% vs 62.8%) as well as higher rates of TIMI 2 flow 
(23.6% vs 15.7%) and similar rates of TIMI O/i flow (p = 0.037). Quantitative 
angiography demonstrated larger reference diameters in patients on IV TNG 
(3.06 & 0.89 (n = 556) vs 2.89 & 0.88 (n = 251), p = 0.02) and preserved flow 
in cc/min in patients on IV TNG (45.8 i 40.0 cc/min, n = 396 vs no IV TNG 
45.1 i 40.0, n = 147, p = NS). IV TNG was also associated with a 4 frame 
slowing in the nonculprit arteries (32.7 i 16.2 vs 28.9 * 11.9, p = 0.0009). 
Only IV TNG was associated with slower non-culprit CTFCs in a multivariate 
model controlling for beta blocker use, SBP, pulse, & Ml location (p = 0.03). 
Conclusions: Following thrombolytic administration, use of IV nitrates 
slows the CTFC (increase transit time down the artery), but due to an in- 
creased vessel diameter overall flow in cc/min is preserved despite slower 
dye transit. It should be confirmed that TNG administration is balanced across 
treatment groups in randomized trials to prevent confounding of visually as- 
sessed flow endpoints such as the TIMI Flow Grade & TIMI Frame Count. 
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1 1173-i 38 1 The Relationship Between Corrected Timi Frame 
Counts and Late Survival After Myocardial 
Infarction 
John K. French, Thomas A. Hyde, Ivan T. Straznicky, Jacquelin Andrews, 
Mayanna Lund, David J. Amos, Andrew Zambanini, Christopher J. Ellis, 
Bruce J. Webber, Stephanie C. McLaughlin, Ralph M.L. Whitlock, 
Hitesh Patel, Harvey D. White. Green Lane /-/ospita/, Auckland, New 
Zealand 
Background: The corrected Thrombolysis in Myocardial infarction (TIMI) 
frame count (CTFC) provides a more reproducible measurement of infarct- 
related artery blood flow than TIMI flow grades. 
Methods & Results: To determine whether CTFC, as well as TIMI flow 
grades, influence late survival after myocardial infarction, 882 patients pre- 
senting with ST segment elevation within 4 hours of symptom-onset ware 
studied. Infarct-artery CTFC and TIMI flow grades were assessed at 3 weeks, 
blinded to treatment and clinical outcomes; late vital status was determined 
in 97.6%. CTFCs were 40 f 29 in 644 patent infarct arteries (median 34 
[IQR - 24 to 471). The CTFC, assessed as continuous variable, influenced 
5-year survival and cardiac mortality (figure), as did TIMI flow grades (both P 
< 0.01). Independent multivariate predictors of 5-year survival were ejection 
fraction or end-systolic volume index (both P < O.OOi), exercise duration (P 
= 0.005), age (P = 0.005), age (P = O.OOE), diabetes (P = 0.02) and CTFC (P 
= 0.02) or TIMI flow (P = 0.02). The same factors predicted IO-year survival, 
except CTFC and TIMI flow which did not. 
Conclusion: The CTFC after infarction was an independent predictor of 
5-year survival, but was not superior to TIMI flow grading. Neither factor 
independently influenced IO-year survival. 
1173-l 39 Predictors of Microvascular lntergrity After 
Reperfused Acute Mvocardial Infarction: Effects 
of bressure-derived bractional Collateral Flow 
Hyun-Sook Kim, Goo-Young Cho, Cheol Whan Lee, Myeong-Ki Hong, 
Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. 
Department of Medicine, University of Ulsan, Asan Medical Center, Seoul, 
Korea 
Microvascular integrity by myocardial contrast echocardiography (MCE) is 
closely associated with myocardial viability after reperfused acute myocar- 
dial infarction (AMI). However, predictors of microvascular intergrity in AMI 
remain to be investigated. We evaluated factors predictive of microvascu- 
lar integrity after successful primary angioplasty (PA) (TIMI 3 flow, residual 
diameter stenosis < 30%) in AMI. MCE was performed in 26 consecutive pa- 
tients with a first AMI (pain onset < 12 hours, age 60.8 & 11.0) immediately 
after PA. MCE score index was derived by assigning scores to individual 
segments within the infarct zone (0, 0.5 and 1 denoting no, intermediate, and 
homogeneous contrast effect, respectively) and deriving the average score 
within the infarct bed. Pressure-derived fractional collateral flow (PDCF) was 
determined using simultaneous measurement of mean aorta pressure (Pa), 
intracoronaty pressure distal to the occluded stenosis (PO) and the right atrial 
pressure (RA): (PO - RA) / (PaRA) * 100. Echocardiography was performed 
before, and 30 days after PA. Clinical, angiographic and procedural variables 
were analyzed. MCE score index was significantly associated with PDCF 
index (r = 0.62, p x 0.01). However, it was not related to preinfarct angina 
within 24 hours (r = 0.04, p = NS), reperfusion time (r = 0.08, p = ns) or 
angiographic collaterals (r = 0.04, p = ns). MCE score indexe was closely as- 
sociated with recovery of regional motion abnormalities at 1 -month follow-up 
(r = 0.54, p < 0.01). 
Conclusions: Pressure-derived fractional collateral blood flow is a pri- 
mary determinant of microvascular integrity after successful PA, indicating 
that collateral flow plays an important role in preserving microvascular in- 
tegrity 
1173-l 40 A Simple Model for Prediction of Mortality in 
Acute Myocardial Infarction: Observations From 
InTIME II 
Elliott M. Antman, Andrew Charlesworth, Carolyn H. McCabe, 
Karl Neuhaus, Eugene Braunwald. Brigham and Women’s Hospital, Boston 
MA, USA 
Background: We evaluated a simple mortality prediction scheme using vari- 
ables that have been established as reliable prognostic factors in myocardial 
infarction (Ml) and are readily identified when patients (pts) are first seen. 
Methods: A total of 15,078 pts were randomized ~6 h from symptoms to 
tPA or the bolus thrombolytic nPA. The average mortality by 30 days (d) was 
6.7%. The proportion of patients presenting with age p 75, Killip Class II-IV, 
or ECG showing anterior MI/LBBB was determined and the impact of these 
risk factors on 30 d mortality was calculated in univariate and multivariate 
analyses. A risk score for predicting 30 d mortality based on the number (#) 
of the above risk factors present was developed. 
Results: 
Risk Factor Age z 75 
Pts with Factor 13.8% 
30 d Mortality 18.4% 
Rel Risk 30 d Mortality 3.a* 
*P < 0.001 by multivariate analysis 
Killip II-IV 
12.6% 
16.6% 
2.8* 
Anterior/LBBB 
42.6% 
9.1% 
1.7* 
Risk Score 
# Risk Factors 0 1 2 3 
% Pts 45.6% 41.4% 11.1% 1.8% 
30 d Mortality 3.1% 6.3% 18.7% 31.7% 
Conclusions: Age p 75, Killip Class II-IV, and anterior MI/LBBB ECG 
pattern are potent predictors of 30 d mortality and when present increase 
the risk of dying 2-4 fold. Used in combination they provide a simple and 
powerful stratification scheme that identifies pts with a IO fold gradient of risk 
ranging from 0.5 to 5 times the average mortality. 
1173-l 41 Admission Heart Rate is a Useful Tool for Risk 
Stratification of Patients With AMI in the 
Reperfusion Era 
Solomon Behar, Elieser Kaplinsky. Neufeld Cardiac Research Institute, 
Sheba Medical Center, Tel Hashomer, Israel 
Background: Baseline heart rate (HR) is associated with increased mortality 
risk in patients (pts) with coronary artery, disease (CAD). 
Methods: We evaluated the impact of admission HR among 2355 uns- 
elected AMI pts hospitalized in all operating CCU’s in our county during a 
5month national prospective survey in the reperfusion era. Pts with com- 
plete AVB (n = 139) were excluded. The remaining pts were divided into three 
groups according to the admission HR, group 1 (HR < 60 b/m). group 2 (HR 
60-79 b/m, group 3 (HR ? 80 b/m). 
Results: The demographic, clinical characteristics, management and 
subsequent mortality in the three respective groups were as follows: 
Group 1 Group 2 Group 3 
(n = 197) (n = 912) (n = 1107) 
HR (mean) 52 69 94 
Men (“A) 80 77 73s 
Age (mean) yrs 63.2 62.0 62.4 
Prior MI (%) 21 20 25* 
Diabetes (%) 16 19 31** 
Killip ?2/admiss.(%) 12 12 31** 
Anterior MI (%) 28 43 54** 
Peak CK (IN.) median 880 1002 1032** 
Thrombolysis (%) 58 50 46* 
PTCNCABG (%) 20 30 26* 
Mortality OFi” (95%GI) 
7-day 0.71 (0.20-l .19) 1.0 2.28 (1.433.76) 
30-day 0.62 (0.25-1.36) 1.0 1.68 (1.16-2.46) 
1 -year 0.39 (0.16-4)0.80) 1.0 1.54(1.13-2.12) 
* p < 0.05; ** p < 0.0001; * Adjusted for age, sex, prior MI, diabetes, hypertension, 
@lockers and Killip ? 2. 
After multiple adjustment low admission HR was associated with lower 
death rates, while high admission HR was independently associated with a 
poorer short and long-term prognosis. 
Conclusion: Admission HR emerged as an independent predictor of early 
and late prognosis after AMI. Admission HR may be useful for therapeutic 
strategy decision making on admission of pts with AMI. 
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1 1174-I 27 ( Efficacy of Very High and Very Low Energy 
Encircling Overlapping Waveform Transthoracic 
Defibrillation: A Comparison With Monophasic 
Waveform Defibrillation 
Craig 8. Clark, L. Ray Davies, Richard E. Kerber. University of /owa, lowa 
City: IA, USA 
Background: Encircling overlapping (EO) waveforms appear superior to 
conventional monophasic waveforms for transthoracic defibrillation, How- 
ever, there are few data on the efficacy of EO defibrillation at high and low 
energies. 
Methods: We studied IO pigs weighing 30-40 kg. After 15 sets of electri- 
cally induced ventricular fibrillation, transthoracic shocks were administered 
from a custom-built defibrillator. Monophasic shocks were given using a 5 
msec truncated exponential waveform; EO shocks used a 12 msec mul- 
tipulse, multipathway waveform which produces an electrical vector which 
rapidly encircles the chest. Energy doses ranged from 70 J-360 J. Four 
shocks at each energy were given and the results averaged. Success was 
defined as termination of VF. 
Results: 
70J IOOJ 15OJ 
Monophasic 0% 15% 11% 
EO 11% 35%* 69%” 
% success, * = p c 0.05, EO vs. monophasic 
200 J 300 J 360 J 
54% 97% 100% 
86%” 97% 100% 
Pulseless electrical activity (PEA) occurred 3 times following monophasic 
shocks and once following EO shocks; all resuscitation attempts from PEA 
were unsuccessful. 
Conclusion: EO shocks for transthoracic defibrillation were superior to 
monophasic shocks at 100, 150, 200 J energies, and were equally good at 
the high energies (300-360 J). PEA was uncommon with either waveform, 
but lethal when it occurred. 
l---d 1174 128 Emergency Access to the Thoracic Central Venous Circulation Using Femoral Venipuncture 
During Cardiopulmonary Resuscitation 
Ari delaHera, Ross D. Tannenbaum, Stephanie Nelson. Provena Saint 
Joseph Medical Center, Jolief, Illinois, USA 
Background: Emergency access to the thoracic central venous circula- 
tion during cardiopulmonary resuscitation (CPR) with subclavian or neck 
venipuncture requires an operator at the head or chest of the patient, crowd- 
ing and interrupting those performing ventilation and chest compression. 
Femoral venipuncture during CPR avoids these pitfalls, but infusion of med- 
ications below the diaphragm may slow their entry into the thoracic central 
venous circulation. Therefore this study was designed to test the hypothesis 
that blind passage of an 80-cm long pigtail catheter to the thoracic central 
venous circulation using femoral venipuncture can be achieved in a high 
percentage of cases during CPR. This novel approach has not previously 
been reported. 
Methods: This was a prospective evaluation of success rate in 28 con- 
secutive patients undergoing CPR in a 538-bed Medical Center. Sixteen 
patients had out-of-hospital arrest resuscitated in the emergency depart- 
ment. A IO-cm long femoral venous sheath was placed, then an 80-cm long 
pigtail catheter was advanced blindly to a predetermined length (the distance 
from the right nipple to the end of the femoral venous sheath). Catheter 
location was verified by postresuscitation chest x-ray. 
Results: An intrathoracic catheter tip location was defined as success, 
and inability to access the femoral vein or catheter tip location below the 
diaphragm failure. In 24 of 28 (89%) patients, successful catheter location 
was accomplished. 
Conclusion: Insertion of a 80-cm long pigtail tip catheter to the thoracic 
central venous circulation position using femoral venipuncture is feasible in 
a high proportion of patients during CPR. 
L 1174 129 Transient Shock After Successful Resuscitation: Clinical Evidence for Post-Cardiac Arrest 
Myocardial Stunning 
Ivan Laurent, Christian Spaulding, Mehran Monchi, Luc-Marie Joly, 
Alain Rozemberg, Fabrice Brunet, Pierre Carli, Simon Weber, 
Jean-Franpois Dhainaut. lnfensive Care Unit and Cardiology Department, 
Cochin Hospital and SAMU de Paris, Necker Hospital, Renk Descartes 
University, Paris, France 
Background: Global prognosis after successfully resuscitated cardiac arrest 
(CA) remains poor. Early death is often related to multiple organ failure 
(MOF) due to low cardiac output. Experimental data suggest that ventricular 
dysfunction can be assimilated to transient myocardial stunning. However, 
clinical trials describing hemodynamic status in survivors of CA and its impact 
on prognosis are lacking. 
Methods and Results: Among 165 consecutive patients admitted af- 
ter successfully resuscitated CA, 73 developed a shock requiring invasive 
monitoring during the first 72 hours. Initial hemodynamic data showed a low 
cardiac index (Cl) which rapidly increased 24 hours after CA (2.05 [I .43-2.901 
at 8rh hour vs 3.19 [2.67-4.201 L.min-’ at 24rh hour, p < O.OOl), indepen- 
dently of preload parameters and inotropic treatment. Despite normalization 
of Cl at 24 hours, a superimposed vasoplegic state delayed the discontinu- 
ation of vaspressor drugs. Patients who died from MOF had a lower cardiac 
output at H24 (Cl: 2.56 [2.27-2.981 vs 3.32 [2.90-4.28] I/min/m”, p = 0.003). 
No differences in hemodynamic and oxygenation parameters were observed 
throughout the study period between patients with poor neurological outcome 
and those who survived with no or minimal sequels. 
Conclusions: Shock during the early post-resuscitation phase in sur- 
vivors of CA is characterized by low cardiac output which is reversible in 
most cases within 3 days and compatible with transient myocardial stunning. 
Early death by MOF is associated with persistent low cardiac output at H24. 
Hemodynamic status is not predictive of neurological outcome. 
1 1174-I 30 1 Low-Risk Patients Undergoing Evaluation of 
Acute Chest Pain Do Not Benefit From Heart 
Rhythm Monitoring 
Douglas A. Tomasian, Robert C. Hendel, Richard Davison, Linda Hellstedt, 
Dan J. Fintel. Northwestern University Medical School, Chicago, Illinois, 
USA 
Background: Patients (pts) with acute chest pain (CP) and nondiagnostic or 
normal (NDINL) ECG represent a common triage challenge in the Emergency 
Department (ED). Chest Pain Units have been shown to be cost-effective 
and efficient for CP evaluation. However, the incidence of major arrhythmia 
(MA) in pts undergoing evaluation for low-risk CP is not well known. 
Methods: 2371 consecutive pts presenting to the ED of a large urban 
tertiay center with acute CP and ND/NL ECG over 28 months were placed 
in a Chest Pain Unit and underwent continuous cardiac monitoring with 
serial cardiac enzymes (C-MB and troponin I), The incidence of recorded 
MA defined as any significant hemodynamically unstable supraventricular 
tachycardia or bradycardia, ventricular tachycardia or ventricular fibrillation 
was determined. The pts were 47.4% female and 52.6% male, ranging in 
age from 20-94 years (median of 53). 
Results: In the 2371 pts, there were no MA events recorded during initial 
hospitalization. 76.6% of pts were discharged home directly from the Chest 
Pain Unit, 11.5% were transferred to the Coronary Care Unit or teleme- 
try/Stepdown for further ischemic workup, 9.6% to a general medical unit, 
and 2.2% had other disposition. The average length of stay from presentation 
to discharge from the Chest Pain Unit was less than 12 hours. 
Conclusion: Chest Pain Units represent an effective means of evaluating 
pts considered to be low risk for coronary artery disease. In our cohort of 
2371 pts, there were no MA revealed by continuous cardiac monitoring. 
Thus, pts with acute CP and ND/NL ECG at presentation are not at risk 
for developing MA during evaluation in a Chest Pain Unit. These findings 
suggest that routine continuous cardiac monitoring provides no additional 
benefit in the care of low risk patients presenting to a Chest Pain Unit. 
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III 889 1 Transthoracic Encircling Overlapping and 
Monoohasic Waveform Defibrillation in Infant and 
Pediairic Models 
Craig B. Clark, L. Ray Davies, Richard E. Kerber. University of Iowa, lowa 
Citx IA, USA 
Background: Only limited data exist on the proper energy doses for infant 
and pediatric defibrillation. In addition, new waveforms for defibrillation have 
been developed which appear superior to traditional monophasic waveforms 
in adults. Our purpose was to evaluate monophasic and new encircling 
overlapping (EO) defibrillation waveforms in a pediatric model. 
Methods: Twelve “infant” piglets (3-6 kg) and 15 “child” piglets (7-12 
kg) were studied. After 15 sets of electrically induced ventricular fibrilla- 
tion, transthoracic shocks were administered from a custom-built defibrilla- 
tor. Monophasic shocks were given using a 5 msec truncated exponential 
waveform; EO shocks used a 12 msec multipulse, multipathway waveform 
which produces a thorax-encircling electrical vector. Energy doses ranged 
from 7-100 J; 4 shocks at each energy were given and the results averaged. 
Success was defined as termination of VF. 
Results: % success, * = p < 0.05, EO vs. monophasic 
Waveform 7J 1OJ 20J 30J 50J 70J 1OOJ 
Monophasic, 3-6 kg 3 5 22 47 88 100 100 
EO, 3-6 kg 16 63* 87* 97* 100 100 100 
Monophasic, 7-12 kg 0 0 0 22 71 83 100 
EO, 7-12 kg 8 15 63’ 86* 1 oo* 100 98 
Conclusion: EO shocks for transthoracic defibrillation were superior to 
monophasic shocks at lower energies in both “infant” and “child” piglets; 
lower energies carry less risk of myocardial toxicity. These new waveforms 
appear promising for pediatric defibrillation. 
4:15 p.m. 
889-2 Comparison of a Biphasic Truncated Exponential 
Waveform to Two Standard Monophasic Waveforms 
for External Defibrillation 
Robert G. Walker, James W. Taylor’, Paul W. Schmitt’, Jeffrey L. Johnson’, 
Gregoty P. Walcott, Fred W. Chapman’, Raymond E. Ideker. University of 
Alabama at Birmingham, Birmingham, AL; ’ Medtronic Physio-Control, 
Redmond, WA, USA 
Background: External defibrillators presently considered the standard of 
care employ either monophasic damped sinusoid (MDS) or truncated expo- 
nential (MTE) waveforms. Although both waveform types satisfy the AAMI 
standard, the specific waveform characteristics of different devices vary 
widely within each waveform category. Currently, biphasic waveforms are 
being introduced, requiring the collection of both basic and clinical data 
demonstrating that the new waveforms are at least substantially equivalent 
to the standard of care. The present study was performed both to evaluate 
the efficacy of a new biphasic truncated exponential (BTE) waveform for ex- 
ternal defibrillation, as well as to assess the influence of the choice of control 
waveform on the results and interpretation of the waveform comparison. 
Methods: In 6 swine, first shock success rates were measured for 150 J 
BTE (Medtronic Physio-Control), 200 J MDS (Lifepak 12, Medtronic Physio- 
Control), and 200 J MTE (HeartStart 3000, Laerdal) shocks. Twenty fib- 
rillation/defibrillation episodes were performed for each waveform in each 
animal. In each episode, ventricular fibrillation was induced with 60 Hz cur- 
rent, and after 15 seconds defibrillation was attempted with a test waveform. 
The order in which the three waveforms were tested was randomized in 
groups of three. 
Results: First shock success rates for the three waveforms were 150 J 
BTE - 96%, 200 J - MDS 67%, and 200 J MTE - 30%. In a statistical model 
accounting for inter-animal variation, the odds of successful defibrillation 
with 150 J BTE shocks were 16 times greater than for 200 J MDS shocks 
(95% confidence interval, 6.9-38.6) and 129 times greater than for 200 J 
MTE shocks (95% confidence interval, 42.4-394.2). While the 150 J BTE 
waveform was superior to both 200 J MDS and MTE waveforms, there was a 
dramatic difference in the success rates of the two monophasic waveforms. 
The odds of successful defibrillation were 8 times greater for the 200 J 
MDS waveform than for the 200 J MTE waveform (95% confidence interval, 
4.0-15.8). 
Conclusions: In this animal model, the BTE waveform was superior to 
both monophasic waveforms. The results also suggest that there is a sub- 
stantial disparity in defibrillation effectiveness among current AAMI standard 
monophasic waveforms. To ensure the validity of future therapy improve- 
ments, prospective waveforms should be compared to the most effective 
current standard. 
4:30 p.m. 
889-3 Importance of Early Defibrillation in Commotio 
Cordis, Sudden Death Due to Low Energy Chest Wall 
Trauma in Sports 
Mark S. Link, Paul J. Wang, Brian A. VanderBrink, Wei Zhu, 
Masaaki Takeuchi, Natesa G. Pandian, Barry J. Maron, N.A. Mark Estes III. 
Tufts-New England Medical Center; Boston, MA, USA 
Background: Sudden death can result from a relatively low energy strike to 
the chest with an object (typically a baseball). Although the victim’s hearts are 
without disease, the etiology of the sudden death is thought to be ventricular 
fibrillation (VF), and resuscitation is often timely, survival is rarely reported 
in these young athletes. In an experimental model of commotio cordis, we 
examined the importance of time to defibrillation and the electrophysiological 
consequences of defibrillation in an attempt to understand the low survival of 
commotio cordis patients. 
Methods: Juvenile swine weighing between 8 and 20 kg were anes- 
thetized with ketamine and isoflurane, and placed prone in a sling. Impacts 
were given during the vulnerable portion of the T-wave with objects propelled 
at 20 to 40 mph. If VF resulted from a chest wall impact defibrillation was 
given at times from immediate to up to 6 minutes later. 
Results: Of 123 episodes of VF, 25 animals (20%) could not be resus- 
citated. All were successfully defibrillated; nevertheless, heart block without 
escape was seen in 11 and pulseless electrical activity (PEA) in 14. Time to 
defibrillation was a predictor of survival (p < 0.001). 
Minutes to Defibrillation 
1 2 3 4 or greater 
Mortality 2i72 (3%) 4/20 (20%) 7/l 3 (54%) 12118 (67%) 
PEA 0 1 5 8 
Heart block 2 3 2 4 
Conclusion: Time to defibrillation was a critical determinant of survival in 
an experimental model of commotio cordis. The necessity of early defibrilla- 
tion and the frequent occurrence of PEA and heart block after defibrillation 
may explain the difficulty with resuscitation of commotio cordis victims. Ear- 
lier access to defibrillation may save the lives of some young athletes who 
are victims of commotio cordis. 
4:45 p.m. 
889-4 Post-Resuscitation Left Ventricular Dysfunction 
Treated With Dobutamine: Dose Response Curves 
Karl B. Kern, Robert A. Berg, Ronald W. Hilwig, Joseph Heidenreich, 
Gina South, Gordon A. Ewy. University of Arizona Sarver Heart Center, 
Tucson, AZ, USA 
Background: Cardiac arrest with successful resuscitation results in left ven- 
tricular stunning. Dobutamine can reverse this stunning. The purpose of 
this study was to examine the dose responsiveness of dobutamine for this 
problem. 
Methods: Twenty swine were studied for left ventricular function after 
resuscitation from 12.5 min of untreated VF. Endpoints were ejection fraction 
(LVEF), isovolumic relaxation (Tau), left ventricular end-diastolic pressure, 
pulmonary artery pressures and cardiac output. Animals were randomized 
to four groups to receive dobutamine 30 min after resuscitation at 0, 2, 5 or 
7.5 (mcg/kg/min). Data was collected at baseline, 25 minutes (prior to drug 
administration), 35 min, 2, 4, and 6 hrs. 
Results: Ejection fractions tell dramatically from baseline levels in all 
groups at 25 min., and improved with each dose 2, 5 and 7.5 mcg/min/kg 
above control at 2 hrs. At 4 and 6 hrs a definite dose response was noted with 
2 mcg being better than 0, but both 5 and 7.5 being significantly greater than 
2 (0.05). A similar pattern was noted with isovolumic relaxation with diastolic 
function becoming compromised (0.05) by 25 min post-resuscitation and 
improving in a dose responsive manner of 2 hrs. By 6 hrs, 2 mcg/kg/min was 
not different than control with 5 mcg/kg/min being significantly different than 
control (0.05), and 7.5 mcg being better yet (0.05). Cardiac output showed the 
same trend with significant differences at 6 hours between all groups. Finally, 
heart rate for all doses by 6 hrs were substantially greater than control, which 
fell over time. 
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Conclusions: In this model of post-resuscitation left ventricular dys- 
function, dobutamine corrected both systolic and diastolic dysfunction in a 
dose dependent fashion with 5 and 7.5 mcgikglmin improving LV function to 
pm-arrest (baseline) levels, with 7.5 dose resulting in isovolumic relaxation 
and cardiac outputs better than baseline. All doses, including 2 mcglkgimin, 
raised heart rates above control levels. 
ORAL 
/ 899 Myocardial Infarction: ischemia and 
Reperfusion 
Wednesday, March 15, 2000, 8:30 a.m.-IO:00 a.m. 
Anaheim Convention Center, Room 213A 
8:30 a.m. 
1 899-l / Genetically Engineered Mice Overexpressing 
arp-Crystallin Exhibit Protection Against Myocardial 
lschemia-Reperfusion Injury 
Partha S. Ray, Gerald A. Cordis, Dipak K. Das, Richard M. Engelman, 
Wolfgang H. Diliman. University of Connecticut Health Center, Farmington, 
CJ; Baysrate Medical Center, Springfield, MA; University of California, San 
Diego, CA, USA 
Background: crp-crystallin, a stress inducible molecular chaperone of the 
small heat shock protein family, is believed to help preserve cytoskeletal and 
microtubular integrity. The object of this study was to investigate whether 
@-crystallin can protect the myocardium from the damaging effects of is- 
chemia-reperfusion (I/R) injury. 
Methods: Transgenic mice overexpressing c@crystallin were produced 
by subjecting B6C3 mice to genetic manipulation. Control and transgenic 
mice (n = 6) were anesthetized and anticoagulated, thoracotomy was per- 
formed and the hearts were excised. After aortic cannulation, left ventricular 
catheter placement and left atrial cannulation, an isolated working heart 
preparation was initiated with a preload of 15 mm Hg and an afterload of 
50 mm Hg. Left atrial pressure, left ventricular pressure (LVP) and aortic 
pressure (AP) were analyzed in real time. The hearts were then subjected 
to 20 min of global ischemia followed by 3 hours of reperfusion (R) after 
recording baseline functional values and collecting perfusate samples. 
Results: The transgenic group displayed significant post-ischemic recov- 
ery of left ventricular function. The values of % recovery of baseline LVPmax, 
dLVP/dtmax and AP in the control vs. transgenic group at R45 min were 
39.77% vs. 75.20%, 19.46% vs. 65.90% and 45.67% vs. 77.69%, respec- 
tively. Development of oxidative stress was less in the trasgenic group as 
indicated by significantly lower perfusate malonaldehyde levels at RI, R7, 
R3O and R:20 mins. Infarct size in the transgenic group was found to be 
smaller than in the control group. 
Conclusion: The results suggest that orb-crystallin does help to protect 
the heart from myocardial I/R injury. Whether this effect is solely due to a 
stabilization of the myocardial contractile apparatus, or additionally, due to 
another mechanism remains to be established. 
8:45 a.m. 
899-2 Geranylgeranylacetone Induces Pharmacological 
Preconditioning in Rat Cardiac Myocytes as a 
Chaperon Inducing Reagent 
Kazuhiro Aoki, Masashi Nishida, Nobushige Yamashita, 
Yoshiaki Nakatsuchi, Yoshiki Akamatsu! Tsunehiko Kuzuya, 
Masatsugu Hori, Michihiko Tada. The Department of Medicine and 
Pathophysiology, Osaka University School of Medicine, Suita, Japan 
Geranylgeranylacetone (GGA), an acylic polyisoprenoid, used as an antiul- 
cer drug for ten years, has been recently shown to induce heat shock protein 
70 (HSP70) in gastric endotheliai cells and confer cytoprotective tolerance 
against oxidative stress (Gasteroenterology 1997 and JCI 1998). The aim 
of this study is to determine whether GGA induces HSP70 in cardiac my- 
ocytes and augment tolerance against ischemia/reperfusion injury. Cardiac 
myocytes were isolated and cultured from neonatal rats. HSP70 expres- 
sion was examined by Western blotting using anti murine HSP70 antibody. 
IschemiaIreperfusion was mimicked by 12 hr hypoxia (95% N2, 5%CO2) 
followed by 1 hr reoxygenation (95% Air, 5%CO2) and myocyte injury was 
assessed by LDH release. GGA (1 FM) treatment induced HSP70 in my- 
ocytes starting from 1 hr after treatment (170% of control level), peaked out 
at 3 hr after treatment (220%) and then gradually decreased. When GGA 
was added to myocyte cultures prior to simulated ischemia, GGA pretreat- 
ment decreased LDH release from myocytes after hypoxia/reoxygenation 
significantly from 42.9 & 1.1% of total LDH in control myocytes to 33.7 & 
1.3% (p < 0.05). These data suggest that GGA induce pharmacological 
preconditioning in rat cardiac myocytes through the expression of HSP70. 
HSP70, a cytoprotective molecular chaperon, have been shown to be in- 
duced by heat shock, a variety of metabolic insults such as heavy metals, 
amino acid analogs, oxidant, and different metabolic poisons. However, these 
agents are cytotoxic and could not be used in clinical application. Therefore, 
GGA could be the first chaperone inducer which confer ischemiaireperfusion 
tolerance to hearts without any toxic effect and be applicable for clinical 
patients. 
9:00 a.m. 
L-l 899 3 The Effects of Ischemic Preconditioning on Adenosine Deaminase and Kinase Activities in the 
Canine Heart 
Masafumi Kitakaze, Hiroshi Asanuma, Shoji Sanada, Segi Takashima, 
Yasunori Ueda, Yasuhiko Sakata, Masanori Asakura, Hisakazu Ogita, 
Tsunehiko Kuzuya, Masatsugu Hori. Department of internal Medicine arid 
Therapeutics, Osaka University, Suifa, Japan 
Background: We have previously reported that the enzyme responsible for 
adenosine production, ecto-5’-nucleotidase, is activated by ischemic pre- 
conditioning (IP), which contributes to the infarct size-limiting effect. Since 
both adenosine kinase (AK) and adenosine deaminase (ADA) also regulate 
cardiac adenosine levels by inhibition of resynthesis from adenosine to AMP, 
and degradation of adenosine to inosine, respectively, we tested whether the 
activities of ADA and AK are modulated by IP. 
Methods: In the canine heart, IP was produced by 4 times of 5 min 
coronary occlusion. 
Results: Five min after the IP procedure, the ADA activity was reduced 
in the IP group compared with the control group (3.6 & 1.3 vs. 5.9 * 1.6 
nmol/mg protein/min, p < 0.05) while the AK activity was unchanged with 
and without IP (3.1 i 0.8 vs. 2.8 & 1.3 nmol/mg proteinimin). Furthermore, 
we sampled the tissues at 15 min of ischemia with and without the precon- 
ditioning procedure. ADA activity remained reduced (4.0 f 0.3 vs. 6.1 i: 0.4 
nmol/mg proteinimin, p < 0.05) in the IP group. The decreases in ADA activity 
were blunted by prazosin (6.3 & 1.5 nmolimg proteinimin) or GF109203X (a 
specific inhibitor of protein kinase C, (6.2 i 1 .I nmolimg protein/min)). The 
size of infarct produced by 90 min of coronary occlusion followed by 6 hours 
of reperiusion was compared in the control and IP groups. IP reduced infarct 
size markedly (12.2 f 2.9 vs. 45.9 * 3.4%, p < O.Oi), which was blunted by 
concomitant administration of ADA (37.8 i 3.5%, p < 0.05). 
Conclusion: We conclude that ischemic preconditioning deactivates 
adenosine deaminase via activation of protein kinase C, which contributes to 
the infarct size-limiting effect of ischemic preconditioning. Protein kinase C 
activation during ischemic preconditioning regulates adenosine deaminase 
as well as ecto-Y-nucleotidase to synergistically trigger or mediate the infarct 
size-limiting effect of ischemic preconditioning. 
9:15 a.m. 
u 899 4 Time-to-Balloon Dependence of Coronary Flow Velocity Reserve After Primary Angioplasty in 
Patients With Anterior Acute Myocardial Infarction 
Paolo Colonna, Massimo Ruscazio, Carlo Caiati, Enrico Onnis, 
Giorgio Longu, Roberta Montisci, Mauro Cadeddu, Giorgio Lai, 
Raimondo Pirisi, Christian Cadeddu, Lijun Chen, Luigi Meloni, 
Sabino Iliceto. lnstifute of Cardiology Cag/iari UniversiQ &a/y 
Background: The coronary flow velocity reserve (CFVR) can be calcu- 
lated in the left anterior descending coronay artery (LAD) by noninvasive 
contrast-enhanced transthoracic second harmonic echo Doppler. In patients 
with acute myocardial infarction (AMI) the primary corollary angioplasty (PA) 
with stent placement is increasingly used as a primary mean for achieving 
reperfusion of the occluded infarct-related artery. We hypothesized that the 
time to reperfusion may influence the dilatory capacity of the microvascular 
bed within the infarct area and the CFVR. 
Methods: The coronary flow within the LAD was recorded in 35 pts with 
first acute AMI, 4.5 + 1.4 days after PA, combining transthoracic color and 
pulsed Doppler with the infusion of Levovist to optimize the signal. CFVR 
was obtained as the ratio of maximal velocity during adenosine infusion and 
baseline velocity at rest. 
Results: In the 20 patients with PA performed within 4 hours from chest 
pain onset the left ventricle ejection fraction at predischarge echocardiogra- 
phy was higher and the WMSI lower, in comparison to the 15 patients with 
PA later than 4 hours from chest pain onset (54.8 i 11% vs 42.6 i II%, p < 
0.01, and 1.69 f 0.2 vs 2.03 i 0.2, p < 0.005, respectively). The CFVR was 
higher in the group with early reperfusion (2.97 & 0.8) than that of late LAD 
reperfusion (2.25 * 0.5, p < 0.005). 
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Conclusions: Patients with PA for anterior AMI and a short time-to-bal- 
loon show a greater extent of microvascular salvage and a higher value of 
CFVR in the LAD. 
9:30 a.m. 
/ 899 5 Upregulation of Inducible Heme-Oxygenase-1, Generator of Carbon Monoxide, in the 
Post-Infarction Myocardium is Dependent on the 
Presence of Nitric Oxide 
David Hou, Karen Aitken, Min Irwin, Tom Parker, Michael J. Sole, 
Jim Tsoporis, Peter Liu. University of Toronto, Canada 
Methods: Under in vitro and then in viva conditions, we tested the hypoth- 
esis that nitric oxide (NO), produced by NOS-2, contributes to the induction 
Background: The inducible form of heme oxygenase (HO-l), a stress re- 
sponsive protein that degrades iron complexes and produces carbon monox- 
of HO-1 
ide (CO), is upregulated in models of cardiac ischemia reperfusion. Previ- 
ously, we identified HO-1 to be localized in the infarct and peri-infarct zones 
post-infarction, temporally parallel to NOS-2 induction. We hypothesized 
HO-1 to have important interactions with NOS-2 for its induction and physio- 
logical action. 
To determine whether NO is necessary in the induction of HO-l. rat 
cardiac myocyte cultures were treated with NOS blocker, L-NAME, with or 
without the potent NOS-2 inducer, interferon (IFN-y). 
In the in vivo experiments, L-Arginine (L-Arg, 1 g/day) was supplemented 
in drinking water to Sprague Dawley rats for a duration of 1 week. Then, one 
group was given L-NAME in addition to the L-Arg supplementation. 
Results: Increase in HO-1 protein production in rat cardiac myocyte 
culture exposed to IF-y was observed within 24 hours of the exposure 
and was completely abrogated with the addition of L-NAME. Similarly, in 
L-Arginine treated rats, the hearts showed a significant increase in cardiac 
HO-1 production. This increase is again reversed by the addition of L-NAME 
to the L-Arg supplementation. 
Conclusions: The upregulation of tissue HO-1 levels post-myocardial 
infarction is at least in part driven by NOS-2 produced NO. This may reflect 
a potential collaborative action between NO and CO. 
9:45 a.m. 
899-6 Bradykinin Pretreatment Protects the lschemic 
Rabbit Heart: The Role of PKC 
Jun Feng, Hong-Ling Li, Eliot Ft. Rosenkranz. The Children’s Hospital of 
Buffalo and the State University of New York at Buffalo, Buffalo, New York, 
USA 
Background: We have shown previously that Bradykinin (BK) pretreatment 
of the rabbit heart improves ischemia tolerance via activation of Tyrosine 
Kinase (TK). This study tests the hypothesis that BK pretreatment also 
requires Protein Kinase C (PKC) activation. 
Methods: Rabbit hearts perfused with Krebs-Henseleit buffer (KHB) on 
a Langendorff apparatus underwent 50 minutes of normothermic ischemia 
with St Thomas’ cardioplegia (STCP) solution. Ten (control) received no 
pretreatment. Ten (BK) were pretreated with IO minutes of 0.1 PM BK in KHB 
before arrest with STCP solution supplemented with 0.1 kM BK Seven (BK 
+ Chel Pretreated) were pretreated with 10 minutes of 20 PM Cheletythrine 
(Chel), a PKC inhibitor, followed by 10 minutes of 0.1 FM BK + 20 FM Chel 
in KHB before arrest with STCP solution supplemented with 0.1 GM BK + 
20 pM Chel. Left ventricular developed pressure (LVDP) and coronary flow 
(CF) were measured after 60 minutes of KHB reperfusion. 
Results: As shown in the table, BK pretreated hearts recovered 51%* and 
75%* of preischemic LVDP and CF respectively compared to 26% and 52% 
in controls. PKC blockade with Chel significantly diminished BK’s salutary 
effect on the recovery of LVDP without reducing CF compared to BK alone. 
LVDP (mmHg) CF (mlimin) 
Group Preischemia Reperfusion Preischemia Reperfusion 
Control 105+fi 27 i 4 (26%)* 43f2 22 i 2 (52%)+ 
BK 114*4 54 It 5 (51%)*t 51 *3+ 31 * 3 (75%$ 
BK + Chel 112&5 39 zt 3 (38%)f 53*3t 29 * 3 (70%)+ 
* = p c 0.01 vs Control, t = p < 0.01 vs Preischemia, $ = p < 0.05 vs BK, ( ) = % 
Preischemia 
Conclusions: BK pretreatment improves the heart’s ischemia tolerance 
by activating PKC in addition to TK. The interaction of TK and PKC is currently 
unknown. 
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8:30 a.m. 
900-l Stent PAMI: 12 Month Results and Predictors of 
Mortality 
Cindy L. Grines, David A. Cox, Gregg W. Stone, Eulogio Garcia, 
Luiz Mattos, Alessandro Giambartolomei, Bruce Brodie, Alexandra 
J. Lansky, William W. O’Neill, Lorelei L. Grines, Judith A. Boura, 
Marie-Claude Morice. William Beaumont ffospita/, Royal Oak, M/, USA 
Methods: We obtained 12 month follow up on the 900 patients random- 
ized to primary stenting (n = 452) vs. primary PTCA (n = 448) in the stent 
PAMI trial. 
Background: Limited data are available regarding long term benefits of 
primary stenting vs. primary PTCA for AMI, and predictors of late outcome in 
these patients. 
Results: At one year follow up, the stent arm continued to have a reduced 
rate of ischemic target vessel revascularization, but tended to have higher 
mortality. 
stsnt f%i PTCA (%1 P-value 
,  
TIMI- Flow 89.5 92.7 0.10 
Death 5.8 3.1 0.07 
Reinfarction 2.9 2.7 1 .oo 
Disabling Stroke 0.4 0.4 1 .oo 
lschemic NR 10.6 21 .o <0.0001 
Any Event 17.0 24.8 <O.Ol 
Multivariate predictors of one year mortality included performance of 
CABG during the initial hospitalization (OR = 38, p = 0.002), age > 70 years 
(OR = 4.0, p = 0.0002), LAD infarct (OR = 3.0, p = 0.003), female gender 
(OR = 2.5, p = O.Ol), and final TIMI flow < 3 (OR = 7.0, p = 0.0001). With 
the removal of TIMI flow as a variable (since a correlation existed between 
stenting and lower TIMI flow grades), the trend for higher mortality with 
stenting remained (OR = 2.0, p = 0.055). 
Conclusions: These data suggest that although primary stenting for AMI 
reduced the rate of ischemic TVR at one year, it was associated with a trend 
toward increased mortality. Before primary stenting for AMI can be routinely 
recommended, additional studies are awaited. 
8:45 a.m. 
900-2 Impact of Venous Graft-Covered Stents in Acute 
Coronary Syndromes: Long-Term Outcome 
Konstantinos Toutouzas, Christodoulos Stefanadis, Eleftherios Tsiamis, 
loannis Kallikazaros, Costas Stratos, Manolis Vavuranakis, 
Konstantinos Tentolouris, Pavlos Toutouzas. Hippokration Hospital, 
University of Athens, Greece 
The treatment of patients (pts) with acute coronary syndromes (ACS) remains 
a problem, due to the thrombogenic atheromatic plaque. Elimination of the 
contact between the culprit atheromatic plaque and the bloodstream may 
be a new therapeutic approach. We sequestrated the culprit lesion by an 
autologous venous graft-covered strut (AVGCS) and we present the 4-year 
follow-up results compared to a control group. 
Methods: A 3-4 an venous graft was removed from the fight cephalic 
vein of 16 pts. A the venous graft was stabilized on the external surface of 
a conventional stent by 3 sutures at each end of the stent. The AVGCS was 
implanted in 16 TCL of 16 pts suffering from ACS Twelve AVGCSs were 
implanted in the LAD, 2 in the LCx and 2 in the RCA. Additionally, in 38 pts 
with ACS 40 uncovered stems were implanted serving as a control group. 
100 Cl.. AVOCS 
3 
_.... .:.- : .._..... . . . . . _ ..,.. 
ia. 
. . . .._.-.-.. _ 
Oonevl 
JACC February 2000 ABSTRACTS - Myocardial Ischemia and Infarction 403A 
Results: The procedure of AVGCS preparation and delivery was per- 
formed without any complication. Angiographic follow-up (6-9 months after 
the procedure) was obtained in 73% of AVGCS group and in 67% of the 
control group. The minimal luminal diameter alter the procedure was similar, 
but at follow-up it was greater in the AVGCS group (2.56 I 0.7 vs 2.01 f 
1 mm, p < 0.01). Angiographic restenosis was not detected in the AVGCS 
group. In contrast 9 restenotic lesions (28.1%) were detected in the control 
group (p < 0.01). The event-free survival rate at 4 years in AVGCS group 
was 94% vs 78% (p = 0.07) (figure). 
Conclusion: Long-term follow-up alter the implantation of AVGCS in ACS 
reveals favorable results. The sequestration of the culprit lesion may be a 
new approach for the treatment of ACS. 
9:00 a.m. 
/ 900 3 Very Early PTCA of infarct Arteries With TIMI 3 Flow 
is Associated With Improved Clinical Outcomes 
Allan M. Ross, Karin S. Coyne, Jonathan S. Reiner, Mouhieddin Traboulsi, 
Anthony Fung, Christopher Thompson, Deneane Boyle, Conor 
F. Lundergan. The George Washington Universify, Washington, DC, USA 
In the “Plasminogen-activator and Angioplasty Comparability Trial” (PACT) 
606 infarct patients within 6 hours of pain onset received ASA, full dose 
intravenous heparin and were randomized to a bolus of rt-PA (50 mg) or 
placebo. The intent (as previously reported) was to ameliorate the negative 
effects of time delays prior to infarct angioplasty by use of half-dose d-PA. 
Immediate angiography (median 51 min. post drug) was followed by protocol 
required PTCA i-i- stent for IRA TIMI grades 0, 1, or 2. When TIMI 3 was 
observed, PTCA was performed at the operator’s discretion. Of 141 patients 
with TIMI 3 on cath lab arrival, 32 had PTCA nonetheless while 109 ware not 
dilated (no PEA). Baseline variables were similar in both groups (including 
% stenosis, 69 f 15% vs 71 f 10%). Immediate angioplasty despite TIMI 
3 flow was associated with reductions in adverse events including recurrent 
ischemia (RI), reinfarction (ReMI), reocclusion (ReOc), need for subsequent 
emergent target vessel revascularization (EmTVR), and 30 day mortality (30 
dM). 
RI ReMI kOC EmTVR 30 dM 
PTCA 0% 0% 0% 0% 0% 
No PTCA 22% 6% 8.8% 12% 2.8% 
P 0.008 0.35 0.35 0.04 0.34 
The combination of these adverse endpoints favored PTCA, p < 0.01 
(Wilcoxon-rank sum). 
Conclusion: Although the sample size is small, these findings (in contrast 
to experiences reported a decade ago) suggest that after pharmacologically 
induced recanalization, considerable benefit may follow very early mechani- 
cal relief (utilizing current techniques) of the typical residual high grade IRA 
obstruction. 
9:15 a.m. 
960-4 Beyond TIMI- Flow: The Importance of Restored 
Mvocardial Perfusion for Survival in High Risk 
Patients Undergoing Primary or Rescue PTCA 
Gregg W. Stone, Alexandra J. Lansky, Roxana Mehran, Michael 
A. Peterson, Luis Gruberg, George Dangas, Kartik Eesai, Steven T. Slack, 
Renee Reed, Brian Proctor, Martin 8. Leon. Washington Hospital Center, 
Washington, DC, USA 
Myocardial perfusion may be impaired after PTCA in AMI despite restoration 
of normal epicardial (TIMI-3) blood flow, which may be partly responsible for 
mortality even after successful PTCA. It has been suggested that the degree 
of myocardial contrast opacification (myocardial blush) after PTCA may be a 
better indicator of repedusion than TIMI flow. 
Methods: To evaluate the prognostic utility of the myocardial blush score, 
independent angiographic core laboratory analysis was performed in 173 
consecutive AMI pts undergoing emergent PTCA. Blush was scored as 
grade 3 = normal (similar to non-infarct vessel), 2 = reduced, and O/l = 
absent or minimal. 
Results: Median age was 61, 28% were women, 24% had diabetes. 
Other high risk features included cardiogenic shock in 17%, need for IABP 
in 44%, and rescue PTCA after failed lytics in 39%. In-hospital and 30 day 
mortality occurred in 8.1% and 9.2% of pts, respectively. TIMI- flow was 
restored in 94% of pts. In contrast, only 28% had blush grade 3, while 42% 
had grade 2 and 30% had grade 011. Mortality strongly correlated with both 
indices: 
TIMI Oil 2 3 Blush O/l 2 3 P (both) 
Death 40% 20% 8.0% Death 17.3% 5.6% 2.1% <O.OOl 
Among the 163 pts wifh T/M/-3 flow, however, myocardial blush was 
absent in 27%, reduced in 44%, and normal in only 29% of pts. Diminished 
myocardial blush was a potent incremental predictor of reduced survival in 
pts with TIMI- flow (Figure; 30 day death = 2.2% with blush O/l, 7.4% with 
blush 2, and 4.3% with blush 3, p < 0.0001). 
Conclusions: Normal contrast opacification of the myocardial bed, a 
surrogate for adequate tissue perfusion, is a more potent and accurate 
predictor of survival than is restored epicardial flow after acute infarct PTCA. 
These data suggest that interventions which normalize myocardial blush 
may reduce mortality. Furthermore, as ~30% of pts undergoing PTCA had 
normal myocardial blush restored, this readily assessed index may serve as 
a sensitive surrogate endpoint for the efficacy of new drugs and devices for 
AMI reperfusion therapy. 
9:30 a.m. 
900-5 Do Proximal RCA Lesions in Acute Ml Benefit From 
Stenting?: The Stent PAMI Randomized Trial 
David A. Cox, Gregg W. Stone, Bruce Brodie, J. Michael Harper, 
Eulogia Garcia, Luis Mattos, John Griffin, William W. O’Neill, Judith Boura, 
Marie-Claude Morice, Cindy L. Grines. Mid Carolina Cardio/ogy/Amicus 
Research Foundation, Charlotte, NC, USA 
Background: In the Stent PAMI trial, AMI pts with proximal LAD lesions 
had adverse outcomes. Whether pts with AMI involving the proximal RCA 
(PRCA) have poorer outcomes that might benefit from stenting. 
Methods: 900 pts with AMI < 12 hours were randomized to either pri- 
mary PTCA or to a heparin-coated stent. All pts underwent clinical and 
angiographic f/up at 6 months. 
Results: 151 pts (16.8%) suffered prox RCA infarction. Pts with PRCA 
infarct had more reinfarctions (5% vs 2%, 13 = 0.015) and more SAT (3% vs 
I%, p = 0.051), but no differences in death, ischemic TVR, or binary reste- 
nosis at 6 mo compared to pts w/o prox RCA infarction. Six mo. outcomes 
stratified by device assignment for the 151 pts with prox RCA infarction: 
PRCA subgroup 
Clinical Events 
PTCA (n = 68) stent (n = 63) P 
Death 
Reinfarction 
lschemic TVR 
Composite 
Angiographic measures 
Reference dia. (mm) 
MLD pre (mm) 
MLD post (mm) 
MLD 6 mo (mm) 
Binarv restenosis 
1.5% 
3% 
21% 
24% 
1 .2% 1.000 
7% 0.296 
12% 0.153 
16% 0.222 
3.13 3.29 0.454 
0.25 0.36 0.221 
2.27 2.82 0.001 
1.68 2.04 0.013 
33% 14% 0.010 
Conclusion: Pts with proximal RCA infarctions had more reinfarctions 
and subacute occlusions, but not increased mortality or TVR compared to 
non PRCA infarcts. Stent placement in PRCA infarcts resulted in greater 
acute luminal gain and less restenosis, with only a trend noted for improved 
ischemic TVR. 
9:45 a.m. 
!-I...! 900 6 Is There a Benefit of Early Angiography in ST Segment Depression Myocardial Infarction? An 
Observational Study 
David M. Shavelle’, Lori Parsons’, Mark J. Sada’, William J. Frenchs, 
Nathan R. Every”. For the NRMl Investigators; ‘Division of Cardiology 
University of Washington, Seattle Washington, Pugef Sound Veterans 
Affairs Medical Center; ‘Saint John’s Cardiovascular Research Center, 
Division of Cardiology Harbor-UCLA Medical Center, Torrance, CA, USA 
Background: It remains unclear whether an aggressive treatment approach 
with very early (~6 hours) angiography and revascularization in ST segment 
depression myocardial infarction (Ml) improves outcome. 
Objective: To compare the short-term outcome of patients who received 
very early (<6 hours) angiography versus early conservative therapy for ST 
segment depression MI. 
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Methods: Patients presenting within 12 hours with ST segment depres- 
sion on the initial electrocardiogram (ECG) were identified from the National 
Registry of Myocardial Infarction (NRMI) data base. The short-term outcome 
of those who received very early (~6 hours) angiography and revascu- 
larization was compared to those who received early conservative therapy. 
Because of baseline differences between treatment groups, propensity score 
methodology using a predicted probability of receiving very early angiography 
was used to identify comparable patients within each treatment group. 
Results: Patients treated with very early angiography and revasculariza- 
tion (N = 2,402) were younger, more likely to be males and smokers, have 
less of a cardiac history and less likely to have diabetes mellitus than those 
who received early consetvative therapy (N = 17,735). Hospital outcome in 
the very early angiography group was similar to early conservative therapy 
for cerebral vascular events (0.8% vs. 1 .O%, p = 0.27) and recurrent Ml (2.1% 
vs. 2.3%, p = 0.57), but was associated with lower mortality (death, 4.9% 
vs. 7.3%, p < 0.001). Comparing patients matched on propensity score (N 
= 1,405) showed mortality was similar in both treatment groups (5.6% vs. 
5.4%, p = 0.87), with no significant mortality benefit of very early angiography 
(OR = 0.89, 95% Cl 0.71 to 1.13). 
Conclusions: The apparent mortality benefit of very early angiography 
and revascularization in patients presenting with ST segment depression Ml 
is a reflection of selection bias. Controlling for baseline differences using 
propensity score methodology indicated no mortality benefit of a very early 
aggressive compared with an early conservative approach. 
POSTER 
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I 1194 132 Chronic Vulnerability of Culprit Lesions in Acute Coronary Syndromes: An Angiographic Analysis 
Jacques Quilici, Pierre ThBroux, Jean Grbgoire, Jean-Claude Tardif, 
Richard Gallo. Montreal Heart Instifufe, Montreal, Canada 
Background: Coronary angiography can not be used to evaluate the vulner- 
ability of intact coronary atherosclerotic plaques. Past studies have shown 
that in over two thirds of patients (pts) presenting with an initial acute coro- 
nary syndrome, the culprit lesion was thought to be insignificant on a previous 
angiogram. However, the further implication of these lesions in subsequent 
coronary events has never been addressed. 
Methods and Results: In this study, we retrospectively analyzed 51 
pairs of angiograms from pts admitted to our coronary care unit with unstable 
angina (UA) or a non-q wave myocardial infarction (NQWMI). Pts were 
selected on the bases of having had one previous angiogram within a 2 
year period and a clearly identifiable culprit lesion on both examinations. Pts 
with angioplasty or bypass surgery in the intervening interval were excluded. 
In those pts readmitted for UA or NQWMI, an identical culprit lesion with a 
diameter stenosis , 50% was responsible for the latest admission in 65.7% 
of ,cases. However, for pts who were previously admitted for stable angina, 
the same culprit lesion was responsible in only 25.0% of cases (p < 0.01). 
Reason for 
Prior Adm 
UA or NQWMI 
Stable Angina 
” Culprit Lesion Culprit lesion Interval between 
Same Different Admissions (mo) 
35 65.7 34.3 10.2 
16 25.0 75.0 14.9 
Conclusion: The culprit lesion in patients with recurrent episodes of UA 
or NQWMI is often identical. In contrast, the culprit lesion is often different 
for pts whose initial clinical presentation was stable angina. This supports 
the concept that unstable coronary plaques are chronically vulnerable. This 
emphasizes the need to develop methods to identify and pacify these lesions 
earlier in their evolution. 
1 1194-l 31 1 P!aque Morphology and Distribution at Coronary 
Sites With Focal Vasospasm in Variant Angina: 
Intravascular Ultrasound Evidence for 
Importance of Immature Atherosclerosis 
Masakazu Yamagishi, Satoshi Saito, Jun Koyama, Kenichi Ito, 
Junko Honye, Steven E. Nissen. Division of Cardiology National 
Cardiovacular Center, Osaka, Nihon Universitl: Tokyo, Japan; Cleveland 
Clinic Foundafion, Cleveland, Ohio, USA 
Background: Previous intravascular ultrasound (IVUS) studies demonstrated 
that coronary atherosclerosis was invariably present at the rite with focal as 
well as diffuse vasospasm even without angiographic disease. However, few 
data exist regarding the morphologic differences of the plaque related to or 
not related to the occurrence of vasospasm. 
Methods: We analyzed the IVUS images from 45 patients with or with- 
out angiographically documented focal coronay vasospasm. At the sites of 
disease, % plaque area that was determined by the formula: {(EEM area - 
lumen area)/EEM area) x IOO), and the plaque arc were determined. The 
plaque echo density was considered as low, if the echo density was equal to 
or lower than that of the adventitia, and considered as high if the echo density 
was higher than that of the adventitia. The calcified lesion was defined as the 
presence of the high intensity echo with the acoustic shadowing. 
Results: In 23 patients with focal vasospasm (<75%), there existed 
atherosclerotic plaque evidenced by IVUS. From 22 patients who did not 
have focal vasospasm, IVUS demonstrated 18 atherosclerotic lesions from 
17 patients. The remaining 5 patients did not have significant lesions by IVUS. 
There was no difference in % plaque area and plaque arc between the plaque 
with (47 f IO%, 298 i 71”) and without (39 f 15%, 249 f 83”) vasospasm. 
Under these conditions, the calcified lesion was more frequently present at 
the rites without than with focal vasospasm (p x 0.05), thus resulting in the 
predominant presence of low echo density plaque without calcification at the 
sites with focal vasospasm. 
Conclusion: These results indicate that the low echo density plaque 
without calcification is predominantly present at the coronary sites with focal 
vasospasm, although other morphologic parameters by IVUS were not dif- 
ferent in each patient group. We suggest that immature atherosclrosis that is 
characterzied by relatively small (<60%) and noncircumferential lesion can 
be closely related to the regional hypereactivity of the coronary segments 
with focal vasospasm. 
L--L--- 1194 133 Plasma F24soprostanes are a Marker of Oxidative Stress Which are Elevated in Patients 
With Unstable Coronary Syndromes 
Patricia J.M. Best, Stephanie H. Wilson, Darcy Richardson, David 
R. Holmes, Jr., Amir Lerman. Mayo Clinic and Foundation, Rochester, MN, 
USA 
Background: Oxidative stress plays a significant role in the pathogenesis 
of atherosclerosis, although the role of oxidative stress in plaque rupture 
has not been established. Fp-isoprostanes are a stable plasma product 
of in vivo oxidative stress. Thus, this study was designed to determine if 
Fz-isoprostanes levels were enhanced in patients with unstable coronary 
syndromes compared to other patients referred for coronary angiography, 
versus normal volunteers. 
Methods: Blood was collected from 71 patients undergoing coronary 
angiography and 31 normal healthy volunteers. Patients with unstable angina 
(n = 34; hospitalized patients with new symptoms within 30 days) or an 
acute myocardial infarction were classified as unstable coronary syndromes 
(UCS) and all other patients referred for coronary angiography (n = 37) 
were classified as stable patients (SP). Total plasma Fp-isoprostanes were 
determined by enzyme immunoassay. 
Results: The mean age of the study population was 60 years (range: 
29-90 years), with 59% being male and 41% female. Plasma Fp-isoprostanes 
did not correlate with age. However, plasma Fp-isoprostanes were signifi- 
cantly elevated in UCS compared with SP or the normal volunteers. 
* 
Conclusion: This study demonstrates that patients with unstable coro- 
nary syndromes have increased peripheral markers for oxidative stress, as 
determined by plasma Fe-isoprostanes. Oxidative stress may play a role in 
the pathogenesis of acute coronary syndromes. 
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fITI. 1194 134 Drfferential Association of Endothelial Nitric 
Oxide Synthase Gene Polymorphism With Acute 
Coronary Syndrome, but not with Variant Angina 
Hyo-Soo Kim, Soo-Yeon Choi, Kyung-Hoon Yoo, In-Ho Chae, 
Dae-Won Sohn, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, 
Yun-Shick Choi, Young-Woo Lee. Seoul National University Hospital, Seoul, 
Korea 
Background: Nitric oxide regulates the vascular tone and inhibits vascular 
smooth muscle cell proliferation and platelet activation. Thus, nitric oxide 
may be involved in the pathogenesis of atherosclerosis and vasospasm. We 
evaluated the influence of eNOS gene polymorphisms on the pathogenesis 
of acute coronary syndrome (ACS) and variant angina (VA). 
Methods: We analyzed the two endothelial nitric oxide synthase (eNOS) 
gene polymorphisms (A/B polymorphism is the variable numbers of tandem 
repeat in intron 4 and T/G polymorphism is a missense mutation in exon 7) 
in 142 normal healthy Koreans and 164 patients with ACS and 104 patients 
with VA. 
Results: The genotype distribution of A/B polymorphism of eNOS gene, 
A/A, A/B, B/B was 5%, 21%, 74% in control group and 2%, 13%, 85% in the 
patients with ACS (p = 0.02 vs control) and 3%, 16%, 81% in the patients with 
VA (p = NS), respectively. The genotype distribution of T/G polymorphism of 
eNOS gene, T/T, T/G, G/G was I%, 16%, 83% in control group and I%, 21%, 
78% in the patients with ACS (p = NS) and O%, 18%, 82% in the patients 
with VA (p = NS), respectively. The odds ratio for ACS of non B/B (A/A &A/B) 
to B/B was 0.489 (95% Cl: 0.257-0.928). We found that age, sex (male), 
diabetes mellitus, hyperlipidemia, smoking, B/B genotype were independent 
risk factors for ACS. But, in VA, smoking was the only significant independent 
risk factor (odds ratio = 5.934, 95% Cl 2.843-12.388, p c 0.05). 
Conclusion: The B/B genotype frequency of eNOS gene was significantly 
higher in patients with ACS than in normal controls, But neither A/B nor T/G 
polymorphism of eNOS gene was associated with VA. These results suggest 
that eNOS gene may play some roles in the pathogenesis of ACS rather than 
vasospasm. 
1 1194-l 35 ) Evaluation of Serum Metalloproteinases and its 
Inhibitors During Acute Coronary Syndromes 
Jose G. Diez, Marcus H. Howell, Rajko Radovancevic, Art Bracey, James 
J. Ferguson. St. Luke’s Episcopal Hospital/The Texas Heart Institute, 
Houston, Texas, USA 
Background: It has been shown that plaque rupture plays a key role in 
the pathophysioiogy of acute coronary syndromes (ACS). It seems that the 
secretion of matrix degrading metalloprotienases (MMP’s) by macrophages 
with subsequent degradation of the fibrous cap may be an important mech- 
anism of plaque rupture. The expression of MMP’s by macrophage-derived 
foam cells has been well-documented in pathology specimens, the expres- 
sion of MMP’s and its inhibitors in peripheral blood needs further evaluation. 
To determine the expression in peripheral blood of MMP-I, MMP-2, MMP-9, 
and Tissue inhibitor of MMP (TIMP-1) during ACS (unstable angina (UA) 
and/or non-Q-wave MI (NQWMI) we performed a prospective case-control 
study with blind evaluation of clinical and serologic variables. 
Methods: The study group (ACS) was given by patients admitted to 
the emergency room and/or coronary care unit due to UA or NQWMI, who 
underwent coronary angiography within 24 hours. The control group (CG) 
consisted of outpatients admitted for elective coronary catheterization. A 
peripheral blood sample was obtained at the time of admission, prior to coro- 
nary angiography. A sandwich immunoassay for concentrations of MMP’s 
and TIMP-I using monoclonal antibodies against each substance was per- 
formed. Clinical and angiographic variables were registered and compared. 
Results: The ACS group had 20 consecutive patients (15 men, 5 women), 
mean age 60 & 15 years. The CG had 20 consecutive patients (14 men, 6 
women), mean age 60 i 11 years. In the ACS group: 12 patients had UA 
and 8 had NQWMI; 13 underwent angioplasty, 6 required elective surgery, 
and 1 medical treatment. There was angiographic evidence of thrombus in 
6 patients. In the CG: All patients had coronary lesions greater than 50%, 8 
(40%) had lesions 2 70%; 2 underwent angioplasty, 3 had elective surgery, 
all others received medical therapy. MMf evaluation: MMP-I in ACS 24ng/ml 
vs CG 16 rig/ml (p = 0.3); MMPP in ACS 1066 rig/ml vs CG 1059 rig/ml (p = 
0.051); MMP-9 in ACS 104 rig/ml vs CG 31.5 rig/ml (p = 0.0001); TIMP-1 in 
ACS 24 rig/ml vs CG 16 rig/ml (p = 0.005). 
Conclusions: Patients with ACS had an increased serum expression of 
Type IV gelatinases (MMP-2 & MMP-9) and tissue inhibitor (TIMP-I) when 
compared with controls. 
1 1194-l 36 1 Multiple Modes of Sudden Cardiac Death in 
Dogs With Infarction and Acute Myocardial 
lschemia Monitored by Telemetry 
Cheryl R. Killingsworth, David E. Ritscher, Gregory P. Walcott, Tracy 
L. Gamblin, Raymond E. Ideker, William M. Smith. University of Alabama, 
Birmingham, AL, USA 
Background: Only a small number of the 350,000 cases of sudden cardiac 
death (SCD) that occur each year in the United States have a device to 
record information about the arrhythmia, thus the electrophysiology of SCD 
remains largely unknown. 
Methods: We used an eight-channel custom-designed telemetry unit 
and an animal model of SCD to study fatal arrhythmias associated with 
existing infarcts and subsequent acute myocardial ischemia. Anesthetized 
dogs (16-21 kg) were instrumented with 3 electrodes placed in the right 
atrium or subcutaneous tissue, and right ventricle. Five epicardial electrodes 
were placed on the left ventricle (LV) in the left circumflex (LCX) and the 
left anterior descending (LAD) coronary artery beds. Occlusion (90 min.) and 
reperfusion of the LAD produced an anterior LV wail infarct. A copper wire 
was placed in the LCX to cause intimal injury in a second arterial bed. Of the 
14 animals studied, 7 died suddenly 24 to 72 hours after the initial surgery. 
There were 3 modes of SCD: complex ventricular ectopy present for 310 min 
that degenerated into ventricular fibrillation (VF, n = 4), normal sinus rhythm 
that suddenly degenerated into VFfollowing R-on-T phenomenon (n = I), and 
bradycardia (~60 beats per minute) that preceded VF (n = 2). Bradycardia 
lasted 13 min with R-R intervals as long as 25.8 s. VF eventually developed 
in all cases of SCD. The maximum ST-segment change during the 5 min. 
before death was significantly greater in the electrograms from the LCX bed 
of animals with tachyarrhythmias compared to bradyarrhythmias (4.0 & 3.4 
mV and 0.2 &I 0.8 mV, respectively). Fast Fourier transform analyses revealed 
no difference in the peak frequency of VF at 10 s between the electrodes in 
the LAD and LCX beds. The peak frequency of VF was significantly faster 
in the 5 dogs with fatal tachyarrhythmias compared to the VF that followed 
profound bradycardia (6.5 f 3.1 and 3.7 i 0.6 Hz, respectively). 
Conclusions: Continuous telemetry monitoring of an animal model of 
SCD demonstrated that within the same animal model, both tachy- and brad- 
yarrhythmias ultimately resulted in VF. Fatal tachyarrhythmias were associ- 
ated with ischemia in the LCX bed and faster VF peak frequency compared 
to bradyarrhythmias. 
1 1194-l 37 / Does Symptom Onset in the Morning Help 
Predict the Diagnosis of Acute Cardiac 
Ischemia? 
Sung W. Choi, James E. Udelson, Robin Ruthazer, Joni R. Beshansky, 
Harry P. Selker. New England Medical Center, Boston, Massachusetts, USA 
Background: A circadian variation has been observed in the presentation of 
myocardial infarction (Ml). We investigated whether this pattern was present 
for all acute cardiac ischemia (ACI: MI and unstable angina [UAP]) and 
whether time of symptom onset may have diagnostic value for ACI. 
Methods: We studied 6,218 patients from the ACI-TIPI Trial who pre- 
sented to emergency departments within 24 hours of self-reported onset of 
chest pain or other symptoms suggestive of ACI. 
Results: Symptoms caused by ACI were more likely to begin GAM-noon 
than if symptom onset were uniformly distributed throughout the day (RR 1 .I4 
[95% Cl 1.04-1.241). However, symptoms caused by stable angina (SA), 
non-ischemic cardiac diagnoses (NIC), and noncardiac diagnoses (NCD) 
showed a similar pattern (RR 1.50 11.32-I ,691, 1.20 [I .I O-1.31], and 1.36 
[I .29-l ,421, respectively). Indeed, among all patients with symptom onset 
GAM-noon, only 18.6% had ACI, vs. an average of 22.2% of patients with 
symptom onset during other times (p = 0.001, Table). 
Emergency Department Patients’ Diagnoses by Time of Day 
Time (n) %ACI %MI %UAP %SA 
Ga-noon (2009) 18.6 9.5 9.2 8.6 
noow6p (1452) 20.6 10.3 10.3 6.5 
6p-12 mn (1475) 22.9 10.0 12.9 7.1 
12 mn-6a (1282) 23.2 11.9 11.2 6.8 
%NIC %NCD 
18.2 54.6 
17.6 55.3 
20.0 50.0 
23.2 46.8 
Conclusion: Thus, there was a morning peak in the onset of symptoms 
suggestive of cardiac ischemia, regardless of the confirmed diagnosis. How- 
ever, the proportion of patients with the final diagnosis of ACI, compared to 
all other diagnoses, was actually lower in the morning hours. These data 
suggest that symptom onset in the morning does not have diagnostic value 
for ACI. 
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1 1194-l 38 1 Activation of Tissue Factor-Dependent 
Coagulation Pathway in Patients With Acute 
Myocardial Infarction 
Amelia Ravera, Paolo Golino, Federico Piscione, Dario Leosco, 
Plinio Cirillo, Massimo Ragni, Mirella Ezban, Davide D’Andrea, 
Massimo Chiariello. University of Nap/es “Federico /I” Nap/es, Italy; Novo 
Nordisk A/S Copenhagen, Denmark; University of Naples “Federicoll” 
Naples, Italy 
Increasing evidence indicate that activation of tissue factor (TF)-dependent 
coagulation plays a key role in intravascular thrombus formation. However, 
its role in acute myocardial infarction (AMI) is not clear yet. Blood samples 
from 10 patients undergoing primary PTCA for AMI were obtained from 
the coronary sinus (CS) and the ascending aorta (Ao) at baseline, after 
balloon dilation, after heparin administration and after stenting. Total tissue 
factor pathway inhibitor (TFPI) plasma levels, the complex TFPl/factor Xa 
(an index of factor Xa generation) and FVllAg plasma levels were measured 
using ELISA kits (American Diagnostica). A significant decrease in total TFPI 
was observed in the CS as compared to Ao, while TFPl/Xa levels were 
significantly higher in the CS than in Ao, indicating generation of factor Xa at 
the site of thrombus formation. Finally, FVllAg levels were significantly higher 
in Ao than in CS, indicating binding of FVII to exposed TF. 
TFPI Ao @g/ml) 
TFPI CS @g/ml) 
TFPI/Xa Ao (nglml) 
TFPliXa CS (@ml) 
FVllAg Ao (nglml) 
FVllAg CS @g/ml) 
Baseline 
101 * 11 
78 & 5* 
4.0 + 0.3 
6.9 f 0.3* 
372 It 26 
281 & 31* 
Dilation 
99*12 
70 zk 5* 
4.1 i 0.3 
7.7 f 0.2* 
351 * 21 
253 + 2.s* 
Heparin 
203 zk 11 
165 zt 13* 
4.6 f 0.3 
7.1 * 0.4” 
347 & 24 
268 + 29* 
sent 
162 * 13 
130&a* 
4.0 i 0.3 
7.2 zk 0.4* 
345 Lt 19 
268 zt 27* 
Thus: 1) in patients with AMI, plasma FVII levels are decreased across the 
coronary circulation, indicating binding of FVII to exposed TF; 2) a simultane- 
ous increased generation of factor Xa also occurs; 3) Plasma TFPI levels are 
decreased across the coronaty circulation, indicating consumption of TFPI 
at the site of thrombus formation; 4) these data suggest that activation of 
TF-dependent coagulation plays a key role in AMI. 
1194-l 39 lschaemic Myocardial Injury in the Acute 
Coronary Syndromes. The Role of Elevated 
Plasma Homocysteine Concentrations 
Mohamed K. Al-Obaidi, Peter J. Stubbs, Paul Collinson, Mark I. Noble, 
Ronan Conroy, Ian Graham. National Heart and Lung Institute, London; 
Royal College of Surgeons, Dublin, UK 
Background: Moderate elevation of plasma homocysteine is an atherogenic 
and prothrombotic risk factor for coronary artery disease (CAD). Elevated 
homocysteine levels are also associated with a graded increase in mortality 
in patients with angiographically confirmed CAD. It is not known whether 
homocysteine levels influence the degree of myocardial injury in patients 
presenting with acute myocardial infarction (Ml) or unstable angina pectoris 
(UAP). 
Methods: We studied consecutive patients presenting with MI (n = 205) 
and UAP (n = 185). Plasma samples were collected on admission and 
prior to clinical intervention and were assayed for homocysteine by high 
performance liquid chromatography and fluorescence detection. The degree 
of myocardial necrosis was determined by measuring cardiac Troponin T 
(cTnT) on admission and 12 hours after admission (peak cTnT). The latter is 
known to strongly correlate with the final myocardial infarct/injury size. 
Results: plasma homocysteine levels correlated with peak but not ad- 
mission cTnT levels in both Ml (r = 0.20, p = 0.008) and UAP (r = 0.25, p < 
0.001). The relationship between peak cTnT and homocysteine was further 
examined by dividing the latter into quintiles. There was a step-up in peak 
cTnT levels in the top homocysteine quintile in Ml (4.1, 3.9, 4.1, 6.2 and 7.7 
hg/l for quintiles 1 to 5 respectively, ANOVA, p = 0.005) and UAP (0.03, 0.03, 
0.02, 0.04 and 0.15 fig/l for quintiles 1 to 5 respectively, ANOVA, p < 0.001). 
In a multivariate regression model the association between peak cTnT levels 
and the top homocysteine quintile remained strong after adjustment of other 
confounders including age, sex, final diagnosis (Ml or UAP) and treatment 
received (thrombolysis) (Odds ratio 1.48 (0.85-2.12) p < 0.0001). The pa- 
tients with UAP were further examined by dichotomising them according to 
peak cTnT levels below (cTnT negative) or above (cTnT positive) 0.1 fig/l, 
the latter is known to be associated with an increase in future cardiac mortal- 
ity and morbidity risk. Homocysteine levels were significantly higher in cTnT 
positive than cTnT negative patients 13.8 (11.7-15.3) vs. 10.3 (9.4-11.3) 
pmol/l respectively, p = 0.002. 
Conclusions: Elevated homocysteine levels are independently associ- 
ated with a higher risk of ischamic myocardial injury in patients presenting 
with acute coronary syndromes. 
) 1194-l 40 / Differences Between Unstable Angina and 
Coronary Angioplasty in Platelet and Leukocyte 
Activation 
Carlos V. Serrano Jr.‘, Roberto Giraldez’ , Jose C. Nicolau’ , 
Margareth Venturinell’, Jose A. Ramires’ , Jay Zweier’. ‘Heart lnsfitute 
(InCor), Univ. of Sao &u/o Medical School, 520 Paula, Brazil: ‘Johns 
Hopkins Univ., Baltimore, MD, USA 
It is unknown if different clinical syndromes associated with plaque rupture 
induce similar blood cell activation and adhesion to the coronary endothe- 
lium. We studied changes in adhesion molecule (AM) expression of platelets 
(GPllb/llla); neutrophils (PMN) - CD18, CD11 b, L-selectin; and, monocyte 
(CD14), after interaction with active lesions of both patients with stable angina 
subjected to coronary angioplasty (PTCA) and with unstable angina (UA). Ex 
vivostimulated PMN superoxide (SO) formation and PMN sequestration in 
the coronay circulation were also assessed. Blood samples were collected 
from the aorta (Ao) and coronary sinus (CS) before and 1.5 min after PTCA (n 
= 13) and within the first 48 hr of UA (n = 18). PTCA induced a marked upreg- 
ulation of CD18, CDllb, CD14 and GPllb/llla with L-selectin shedding and 
reduced SO formation whereas only minor downregulation and decreased 
SO production indicated activation in UA (table). However, a significant de- 
crease in PMN count in the CS compared to the Ao was only observed in 
UA: 91 f 3%* vs 95 f 9% post-PTCA. The reduced reponses after ex viva 
stimulation may be explained by previous in viva activation of PMNs. Results 
in % changes CS/Ao parameters: p 5 ‘0.05, tO.OO1, *0.04. 
GP cm8 CDllb L-se1 CD14 so 
Pre-PTCA 94 i 5 103*3 10558 94f5 102+7 103*5 
Post-PTCA 142 * 14* iaah i2* 163f 16* 30 i a* 157 zk 12* 54h9 
UA a2 * a 99 * 9 121 * 15 79 * 5t 96 rt 7 77*9* 
Thus, the magnitude of cellular activation depends on the underlying clin- 
ical setting and just partially contributes to cell adhesion to the endothelium 
-probably due to differences in the extention of vascular lesion. 
( 1194-I 41 ( Is the Morning Peak of Acute Myocardial 
Infarction’s Onset due to Sleep Related 
Breathing Disorders? A Prospective Study 
Victor Aboyans, Claude Cassat, Philippe Tapie, Philippe Lacroix, 
FranCois Tabaraud, Franpois Bertin, Patrice Virot, Marc Laskar. CHU 
Dupuytren, Limoges, France 
Background: The circadian pattern of the onset of myocardial infarction (Ml) 
in epidemiological studies denotes a peak in the first hours of the morning. 
Our aim was to assess the prevalence of sleep apnea syndrome (SAS) in 
patients with Ml and to study the relationship between sleep-related breathing 
disorders (SRBD) and the Ml’s onset. 
Methods: Forty consecutive men aged ~65 years admitted for a con- 
firmed acute Ml were enrolled. The hour of the first clinical symptoms was 
recorded. The nycthemeral distribution was studied by four periods of 6 
hours. All patients had a standard nocturne polysomnography after dis- 
charge and cardiac rehabilitation. Sleep apnea syndrome was defined when 
polysomnography revealed more than 10 episodes of apnea or hypopnea 
per hour. 
Results: Twelve patients (30%) had significant SRBD (SAS group) and 
were compared to the other 28 patients (control group). Age and left ventricu- 
lar ejection fraction were similar between the two groups. In the SAS group, a 
significant peak of the onset of Ml was observed from 6 a.m. to noon (58.3% 
vs 25% in the control group, p < 0.05 by Fischer’s exact test). Conversely, in 
the control group, nocturne (midnight to 6 a.m.) onset of Ml was ignificantly 
more frequent (28.6% vs 0% in SAS group, p < 0.05). 
Conclusion: The morning peak of the Mrs onset is related to a high 
prevalence of breathing disorders during slee+ High sympathetic activity 
reported in different studies in patients with SAS might contribute to this 
relationship. Therefore screening SRBD in patients with a high risk of cardiac 
events could be required. 
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L-..il. 1195 127 ST Resolution at 90 and 180 Minutes in Patients With Acute Myocardial Infarction Treated With 
Lanoteplase or Alteplase. Results of the 
InTIME- ECG ST Resolution Substudy 
K.-L. Neuhaus, U. Zeymer, U. Tebbe, 2. Sadowski, D. Wojciechowski, 
A. Pangerl, E. Braunwald, Ft. Schrbder. For the InTIME- Investigators; 
Medizinische Klinik /I, Klinikum Kassel, Germany 
Background: ST resolution (STR) obtained at 90 and 180 minutes after start 
of thromboiysis in patients with acute myocardial infarction (AMI) is a marker 
of myocardial reperfusion and a good prognosticator of mortality. 
Methods: Patients with AMI < 6 hrs were randomised in a 2:l fashion to 
receive lanoteplase (120 ug/kg) or front-loaded alteplase. All 3593 patients 
recruited in Germany and Poland were enrolled in the ECG STR substudy, 
and ECGs were obtained at baseline and after 90 and 180 min after start 
of thrombolysis. Of these 3030 had a baseline ECG evaluable for STR. As 
in previuos studies STR was graded as complete (170%) partial (7030%) 
and no (~30%). 
Results: There was no difference in the clinical and ECG baseline vari- 
ables between the alteplase and lanoteplase group. The mean STR was 
52.5% versus 44.2% (p = <O.OOOl) at 90 min and 64.8% versus 57.4% (p < 
0.0001) at 180 min in the lanoteplase and alteplase group, respectively. The 
incidence of STR categories is shown in the table. 
STR 90 mtn 180 min 
Coma. 
Lanotep. 
42.7% 
Altepi. 
35.2% 
p-V&X 
0.0003 
Lanoiep. 
55.3% 
Altep. 
47.5% 
p-VC!lUe 
0.0001 
Pa& 35.8% 35.2% n.s. 32.1% 34.3% n.s. 
NO 21.5% 29.7% 0.0001 12.6% 18.2% 0.0001 
Enzymatic infarct size measured as peak CKfraction of upper normal limit 
was reduced with lanoteplase compared to alteplase (Median 8.9 vs. 9.4, p 
= 0.048). 
Conclusion: Lanoteplase is significantly more effective than alteplase in 
accelerating reperfusion in patients with AMI as indicated by improved STR, 
resulting in smaller enzymatic infarct sizes, which, however, did not translate 
into a difference in overall 30-day mortality. 
/1195-l 28 1 Noninvasive Transthoracic Low Frequency 
Ultrasound Greatly Augments Thrombolysis in a 
Canine Model of Acute Myocardial Infarction 
Robert J. Siegel, Shaul Atar, Huai Luo, Andrea V. Brasch, Thomas 
M. Peterson, Dharmendra Pal, Tomoo Nagai, Jang-Seong Chae, Michael 
C. Fishbein. Cedars-Sinai Medical Center, Los Angeles, CA, USA 
Background: While thrombolysis has been a major advance in treatment 
of acute myocardial infarction (AMI), it is still limited by time to reperfusion, 
patency rate, and bleeding complications. 
Purpose: To evaluate the use of noninvasive transcutaneous ultrasound 
for augmentation of coronary thrombolysis with t-PA in a canine model of 
AMI. 
Methods: In a closed chest canine model (n = 24) thrombotic occlusion 
of the left anterior descending coronary artery (LAD) was electrically induced 
via guide wire and documented by ECG and angiography. 109 + 62 minutes 
after occlusion, t-PA (1.42 mg/kg) was given intravenously over 90 minutes. 
12 of 24 dogs also had concomitant transcutaneous application of ultrasound 
over the anterior chest wall with a specially designed, low frequency (26 kHz) 
ultrasound (USD) device with a cooling unit (Cybersonics, Inc.). 
Results: 
i-PA alone t-PA + USD P value 
TIMI flow? 1 @90 min 3112 (25%) 11/12(92%) 0.0028 
TlMl3flow @90 min 2112 117%) 11112 (92%) 0.0006 
Re-occlusion @180 min l/3 k3%1 0 6%) 
Conclusion: In vivo, noninvasive transthoracic application of low fre- 
quency ultrasound 1) greatly augments the efficacy of t-PA mediated throm- 
bolysis, 2) appears safe and 3) has substantial potential as a noninvasive 
adjunct to improve coronary thrombolysis patency without increasing bleed- 
ing risk. 
1 1195-I 29 ] InTIME-Pb: Omission of Heparin Bolus Lowers 
Rate of Intracranial Hemorrhage With 
Lanoteplase 
Robert P. Giugliano, Elliott M. Antman, Carolyn H. McCabe, Sally S. Cutler, 
Paul Chew, Allen M. Skene, Robert G. Wilcox, Karl L. Neuhaus, 
Eugene Braunwald. Brigham & Women’s Hospital, Boston, MA, USA 
Background: Intracranial hemorrhage (ICH) occurred in 1.12% of 10,037 pts 
with acute Ml in InTIME- (IT-21 who received lanoteplase (nPA) + heparin 
bolus (70 U/kg, max 4000 U) + heparin infusion (15 U/kg/h, max 1000 U/h). 
Prior studies suggest lower heparin doses are associated with lower ICH 
rates. 
Methods: 1491 patients with AMI were enrolled in InTIME-2b (/%2b), an 
open-label study of nPA with heparin administered as an initial infusion of 
15 U/kg/hr (max 1000 U/hr) without a heparin bolus. ICH rates in /%2b were 
compared to those observed in IT-2 in two patient cohorts: intention to treat 
(ITT = all pts enrolled), and per protocol therapy (nPA and heparin as outlined 
in the protocol). 
Results: Despite enrolling more elderly, women, and low-weight patients 
in /Q/J (table I), the absolute ICI-i rates decreased by 0.25% in the ITT 
cohort and by 0.40% in the per protocol cohort with omission of the heparin 
bolus in IT-2b. There were no differences in 30-day mortality between the 
two studies when adjusted for baseline characteristics in either the ITT or per 
protocol therapy cohorts. 
# patients 
Age > 75 yrs, % 
Women, % 
Wgt 5 67 kg, % 
SBP > 160, % 
ICH @30 d, % 
Fatal ICH, % 
Adjusted 30.day 
mortality, % 
IUcohoti 
IT-2 /%Zb A/l000 %A 
10037 1491 
13.8 14.5 +7 +5.1 
24.6 27.0* +24 +lO 
19.7 22.71 +30 +15 
13.6 12.6 -10 -7.4 
1.12 0.87 -2.5 -22 
0.66 0.54 -1.2 -18 
6.77 7.04 +2.7 14.0 
Per protocol therapy 
IT-2 K?b A/l000 %A 
7948 1331 - 
13.7 14.4 +7 +5.1 
25.0 27.0 +20 +8.0 
20.3 22.5 c22 +11 
13.4 12.8 -6 -4.5 
1.08 0.68 -4.0 -37 
0.68 0.38 -3.0 -44 
6.54 6.47 -0.7 -1.1 
“p < 0.05 and tp = 0.01 when compared to IT-2 
Conclusions: Omission of the initial adjunctive heparin bolus when ad- 
ministered with nPA was associated with an approximate 25% reduction in 
the rate of ICH without altering the impact of nPA on mortality in AMI. This 
observation emphasizes the need for the evaluation of alternative lower-dose 
heparin regimens in future trials of reperfusion regimens for Ml to reduce the 
risk of ICH. 
1195-I 30 Clinical Outcome Remains Poor in Diabetics 
With Myocardial Infarction Despite Early 
Fibrinoltyic Therapy: Findings From InTIME II 
Robert N. Piana, Robert P. Giugliano, Stephanie Coulter, James de Lemos, 
Carolyn H. McCabe, Elliott M. Antman, Allan M. Skene, Karl Neuhaus, 
Eugene Braunwald. Brigham & Women’s Hospital, Boston, MA, USA 
Background: The outcome of early fibrinolysis among diabetics (DM) with 
Ml in the current era of very aggressive primary and secondary medical 
therapy is not well defined. InTIME- randomized 15,078 pts to tPA or nPA 
for MI. Among 14,965 pts with complete data, those with DM (2,095) had a 
greater prevalence of comorbidities than did pts without DM (12,870): 275 
years: 16 vs 13%; Prior Ml: 22 vs 15%; Heart Failure: 7 vs 2%; CCSC 1 
2: 21.1 vs 16.1%; CABG: 4 vs 2%; (All P 5 0.001). However, pts with DM 
were also on more intensive baseline medical therapy: ASA: 27 vs 19%: Beta 
Blocker: 18 vs 15%; Lipid Lowering: 14 vs 9%; ACE Inhibitor: 27 vs 11%; (All 
P < 0.001). Time from pain to fibrinolysis was delayed in those with DM vs 
those without DM (52 h in 22.1% vs 25.9% and 53 h in 48.9% vs 55.5%; 
P < 0.0001). Among 1,796 North American pts with data on ST resolution, 
complete (~70%) resolution of ST elevation at 60-90 min was achieved in 
As shown in the table, TIMI 3 flow is greatly augmented (>5 fold) by 
application of low frequency transcutaneous ultrasound to the chest wall. 
Furthermore, gross and microscopic analysis confirmed the angiographic 
patency rate. No injury secondary to ultrasound application was detected in 
the skin, soft tissue, heart or lungs. 
30 Day Outcome DM No-DM OR [95% Cl] P 
Death 10.1 6.1 1.7 [1.4-2.01 <0.0001 
Severe Heart Failure 3.3 2.2 1.4[1.1-2.01 0.004 
Death/Recurrent MI 14.0 10.5 1.4 [1.3-l .7] <0.0001 
Death/Ml/Severe CHF/NF CVA 16.6 12.3 1.4 [1.3-l .7] <0.0001 
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only 28.2% of those with DM, while complete resolution was achieved in 
37.5% of pts without DM (P = 0.008). 
Even after adjustment for 17 other baseline characteristics predictive of 
mortality, DM was associated with a 35% increase in 30 d mortality (P = 
0.002). Mortality at 30 d was not increased in pts with DM on insulin vs pts 
with DM not on insulin. 
Conclusion: Clinical outcome after fibrinolysis given r6 h from Ml re- 
mains worse for pts with DM than for those without DM, despite recent 
intensive efforts to target the diabetic population for aggressive treatments 
for coronary disease. The adverse clinical outcome among pts with DM may 
relate to a high prevalence of important comorbidities, delays in the recog- 
nition of symptoms of MI, and possibly reduced effectiveness of fibrinolysis 
as reflected by less complete resolution of ST elevation. Pts with DM who 
sustain Ml remain at high risk despite early fibrinolysis, and strong consid- 
eration of early coronary intervention may therefore be appropriate in this 
population. 
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) 1196-l 01 ) MARISA: Monotherapy Assessment of 
Ranolazine in Stable Angina 
Andrew A. Wolff. The MARISA Investigator. and CV Therapeutics, Pa/o 
Alto, California, USA 
Background: Ranolazine (Ran), a potential anti-angina1 agent, is a partial 
inhibitor of fatty acid oxidation (pFOX inhibitor). Shifting ATP production away 
from fatty acid oxidation toward carbohydrate oxidation, Ran reduces oxy 
gen demand without decreasing cardiac work, and maintains coupling of 
glycolysis to pyruvate oxidation, which minimizes lactate accumulation. In 
three earlier placebo-controlled stable angina studies, oral Ran (immediate 
release) at 2240 mg, alone or in combination with other anti-anginals, in- 
creased exercise times without changes in rest or exercise heart rates or 
decreases in rest or exercise blood pressures. In these earlier trials, statis- 
tically significant increases in exercise times occurred only near peak Ran 
plasma levels (1-3 hr after dosing). A new sustained-release (SR) formula- 
tion keeps plasma levels in the expected therapeutic range with bid dosing. 
MAKISA is the first study of Ran SR in stable angina. 
Methods: Patients withdrawn from other anti-angina1 drugs with repro- 
ducible angina-limited exercise duration and ~1 mm ST depression were 
randomized to Ran (500 mg bid, 1000 mg bid and 1500 mg bid) and match- 
ing placebo (Pbo) in a double-blind, four-period, Latin square crossover 
design. Exercise testing with a modified Bruce protocol was performed at 
both trough (12 hr after dosing) and peak (4 hr after dosing). 
Results: 49 centers in the USA, Czech Republic, Poland, and Canada 
randomized 191 patients. 168 completed all 4 double-blind treatment periods; 
7 more completed 3 of 4 periods. These 175 patients were included in the 
primary analysis of efficacy, shown below: 
Placebo 500 mg bid 1000 m bid 1500 m bid 
trough peak trough peak trough peak trough peak 
Exercise Duration 511 504 533 532 545 555 559 561 
(se4 
p-value vs. placebo - - 0.003 <O.OOl <O.OOi <O.OOl <O.OOl <O.OOi 
TimetoAngina(sec) 412 418 437 452 457 474 472 487 
p-value vs. placebo - - 0.005 <O.OOl <O.OOl <O.OOi <O.OOl <O.OOl 
TimetolmmST 448 442 470 479 491 502 514 508 
Depression (set) 
p-value vs. placebo - - <O.OOi <O.OOl <O.OOi <0.001 <O.OOl <O.OOi 
Ran had no clinically meaningful effects vs. Pbo on rest or exercise blood 
pressure or heart rate. Dizziness, nausea, asthenia and constipation were 
more common on Ran than on Pbo, mostly at 1500 mg bid. 
Conclusion: pFOX inhibition by Ran may be useful in angina, especially 
when hemodynamic effects are undesirable. 
( 1196-i 02 1 Improvement in Endothelium-Dependent 
Function in Patients With Class II & Ill Angina by 
a Medical Food 
Andrew J. Maxwell, Michael P. Zapien, Barbara Anderson, Peter H. Stone. 
Cooke Pharma, Belmont, CA; Brigham & Women’s Hospital Boston, MA, 
USA 
Background: We investigated the vascular effects of a food bar enriched 
with L-arginine and a combination of other nutrients known to enhance 
the synthesis or activity of endothelium-derived nitric oxide in patients with 
coronary artery disease (CAD). 
Methods: Using a randomized, double-blind, crossover design, 20 pa- 
tients with documented CAD and Canadian Cardiovascular Society Class II 
& Ill angina were assigned to consume, in random order, placebo and active 
bars (2 bars/day for 2 weeks separated by 4 weeks washout period). Each 
active bar (HeartBai”, Cooke Pharma) contains 3.3 g of L-arginine as well 
as antioxidant vitamins, minerals & isoflavenoids, B vitamins, niacin & fiber. 
Placebo bars are equicaloric with matched taste and consistency but devoid 
of the active components. Flow-mediated (endothelium-dependent) vasodi- 
lation of the brachial artery was measured while fasting using high-resolution 
ultrasonography before and after (the morning after the last evening bar) 
each set of bars. 
Results: Before any intervention, baseline vasodilation was reduced (6.7 
f 1.4 SE % increase in diameter following flow stimulus) compared to healthy 
controls. Likewise, at the end of the washout period, vasodilation was reduced 
(6.5 & 1.1%). However, there was a significant improvement in vasodilation 
in the active group (to 9.4 i 1.2%) compared to the placebo group (6.2 f 
1.4%) following 2 weeks of intervention (p 4 0.03). Both sets of bars were 
well tolerated and no significant adverse side-effects were reported. 
Conclusion: This L-arginine-enriched medical food enhances endothelial 
function, is unique and convenient & may have a role in the management of 
individuals with CAD. 
1 1196-I 03 1 Myocardial Innervation After Percutaneous 
Myocardial Laser Revascularisation 
Fabian Stahl, Bernward Lauer, Frank Bengel’, Markus Schwaiger’ , 
Gerhard Schuler. Department of Cardiology - Heart Center - University of 
Leipzig; ‘Clinic for Nuclear Medicine, Technical University of Munich, 
Germany 
Background: In the majority of patients with end-stage coronary artery dis- 
ease and intractable angina pectoris percutaneous myocardial laser revascu- 
larisation (PMR) leads to an immediate and significant improvement of clinical 
symptoms and increased exercise capacity. Pathophysiological mechanisms 
are not yet clear. 
Methods: To analyse the sympathetic innervation dynamic PET with C-l 1 
hydroxyephedrine (HED) was performed in 7 patients before and 2-42 days 
after PMR. The percentage of the left ventricle with reduced HED-uptake 
(mean - 2 SD of normal) and absolute HED retention (min-‘) in the target 
region (TR) were determined. 
Results: 
Patient HED % before HED % after min-’ before min-’ after 
1 61 44 6.31 6.37 
2 17 31 9.62 10.14 
3 66 66 8.53 7.80 
4 4 11 9.75 9.18 
5 48 76 9.28 7.74 
6 31 67 7.48 6.92 
7 36 53 7.17 4.62 
The percentage of denetvation (HED %) was decreased after PMR in 1 P, not 
changed in 2 P and increased in 4 P. However regional HED-retention in the 
TR remained unchanged in 5 P and was reduced in 2 P. Reduced HED-uptake 
in 1 P was probably due to left ventricular perforation during PMR. 
Conclusion: These results indicate that in most P clinical improvement 
after PMR does not seem to be due to myocardial denervation. 
1 1196-l 04 ) Fast Platelet Suppression by Lycine 
Acetylsalicylate in Chronic Stable Coronary 
Patients. Potential Cllnical Impact Over Regular 
Aspirin for Coronary Syndromes 
Enrique P. Gurfinkel, Raul Altman, Alejandra Scazziota, Ricardo Heguilen, 
Branco Mautner. Centro de Estudios Medicos y Bioquimicos and 
Laboratorios Bago, Buenos Aires, Argentina 
Background: The rapid utilization of fibrinolytics following Q-wave myocar- 
dial infarctions has clearly modified the evolution of this disease. However, it 
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is still not known if the immediate inhibition of platelet aggregation during the 
coronary event improves outcomes. 
Methods: Ten patients suffering from chronic stable angina participated 
in this study to compare the efficacy and speed of the inhibition of platelet 
aggregation (PA) with 320 mg. of Lycine Acetylsalicylate (LA) versus 320 
mg. of aspirin, All patients suspended the use of aspirin and any other 
anti-inflammatory agent for 15 days prior to beginning the study. They were 
randomly assigned to LA or aspirin. Blood specimens were obtained to 
measure the PA at admission, and 5 min, 10, 20, 30 and 60 rain after 
ingestion. Patients continued to take the assigned drug once a day for the 
following four days. On the fifth day, a new blood sample was taken. After 
this, patients were given a 15 day wash-out period, and then crossed over 
to the opposite drug. The samples were analyzed immediately using platelet 
rich plasma stimulated with ADP 2 kmol/l, Collagen 1 pg/ml, epinephrine 20 
@mol/l, and sodium arachidonate acid 0.75 mm/i. 
The same level of inhibition of the PA after 30 and 60 minutes of aspirin 
was obtained with LA after 5 minutes following ingestion. 
Results: (see Table) 
Sodium 
Aranhirionate 
Collagen ADP Epinephrine 
LA 16.3s 25.9 18.9 * 20.1 27.3% 18.4 22.0 i- 9.9 
Aspirin 57.6 i 8.2 47.2 * 10.5 39.7 zk 21.8 55.4 ?c 10.9 
p value 0.00014 0.00092 0.18 0.00002 
Conclusions: The inhibition of the PA immediately following the LA may 
have significant clinical implications for the treatment of coronary syndromes. 
1196-I 05 Effects of Sustained-Release Diltiazem on 
Circadian Pattern of lschemia During Daily Life 
Prakash C. Deedwania. For the Dilator XR lschemia Study Groups; 
VACCHCS, Fresno, CA; UCSF School of Medicine, San Francisco, CA, USA 
Significant controversy surrounds the use of calcium channel blockers (CCBs) 
in patients with CAD. Whereas it is evident that short-acting dihydropyridine 
CCBs may have deleterious effects in CAD patients, the CCBs with heart rate 
limiting effects are still used for treatment of patients with CAD and angina. 
However, the antiischemic efficacy of newer sustained-release preparations 
on the circadian pattern of ischemia during daily life has not been well defined. 
Accordingly, we examined the efficacy of sustained-release diltiazem (Dilicor 
XR, Rhone-Poulenc Rorer) by 48hour continuous ambulatory ECG monitor- 
ing (AEM) performed during daily activities in 120 patients with established 
CAD, stable angina, and ischemia (12 mini48 hr) during AEM. At baseline, 
there was an average of 11 ischemic episodes with an average duration of 
220 min per 48hour period. During treatment with Dilator (480 mg/qd), the 
number of ischemic episodes significantly decreased from 11 to 5.7 (48%$, 
p < 0.0001). lschemia was completely suppressed in 42% of patients. The 
hourly evaluation of ischemic activity revealed greatest efficacy of diltiazem 
in suppressing ischemia during the morning hours (6 am to noon) and noon 
to 6 pm (both p < 0.001 compared to baseline). We also evaluated the ef- 
fects of diltiazem on heart rate (HR) by comparing hourly HR at baseline and 
end of the study. Although diltiazem significantly reduced HR throughout the 
monitoring period, the effect was most pronounced between 6 am and 6 pm. 
Conclusion: Sustained-release diltiazem is effective in suppressing is- 
chemia, especially during the daytime (6 am to 6 pm) period. These antiis- 
chemic effects correlated with reduction in HR. These data suggest CCBs 
with heart rate limiting effects are effective antiischemic agents in patients 
with CAD who are at risk of ischemia during daily life. 
/ 1196-l 06 1 A *O’Tl Scintigraphic Evidence of 
Trimetazidine-Mediated improvement of 
Coronary Microcirculation in Patients With 
Chronic Stable Angina 
Enrico Di Girolamo, Fulvio Potere, Cesare Di lorio, Panfilo Sabatini, 
Luigi Leonzio, Antonio Barsotti. Cardiosurgical Department, Chiefi, ltaly 
Background: Trimetazidine improves myocardial metabolism by inhibition 
of fatty acids’ B-oxidation and reciprocal activation of piruvate oxidation, thus 
reducing the production and accumulation of H’ and lactate during ischemia. 
The aim of the study was to assess, by exercise stress 201TI scintigraphy, 
whether trimetazidine could improve myocardial microcirculation in patients 
with chronic stable coronary artery disease. 
Methods: Twenty-nine consecutive patients (20 male, 9 female; mean 
age was 57.3 rt 12.4 years) with chronic stable angina and in whom revaseu- 
larization procedures were either contraindicated or refused were referred for 
study. Each of the patients underwent baseline exercise stress *aiT scintig- 
raphy. were given 60 mg daily trimetazidine added to standard anti-ischemic 
therapies and underwent repeat soiT scintigraphy after two months. The 
extension of reverse 201TI accumulation defect was evaluated by an image 
analysis software. 
Results: Baseline nuclear imaging showed a mean reverse *oiTI defect 
of 24.7 i 11.6%. At test repeat after two months of trimetazidine therapy, a 
significant reduction of defect to 16.9 f 7.8% was observed (-31.4 + 11.8%, 
p = 0.0032). Moreover, in 17 patients (70.8%) a significant improvement of 
the ischemic threshold was obtained. Side effects were negligible. 
Conclusions: Trimetazidine w,as found to significantly improve myocar- 
dial microcirculation in patients with chronic stable coronary artery disease. 
The reduced production and accumulation of osmotic catabolites during is- 
chemia may result in a minor cell swelling and extravascular compression 
on the coronary microvascular network. Furthermore, we should not exclude 
some direct effects of trimetazidine on the endothelial homeostasis and bal- 
ance between vasoconstrictor and vasodilator agents. 
1196-I 07 Troglitazone Improves Endothelial and Exercise 
Performance in Patients With Coronary Artery 
Disease 
Tatsuaki Murakami, Sumio Mizuno, Yoshiyuki Arai, Masateru Ohnaka. Fukui 
Cardiovascular Center, Fukui, Japan 
Background: No prior investigation evaluated impacts of troglitazone, an 
insulin sensitizer, on clinical manifestations of ischemic heart disease. This 
study aimed to investigate whether troglitazone has impacts upon clinical 
manifestations of coronary artery disease. 
Methods: We administered troglitazone for four months in diabetic pa- 
tients with angiographically documented coronary artery disease and is- 
chemic change on treadmill exercise test (T-group, n = 9). At baseline and 
at four months after medication, we assessed changes of exercise toler- 
ance (appearance time of ischemic ST segment change) and non-invasively 
measured the reactive changes in lumen diameter of right brachial artery 
following transient occlusion for five minutes (FMD; flow-mediated endothe- 
lium-dependent vasodilation), and after sublingual administration of (300 Fg) 
glyceril trinitrate (NTG; endothelium-independent vasodilation). Nine diabetic 
patients with angiographically documented coronary artery disease and is- 
chemic change on treadmill exercise test and followed without troglitazone, 
served as control subjects into this study (C-group). 
Results: Exercise time (minutos) were significantly extended after medi- 
cation in T-group (p < 0.01) but not in C-group. FMD was improved after med- 
ication in T-group (p < 0.01) but not in C-group. NTG remained unchanged 
in both groups. Extension of exercise time was correlated to improvement of 
FMD (Extension of exercise time (y) vs. improvement of FMD (x); y = 0.72 + 
0.23x, r = 0.79, p = 0.03). 
Baseline T Follow-up T Baseline C Follow-up C 
Exercise Time 5.Oil.O 6.4 zt 1.5 5.1 * 1.2 5.3i 1.4 
FMD 3.9 dz 1.6% 6.7 zt 3.0% 4.2 zlz 2.6% 4.4 + 2.0% 
Conclusion: These findings suggest that troglitazone reverses exercise 
intolerance linked with arterial endothelial dysfunction in patients with coro- 
nary artery disease. 
L--.LL 1196 108 Superiority of Clopidogrel Versus Aspirin in Patients With a History of Diabetes Mellitus 
Deepak L. Bhatt, Steven P. Marso, Alan T. Hirsch, Peter Ringleb, 
Werner Hacke, Eric J. Topol. Cleveland C/inic, C/eve/and, Ohio, USA 
Background: Following an ischemic event, diabetic patients have a high rate 
of recurrence. We sought to determine whether the ADP receptor antagonist 
clopidogrel would be more efficacious than aspirin in preventing ischemic 
events in diabetic patients with atherosclerosis. 
Methods: Without any double counting of events, the rates of vascular 
death, MI, all-cause stroke, and rehospitalization for ischemic events (angina, 
transient ischemic attack, limb ischemia) or for bleeding were determined for 
3866 diabetic patients randomized to either clopidogrel or aspirin in the 
CAPRIE study. 
Results: The event rate per year was 12.7% in the 7594 non-diabetic 
patients randomized to aspirin and 11.8% in the 7639 non-diabetic patients 
randomized to clopidogrel, p = 0.096. The event rate per year was 17.7% 
in the 1952 diabetic patients randomized to aspirin and 15.6% in the 1914 
diabetic patients randomized to clopidogrel, p = 0.042. The absolute risk 
reduction was even greater in diabetic patients receiving insulin, from a 
215% event rate per year with aspirin to 17.7% with clopidogrel, p = 0.106. 
While the absolute risk reduction was larger in the diabetic patients due to 
their higher event rates, the relative risk reduction achieved with clopidogrel 
was similar in diabetics and non-diabetics (12.5% versus 6.1%, p value for 
interaction = 0.361). In a multivariate model incorporating baseline clinical 
characteristics, clopidogrel therapy was independently associated with a 
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decrease in vascular death, MI, stroke, and rehospitalization for ischemia or 
bleeding in diabetic patients, p = 0.032. 
Conclusion: Clopidogrel is especially potent in reducing the elevated risk 
for recurrent ischemic events in diabetic patients with a history of vascular 
disease. 
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I 908 1 Elevated Levels of D-Dimer in Patients With Unstable Angina Predict Higher Risk of Thrombotic 
Complications 
Carlos Aguiar, Jorge Ferreira, Miguel Ribeiro, Isabel Freire, Teresa Gago, 
Ricardo Seabra-Gomes. Santa Cruz Hospital, Camaxide, Portugal 
Background: An elevated concentration of D-dimer, a degradation product 
of heightened fibrinolysis, may reflect increased fibrin turnover as in ongoing 
thrombosis. Since thrombosis plays an important role in the pathogenesis 
of acute coronary syndromes, we evaluated the prognostic value of D-dimer 
levels in patients with unstable angina. 
Methods: 54 patients hospitalized for Braunwald class IIIB unstable 
angina and not presenting co-morbid conditions known to increase D-direct 
levels were prospectively studied. D-dimer was measured on admission using 
a quantitative fibrin-specific ELISA. Endpoint was death, non-fatal myocardial 
infarction or severe recurrent ischemia, whichever occurred first by 30 days 
follow-up. We determined the effect of baseline variables (demographics, 
risk factors, previous history of myocardial infarction or revascularization, 
electrocardiographic changes on admission, cardiac troponin I and D-dimer) 
on endpoint rate and the effect of D-dimer level on time to endpoint. 
Results: Elevated levels of D-dimer were present in 17 (31.5%) patients 
and were the only baseline variable associated with a significantly higher 
30-day event rate (relative risk 2.57; 95% Cl 1.47, 4.51; p = 0.004). Kaplan- 
Meier event-free survival curves for D-dimer top risk tercile (T3 2 490 rig/ml) 
and the lower 2 risk terciles (Tl + T2) are shown in the figure. 
Conclusion: In a population of patients with unstable angina, D-dimer 
assay identified those with higher risk of thrombotic complications and who 
may benefit from more aggressive therapies. 
lo:45 a.m. 
Prior Peripheral Vascular Disease and 
Cerebrovascular Disease are Independent 
Predictors of Increased 1 Year Mortality in Patients 
With Acute Coronary Syndromes: Results From 
OPUS-TIM1 16 
Gad Cotter, Christopher P. Cannon, Carolyn H. McCabe, 
Andrew Charlesworth, A. Caspi, Eugene Braunwald. Assaf-Harofeh Medical 
Center, Tel Aviv, lsraef; Brigham and Women’s Hospital, Boston, MA, USA 
Background: Peripheral vascular disease (PVD) and cerebrovascular dis- 
ease (CVAITIA) frequently coexist in patients with coronary artery disease, 
and recent data from the CAPRIE trial of stabilized patients suggests they 
are at increased risk of death. 
Methods: We examined this relationship in 10,269 patients with acute 
coronary syndromes in the OPUS-TIM1 16 trial of orbofiban plus aspirin vs. 
aspirin alone. We evaluated mortality, composite events (Death, MI, recurrent 
ischemia, or stroke) and stroke, and used multivariate analysis to control for 
differences in baseline characteristics. 
Results: Patients with prior PVD or CVAI’TIA were older, had more fre- 
quent evidence of prior coronary disease (Ml, angina, coronary bypass 
surgery) and coronary risk factors. One year outcomes are shown (each 
univariate p i 0.0001) 
1 year 
events 
Death 
Composite 
PVDI 
CVAiTlA 
(N = 1169) 
7.4 
29.0 
No PVDI 
CVAfTIA 
(N = 9100) 
3.5 
19.6 
MV Odds 
Ratio 
1.44 
1.21 
P value 
0.0045 
0.0035 
Strokes were also higher in patients with prior PVDICVMIA (1.8% vs. 
0.8% p = 0.0007). Evaluating number of vascular beds with disease, mortality 
increased from 3.5% for only coronary, 6.7% for either PVD or CVA/TIA and 
12.1 for all three vascular beds (p < 0.0001). Orbofiban did not lead to a 
reduction in events. 
Conclusions: Patients presenting with acute coronary syndromes who 
have prior PVD or CVWIA are at increased risk of death, recurrent ischemic 
events and stroke. Quickly evaluating the “burden of vascular disease” can 
help risk stratify patients with ACS. Our data also suggest the need for more 
effective therapies targeted at this group of patients with diffuse vascular 
disease. 
11:OO a.m. 
908-S Recurrent lschemia During Continuous Multilead 
ECG-lschemia Monitoring Identifies Patients With 
Unstable Angina at High Risk of Subsequent 
Cardiac Events. Meta-Analysis of Three Studies 
Involving 995 Patients 
Martijn Akkerhuis, Peter A.J. Klootwijk, Simon Meij, Wietze Lindeboom, 
Maarten L. Simoons. Thoraxcenter, Erasmus University: Rotterdam; 
Cardialysis By Rotterdam, The Netherlands 
Background: Recurrent ischemia detected by continuous ECG monitor- 
ing in patients (pts) with unstable angina has been reported to carry an 
increased risk of unfavorable outcome. Computer-assisted continuous multi- 
lead ECG-ischemia monitoring offers an accurate continuous real-time mea- 
surement of the QRS-complex and ST-segment. 
Purpose: We aimed to provide a more accurate assessment of the 
impact of recurrent ischemia detected by continuous multilead ST-segment 
monitoring on the occurrence of death and Ml in pts with unstable angina. 
Methods: For that purpose, we performed a meta-analysis involving ST- 
monitoring data of 995 pts enrolled in three different studies on GP llbillla 
inhibition in unstable angina (CAPTURE, PURSUIT, FROST). Pts were mon- 
itored for the first 24 h after enrollment with a computer-assisted IP-lead 
or vectorcardiographic ECG-ischemia monitoring device. In a retrospective, 
blinded analysis, recurrent ischemic episodes were identified by a computer 
algorithm. The relationship between recurrent ischemia and mortality as well 
as the composite of death or Ml at 30 days was evaluated after multivariable 
adjustment. 
Results: Mortality at 30 days was 2.2%. The composite of death or Ml had 
occurred in 86 pts (8.6%) after the 30-day follow-up period. After multivariable 
adjustment, the presence of ‘2 recurrent ischemic episodes was significantly 
associated with an increased risk of mortality as well as death or Ml (Figure). 
Odds ratio plot with 95%CI for adverse outcome 
in Dts with 2 2 wisodes of recurrent ischemia OR 95%CI p-value 
30 days Death I 3.5 (1.3,9.5) 0.01 
Death or MI 2.1 (1.2, 3.9) 0.01 
/ 
0.1 1 10 
Odds ratio plot with 95%CI for adverse outcome in pts with ~2 episodes of recurrent 
ischemia. 
Conclusion: In pts treated for unstable angina, the profound impact of 
recurrent ischemia on survival and the incidence of Ml emphasizes the need 
for integration of continuous multilead ECG-ischemia monitoring systems in 
coronary care units and emergency wards to identify pts at increased risk of 
an unfavorable outcome who may benefit from more intensive antithrombotic 
therapy or revascularization. 
11:15 a.m. 
908-4 Quantitative Electrocardiographic Variables Predict 
Adverse Outcomes in Non-ST Elevation Acute 
Coronary Syndromes: Results From GUSTO Ilb 
Mauricio G. Cohen, Michael P. Hudson, Christopher B. Granger, David 
F. Kong, Laura H. Gardner, Galen S. Wagner, Robert M. Califf, 
Stefano Savonitto, Eric J. Topol. Duke Clinical Research lnsfifute, Durham, 
NC; Cleveland Clinic, Cleveland, OH, USA; Ospedale Niguarda Ca Granda, 
Milano, Italy 
Background: Non-ST elevation acute coronary syndromes (ACS) comprise 
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a spectrum of ischemic manifestations with widely varying prognoses. Simple 
ECG variables have been found to identify patients at increased risk for 
adverse outcomes, 
Methods: To determine the prognostic value of quantitative analysis of 
core laboratory ECG data, we analyzed 6773 patients with non-ST elevation 
ACS enrolled in GUSTO Ilb, an international randomized comparison of 
hirudin vs. heparin. 
Results: Predictors of 30-day death and myocardial infarction were as 
follows: 
Variable X2 OR (95% Cl) P value 
# ofleadswith ST 4 >l mm 63.4 1.11 (1.08-1.15) 0.0001 
Sumof STJ. 62.6 1.07(1.06-1.09) 0.0001 
Bundle branch block 14.2 1.51 (1.08-2.05) 0.0002 
Rate (per 20 bpm increase) 14.1 1.20(1.09-1.32) 0.0002 
QRS duration (msec) 12.0 Non-linear effect 0.002 
T-wave inversion 2 1 mm 0.97 1.12 (0.90-1.42) 0.33 
# ofleadswith Qwaves 0.60 1.03 (0.95-1.111 0.44 
Conclusions: In patients with ACS, extent of ST &, presence of bun- 
dle branch block, increased heart rate, and QRS duration ill the admission 
ECG are significant predictors for adverse outcomes. The relationship be- 
tween baseline quantitative ECG variables, clinical variables, and short- and 
long-term outcomes need further multivariable analysis. 
II:30 a.m. 
I 908 5 , Early and Striking Mortality Reduction After Acute 
Coronary Syndromes Following Lipid Lowering 
Therapy 
Herbert D. Aronow, Matthew T. Roe, Michael S. Lauer, Penny 
S, Houghtaling, A. Michael Lincoff, Robert A. Harrington, Robert M. Califf, 
Eric J. Topol. C/eve/and Clinic Foundation, C/eve/and, OH, USA 
Background: Lipid lowering agents (LLA) reduce mortality in patients with 
stable coronary syndromes. However, the potential benefit of LLA following 
acute coronary syndromes (ACS) has not been well characterized. 
Methods: We compared 6-month mortality among patients from the 
PURSUIT trial with non-ST-elevation ACS who were discharged following 
the initial hospitalization on LLA (n = 2141) to those who were not (n = 
6374). A propensity analysis was used to match patients on the probability 
of receiving a LLA. The resulting propensity score was entered into a Cox 
model. 
Results: Overall, there were 354 deaths through 6 months. Treatment 
with LLA was associated with reduced incidence of death at 6 months [Fig- 
ure]. After adjusting for age, gender, hyperlipidemia, heart failure, medica- 
tions, baseline ECG and other possible confounders, treatment with LLA was 
associated with a markedly reduced risk of 6 month mortality (Risk Ratio = 
0.47, 95% Cl 0.32-0.70), p = 0.0002). 
Conclusion: This is the first study to link LLA therapy with a significant 
reduction in early mortality following an ACS. 
11:45 a.m. 
IILl. 908 6 Activated Protein C Resistance and Von Willebrand 
Factor are Useful Markers for 1 Year Mortality After 
Acute Coronary Syndromes 
Rosa-Maria Lid&, Jaume Figueras, Anna Angles, Cristina Moure, 
Teresa Escude, Elisabeth Gallart, Jordi Soler-Soler. Hospital General Vail 
d’Hebron, Barcelona, Spain 
Background: It has been hypothesized that activation of coagulation system 
may persist after an acute coronary syndrome (ACS) but its relation with 
one year mortality is unclear. We analyzed the 1 year prognostic value of 
resistance to activated Protein C (APCr) and von Willebrand factor (vWF) in 
214 patients with ACS treated with aspirin. 
Methods: Plasma concentrations of APCr expressed as ratio and vWF 
expressed as % were analyzed at hospital discharge and at 3 months. 
Patients treated with oral anticoagulants or who had been revascularized 
during the preceding 6 months were excluded 
Results: During a 13 & 3 months follow-up 12 patients died of a cardiac 
cause. At hospital discharge APCr values were lower in nonsurvivors than 
in survivors (0.83 f 0.1 vs 1.0 f 0.1, p < 0.001) and at 3 months, values 
remained lower in the 6 patients who died beyond this period (0.88 & 0.1 
vs 1.01 i 0.1, p = 0.02). Also, vWF values at discharge were higher in 
non survivors than in survivors (299 i 94 vs 249 f 87%, p = ns) and the 
difference at 3 months reached statistical significance (276 & 82 vs 210 * 
78%, p = 0.04) 
Conclusion: The fact that in non survivors APCr values are persistently 
reduced during at least the first 3 months after discharge and vWF remains 
increased suggest that coagulation derangements may contribute to mortality 
in the follow-up of patients with ACS. 
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